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Abstract  
The purpose of this thesis was to explore the nature of Eating Disorders in Type 1 Diabetes. 
Whether or not Eating Disorders are more prevalent in this demographic is a topic of 
contention but regardless there is a consensus that those with comorbid Type 1 have 
considerably worse outcomes and are significantly more difficult to treat. It has been argued 
that this may be due to a feature unique to this population; insulin omission for weight 
control.  
The first aim of this thesis was to systematically review how Eating Disorders have been 
measured in Type 1 Diabetes, paying particular attention to whether researchers have taken 
the role of Diabetes regimen and insulin omission into account. Following this a comparison 
between two Eating Disorder scales, one Diabetes specific the other not, was made in order 
to compare prevalence rates, to explore which items may be potentially biased and to 
investigate what the effect of modification may be. The structure of the Diabetes specific 
scale (the Diabetes Eating Problem Scale Revised) was then explored 
The second aim of this thesis was to replicate a pilot study that aimed to explore demographic, 
psychological and health seeking features of those with Type 1 Diabetes related Eating 
Disorders. This formed the basis of a structural model whereby psychological and Diabetes 
specific traits were hypothesised to predict Eating Disorder behaviour and elevated blood 
glucose levels. A questionnaire built for that study regarding patient attributions was also 
reanalysed using new data.  
The final aim was to investigate how Eating Disorders in Type 1 Diabetes have been 
treated by reviewing literature from the last 2 decades, paying particular attention as to how 
treatment providers have accommodated the unique needs of those with T1D and whether 
or not programmes have been successful in relation to both psychological and biological 
outcomes.   
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1 Introduction: Eating Disorders including Insulin Omission for Weight Loss in 
those with Type 1 Diabetes    
1.1 History 
Diabetes is a dreadful affliction, not very frequent among men, being a melting 
down of the flesh and limbs into urine. The patients never stop making water and 
the flow is incessant, like the opening of aqueducts. Life is short, unpleasant and 
painful, thirst unquenchable, drinking excessive, and disproportionate to the large 
quantity of urine, for yet more is urine passed. One cannot stop them either from 
drinking or making water… If for a while they abstain from drinking, their 
mouths become parched and their bodies dry; the viscera seem scorched up, the 
patients are affected by nausea, restlessness and a burning thirst, and within a 
short time they expire. (quoted from Poretsky 2010, p. 20) 
The above is deemed to be the first clinical description of what we now recognise as Type 1 
Diabetes Mellitus (T1D). It comes from the physician Aretaues of Cappadocia, a close 
contemporary of Hippocrates, and dates to the end of the Hellenistic period (Medvei, 1993). 
Although earlier descriptions of specific related symptoms had appeared in Ancient Egypt 
(via the Ebers papyrus) as early as 1550BCE and the term Diabetes had been used by 
Apollonius of Memphis after the Greek verb διαβαίνω (diabaino) meaning literally: to run 
through (Papaspruos, 1964) Aretaues was the first to identify the syndrome as a whole. The 
suffix ‘Mellitus’ from the Greek meaning ‘sweet like honey’ to reflect the sugary smell 
detected via the urine, was added by Thomas Willis when he dedicated a chapter of his book 
to ‘The Pissing Evil’ (Willis, 1694). The term was solidified by the Scottish military surgeon 
John Rollo in his 1797 work titled An Account of Two Cases of the Diabetes Mellitus.  
By the 19th century T1D had a clinical description if not an understanding of aetiology. Those 
from antiquity had hypothesised that the lungs, the blood and the kidneys among others were 
to blame for the disease and treatment suggestions ranged from enemas, goats cheese and 
rice to cataplasms and the much extolled ancient remedy Theria (Karamanou, Protogerou, 
Tsoucalas, Androutsos, & Poulakou-Rebelakou, 2016). None of these would be successful. 
This was to change mid-century with the discovery that removing the pancreas in canines 
provoked diabetic symptomology. After returning pancreatic tissues via grafting the dogs 
returned to their normal state suggesting that the pancreas was the organ most likely to be 
critical.  Further research undertaken in the latter part of the 1800s showed that pancreatic 
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formulations injected in to pancreatectomised dogs lowered their blood sugar (Karamanou et 
al., 2016). This formulation was initially given the name ‘Isleton’, later changed to ‘Insulin’. 
These experiments led to the first injection of insulin using a human subject in 1922 by 
Frederick Banting and Charles Best, saving the young boy’s life and earning the research 
teams involved a Nobel Prize (Bliss ,1982) 
1.2 Aetiology 
Nearly a century has passed since insulin treatment saved sufferers from what was previously 
a terminal illness and much more about this ‘dreadful affliction’ is understood. T1D is an 
autoimmune disorder whereby the body mistakenly attacks the insulin producing beta cells 
of the pancreas until they are destroyed leaving the patient unable to process carbohydrate. 
The absence of insulin leads to accumulating glucose in the bloodstream which if left 
untreated is eventually fatal. The exact aetiology of T1D is still the subject of worldwide 
study. Genetic factors have been suggested, in particular the high risk genotypes DR3/4 -
DQ8 or DR4/DR4. Lifetime prevalence in probands is estimated to be around 6% (15 times 
the risk compared to the normal population) and concordance in monozygotic twins is more 
than 60% over the lifetime. Those with fathers who have the illness are also more at risk than 
those whose mothers do (Steck & Rewers, 2011). Certain viruses have been implicated. 
Enteroviruses such as the Coxsackie B are known to infect and inflame the beta cells of the 
pancreas which may lead to autoimmunity. Congenital Rubella Syndrome has also been 
positively associated with T1D development (Filippi & von Herrath, 2008). Environmental 
factors may also prove important. Studies in migrant populations have shown that prevalence 
concords to the host country rather than that of origin (Bodansky, Staines, Stephenson, Haigh 
& Cartwright, 1992). Children who have been exposed to crowds or who attended day care 
in infancy are also less likely to develop T1D. It is thought that this is due to immune system 
fortification via contact with potential antigens, also known as the hygiene hypothesis (Gale, 
2002).  There is even season of birth variation with children born in in the spring/summer 
more likely to develop T1D than those in the autumn/ winter, suggesting a role for prenatal 
exposure to vitamin D. There do not appear to be significant differences in gender (Maahs, 
West, Lawrence & Mayer-Davis, 2010). 
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1.3 Epidemiology 
Whatever the exact aetiology, the incidence of T1D globally is increasing at an estimated 
rate of between 2 – 5% per annum and this increase is particularly marked in infants under 5 
(Maahs et al., 2010). The disease is more common in western society and in Caucasians. The 
highest incidence of new diagnoses in children are in Europe (20 per 1000) followed by North 
America and the Caribbean (16.7 per 1000) (Patterson et al., 2014). Age of onset is most 
frequent between the ages of 10 – 14 (Maahs et al., 2010) but around 1 in 4 are diagnosed as 
adults (Patterson et al., 2009). In the UK there are an estimated 370,000 adults currently 
living with T1D, (NICE 2015) equating the prevalence to roughly 25 out of 100,000 
individuals. 
1.4 Treatment, Outcomes and Co-Morbidity 
For individuals with T1D insulin is essential for survival. Patients must attempt to mimic 
what the pancreas would do naturally by administering synthetic insulin into the body to 
regulate blood glucose levels. There are currently two main delivery methods for this, the 
first is multiple daily injections, whereby long acting insulin is injected to replicate a normal 
baseline in the blood and further short acting insulin is injected to cover any incoming 
carbohydrate or to correct elevated levels. The second method utilises an insulin pump which 
infuses constant rapid acting insulin subcutaneously and can be adjusted in real time in order 
to respond to meals or hypoglycaemia.  Both methods require the patient to pay close 
attention to their diet and many utilise a carbohydrate to insulin ratio in order to estimate 
medication needs. It is not just food, however, that affects blood glucose. Temperature 
changes (Koivisto, Fortney, Hendler & Felig, 1981), weight gain (Kilpatrick, Rigby & Atkin, 
2007), illness, infection, stress, hormonal changes (McDonnell & Umpierrez, 2012), 
injection technique, injection site and exercise (Binder, Lauritzen, Faber & Pramming, 1984) 
among many others things have been shown to affect glucose levels. This makes controlling 
T1D in everyday life more educated guess work than simple mathematics. There are high 
intra and inter - individual differences in how insulin absorbs and acts in the body which also 
vary temporally complicating successful management further (Heinemann, 2002). 
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Current guidelines suggest that those with T1D should keep their BG as close to that of non 
Diabetics as possible which is between 4 – 7 mmols and should aim for an HbA1c 
(glycosylated haemoglobin over 3 months) of 6.5% (NICE, 2015). In order to do this, those 
with T1D are advised to check their blood glucose between 4 – 10 times a day and take steps 
to rectify high or low levels, see a Diabetes specialist regularly, have annual checks for 
Diabetes related complications, follow an appropriate diet and attend structured education 
programmes (NICE, 2015). However, the difficulties involved in attempting to manually 
replicate such a complicated biological process means that two errors are common. 
Hypoglycaemia occurs when there is too much insulin in the blood and therefore not enough 
glucose in the brain leading to short term cognitive impairments and a biological response 
similar to ‘fight or flight’. If this is not treated with glucose in an immediate manner 
hypoglycaemia can result in coma and death. Conversely hyperglycaemia occurs when there 
is not enough insulin in circulation and therefore glucose cannot be removed from the blood.  
Initially this causes fatigue, polyuria and weight loss but will progress to life threatening 
Diabetic Ketoacidosis (DKA) if insulin is not administered. As the body is not receiving 
energy from food due to the absence of insulin, it turns to its own stores for fuel. The process 
of burning fat and tissue for energy produces ketones and turns the blood acidic. At this stage 
DKA becomes catastrophic, massive weight loss, Kussmaul breathing1, rapid dehydration, 
vomiting and cardiac trauma may further develop into multiple organ failure, coma and or 
death.  
Over the long term, hyperglycaemia is responsible for most complications arising from T1D. 
High blood glucose degrades almost every bodily system, but nerve damage is the most 
common complaint (Diabetes Control & Control Trial, 1993). This nerve damage takes 
several forms. In the stomach it hampers the passage of food through the digestive tract 
eventually resulting in gastroparesis, in the extremities peripheral neuropathy causes 
numbness or painful stinging sensations, in the eyes retinopathy occurs which may lead to 
                                                 
 
1 Kussmaul Breathing: low, shallow breathing caused by prolonged diabetic ketoacidosis (Kussmaul 
1874)  
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blindness, autonomic neuropathy can cause fainting and low blood pressure and nerve 
damage in the kidneys can advance to nephropathy. Having T1D is also a risk factor for 
cardio vascular disease and even with good control, mortality increases and life span is 
reduced significantly (Lind et al., 2014). Furthermore, as a systemic illness T1D often 
accompanies other chronic conditions with 33% of new cases in children presenting 
alongside other autoimmune diseases (Triolo et al., 2011).  Celiac Disease, Autoimmune 
Thyroid Disease (both hypo and hyper), Addison Disease, Vitiligo and Rheumatoid Arthritis 
are significantly more common in those with T1D than in the general population. In some 
cases, these conditions and the corresponding treatment may interfere with insulin action and 
BG metabolism further complicating successful T1D management (Franzese, Mozzillo, 
Nugnes, Falco & Fattorusso 2011). Currently only around a 3rd of UK based T1Ds manage 
to attain the HbA1c targets set by their care team and 15% have levels equivalent to more 
than 10% (Diabetes UK., 2016). 
1.5 Psychological and Social Implications  
Possibly unsurprisingly there are many psychological and social implications of living with 
such a relentless chronic illness. In fact, the needs are as such that the American Diabetes 
Association has produced a position statement suggesting Diabetic stages of development to 
accompany that of typical maturation. These stages include advice such as ‘reassuring the 
child that Diabetes is no-one’s fault’ and suggesting that treatment priorities include vigilance 
around weight and body image concerns (Please see table 1.1 below, Chiang, Kirkman, Laffel 
& Peters, 2014). None the less the evidence suggests that T1D is disadvantageous in a 
multitude of ways; educational attainment is reduced, school completion rates are lower and 
although there is some suggestion that psychological issues may ease with maturation, 
referral to mental health services are significantly more prevalent in this demographic 
(Dahlquist & Källén, 2007; Northam, Lin, Finch, Werther & Cameron, 2010). T1D also 
restricts access to particular careers such as those in the military and although the blanket ban 
from hiring those with T1D from emergency services in the UK has been lifted in lieu of 
individual health assessments (Diabetes UK, 2016b), these may still prove restrictive and 
disappointing to children and young people who may have had conflicting aspirations at the 
time of diagnosis. 
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Table 1.1: Major Developmental Issues and their Effects on Diabetes in Children and 
Adolescents replicated from Chiang, Kirkman, Laffel & Peters, 2014. 
Developmental Stages 
(Ages) 
Normal Developmental 
Tasks 
Type 1 Diabetes 
management priorities 
Family issues in Type 1 
Diabetes management 
Infancy (0 – 12 months) Developing a trusted 
relationship or bond 
with primary caregivers 
Preventing and treating 
hypoglycaemia 
Avoiding extreme 
fluctuations in blood 
glucose levels 
Coping with stress 
Sharing the burden of 
care to avoid parent 
burnout 
Toddlers (13 – 26 
months) 
Developing a sense of 
mastery and autonomy 
Preventing and treating 
hypoglycaemia 
Avoiding extreme 
fluctuations in blood 
glucose levels due to 
irregular food intake 
Establishing a schedule  
Managing the picky 
eater 
Limit setting and coping 
with toddler’s lack of 
cooperation with 
regimen 
Sharing the burden of 
care  
Preschool and early 
elementary school (3 – 7 
years) 
Developing initiative in 
activities and 
confidence in self 
Preventing 
hypoglycaemia  
Coping with 
unpredictable appetite 
and activity  
Positively reinforcing 
cooperation with 
regimen 
Trusting other 
caregivers with Diabetes 
management  
Reassuring the child 
that Diabetes is no – 
one’s fault  
Educating other 
caregivers about 
Diabetes management  
Older elementary school 
(8 – 11 years) 
Developing skills in 
athletic, cognitive 
artistic and social areas 
Consolidating self – 
esteem with respect to 
the peer group   
Making Diabetes 
regimen flexible to 
allow for participation 
in school or peer 
activities  
Child learning short and 
long-term benefits of 
optimal control  
Maintaining parental 
involvement in insulin 
and blood glucose 
management tasks while 
allowing for 
independent self – care 
for special occasions 
Continuing to educate 
school and other 
caregivers 
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Developmental Stages 
(Ages) 
Normal Developmental 
Tasks 
Type 1 Diabetes 
management priorities 
Family issues in Type 1 
Diabetes management 
Early adolescence (12 – 
15 years) 
Managing body changes 
Developing a strong self 
of self-identity  
Increasing insulin 
requirements during 
puberty 
Diabetes management 
and blood glucose 
control becoming more 
difficult  
Weight and body image 
concerns  
Renegotiating parent 
and teenager’s roles in 
Diabetes management to 
be acceptable to both  
Learning coping skills 
to enhance ability to 
self-manage  
Preventing and 
intervening in Diabetes 
related family conflict  
Monitoring for signs of 
depression, Eating 
Disorders and risky 
behaviours  
Later adolescence (15 – 
18 years) 
Establishing a sense of 
identity after high 
school (decisions about 
location, social issues, 
work and education) 
Starting an ongoing 
discussion about 
transition to a new 
Diabetes team 
(discussion may begin 
in earlier adolescent 
years)  
Integrating Diabetes 
into new lifestyle 
Supporting the 
transition to 
independence  
Learning coping skills 
to enhance ability to 
self-manage  
Preventing and 
intervening in Diabetes 
related family conflict  
Monitoring for signs of 
depression, Eating 
Disorders and risky 
behaviours 
 
Social relationships are also affected. T1D adolescents report less trust and intimacy with 
their romantic partners than controls (Jacobson et al., 1997). Romantic relationships are not 
the only ones that suffer. The family environment may have to adapt rapidly to cope with the 
diagnosis of a member and while it has been shown that increased parental involvement in 
T1D management relates to better BG levels (Schafer, McCaul & Glasgow, 1986) it may 
also lead to increased conflict (Miller-Johnson et al., 1994). The effect of diagnosis can be 
so overwhelming that in children and young people the risk of developing a psychiatric 
condition is threefold within the following six months and suicide attempts are significantly 
33 
 
more common than in controls (Butwicka, Frisén, Almqvist, Zethelius, & Lichtenstein, 
2015). 
Unfortunately, adults do not fare much better in terms of prognosis, (Bryden, Dunger, 
Mayou, Peveler & Neil, 2003). Both men and women with T1D are more likely to be 
unmarried, citing psychological pressures and job discrimination as contributory factors 
(Aono et al., 2000).  They also have higher rates of common mental disorders, in particular 
those related to anxiety and depression in comparison to controls (Das-Munshi et al., 2007). 
Adult, child or young person, most studies find that psychosocial problems are predictive of 
poorer blood glucose management (Hislop, Fegan, Schlaeppi, Duck, & Yeap., 2008; Bryden 
et al 2003; Kakleas, Kandyla, Karayianni, & Karavanaki, 2009; Das-Munshi et al., 2007). 
1.6 Type 1 Diabetes and Eating Disorders 
Of all the mental illnesses that have been suggested to be more prevalent in those with T1D, 
one is particularly prominent. Recent research suggests that by the age of 25, 60% of T1D 
females will have experienced a clinically significant Eating Disorder (ED) (Colton et al 
2015). Although at first glance this percentage may seem incredibly high, it is concordant 
with other research that suggests that around 40% of female T1Ds between the ages of 15 – 
30 deliberately induce hyperglycaemia and DKA in order to produce weight loss2, and that 
there is an increased risk of developing Anorexia and/or Bulimia. Although in males it was 
initially thought that EDs were not more prevalent in those with T1D more recent research 
suggests that this is not the case with insulin omission being reported in up to a quarter of 
male research respondents. It has also been shown that T1D males have a higher drive for 
thinness than their non diabetic counterparts (Rodin, Craven, Littlefield, Murray & Daneman, 
1991; Fairburn, Peveler, Davies, Mann & Mayou, 1991; Striegel-Moore, Nicholson & 
                                                 
 
2 As stated above when the body does not have sufficient amounts of insulin, glucose escapes into the 
blood and is excreted through the urine, this means that those calories are not absorbed. Furthermore, 
when hyperglycaemia evolves into DKA the body burns fat and tissue for energy that is no longer 
provided by food resulting in substantial weight loss. This practice is commonly known as 
‘Diabulimia’ (BBC, 2017) 
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Tamborlane, 1992; Polonsky et al., 1994; Peveler et al., 2005; Jones, Lawson, Daneman, 
Olmsted & Rodin, 2000; Markowitz et al., 2010; Svensson, Engström & Aman, 1992). 
There are substantial issues when 
investigating ED in T1D. T1D 
management requires the patient to think 
carefully and constantly about food, 
exercise and numbers. Getting insulin 
dosing wrong can have serious 
consequences. As such those with T1D 
may engage in food behaviour that to the 
uninitiated appear at best odd and a 
worst, disordered. For example, a meal 
may be skipped due to high blood 
glucose, a rigid feeding schedule may be 
utilised, a low carbohydrate diet may be employed, (cutting out a whole food group), both 
hyper and hypoglycaemic states promote hunger (and potentially bingeing especially in the 
impaired cognitive state which accompanies hypoglycaemia) and it is clinically 
recommended to keep records of what is being consumed. These actions, according to the 
National Eating Disorders Association (2018), are all behavioural signs of an ED.  
There are also specific aspects of Diabetes management that may promote ED behaviour. 
Fear of hypoglycaemia may lead to a patient reducing food intake and thus injections (Ishmail 
& Treasure., 2010; Rodin et al., 2009; Goebel-Fabbri et al., 2008). Given that food may be 
restricted this can lead to moralising and shaming which promotes ED like cognitions 
(Goebel-Fabbri, Uplinger, Gerken & Mangham., 2009; Tierney, Deaton, & Whitehead 
2009). Hypoglycaemia may trigger what is commonly seen in bulimia (a loss of control over 
eating) which may then promote inappropriate compensatory behaviours. (Criego, Crow & 
Goebel-Fabbri, 2009; Rodin et al., 2002).  Weight monitoring is also a standard requirement 
of T1D and may be commented on or discussed in clinic. Again then, the nature of T1D may 
maintain unhealthy cognitions related to food, numbers and weight. 
Figure 1.1: Young Girl with Type 1 Diabetes 
before and after Insulin Treatment. Reproduced 
from Polonsky (2012). 
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In regard to insulin behaviour, controversy occurs when defining insulin omission as an ED 
behaviour. The Diagnostic Statistical Manual has now included insulin omission under 
criteria for both Anorexia (AN) and Bulimia Nervosa (BN) but the habit of researchers has 
also been to classify it under Eating Disorder not Otherwise Specified (EDNOS) (Please see 
chapter 2). Although recent advances have ensured that HCPs should be aware of the 
behaviour in relation to EDs3 there is disagreement on how to treat insulin omission as an 
ED symptom. Clinical diagnoses are difficult, and often applied as a measure of BMI rather 
than symptomology. This is particularly problematic for the patients themselves who see 
insulin omission for weight loss or ‘Diabulimia’ as a distinct, unique and incomparable 
illness. They also find that standard ED approaches which focus on relaxing food rules and 
not counting calories are incompatible with successful T1D management. (Hastings, 
McNamara, Allan, & Marriott 2016; MacDonald et al 2018; Staite et al 2018; Allan 20154).  
The issues above may help explain why standard screening measures are problematic when 
used in this population. Instruments may be over – sensitive to the eating behaviours that 
accompany hyper and hypoglycaemia and may completely exclude the mechanisms of 
insulin omission (Powers et al., 2012), for example; bingeing after a hypo or restricting food 
due to a hyper may be misattributed to an ED rather than the treatment for problematic BG. 
These misconceptions may also help explain why those with T1D appear to be much more 
resistant to standard ED treatment, have much worse clinical outcomes relating to recovery 
and drop out of treatment at much higher rates (please see chapter 8). Furthermore, the 
majority of programmes which have attempted to improve outcomes for those with T1ED 
have had no success in reducing HbA1c (please see chapter 8).  
This is disturbing as those with T1ED face devastating physical consequences. Goebel-
Fabbri et al. (2008) found that insulin restriction at baseline was associated with a threefold 
risk of mortality at 11 year follow up. Insulin omitters also had a much-reduced mean age of 
                                                 
 
3 Please Appendix A for commentary on the 2017 Nice Guidelines by the researcher 
4 Please see Appendices B - E for copies of these articles which were either authored or co-authored 
by the researcher 
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death (45 years vs 58 years). Nephropathy, Neuropathy and Retinopathy are also much more 
common among those with T1ED and the onset of complications was much earlier in life. 
(Goebel – Fabbri et al., 2008; Rydall, Rodin, Olmsted, Devenyi & Daneman, 1997) 
1.7 The Current Study  
The purpose of the current thesis is to explore several aspects related to EDs in T1D (T1EDs) 
Study 1: Given the wildly variating estimates of both clinical EDs, Disturbed Eating 
Behaviour (DEB) and insulin omission in the T1D population a systematic review was 
undertaken to investigate what instruments have been used to make assumptions, whether or 
not they take Diabetes regimen into consideration, what diagnoses or cut-off points they 
utilise, how insulin omission is measured, what the prevalence of insulin omission is and 
what the difference is in prevalence estimates between the scales used.  
Study 2: The purpose of study 2 was to compare 2 popularly used ED scales, the Eating 
Attitudes 26 (EAT-26) item which is not Diabetes specific and the Diabetes Eating Problem 
Survey Revised (DEPS-R) which is Diabetes specific using a large cross sectional sample of 
individuals with T1D. This study compared rates of those screening as clinically concerning, 
investigated a potential subscale in the DEPS-R relating to insulin omission and modified the 
EAT-26 by consulting experts in the field as to items which may be biased by aspects of T1D 
rather than relate directly to ED symptomology. It also aimed to explore the factor structure 
of the DEPS-R questionnaire.  
An exploratory pilot study was undertaken by the researcher in 2013, in partial fulfilment of 
a BSc Psychology degree, in order to ascertain certain characteristics of those with T1D 
Diabetes who self-identified as having recovered from an Eating Disorder. The three primary 
aims of the study were to investigate psychiatric co-morbidity, to build a clinical profile of 
the participants and to create a questionnaire based on a literature search for suggestions as 
to why those with T1D were at a higher risk of Eating Disorders. This questionnaire (40 
items) was then subjected to a exploratory factor analysis in order to reveal underlying latent 
variables that patients attributed to the development of their Eating Disorder. The study 
which included 98 participants (96 female) found high levels of psychiatric comorbidity. The 
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40 item questionnaire suggested a five factor solution These factors related to specific 
Diabetes distress, Diabetes diet, classic risk factors, self-esteem and family communication 
and negative attention5.  
Study 3: The purpose of study 3 was to use a large cross-sectional sample of T1Ds and several 
psychometric scales in order to ascertain if there were relationships between psychological 
and demographic factors and Diabetes specific ED symptomology and glucose control. In 
order to do this the Diabetes Eating Problem Survey Revised and HbA1c were employed as 
outcome measures. Structural Equational Modelling was utilised as the methodology. 
Psychometric and demographic variables were chosen as they related to the published 
literature and the pilot study.  
Study 4: Study 4 was a replication of the factor analysis undertaken as part of the pilot study. 
The initial study only utilised those who had been in recovery for a period of no less than 2 
years and thus attributions may have been biased in favour of retrospection. As such a sample 
containing both those who have recovered and those still suffering was utilised to yield a 
more valid attribution model which could also be subjected to a confirmatory procedure. The 
study also collected data on health seeking behaviour, co-morbid mental health diagnoses, 
clinical ED diagnoses and what participants thought their ED diagnosis should have been.  
Study 5: The purpose of study 5 was to provide a brief literature review of treatment 
programmes that have been used in those with T1ED and provide a critical analysis given 
the results already reported in this thesis.  
  
                                                 
 
5 The pilot study is provided in Appendix F and parts of the results were published in Appendix E 
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2 Eating Disorders and Insulin Omission for Weight Loss in those with Type 1 
Diabetes: A Systematic Review 
2.1 Introduction  
Eating Disorders in those with Type 1 Diabetes has been a subject of interest since reports of 
individuals with concurrent Anorexia and T1D started appearing in journals in the 1950s 
(Chimenes, 1955). Initially these cases were viewed as somewhat of an oddity, a rare 
combination that should provoke little clinical concern as the comorbidity was not associated 
with degradation of BG management (Crisp, 1978). However, disagreeing case reports 
emerged in the 1980s suggesting that EDs in the presence of T1D may represent a significant 
issue capable of producing ‘dire consequences’ (Roland & Bhanji 1982, p.1). The issue began 
to attract wider attention with a number of articles appearing that also warned of the impact 
including Bulimia and Diabetes: a potentially life-threatening combination (Hillard, Lobo, 
& Keeling, 1983) and Bulimia, anorexia nervosa, and Diabetes. Deadly combinations 
(Hillard & Hillard, 1984). The initial results painted a bleak picture, Rodin et al. (1985) in 
the first systematic study on the subject, suggested that in T1D adolescents, Anorexia and 
subthreshold variants thereof were present in 8.7% of the sample representing a 6 fold 
increase compared to the non T1D population while Bulimia and subthreshold syndromes 
were present in 10.8%, representing a two fold increase. Reading this paper with a 
contemporary understanding of issues in researching this population however foreshadows 
many of the problems still apparent; insulin omission for weight control is not mentioned, 
the instruments used (EAT-26, EDI) are not modified in any way to accommodate T1D 
regimen effects, the follow up clinical interview does not appear to have been modified either 
and the sample size is arguably too small to make meaningful conclusions. 
The state of research into T1ED currently faces similar challenges. Methods of reporting vary 
widely, diagnoses of clinical, subclinical, Disordered Eating Behaviour (DEB) and the role 
of insulin omission is still contentious and sample sizes are often small. While some studies 
use self-report questionnaires and suggested cut-off points for further examination, others 
use clinical or semi-structured interviews. The issues of using self-report measures are well 
documented with issues such as validity, bias, reporting errors and boredom effects (for a 
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review please see Gerald & George, 2010) and as such the clinical interview is deemed the 
gold standard of diagnostic procedures. However, the use of interviews can be costly, timely 
and resource intensive, whereas self-reports offer a quicker, cheaper and easier to disseminate 
option. Plus, interviews are not free of issues; a working understanding of the needs of certain 
populations must be known to the questioner or demographic specific aspects (such as insulin 
omission) may stay uncovered, furthermore participants may be less willing to admit 
behaviours to an interviewer (d’Emden et al., 2012; Sevenson et al., 2003). 
Eating Disorder research utilises both self-report and interview data in order to describe 
patterns of cognition and behaviour related to the illness. While some offer the potential of 
clinical diagnosis others rely on cut-off points which indicate the need for further assessment. 
While instruments such as the Eating Attitudes Test (Garner & Garfinkel, 1979) or the Eating 
Disorders Examination Questionnaire (Fairburn & Beglin, 1994) or any other number of 
instruments may be entirely suitable for measuring ED symptomology in the general 
population, the nature of T1D has not been taken into account in many studies employing 
these measures in this population. As stated in the introduction, for example, many T1Ds 
deliberately employ a low carbohydrate diet thus avoiding whole food groups and utilise diet 
products which has been shown to improve blood glucose control (Brand-Miller, Hayne, 
Petocz & Colagiuri, 2003). Hypo and hyperglycaemic states promote biological hunger and 
in the case of hypoglycaemia can lead to eating which is out of control (Daneman et al., 2006) 
and potentially shame inducing as an indication of failure to adhere to Diabetes regimen 
(Sparud, Lundin, Öhrn, & Danielson, 2010).  Blood glucose concerns mean that patients may 
avoid a meal or have the outward appearance of adopting ‘strange’ eating patterns and it 
could be argued that the very nature of T1D creates an environment where a patient is reliant 
on being preoccupied with food. This is problematic in research which utilises instruments 
that deem these sorts of behaviours as indicative of an ED. 
In T1EDs, diagnostic problems are also apparent.  One of the main issues of contention is 
whether insulin omission for weight loss purposes is included as a feature of an ED.  In order 
to explain these issues further it is necessary to look at how changing definitions in the 
Diagnostic Statistical Manual (DSM) have affected the diagnostic criteria for Eating 
Disorders and the role of insulin omission within them.  The DSM III (1980) has no mention 
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of insulin omission in the guidelines for EDs and neither does the revised version (1987). 
Insulin omission is first mentioned in the ED section in the DSM IV (1994) within the notes 
for Bulimia, the same is published in the DSM IV revised (2000):     
 Individuals with Diabetes mellitus and bulimia nervosa may omit or reduce 
insulin doses in order to reduce the metabolism of food consumed during eating 
binges. (p. 546)  
Insulin omission may be viewed as a form of purging within the Bulimia framework. In its 
most recent incarnation, the DSM V ( 2013) insulin omission is included as a clinical feature 
of both Anorexia and Bulimia. While the section in Bulimia remain identical, in the clinical 
features of Anorexia the following is written:  
Individuals with anorexia nervosa may misuse medications, such as by 
manipulating dosage, in order to achieve weight loss or avoid weight gain. 
Individuals with Diabetes mellitus may omit or reduce insulin doses in order to 
minimize carbohydrate metabolism (p. 376) 
The changing status of insulin omission is significant and may contribute to the widely 
fluctuating estimates in prevalence of EDs in this demographic. Further problems are 
revealed when asking how some with T1ED for whom insulin omission is the main weight 
loss mechanism, would actually be diagnosed with an ED as Allan and Nash (2014) state:  
Under these diagnostic criteria, one may ask: “what is the difference between 
people with Diabetes and anorexia and those with Diabetes and bulimia?” 
Simply put, the answer is weight; however, determining Eating Disorder 
severity by weight is not relevant to people with type 1 Diabetes who omit 
insulin. The measure of severity for this demographic would more accurately be 
HbA1c. Furthermore, these diagnostic criteria propagate the idea that one 
simply has anorexia or bulimia with Diabetes as a footnote. We know that there 
are Diabetes-specific environmental factors that contribute to the development 
of diabulimia and, perhaps more importantly, that Eating Disorder treatment 
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programmes that do not address the Diabetes-related factors fail abjectly (p. 
386) 6 
2.2 The Current Study  
A comprehensive systematic review and meta-analysis of the prevalence of Eating Disorders 
in Type 1 Diabetes was published by Nielson in 2002. The author was primarily interested 
in demonstrating whether AN, BN, EDNOS and subthreshold EDs were more prevalent in 
the T1 population when analysing studies that employed clinical interviews supplemented by 
validated self-reports between 1986 – 2000. The author concluded that while AN was not 
more prevalent in those with T1, BN was and T1D carried a threefold risk. It was also found 
that subthreshold ED and EDNOS were more common carrying a twofold risk. The author 
also highlights that insulin omission is an important mechanism but that studies examining 
this as a feature of an ED are scarce. Mannuci et al. carried out a similar metanalysis in 2005 
but they only reviewed papers that utilised clinical interviews with non T1D controls, 
reported diagnoses of AN or BN, EDNOS was not considered (the authors state it had an  
‘uncertain definition’ p. 417), males were excluded and only 8 papers were included in the 
analysis. They concluded that while AN was more prevalent in T1D participants the 
differences between controls was non-significant. For BN there was a significant difference, 
those with T1D had higher prevalence as did they for the 2 conditions combined. Insulin 
omission is not mentioned anywhere in the text (Mannucci et al., 2005).  By 2013 a more 
relaxed approach to what constitutes ED behaviour was taken by Young et al. who conducted 
a systematic review and meta-analysis comparing T1D adolescents to controls in rates of 
both clinical EDs and DEB. They also specifically investigated the relationship between these 
measures and glycaemic control and included measures that were modified for T1D and took 
insulin omission into account. They highlighted many of the problems associated with 
researching these behaviours in this demographic:  
                                                 
 
6 Please see Appendix G for full article 
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Commonly used generic measures of eating problems validated in a general 
population might inflate the prevalence of eating problems in those with Diabetes, 
because they assess the extent to which individuals worry about their diet, reduce 
the intake of certain food groups and eat when they are not hungry. As a 
consequence of low blood glucose, or their insulin regimen, individuals with 
Type 1 Diabetes may score highly on such items, as they may restrict foods with 
high carbohydrate content or eat when they are not hungry (often because of the 
need to treat hypoglycemia). Furthermore, generic measures are not designed to 
acknowledge insulin omission as either weight loss behaviour or general non-
adherence to treatment. Many previous studies have used generic measures 
validated in the general population, and this may contribute to higher or biased 
prevalence estimates. (Young et al., 2013, p. 190)  
The authors conclude that both ED and DEB are more common in adolescents with T1D and 
that both are associated with impaired glycaemic control regardless of whether the instrument 
was modified for T1D.  
Given the reservations of previous researchers and their highlighting of the substantial issues 
faced when researching T1EDs the purpose of the current study is to provide an updated 
broad overview of how EDs in the T1 population have been investigated since the publication 
of the 2002 Neilsen review. As such the current study will systematically review how Eating 
Disorders in Type 1 Diabetes have been researched and whether previous assumptions made 
about this population are valid by considering the sample size, age of participants, the 
primary methodology, sample recruitment , the measurement instrument used, whether that 
measurement has been modified for T1D regimen, the prevalence of diagnoses or number of 
those scoring above designated cut-off points reported if any, whether and how insulin 
omission was measured and what the prevalence of insulin omission is.   
2.3 Methodology   
2.3.1 Search Terms and Databases 
A comprehensive search was run using the MEDLINE & PubMed Databases using the 
following terms. (Diabetes Mellitus, type 1* [MeSH Terms]) AND (Feeding and Eating 
Disorders* [MeSH Terms]), Diabetes mellitus, type 1/ psychology [MeSH Terms], Diabetes 
mellitus, type 1/ psychology [MeSH Terms] AND “Eating Disorder*” [All Fields] and 
Feeding and Eating Disorders* [MeSH Terms] AND “Type 1 Diabetes” [All Fields]. A 
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search was similarly run on PSYCH INFO using the terms ‘Eating Disorders’, ‘Type 1 
Diabetes’, ‘Type 1 Diabetes Mellitus’   
Following this a hand search of the references section of relevant papers was used to identify 
any other papers which may have been unidentified by the original search.   
2.3.2 Inclusion/ Exclusion Criteria  
Inclusion Criteria  
1) English Language  
2) Has some measure of Eating Disorders or Disordered Eating Behaviour in Type 1 
Diabetes  
Exclusion Criteria  
1) Review Articles (although used in identifying references) 
2) Individual Case Studies 
3) Do not measure Eating Disorders in Type 1 Diabetes  
4) Studies with Diabetes type not differentiated  
5) Studies not in English language 
213 papers were initially identified by the search. Of these 47 duplicates were removed. Of 
the remaining 166 papers, all were read by 2 postgraduate research assistants who wanted to 
gain experience in the methodology of systematic reviewing and reviewed again by the 
researcher to ascertain suitability for inclusion in the review. Papers using the same sample 
of (n = 4) were removed, 60 papers were retained for the analysis (please see figure 2:.1 
below)  
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2.3.3 Data Extraction  
From every study the authors, country of origin, sample size, recruitment methods, study 
design and gender were extracted, The measures utilised by each paper were recorded 
alongside whether or not the instruments were modified in any way to account for the effects 
of Type 1 Diabetes. The diagnoses or cut-off criteria and the prevalence of insulin omission 
observed in the sample was then reported if it was available.   
Figure 2.1: Flow Chart of Search Process  
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2.4 Results  
Table 2.1: Self Report Research  
Author/ Year/ 
Country of 
Origin 
n 
(f/m) 
Age 
Range or 
x (sd) 
Primary 
Method 
Sample  Instruments Diagnoses and 
Prevalence 
Adapted? Insulin 
Omission 
Measured? 
Insulin 
Omission 
(n) 
Altinok et al., 
2017 (Turkey) 
110/ 
90 
9 - 18  Cross 
Sectional  
Routine Clinic 
Visit  
DEPS-R 29. 1%f > cut-off 
17.8%m > cut-off 
Yes  Yes  22%f, 
25%m 
Doyle et al., 
2016 (US) 
27/ 33  18 -28  Observational Routine clinic 
visit  
DEPS-R 29.6% f > cut-off 
18.2% m > cut-off 
Yes Yes n/r 
Bachle et al., 
2016 (Germany) 
402/ 
417 
11 - 21 Population Nationwide 
Survey 
SCOFF 30.9%f/ 11.1% m > cut-
off 
No Yes 6.9%f, 
7.2%m 
Powers et al., 
2016 (US)  
153/ 
115 
x = 19 
(9.2) 
Cross 
Sectional  
Questionnaire 
via health 
records  
EDEQ Probable ED 7.8%* 
Possible ED 34%* 
No ED 58.2% * 
No n/r n/r 
Bachle et al., 
2015 (Germany) 
126/ 
85 
18 – 21 Population 
Study, 
Control 
Nationwide 
Survey 
SCOFF 30.2%f, 9.5%m > cut-off No No n/a 
Caccavale et al., 
2015 (US) 
73/78 13 – 18 Cross 
Sectional  
Routine clinic 
visit  
DEPS-R n/r Yes Yes n/r 
Zuijdwijk et al., 
2014 (Canada) 
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x = 15.8 
(1.7) 
 
Scale 
Validation 
Not stated  EDI 
SCOFF  
EDI high risk 23.2% 
Scoff at risk 27.9% 
Yes Yes n/r 
Baechle et al., 
2014 (Germany) 
289/ 
340 
11 – 17  Population  Nationwide 
Survey 
SCOFF DEB 31.2%f/ 11.7%m Yes Yes 20.5%f 
18.5%m 
Johnson et al., 
2014 (UK) 
57/ 39 19 – 21  Observational  2 clinics: Not 
Reported  
DEPS-R  Elevated DEB 35.1% * Yes Yes n/r 
Sivertsen et al., 
2014 (Norway)  
21/ 19 16 – 19  Control  population/ 
registry 
EDS  n/a No No n/a 
Merwin et al., 
2014 (US) 
189/ 
112 
18 – 76 Model 
Validation 
2 Diabetes 
Clinics: Email 
invitation 
DEPS-R, 
Researcher 
Constructed 
< DEPS-R cut-off 22%* Yes Yes n/r 
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Author/ Year/ 
Country of 
Origin 
n 
(f/m) 
Age 
Range or 
x (sd) 
Primary 
Method 
Sample  Instruments Diagnoses and 
Prevalence 
Adapted? Insulin 
Omission 
Measured? 
Insulin 
Omission 
(n) 
Williams et al, 
2014 (Australia) 
42/ 19 13 – 17 Cross 
sectional 
Advertising 
through 
charity 
EAT-40 n/r No No n/a 
d’Emden et al., 
2013 (Australia) 
66/ 58 13 – 18  Cross 
Sectional  
Routine clinic 
visit  
YEDEQ, EDI 3RC YEDEQ, DEB 32.3%f, 
25.9%m,  
EDI - 3RC, n/r  
Yes Yes 7.6%f 
3.4%m 
Phillipi et al., 
2013 (Brazil) 
141/ 
48 
12 – 56 Cross 
Sectional  
3 Diabetes 
Clinics: 
Invitation 
BITE, EAT-26, 
BES 
cut-off 
EAT 45%  
BITE 40%  
BES 16% 
Cumulative 58.7%* 
No Yes 14.8%f 
0%m 
Bernstien et al., 
2013 (US) 
73/ 77 11 – 25 Cross 
sectional 
Routine clinic 
visit  
Eating Disorder 
Screen for Primary 
Care  
DEB 20.7%* No Yes 13.30%* 
Markowitz et 
al., 2013 (US) 
baseline 
19f/ 
24m 
10 – 17  Longitudinal  3 Diabetes 
Centres: Not 
Reported 
DEPS-R n/a Yes Yes 14%* 
Wisting et al., 
2013 a/b 
(Norway) 
390/ 
380 
11 – 19 Population  Routine clinic 
visit  
DEPS-R, EAT12  DEPS-R cut-off 27.8% f, 
8.6%m 
EAT no Yes 36.8%f, 
9.4% m 
Tse et al., 2012 
(US) 
72/ 79 8 - 13 Cross 
sectional  
Routine clinic 
visit  
DEPS  Low Risk 85% 
At Risk 15%* 
Yes  Yes  n/r 
Quick et al., 
2012 (US) 
20f 18 – 26  Control  Flyers in 3 
universities  
EDEQ, TFEQ, 
NEQ 
n/a EDEQ yes, 
TFEQ no, 
NEQ no  
Yes n/r 
Goebel-Fabbri 
et al., 2011 (US) 
207f X = 44 
(12) 
Longitudinal Routine clinic 
visit  
BITE 
Researcher 
Constructed 
n/a No Yes 36% 
Alice Hsu et al., 
2009 (Taiwan) 
42/29 10 - 22 Control Routine clinic 
visit  
BITE, EAT-26  BITE cut-off 4.8% f / 
3.4% m  
EAT cut-off 23.8% f/ 
17.2% m 
No No n/a 
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Author/ Year/ 
Country of 
Origin 
n 
(f/m) 
Age 
Range or 
x (sd) 
Primary 
Method 
Sample  Instruments Diagnoses and 
Prevalence 
Adapted? Insulin 
Omission 
Measured? 
Insulin 
Omission 
(n) 
Markowitz et 
al., 2010 (US)  
63/ 49 13 – 19  Scale 
Validation 
Routine clinic 
visit  
DEPS-R n/a Yes Yes 24%m, 
29%f 
Ackard et al., 
2008 (US) 
73/73 12 - 21 Control Routine clinic 
appointment, 
letter  
AHEAD   Any unhealthy weight 
control behaviour 4.3% 
m/ 20.7f 
Less extreme unhealthy 
weight control 3.7%m/ 
16.1%f  
Extreme unhealthy 
weight control 2.3%m/ 
5.1% f 
Yes Yes  2.8%m 
17.7%f 
Sim et al 2009., 
(US) 
20f 15.8 
(20.11 
months) 
Cross 
Sectional  
3 outpatient 
clinics: 
Invitation 
EDEQ n/r No No n/r 
Markowitz et 
al., 2009 (US) 
90f 12 - 18 Cross 
Sectional  
Paediatric 
Clinic or 
Summer 
Camp: 
Invitation 
EDEQ, TFEQ, PFS EDEQ  20% within 
Clinical Range  
No No n/r 
Goebel – Fabbri 
et al., 2008 (US) 
234f 13 – 60  Longitudinal  Routine clinic 
visit  
BITE, EDI  n/r No Yes 30% 
Smith et al., 
2008 (UK) 
40f 11 – 19  Comparison/ 
control 
4 Clinic: 
Routine clinic 
visit  
EDEQ BN 15%  
BED 12.5% 
No No n/a 
Ryan et al., 
2008 (France) 
16/ 27 x = 38.3 Cross 
Sectional  
Outpatients: 
sent an 
invitation 
QWEPR 
TFEQ  
Over Eating or Binge 
Eating 26%m 0% female  
No No n/a 
Battaglia et al., 
2006 (US) 
69f 12 – 18 Cross 
Sectional  
Routine clinic 
visit  
EDI, EAT-26 
(Dietary Restraint 
Subscale)  
n/a EAT-26 
No, EDI 
Yes 
Yes 15% 
Pinar et al 
2005., (Turkey) 
23/ 22 12 – 18  Control Outpatient 
Clinic 
EAT-40  68.9% > cut-off * No Yes 40%* 
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Author/ Year/ 
Country of 
Origin 
n 
(f/m) 
Age 
Range or 
x (sd) 
Primary 
Method 
Sample  Instruments Diagnoses and 
Prevalence 
Adapted? Insulin 
Omission 
Measured? 
Insulin 
Omission 
(n) 
Pollock-BarZiv 
& Davies, 2005 
(Canada) 
52f 12 – 27 Cross 
Sectional 
Adverts via 
the internet 
and the 
community 
EDEQ, DSMED Combined 27% > cut-off Yes Yes 27.50% 
Iafusco et al., 
2004 (Italy)  
92/ 
101 
8 – 18  Control Not Reported EDEQ Clinical Eating Disorder 
0%   
Subthreshold 5%   
Yes Yes n/r 
Maharaj et al., 
2003 (Canada)  
88f x = 15 
(2.2) 
Cross 
Sectional  
Children’s 
Hospital 
EDI, DSMED Combined Highly Eating 
Disturbed 20.5%,  
Mildly Eating Disturbed 
34%, 
Non-Eating Disturbed 
45.5% 
No Yes 17% 
Schwartz et al., 
2002 (US) 
45f 12 - 18  Cross 
Sectional 
Routine clinic 
visit  
EDEQ n/a No No n/r 
Neumark – 
Sztainer et al., 
2002 (US) 
70/ 73 12 – 21 Cross 
Sectional 
Routine clinic 
appointment, 
letter  
AHEAD No weight control 46.4% 
m / 7.6% f, 
Healthy weight control 
37.7% m/ 54.5% f, 
Unhealthy weight control 
13% m / 18.2% f, 
Very Unhealthy weight 
control 2.9% m /19.7% f 
Yes Yes 1.4%m/ 
10%f 
DEPS-R = Diabetes Eating Problem Revised, SCOFF =  Sick, Control, One, Fat,  Food. YEDEQ/ EDEQ = The Eating Disorders Examination and Youth Eating Disorders 
Examination Questionnaire, EAT = Eating Attitudes Test, EDI = The Eating Disorder Inventory, EDS = The Eating Disturbance Scale, BITE = Bulimia Inventory Test 
Edinburgh, BES = The Binge Eating Scale, TFEQ = The Three Factor Eating Questionnaire, NEQ = The Night Eating Questionnaire,  AHEAD = Assessing Health and 
Eating among Adolescents with Diabetes, QWEPR = Questionnaire of Weight and Eating Patterns, DSMED = The Diagnostic Survey for Eating Disorders, PFS = Power 
of Food Scale 
n/r = not reported, n/a = not applicable, 
DEB = Disordered Eating Behaviour.  
*Gender split not reported, n/r = not reported, n/a = not applicable, sub = subthreshold  
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Table 2.2: Interview Based Research 
Author/ Year/ 
Country of 
Origin 
n 
(f/m) 
Age Range 
or x 
Primary 
Method 
Sample Instruments Diagnoses and Prevalence Adaptation
? 
Insulin 
Omission 
Measured? 
Insulin 
Omission (%) 
Wisting et al 
2017 (Norway) 
61/ 
43m 
x=15.7 (1.8) Cross 
Sectional 
Nationwide 
Study  
ChEDE n/r Yes Yes n/r 
Wisting et al 
2015 (Norway) 
61/ 
44 
12 – 20 Cross 
Sectional 
Nationwide 
Study  
ChEDE n/a Yes Yes n/r 
Colton et al 
2015 (Canada)  
71f 19.2 – 27.8 Longitudinal 1 Clinic: 
Invitation 
EDE AN 2.8% AN 
BN 1.4%  
EDNOS 28.2%  
subED 8.5%   
DEB 59%   
Yes Yes 26.80% 
Wilson et al 
2014 (Ireland) 
30/ 
20  
14 – 16  Cross 
Sectional  
1 Clinic: 
Invitation 
ChEDE no ED %100 Yes Yes 0% 
Colton et al 
2013 (Canada) 
98f  14 – 18  Longitudinal 1 Clinic: 
Invitation 
EDE ED criteria 13.3%   
BN 3.1%  
EDNOS 3.1% 
subED 7.1%  
DEB 35.7%  
Yes Yes n/r 
Grylli et al 2010 
(Austria)  
76f x=17.2 (2.1) Cross 
Sectional  
Outpatients: 
Invitation, 
Various 
Districts 
EDE  EDNOS 11.8%  
subED 18.4%  
No No n/a 
Olmsted et al 
2008, (Canada) 
baseline 
126 f 9 – 13  Longitudinal Routine 
clinic visit  
ChEDE DEB  15%  Yes Yes 2.40% 
Peveler et al 
2005 (UK) 
87f 11 – 38 Longitudinal  Follow up EDE Clinical ED 14.9%, 
subED 11.1% 
Yes Yes 35.60% 
Colton et al 
2004 (Canada) 
101f 9 -14 Control Routine 
clinic visit  
ChEDE EDNOS % 2 
subED % 6 
Yes Yes 2% 
*Gender split not reported, n/r = not reported, n/a = not applicable, sub = subthreshold, AN = Anorexia Nervosa, BN = Bulimia Nervosa, EDNOS = Eating Disorder Not 
Otherwise Specified, DEB = Disordered Eating Behaviour, EDE/ ChEDE = Eating Disorder Examination/ The Child Eating Disorder Examination 
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Table 2:3: Mixed Methods Research (Self Report & Clinical Interview) 
Author/ Year/ 
Country of Origin 
n (f/m) Age 
Range or 
x (sd) 
Primary 
Method 
Sample Instruments Diagnoses and Prevalence Adapted? Insulin 
Omission 
Measured? 
Insulin Omission 
(n) 
d’Emden 2012 
(Australia) 
66/ 58 13 – 18  Scale 
Validation  
  
Routine clinic visit  
  
YEDEQ correlational design  Yes  Yes  3.4%m  
EDI 7.6%f 
chEDE 3.90% 
Grylli et al 2005 
& 2004(Austria) 
96/ 103 14.1 (2.6)  Cross 
sectional  
10 Clinics: Sent 
Letter, approached 
during Routine 
Clinic Visit or 
Diabetes Camp 
EAT-26, EDI > cut-off 31.25f%, 4.6%m  No  No  n/a 
30/ 5  Observational EDE No ED, 30%f  
BN 6.6%f 
EDNOS 6.6%f 
subED 40%f, 1%m  
26%f 0%m 
Garcia – Reyna 
2003 (Spain) 
38/ 60 12 – 16  Control  Not Reported EAT-40  > cut-off 3.1% No  No  n/a 
13* Clinical 
Interview 
EDE EDNOS 5.3%f, 1.7%m   
subED 10.5%f, 10%m 
Sevenson et al 
2003 (Sweden) 
141m 14 – 18  Control  Routine clinic visit  EDI – C DFT (EDI) 1.4%  Yes Yes 2.10% 
RABT Clinical ED (RAB) 0% 0.00% 
*Gender split not reported, n/r = not reported, n/a = not applicable  
sub = subthreshold AN = Anorexia Nervosa, BN = Bulimia Nervosa, EDNOS = Eating Disorder Not Otherwise Specified, DEB = Disordered Eating Behaviour 
EDE/ ChEDE =  Eating Disorder Examination/ The Child Eating Disorder Examination, YEDEQ/ EDEQ = The Eating Disorders Examination and Youth Eating Disorders 
Examination Questionnaire, EDI = The Eating Disorder Inventory, EAT = Eating Attitudes Test, DFT = Drive for Thinnes, RABT = Rating for Anorexia and Bulimia 
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2.4.1 Country of Origin  
Research came from 16 different countries with America producing the majority of articles. 
The UK only produced 3 pieces of research that was included in the systematic review.  In 
non-clinical samples, the highest level of self-reported symptomology in young people came 
from Turkey with 68.9% of the 45 mixed gender respondents scoring above the cut-off point 
for clinical concern on the EAT 40. This research also provided the highest level of insulin 
omission seen in young people with 40% of the sample reporting this behaviour (Pinar et al 
2005).  Researchers from Ireland using a mix gender sample and the Eating Disorder 
Examination, and from Sweden using a male only sample and the RABT found 0% ED 
symptomology (Wilson et al., 2014; Sevenson et al., 2003). The same participants in the Irish 
study reported 0% insulin omission and an Austrian sample reported the same for young 
males (Wilson et al., 2014; Grylli et al., 2005, 2004). 
In adult and mixed samples, the highest level of symptomology was found using a composite 
of risk measures in Brazil at 58.7% (Phillipi et al., 2013) and the highest rate of insulin 
omission reported was 36% in the US (Goebel- Fabbri et al., 2011). The lowest rates reported 
was 0% binge eating symptomology in females using the QWEPR in France (Ryan et al., 
2008) and 0% insulin omission in males in Brazil (Phillipi et al., 2013) 
This having been said there is a lack of international diversity represented to be able to 
extrapolate these conclusions. Several countries only produce 1 piece of eligible research for 
the systematic review and there is no representation from large swathes of the globe as can 
be seen in figure 2.2.  
Table 2.4: Country of Origin 
Country No of Articles  
US 21 
Canada 8 
Norway 5 
Japan 4 
Australia 3 
UK 3 
Germany 3 
Austria 3 
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Country No of Articles  
Spain 2 
Brazil 1 
Taiwan 1 
France 1 
Turkey 2 
Italy 1 
Ireland 1 
Sweden 1 
  
Figure 2.3: Country of Origin  
 
2.4.2 Sample Size 
One of the main limitations of research in T1EDs is the small sample sizes utilised. In non-
clinical samples just under half of the studies included utilised a sample size of less than 100 
participants, 2 of the studies only included 20 participants and only 4 of the studies utilised 
a large-scale sample of 500 participants or more. As a relatively rare disease this may be 
understandable, but results must be approached with a certain amount of caution due to this 
issue. This having been said in research utilising large samples there is not a marked 
53 
 
difference in prevalence than in those using smaller sample sizes, they neither represent the 
highest or lowest estimates (as can be seen in tables 2.1 – 2.3). 
Figure 2.3: Sample Sizes in Non Clinical Samples  
 
2.4.3 Gender  
Although the majority of papers utilised a mixed gender sample, when one gender was 
examined separately it was typically female. In the 1 sample in this review that utilised an 
exclusively male sample, nearly negligible rates of ED symptomology using both self-report 
and clinical interview were reported, although insulin omission was evident in 2% (Sevenson 
et al., 2003). Rates of symptomology in males in other studies varied substantially. The 
highest rates of symptomology in young males was 25.9% using a composite of the YEDEQ 
and the EDI by d’Emden et al. (2013) and the lowest was 0% using the EDE (Wilson et al., 
2014; Grylli et al 2005, 2004). Also, among young males, insulin omission rates vary with 
the highest levels reported as 24% (Markowitz et al., 2010) and the lowest as 0% (Grylli et 
al., 2005, 2004). In the 1 article reporting any gender separated results in adults, 0% insulin 
omission was found (Phillipi et al., 2013). For males it is important to note that rates of 
internal consistency may be lower using self-report scales such as the EDI and YEDEQ 
potentially because these instruments have typically been validated in those with clinical 
Eating Disorders who are typically female (d’Emden et al., 2012).  
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There do appear to be gender differences in regard to the type of ED symptomatology 
reported. Levels of ED symptomology are much higher in females than males in youth 
samples, using the EDI at least mild levels of Eating Disturbance was found in 54.5% of the 
female group (Maharaj et al., 2003) and insulin omission seen in as many as 36.8% (Wisting 
et al., 2013 a/b). In the adult samples using the EDE high levels of clinical behaviour was 
also seen, in one study 60% of the female sample demonstrated disturbed eating behaviour 
(Colton et al., 2015). In two studies insulin omission of 36% was reported (Peveler et al., 
2005; Goebel-Fabbri et al., 2011). Alice Hsu et al. (2008) reported higher levels of vomiting 
and use of diet pills in T1D adolescent females than males but they also found higher levels 
of bulimia like behaviour in T1D boys than in the general population.  Similar results were 
found by Pinar et al. (2005). In research utilising the DEPS-R, females score higher than 
males even if the difference between genders is insignificant (Doyle et al 2016). In two 
studies however, insulin omission was found to be more prevalent in males than in females 
(Altinok.  2017; Bachle et al., 2015). Given that this is more recent research it highlights the 
need for further research into male only samples. 
In the clinically diagnosed T1ED samples, research subjects were nearly completely females, 
in the 10 articles only 12 of the total participants were male as can be seen in table 4.  
 Figure 2.4: Gender of Participants in Non-Clinical Samples 
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2.4.4 Age Range  
The majority (n = 38) of research utilising non-clinical samples into T1EDs focussed on 
children, adolescents and young adults aged 8 – 21 years old. The remainder (n = 12) 
focussed on either a mixed age range or adults 11 – 76 years old. In general, it seems that ED 
symptomology and rates of insulin omission are higher in adult samples than in samples 
utilising exclusively children and young people. In clinical samples (n = 10) the majority of 
research used adolescent and adult samples with ages ranging from 14 - 44 but this is maybe 
to be expected as this research was primarily conducted in patients attending some sort of 
clinic for their ED. 
Figure 2.5: Age Range of Participants in Non-Clinical Samples  
    
2.4.5 Design  
2.4.5.1 Methodology  
2.4.5.1.1 Cross Sectional  
Most of the research undertaken used a cross sectional design and utilised only patients with 
Type 1 Diabetes. It should be noted that the cross-sectional research all utilised point 
prevalence with some of the scales asking what behaviour had been carried out over the last 
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month or the last 3 months. None of the studies were looking at lifetime prevalence. Since 
there appears to be little consensus as to what the most appropriate instrument to use in there 
is also little agreement among the cross-sectional research as to prevalence rates. Phillipe et 
al. (2013) used a composited measure of the Binge Eating Scale, the BITE and the EAT and 
found that cumulatively 58.7% of the sample was at risk for ED behaviour whereas Grylli et 
al. (2004, 2005) using a combination of the EAT and the EDI found ED behaviour in only 
4.6% of male respondents. Only 2 papers attempted to describe clinical diagnoses in the 
sample, Wilson et al. (2014) found a 0% rate of clinical EDs using the chEDE in an 
adolescent sample but Grylli et al. (2010) found 11.8% of EDNOS and 18.4% subthreshold 
EDs using the EDE. Insulin omission rates were reported by 8 of the cross-sectional papers 
with the highest level (27.5%) reported by Pollock-BarZiv (2005) and the lowest level (0%) 
reported by Wilson et al (2014).   
2.4.5.1.2 Observational Studies  
3 observational studies were reported in the literature. 2 of these studies used the DEPS-R 
and found as many as 35% of the mixed samples of young people/ young adults scoring 
above the cut-off point (Doyle et al., 2016; Johnson et al., 2014) Another study used the 
EAT-26 and the EDI to screen youth who would then go on to attend a clinical interview if 
they scored above the cut-off point. Of those who did subthreshold EDs and insulin omission 
were found in 40% and 56% of the females respectively (Grylli et al., 2004, 2005).   
2.4.5.1.3 Control Studies  
Controlled studies were primarily concerned with comparing rates of Eating Disorders and 
Eating Disorder symptomology in those with and without T1D. There is conflicting evidence 
as to whether this is the case.  
Using an unmodified version of the EDI Kaminsky and Dewey (2013) found no differences 
in adolescent ED behaviour and body image ratings but this research only utilised a T1D 
control group of 27. A similar result was found using the Eating Disturbance scale, but this 
research also utilised a very small sample size of Diabetics (n = 40) compared to a control 
group of 9843 (Sivertsen et al., 2014). Using a much larger population based study and the 
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SCOFF, Baechle at al. (2014) came to the same conclusion even though high levels of those 
with T1D were above the cut-off point (31.2%f, 11.7%m). Ackard et al. (2008) used the 
AHEAD protocol within project EAT (eating amongst teens) in order to ascertain the 
differences between healthy adolescents and their diabetic peers, they assessed whether any 
kind of weight control was present including behaviour that they deemed ‘healthy’ such as 
exercising. They found that those with T1D were more likely to endorse healthy behaviours 
(such as having regular meals) they also found that they were less likely to report weight 
dissatisfaction concluding that T1 may be a protective factor, although they still found 
significant prevalence of insulin omission. In a study where adolescent girls with T1D were 
compared with healthy controls and a group with scoliosis it was found that Bulimia and 
binge eating were significantly more prevalent than in either of the other groups (Smith et 
al., 2008). 
Of the other control studies, though there was significant evidence that T1D is a risk factor 
for EDs, where adults with T1D have been encapsulated into a larger sample of patients with 
‘Diet Related Chronic Health Conditions’ it was found that the latter group were twice as 
likely to have been diagnosed with an Eating Disorder than healthy controls (Quick et al., 
2012). Using the EAT-26 and the BITE it was found that in a Taiwanese control study T1D 
females and males scored higher on the BITE and on the Bulimia subscale of the EAT-26 
than their non diabetic counterparts. Pinar et al. (2005) found that Disordered Eating 
Behaviour was 4 times as common in diabetic adolescents than their non-diabetic peers. A 
study using only male adolescents found that Type 1 boys were heavier and had a higher 
drive for thinness using the EDI DFT subscale than their non-diabetic peers (Sevenson et al., 
2003).  In a mixed gender study using a modified version of the EDEQ it was found that 
adolescents with T1D were more likely to have sub threshold EDs than their non T1D 
counterparts (Iafusco et al., 2004). In Spanish research both EDNOS and subthreshold EDs 
were found in significantly more T1D adolescents than in non-diabetic controls (Garcia – 
Reyna et al 2003).  
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2.4.5.1.4 Longitudinal Studies  
There is a paucity of longitudinal studies in this demographic, in one of the few reviewed 
Goebel-Fabbri et al. (2008) found that insulin restriction at baseline predicted a number of 
negative outcomes such as rates of nephropathy. It also increased the risk of mortality by 3.2 
times and decreased life span from an average of 58 to 44 years at 11 year follow up. Similar 
results were found by Peveler et al. (2005), insulin restriction and Eating Disorder 
symptomology at baseline indicated higher levels of mortality and microvascular 
complications at 8 – 12 year follow up. 
In terms of prevalence Colton et al describe a series of studies where 126 females with T1D 
were followed for a 14 year period. They found that there was a cumulative probability of 
60% of ED onset before the age of 25 and a high chance of recurrence regardless of whether 
patients had initially demonstrated remission. (Colton et al., 2015). In a shorter-term 
longitudinal study of baseline, 1 and 6 months it was found that initiation of insulin pump 
therapy led to less endorsement of Eating Disorders behaviours (Markowitz et al., 2013). 
2.4.5.1.5 Population Based Studies  
There was very little in the way of large scale population studies reviewed. Of the 3 
undertaken in Germany using the SCOFF (Baechle et al., 2014, 2015, 2016) there was a large 
proportion of participants scoring above the cut-off point, particularly females. In a 
population study of Norwegian patients using the DEPS-R it was found that 27.8% of females 
were above the cut-off point and 36.8% reported at least occasional insulin restriction. For 
males 8.6% scored above the cut-off point and 9.4% reported insulin omission (Wisting et 
al., 2013)  
2.4.5.1.6 Model Validation 
One study used a model generating methodology in order to ascertain if there are 
relationships between Eating Disorder symptomology, eating patterns, hypoglycaemia, 
insulin omission and other appetite factors (Merwin et al., 2014). The authors concluded that 
disinhibited eating led to more maladaptive cognitions and behaviours.  
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2.4.5.1.7 Scale Validation 
Three studies were undertaken in order to validate the use of certain instruments in the T1D 
population. Markowitz et al. (2010) proposed a shorter and updated version of the DEPS 
(Antisdel et al., 2001) that would consider newer ways of managing T1D, such as MDI and 
pump therapy. In order to validate the DEPS-R several measures and a youth sample was 
used, parents and clinicians were also consulted. The Diabetes Family Conflict Scale (Hood, 
Butler, Anderson & Laffel, 2007), the Blood Glucose Monitoring Communication 
questionnaire (Hood, Butler, Volkening, Anderson & Laffel, 2004), the Paediatric Quality of 
Life Inventory (Varni, Seid & Rode, 1999), the Problem Areas in Diabetes Survey–Parent 
version (Antisdel, 2000), and the Diabetes Quality of Life for Youth questionnaire (Ingersoll 
& Marrero, 1991) were all completed by participants and their parents while medical records 
were consulted regarding other relevant medical information and a consultant completed the 
a questionnaire relating to compliance which included items on insulin omission (Jacobson 
et al., 1990). The authors argue that the use of these particular instruments demonstrate 
concurrent validity of the DEPS-R as the presence of an ED would cause probable disruption 
that can be can be measured thusly. While they state that the instrument is sensitive to the 
presences of EDs as can be seen by the correlation with the aforementioned factors and that 
physician adherence rating is related to DEPS-R scores they did not take clinical ED 
diagnoses or any other ED behaviour into account during the validation process.  
d’Emden et al also used a scale validation methodology to assess whether the YEFEQ and 
the EDI3RC were suitable for use in adolescent T1Ds by comparing them with the chEDE. 
The authors kept the original questions in the YEDEQ and the EDI3RC but added in 
questions on insulin omission to be similarly rated as a disturbed eating behaviour. The 
authors conclude that both subscales are suitable for use in the T1D demographic, even 
though they state that there are items which could be potentially biased (d’Emden et al 2012).       
Zuijdwijk et al. (2014) developed a modified version of the SCOFF that replaced the 5th 
question with another on insulin omission and validated it via scores on a modified EDI 
which removed questions on dietary restrictions which could potentially be attributed to T1D. 
The authors conclude that as there is agreement between the two instruments that their 
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version of SCOFF is suitable for use in the population. However, they deliberately excluded 
those who had a clinical ED diagnosis which would have provided a reference category and 
better ecological validity.    
Figure 2.6: Methodology Utilized in Non-Clinical Samples  
 
2.4.5.2 Sample Recruitment  
The method of sample recruitment may go some way to explain the amount of variation 
reported in symptomology. Most of the research utilises samples from small geographical 
areas such as a paediatric clinic or a few hospitals in the region. The most common type of 
recruitment took place during a routine clinical visit. This may have to be considered in terms 
of selection bias, as only those who regularly attend clinic during the study period may have 
been approached. It may be that as such research has been based on more typically adherent 
patients. This is alarming as the conclusions made in the literature would therefore be 
conservative.  
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Figure 2.7: Recruitment Type Utilized in Non-Clinical-Samples  
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2.4.6 Scales Used  
Figure 2.8: Scale & Interview Instruments used in Non Clinical Samples 
  
2.4.7 Not Diabetes Specific  
2.4.7.1 The Eating Disorders Examination and Youth Eating Disorders Examination—
Questionnaire (EDEQ/ YEDEQ) 
The EDEQ and the YEDEQ were the most commonly used self-report measures. They are 
short self-reports based on the main tenets of the EDE proposed by Fairburn and Beglin in 
1993 (please see section 2.4.9.1 below). As such the items measure the EDE’s 4 core 
restraint, eating concern, shape concern and weight concern. Questions include Has thinking 
about food, eating or calories made it very difficult to concentrate on things you are 
interested in (for example, working, following a conversation, or reading)?, Over the past 28 
days how many times have you eaten what other people would regard as an unusually large 
amount of food (given the circumstances), Over the past 28 days, on how many days have 
you eaten in secret (ie furtively)? Do not count episodes of binge eating and How much would 
it upset you if you had been asked to weigh yourself once a week (no more, or less often) for 
the next four weeks. Responses are based on a 6 item Likert scales with responses from ‘0 
days’ to ‘everyday’ and scores to the subscales are then divided and reported as means and 
standard deviations. A global score can also be attained by summing the subscales and 
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dividing by 4. While Fairburn and Belgin do not explicitly recommend cut-off points they do 
provide community norms in order to compare scores (Bohn et al., 2008).  
The EDEQ has been modified by some researchers to include insulin misuse as a disturbed 
eating behaviour while keeping the original scoring intact however what these items are is 
often not reported.  
Questions regarding insulin misuse for weight control were added by us with 
permission from the authors and rated similarly as a disturbed eating behaviour, 
but the original scoring of the tools remained intact (d’ Emden et al., 2012, p. 
974). 
Similarly, other researchers claim that the EDEQ has been modified to account for T1D but 
do not explain how (Iafusco et al., 2004). Quick et al. (2012) consider insulin omission as a 
compensatory behaviour in the binge eating scale of the EDE where 4 or more incidents 
within the defined time is considered of clinical importance.    
Out of the papers reviewed using either the EDEQ or its youth version only 5 provided 
information regarding diagnoses or cut-off points. In a youth sample using an unmodified 
version of the EDEQ Markowitz et al. (2010) found that 20% of the female only sample 
scored above the cut-off point. Using a smaller but mixed age sample of females and a 
modified version of the EDEQ, Pollock-BarZiv et al. (2005) found a higher rate of 
participants scoring above the cut-off threshold at 27%. Utilising an adult mixed gender 
sample and a modified version of the EDEQ over 40% of participants were screened as 
potentially clinically concerning (Powers et al., 2016) and in the one study that used the 
EDEQ for diagnostic purposed (unmodified) in a small sample of females it was found that 
15% had probable BN and 12.5% BED. In another article, while no cases of full threshold 
ED were found in the mixed gender sample using a modified version of the EDE, 5% of the 
sample were reported to have subthreshold ED behaviours (Iafusco et al., 2004). 
2.4.7.2 The Eating Disorder Inventory 
The EDI was proposed by Garner et al. in 1983 as a comprehensive 64 item self-report 
answered on a 6 point Likert scale from ‘always’ to ‘never’. It was designed to detect 
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cognitive and behavioural indicators of AN and BN. The Scale has been revised with the 
most recent version being released in 2004. The current version, EDI3, comprises 91 items 
which make up 12 subscales and 6 composite scores. The subscales are Drive for Thinness 
(DT), Bulimia (B), Body Dissatisfaction (BD), Low Self-Esteem (LSE), Personal Alienation 
(PA), Interpersonal Insecurity (II), Interpersonal Alienation (IA), Interoceptive Deficits (ID), 
Emotional Dysregulation (ED), Perfectionism (P), Asceticism (A), and Maturity Fears (MF). 
The composite scores are computed. They are the Eating Disorder Risk Composite (EDRC) 
which includes the DT, B and BD scales, Ineffectiveness Composite (IC) which includes 
LSE and PA, Interpersonal Problems Composite (IPC) which comprises II and IA, Affective 
Problems Composite (APC) which uses ID and ED, Overcontrol Composite (OC) which 
sums the scores from P and A, and General Psychological Maladjustment (GPMC) which 
uses all of the psychological subscales to provide a composite. The scores generated are then 
compared to non-clinical samples using percentiles in order to ascertain the clinical profile. 
It also comes with another self-report form which investigates frequency of behaviours and 
therefore has the potential to be used for DSM diagnostic purposes. 
There were early attempts to modify certain parts of the EDI to account for T1D specific 
effects. In 1989 Steel, Young, Lloyd & Macintyre utilised the following protocol to identify 
potentially biased items:  
Ten members of the medical staff working in the diabetic clinic were asked to 
complete the EAT and EDI as though they were sensible young Diabetics 
without an Eating Disorder, so as to identify any questions to which 
respondents might give biased answers simply by following recommended 
diabetic treatment guidelines. A question was considered to be biased if over 
half the medical staff independently suggested it to be so (Steel et al., 1989, p. 
515) 
The questions removed were all from the drive for thinness scale I eat sweets and 
carbohydrates without feeling nervous. I think about dieting, and I feel extremely guilty about 
over – eating. Jones et al. report removing potentially similar items and suggesting cut-off 
points for the EDI which is a protocol adopted by other researchers (Jones et al., 2000; 
Zuijdwijk et al., 2014)     
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Other studies do not claim to have altered the original structure of the EDI or its composites 
but rather have added to them, while still keeping the original scoring matrix intact, by asking 
questions regarding insulin omission. The protocol adopted by Meltzer has been emulated in 
several other research papers (d’Emden et al 2012, 2013; Battaglia et al 2006).  
Two additional questions asking about insulin manipulation were included on 
the EDI (“I skip insulin shots to lose weight” and “I take less insulin than I am 
supposed to, to lose weight”). Participants responded to questions on a six-point 
Likert scale; response options ranged from “always” to “never”. (Meltzer et al.,  
2001, p.679)  
Although the measures have been modified or added to, only two of the papers reviewed 
actually provided prevalence rates (cut-offs or otherwise) using exclusively either the EDI or 
an EDI composites (as can be seen in table 2.1). Zuijdwijk et al. (2014) found that 23.2% of 
the female only sample was at risk and Sevenson et al. (2003) found that males with Type1 
Diabetes have a higher drive for thinness than their non diabetic peers although only 1.4% 
scored above the cut-off point for the drive for thinness subscale. 
2.4.7.3 Eating Attitudes Test  
The EAT was originally developed in 1979 to detect AN and sub AN behaviour (Garner & 
Garfinkel. 1979). The EAT is one of the oldest and most widely used self-report screening 
tests. It was initially comprised of 40 items on a 6 point Likert scale from ‘always’ to ‘never’ 
and was later reduced by Garner et al. in 1982 to 26 items. It is advised to be used as a risk 
assessment tool rather than a diagnostic instrument with those scoring more than 20 advised 
to see a qualified ED specialist (Patton, Johnson-Sabine, Wood, Mann, & Wakeling, 1990;  
Dotti & Lazzari, 1998). The questions in the EAT-26 also form 3 subscales, dieting, bulimia 
and food preoccupation and oral control. Items include Am terrified about being overweight, 
Find myself preoccupied with food and Avoid eating when I am hungry. A cut-off point of 20 
is recommended for further clinical investigation. A 12 item version was also constructed in 
Norway which utilised a total score of 10 and a cut-off point of 9 as clinical concern (Wisting 
et al., 2013 a/b). 
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Proportion of those scoring above the cut-off point for the EAT varies by study, one 
Tawainese (Alice Hsu et al., 2009) study reported a prevalence of 23.8% females and 17.2% 
males while a study from Turkey suggested that 68.9% of the mixed sample screened above 
(Pinar et al., 2005). In a sample including predominantly male participants only 3.1% of the 
sample screened above the cut-off point (Garcia – Reyna et al., 2003). In a mixed sample 
from Brazil it was found that 45% of the sample screened above the cut-off point (Phillipi et 
al., 2013). It should be noted that none of the research reviewed modified the EAT to take 
Diabetes specific effects into consideration.  
2.4.7.4 Sick, Control, One, Fat, Food (SCOFF)  
The SCOFF was designed to give non ED specialists a brief measure of whether a patient is 
at risk using the main tenets of AN and BN and 5 yes/ no questions. Do you make yourself 
Sick because you feel uncomfortably full? Do you worry that you have lost Control over how 
much you eat? Have you recently lost more than One stone (14 lb) in a 3-month period? Do 
you believe yourself to be Fat when others say you are too thin? Would you say that Food 
dominates your life?  If a participant answers yes to two or more questions then the authors 
argue that they are likely either AN or BN (Morgan, Reid  & Lacey, 1999) 
4 papers reviewed included the SCOFF or a modified version of the SCOFF as a measure 
with 3 coming from the same first author. These studies found a high level of participants 
scoring above the cut-off point with around 30% of females and 10% of males answering in 
the affirmative to two or more questions.  Several researchers offered specific modifications 
for the scales that would make them less biased to Diabetes specific regimen and 
psychological effects for example a modified SCOFF (MSCOFF) was proposed whereby the 
last question was removed and replaced by a question addressing insulin Do you ever take 
less insulin than you should? (Zuijdwijk et al 2014) or How often did you inject too little or 
no insulin after carbohydrate intake during the last week? with the response categories 
‘never’, ‘once or twice a week’, ‘3 to 5 times a week’, ‘(almost) every day’, or ‘more than 
once a day’ (Baechle et al., 2014).  
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2.4.7.5 Bulimia Inventory Test Edinburgh (BITE) 
The BITE is a self-report form based on the DSM 3 criteria for Bulimia and is designed to 
show risk of BN and sub BN using yes/ no questions and a 7 point Likert scale, with a 
threshold cut-off for further clinical investigation. The scale is divided into two subscales, 
‘symptoms’ which contains 27 items and ‘severity’ which contains 6 items. Items include Do 
you ever fast for a whole day? (symptom) and If yes, how often is this? (severity) as well as 
items such as Do you feel a failure if you break your diet once? and Do you count the calories 
of everything you eat, even when not on a diet? The total score is then computed with scoring 
over 15 indicating a probable Eating Disorders. Three questions are also used to compute the 
severity (6, 7 and 27) if the score of those three items is more than 5 then that is also indicative 
of an Eating Disorder (Henderson & Freeman 1987). 
Of the 4 papers using the BITE to investigate rates of EDs in the T1D population none were 
modified to take T1D into account and only 2 were used in a way that provided cut-off points. 
Alice Hsu et al. (2008) found that 4.8% f / 3.4% m scored above the cut-off point in a youth 
sample and Phillipe et al. (2013) found that 16% scored above the cut-off point in a larger 
scale sample using a mixed age sample. 
2.4.7.6 The Three Factor Eating Questionnaire  
The TFEQ (Stunkard & Messick, 1985; Karlsson, Persson, Sjostrom & Sullivan, 2000) is an 
18 item scale devised of 3 subscales cognitive restraint (CR), uncontrolled eating (UE), and 
emotional eating (EE) using a 4 point Likert scale including responses such as ‘Definitely 
True’ to ‘Definitely False’ for 17 questions and a 1 – 8 rating for question 18. Questions 
include When I smell a delicious food, I find it very difficult to keep from eating, even if I 
have just finished a meal, I consciously hold back at meals in order not to weight gain and 
When I feel anxious, I find myself eating.  This scale is not generally used to make clinical 
assessments, rather to look at relationships between food related behaviour and as such no 
cut-off points have been suggested. In the three papers that reported using the TFEQ no cut-
off information was provided and no amendments to account for T1D were reported.  
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2.4.7.7 The Diagnostic Survey for Eating Disorders  
The purpose of the DSED is to ascertain whether participants are engaging in behaviours that 
coincide with the DSM diagnostic criteria for Eating Disorders. As such it asks questions 
regarding the frequency of behaviours. 
The DSED has been modified for use in the diabetic population by including questions on 
insulin omission (Rodin et al., 1991) which was later expanded on by Rydal et al. (1997) as 
they state:  
Three mutually exclusive, hierarchical categories were used. Highly disordered 
eating was defined as the occurrence of one or more of the following forms of 
disordered behavior at least twice per week during the preceding three months: 
binge eating, omission or underdosing of insulin to promote weight loss, self 
induced vomiting, or use of laxatives. Moderately disordered eating was 
defined as the occurrence of one or more of these forms of disordered behavior 
at least twice per month, but less than twice per week, during the preceding 
three months. Non - disordered eating was defined as the absence of disordered 
behavior or its occurrence less than twice per month during the preceding three 
months (Rydall et al., 1997, p. 1850) 
This protocol has been used by another two researchers (Maharaj et al., 2003; Pollock-BarZiv 
et al., 2005) but neither researcher reported cut-off points using only this measure, rather they 
used a composite of this and other scales to determine Eating Disorder behaviour. 
2.4.7.8 The Power of Food Scale  
The PFS was designed to assess desire for highly palatable foods and the ‘psychological 
impact of living in food-abundant environments’ using three different proximity subscales 
food available, food present, and food tasted. It rates answers on a 5 point Likert scale from 
‘don’t agree at all’ to ‘strongly agree’ over 15 items. Items include It's scary to think of the 
power that food has over me and It seems like I have food on my mind a lot (Cappelleri et al., 
2009) This scale is not generally used to clinically suggest Eating Disorders but rather to 
explore relationships with other factors such as BMI in obesity research (Lowe et al., 2009) 
and cut-off points are not recommended by the authors. Only one paper used the power of 
69 
 
food scale, unmodified, and found that higher scores were implicated in those who were 
overweight (Markowitz et al., 2009).  
2.4.7.9 The Eating Disorder Screen for Primary Care  
The ESPC was constructed to allow for quick screening of patients presenting in primary 
care. The screener is 5 questions long and are answered yes or no. These questions represent 
‘abnormal’ or ‘normal’ and questions include Does your weight affect the way you feel about 
yourself? Any abnormal answers are considered indicative of Eating Disorder risk (Cotton, 
Ball & Robinson, 2003). Only one paper utilised this scale, unmodified and found a 
prevalence of 20.7% of Eating Disorder in the mixed gender sample. 
2.4.7.10 The Eating Disturbance Scale  
The EDS is a brief 5 item scale based on a likert scale ranging from 1 – 7 with response 
options that are varied to the question being asked and investigates behaviour over the 
preceding 30 days. Items include Are you satisfied with your eating habits? and Have you 
felt guilty about eating? The authors suggest that scores of 16 and above are indicative of an 
Eating Disorder (Rosenvinge et al., 2001). Only one study utilised this scale which was not 
edited to account for Diabetes and did not report those screening above the cut-off point.   
2.4.7.11 The Binge Eating Scale  
The BES was initially devised for use amongst obese patients to detect abnormal eating 
patterns by Gormally, Black, Daston & Rardin in 1982. The scale comprises 16 items with 
differing responses that are then scored to demonstrate higher levels of binge eating. The 
answers are given on a three or four point Likert scale which asks participants to describe 
which is most like them for example question 1 asks them to select between  I don’t feel self-
conscious about my weight or body size when I’m with others, I feel concerned about how I 
look to others, but it normally does not make me feel disappointed with myself, I do get self-
conscious about my appearance and weight which makes me feel disappointed in myself and 
I feel very self-conscious about my weight and frequently, I feel intense shame and disgust 
for myself. I try to avoid social contacts because of my self-consciousness. The items are then 
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scored, and the following categorisations given, Non-binging; less than 17, Moderate 
binging; 18-26 or Severe binging; 27 and greater. Only one paper reported rates of binge 
eating as being clinically concerning in 16% of mixed gender T1 patients and the scale was 
not adapted for use among those with T1D (Phillipi et al., 2013). 
2.4.7.12 The Night Eating Questionnaire 
The NEQ evaluates whether Night Eating Syndrome is likely by asking 14 questions using 
response scales on a 5 point Likert scale with responses varying per question. Questions 
include How much control do you have over your eating between supper and bedtime? And 
When you snack in the middle of the night, how aware are you of your eating? Scores are 
added and there are 2 cut-off points, Scores above 25 indicate that Night Eating Syndrome is 
likely and scores above 30 indicate that NES is highly likely. (Allison et al., 2008). Only one 
sample used the NEQ in order to compare night eating in those with diet related health 
conditions to healthy controls of which no significant differences were found. The 
questionnaire was not modified for Diabetes (Quick et al., 2012). 
2.4.7.13 Questionnaire of Weight and Eating Patterns  
The QWEP was initially construed to be able to diagnose Binge Eating by investigating 
various components needed for a DSM IV BED or BN diagnosis. It utilises 26 questions 
using a variety of responses ranging from yes/ no to 5 point Likert scales including During 
the past six months, did you often eat within any two-hour period what most people would 
regard as an unusually large? amount of food? And During the past six months, on average, 
how often did you have times when you ate this way-that is, large amounts of food with the 
feeling that your eating was out of control? 5 of the questions relate to a diagnosis of BED 
and 8 of the questions relate to BN and the scoring relates to DSM IV criteria. (Spitzer et al., 
1992) In the one paper reporting using the QWEP binge eating was found in 26% of the male 
respondents and 0% of the female participants. The questionnaire was not modified for 
Diabetes. It should be noted that parts of the QWEP have been used in larger studies utilising 
a number of scales such as the AHEAD study (Neumark – Stzainer et al., 2002). 
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2.4.8 Scales Used – Diabetes Specific  
2.4.8.1 Diabetes Eating Survey Revised  
In order to overcome some of the issues with diagnosing EDs in the T1D population a new 
survey was proposed. The first version of the Diabetes Eating Problem Survey (DEPS) 
included 28 self-report questions on a Likert scale. Published in 2001 (Antisdel, Laffel & 
Anderson, 2001), it was one of the first scales to recognise that generic screening instruments 
for Eating Disorders may over diagnose Bulimia based on Diabetes factors while 
simultaneously avoiding the important role of insulin omission. The scale was shortened to 
16 items and renamed the Diabetes Eating Problem Survey Revised (DEPS-R) by Markowitz 
et al. in 2009. Examples of questions are Losing weight is an important goal to me, I feel that 
it’s difficult to lose weight and control my Diabetes at the same time. I alternate between 
eating very little and eating huge amounts and I would rather be thin than to have good 
control of my Diabetes. The scale utilises responses on a 6-point Likert scale from  ‘never’ 
to ‘always’ and scores over 20 are deemed to be clinically concerning. 
The DEPS-R was a popular choice for screening instruments with 9 researchers utilising it 
this having been said only 5 of the studies published cut-off points. In one large scale study 
using registry data from children and adolescents 27.8% of females and 8.6% of males 
screened above the cut-off point (Wisting et al/. 2013 a/b). In a sample using a younger age 
group (8 – 13) 15% screened above the clinical cut-off point. In studies using adults, Merwin 
et al. (204) found 22% of respondents screened above the cut-off point and Doyle et al. (2017) 
found a greater prevalence in women (29.6%) than in men (18.2%). The questionnaire also 
asks specific questions about insulin omission. Merwin et al (2014) suggest that: 
Five items on the DEPS-R assess manipulation of the diabetic treatment 
regimen for weight control purposes or related attitudes….including: “I try to 
keep my blood sugar high so that I will lose weight” (Keep BG High: DEPS-
R9), “I try to eat to the point of spilling ketones in my urine” (Spill Ketones: 
DEPS-R10), and “I feel fat when I take all of my insulin” (Feel Fat: DEPS-
R11). The remaining two DEPS-R items that assess manipulation of the 
diabetic treatment regimen for weight control purposes include: “After I 
overeat, I don’t take enough insulin to cover the food” and “After I overeat, I 
skip my next insulin dose.” (Merwin et al., 2014, p. 125) 
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However, researchers do not generally separate out different types of ED behaviour using the 
DEPS-R.  
2.4.8.2 Assessing Health and Eating among Adolescents with Diabetes (AHEAD) 
The AHEAD study was undertaken by the Children’s Diabetes Clinic at St Paul Hospital in 
Minnesota. Part of the AHEAD study asked questions similarly to that in Project Eat; a large 
scale study aimed at assessing adolescent Eating and Health practices. It was modified for 
Diabetes by including two additional questions that indicate ‘extreme weight control 
behaviours’ 1) Skipped insulin doses, and 2) Took less insulin that prescribed. It also 
measures behaviours like current dieting status, and frequency of meals (Akard et al., 2008) 
The response scales and cut-off points vary depending on the question being asked7.  2 studies 
used the AHEAD protocol to assess levels of Eating Disturbance in T1Ds. The AHEAD 
questionnaire divides symptomology into subcategories of weight control in one study there 
were distinct gender differences seen with nearly half of the males displaying no weight 
control whatsoever compared to just 7.6% of females.   
2.4.9 Interviews Used  
2.4.9.1 The Eating Disorder Examination (Fairburn, Cooper & O’Connor 2014). 
The EDE, currently on its 17th updated version is a semi structured interview with emphasis 
placed on the fact that it is an investigator rather than respondent led interview that 
encourages some fluidity around the core questions in order to get a full picture of the 
respondents eating attitudes and behaviour. It can be used for current symptomology by 
                                                 
 
7 This was an extremely large study that used a huge variety of scales. The whole list can be 
found at the University of Minnesota website: 
(http://docs.sph.umn.edu/epich/eat/EAT2010_FEAT_Psychometrics.pdf) 
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focusing on a previous 28 day period or for diagnostic purposes by extending this to 3 
months. Interviewers need specific training to administer the interview, as the author states:  
 With investigator-based interviews interviewers need training to ensure that 
they fully understand the concepts being assessed. The structure in such 
interviews lies in the detailed specifications provided for the interviewer of the 
concepts to be rated and the rating scheme, rather than in the precise wording of 
individual questions. In summary, investigator-based interviews such as the 
EDE require that interviewers be trained both in the technique of interviewing 
and in the concepts and rules governing the ratings. (Fairburn et al., 2014, p. 3)    
The EDE measures the frequency of specific ED behaviours such as binging and purging and 
also more general information based on 4 subscales, restraint, eating concern, shape concern 
and weight concern. Most updates have reflected changes to ED diagnosis and are in line 
with changes in the DSM, for example the most recent version removed amenorrhea from 
the diagnostic portion of the interview as it was also omitted from the DSM V’s criteria for 
AN (Fairburn et al., 2014). 
Researchers have modified the EDE in order to account for Diabetes specific aspects of ED 
behaviour as Grylli et al note:  
The EDE version that we used takes into consideration the potential presence of 
insulin omission/misuse as a compensatory measure and contains an 
appropriate semi-structured module. (Grylli et al., 2004, p. 231) 
There is no further information on how this interview has been modified or what questions 
are asked regarding insulin omission. Similarly, Colton et al. (2013, 2015) describes insulin 
omission in terms of a ‘Disturbed Eating Behaviour’ but don’t explain how the EDE was 
modified in order to assess prevalence rates This having been said this was part of a 
longitudinal study so this may reflect evolving attitudes on nomenclature. Peveler et al. 
(2005) also describe insulin omission prevalence rates but do not report modifications. 
Several researchers make no mention of any modifications to the interview to account for 
Diabetes specific factors (Garcia – Reyna et al., 2003; Grylli et al., 2010).  
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2.4.9.2 The Child Eating Disorder Examination (chEDE) 
The ChEDE (Bryant‐ Waugh, Cooper, Taylor & Lask, 1996) applies the same principles as 
the EDE but uses modified language in order to deal with a younger demographic. They also 
use a sort task to assess ideas about weight and shape where by the investigator makes lists 
of things that are important to you in how you see yourself or think about yourself and things 
that are important to you when you think about how good you are as a person. Further 
modifications look at intent rather than action given that children’s lives are more likely to 
be structured by their parents.  
While it appears apparent that insulin omission or other Diabetes specific aspects have been 
taken into account, some researchers do not explain how this was done (d’Emden et al., 2012; 
Wilson et al., 2014) or whether it was done as part of a modified chEDE or as an adjunct 
(Wisting et al., 2017). In 2008 Olmsted et al. describe a longitudinal study whereby questions 
about the use of insulin omission for weight control were added to the 38 standard questions 
in order to assess disturbed eating behaviour. Other questions were modified to ensure that 
behaviours described were in fact due to weight and shape concerns rather than due to T1D 
regimen and several other researchers utilise this protocol (Wisting et al., 2015; Colton et al., 
2013).  
Other researchers are equally as vague when it comes to describing how insulin omission is 
approached for example Colton et al (2004) state:  
Insulin dosage omission or reduction was diagnosed only if it was primarily a 
purging strategy to promote weight loss and not if it was occurring for other 
reasons. All ratings of disturbed eating behavior were based on the cEDE 
interview (Colton et al., 2004, p. 1656). 
It should be noted that in mixed method research whereby insulin omission is reported by 
both self-report and then verified in an interview that reported rates are lower in interview 
representing a possible limitation of the interview (d’Emden et al., 2012).  
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2.4.9.3 Rating for Anorexia and Bulimia (RABT) 
The authors of the RABT state that it was designed in order to account for the fact that most 
interviews used in Eating Disorders were designed for English Speakers and thus had little 
diagnostic use outside English speaking environments (Clinton & Norring, 1999). It consists 
of 56 items addressing 4 subscales; Body‐ shape and Weight Preoccupation, Binge‐ Eating, 
Anorexic Eating Behaviour and Compensatory Behaviour. Only one paper used this 
interview and it found a 0% of Eating Disorders and 0% insulin omission and did not explain 
how or if Diabetes specific aspects of ED were addressed (Svenson et al, 2009).  
2.4.10 Mixed Methods Research  
In research utilising both self-report and a clinical interview lower levels of insulin omission 
are reported via interview compared to the self-reports in the same sample (d’Emden et al., 
2012) In research where not only those who screen as clinically concerning are then clinically 
interviewed there are substantial levels of Eating Disorders seen in both male and female 
participants versus controls (Garcia- Reyna et al., 2003). It may be that a mixed method 
approach whereby questionnaires are used for screening purposes and all are followed up 
with an interview would give a clearer clinical picture.   
2.4.11 Reported Data 
Figure 2.9: Number of Papers which used Adapted Measures   
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Figure 2.10: Number of Papers Reporting Insulin Omission   
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Figure 2.11: Percentage of Participants Scoring above the cut-off point in Self-Report Research  
 
*= Gender split not reported, UM = unmodified   
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 Figure 2.11: Percentage of Participants meeting Clinical ED Criteria in Interview Based Research  
 
 
*= Gender split not reported, sub = subthreshold, AN = Anorexia Nervosa, BN = Bulimia Nervosa, EDNOS = Eating Disorder Not Otherwise Specified, DEB = Disordered 
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2.4.12 Diagnoses & Insulin Omission  
There are conflicting prevalence rates of EDs in the T1 population by clinical diagnosis. It is 
important to note that regardless of insulin omission being mentioned it is not clear in any of 
the papers how this behaviour has been categorised in terms of diagnosis. This is perhaps not 
surprising given the vague terminology of the DSM IV and DSM V (please see section 2.1) 
which gives little instruction on aspects such as degree or frequency of omission.  
Several authors (Grylli et al., 2004, 2005, 2010; Garcia-Rayna et al., 2003; Colton et al., 
2004, 2015) reported utilising an operationalised definition of EDNOS and subthreshold ED 
defined by Jones et al. in a 2000 research article, the authors state; 
Based on DSM-IV criteria a minimum of four clinical symptoms over the past 
three months were necessary for the diagnosis of anorexia or bulimia nervosa. 
DSM-IV provides broad suggestions for diagnosis of Eating Disorders not 
otherwise specified. We operationalised the diagnosis of these disorders more 
precisely based on DSM-IV criteria and criteria used in previous controlled 
prevalence studies…Subthreshold Eating Disorders were considered to be milder 
eating disturbances with a lower frequency or severity of symptoms over the past 
three months than those specified in DSM-IV. (Jones et al., 200, p.1564) 
Colton et al. (2004) later reproduced the definitions in greater detail  
Eating Disorder not otherwise specified 
1. All the criteria for anorexia nervosa except for amenorrhea; or 
2. All the criteria for anorexia nervosa except the subject does not report a fear 
of weight gain or does not report a disturbance in the way in which their body 
weight and/or shape is experienced; or 
3. All the criteria for bulimia nervosa except that the subject does not report self-
evaluation being unduly influenced by shape and/or weight; or 
4. All the criteria for bulimia nervosa except that the frequency of binge eating 
and purging behavior occurred at least once per week for 3 months, or two times 
per week over the previous 4 weeks; or 
5. An individual regularly engages in inappropriate compensatory behavior in the 
absence of binge eating (e.g., recurrent self-induced vomiting or insulin omission 
for shape and weight control at least one time per week for the past 3 months, or 
twice weekly over the previous 4 weeks); or 
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6. An individual engages in recurrent episodes of objective binge eating (at least 
one time per week for the past 3 months, or twice weekly over the previous 4 
weeks). 
Subthreshold Eating Disorders 
1. An individual engages in occasional (three or more times) binge eating, and/or 
purging over the past 3 months; or 
2. An individual whose self-evaluation is unduly influenced by shape or weight, 
and who regularly engages in extreme dietary restraint (<500 kcal/day); or 
3. An individual whose self-evaluation is unduly influenced by shape or weight, 
and who regularly engages in intense, excessive exercise for the purpose of 
weight control (at least five times weekly) over the past 3 months (Colton et al., 
2004, p. 1656) 
Though these definitions have been commonly used that does not mean that they are 
appropriate, for example the original authors found that although insulin omission for weight 
loss was present in a higher number of patients with a diagnosed ED and subthreshold 
disorders they also found it in those who they deemed to have no ED (Jones et al., 2000). It 
is also worrying that those who are withholding insulin but are diagnosed with subthreshold 
ED or no ED are deemed to be less clinically concerning given that DKA is a momentary 
event. It is, to a certain extent, irrelevant if it is a chronic behaviour. DKA is a life-threatening 
condition that these participants are at obvious risk of.  Further issues are apparent aside from 
insulin omission, both Grylli et al. (2004, 2005) and Colton et al. (2004) highlight that intense 
exercise may be a prescribed behaviour and that it is beneficial to T1D management but may 
be described as pathological in such a paradigm. They also highlighting that other typical 
bulimic behaviours are much less common (Grylli et al., 2004, 2005, Colton et al., 2004).  
Only one self-report gave diagnostic estimates. It utilised the EDE-Q (Smith et al., 2008) 
finding that 15% of the female only sample had probable BN and 12.5% had probable BED. 
In interview-based research in youth samples no participants were diagnosed with AN but in 
one sample using adults a 2.8% prevalence was found (Colton et al., 2015). BN and EDNOS 
was more commonly found in youth samples and subthreshold Eating Disorders were found 
in as many as 40% (Grylli et al., 2005, 2004) the EDE or chEDE was used to ascertain these 
diagnoses but it should be noted that as well as varying rates of diagnoses being found, one 
study also found a 0% rate of any clinical ED (Wilson et al., 2014). This research was 
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undertaken with T1D teenagers and their parents however potentially leading to under-
reporting of behaviours. Similarly, in 1 study using an alternative interview the RABT, 0% 
clinical diagnoses were found, although this used a male youth sample only. In adult samples, 
only 1 article reported diagnoses rates (Colton et al., 2015) so it would be unwise to 
extrapolate from that. Only 11 papers reported clinical diagnoses. As can be seen in figure 
2.12 the estimates of clinical diagnoses vacillate too wildly to make any general estimates of 
prevalence. Furthermore, it could be argued that given the substantial issues in measuring 
EDs in this population, which have never been appropriately addressed, one would be advised 
against making any conclusions. Also rates of insulin omission for weight loss, arguably the 
most dangerous behaviour those with T1ED can engage in,  do not equate to rates of ED 
reported, for example Grylli et al. (2010) found only a 13.2% rate of clinical diagnoses (BN, 
EDNOS) but 26% of their sample reported insulin omission for weight control, Sevenson et 
al. (2003) found a 0% rate of clinical EDs but a 2.1% rate of insulin omission and Peveler et 
al. (2005) found only a 14.9% rate of clinical diagnosis but a 35.5% rate of insulin omission.  
There are further issues when looking at how insulin omission has been measured as can be 
seen in table 2.7. There is no consensus as to what constitutes insulin omission in a clinically 
significant way. There is no mention as to how omission is encapsulated into ED diagnoses.    
What also seem to be apparent is that in clinical samples of T1EDs who have an ED diagnosis 
insulin omission is a common feature regardless of diagnosis type (please see table 2.6) 
suggesting that this is either a transdiagnostic feature or that this is the key tenet of T1ED. It 
is also notable that despite reservations that AN is not commonly seen in T1D, it is observed 
by all reporting prevalence except for Takii et al. (2002, 2003) who were utilising those with 
BN only.  Also, research using those with diagnosed EDs tends to focus on adult samples in 
a reversal of what is seen in other research into T1ED.  
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Table 2.5:  Diagnoses in non-Clinical Samples  
Author/ Year/ Country 
of Origin 
n (m/f) Age Range 
or x 
Primary Method DSM Instruments Diagnoses and 
Prevalence 
Adaptation? Insulin 
Omission 
Measured
? 
Insulin 
Omission 
(n) 
Colton et al 2015 
(Canada)  
71f 19.2 – 27.8 Longitudinal DSM-IV-
TR 
EDE AN 2.8%   
BN1.4%   
EDNOS 28.2%  
subED8.5%   
Yes Yes 26.80% 
Wilson et al 2014 
(Ireland) 
30f/ 
20m  
14 – 16  Cross Sectional  n/r ChEDE no ED %100 Yes Yes 0% 
Colton et al 2013 
(Canada) 
98f  14 – 18  Longitudinal DSM IV EDE BN 3.1%  
EDNOS 3.1%  
subED 7.1%  
Yes Yes n/r 
Grylli et al 2010 
(Austria) 
76f x  = 17.2 
(2.1) 
Cross Sectional  DSM-IV-
TR 
EDE EDNOS 11.8%,  
subED 18.4% 
No No n/a 
Smith et al 2008 (UK) 
 
40f 
 
11 – 19  
 
Comparison/ 
control 
 
DSM - IV EDEQ 
 
BN 15%, 
BED 12.5% 
 
No No n/a 
Peveler et al 2005 (UK) 87f 11 – 38 Longitudinal  DSM IV EDE Clinical ED, 14.9% 
subED, 11.1% 
Yes Yes 35.60% 
Colton et al 2004 
(Canada) 
101f 9 -14 Control DSM - IV ChEDE EDNOS  2, %  
subED 6% 
Yes Yes 2% 
Grylli et al 2005 & 
2004(Austria) 
30f/ 5m  14.1 (2.6) Clinical 
Interview 
DSM - IV EDE BN 6.6%f,  
EDNOS 6.6%f 
subED 40%f, 1%m 
No No  26%f 
0%m 
Garcia – Reyna 2003 
(Spain) 
13* 12 – 16 Clinical 
Interview 
n/r EDE EDNOS 1.7%m, 5.3%f  
subED 10%m, 10.5%f 
No No n/r 
Svenson et al 2003 
(Sweden) 
141m 14 – 18  Control  DSM - IV RABT Clinical ED  0% Yes Yes 0.00% 
*Gender split not reported, n/r = not reported, n/a = not applicable, sub = subthreshold. sub = subthreshold AN = Anorexia Nervosa, BN = Bulimia Nervosa, EDNOS = 
Eating Disorder Not Otherwise Specified,  
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Table 2.6: Research with Clinical ED Patients 
Author/ Year/ 
Country of Origin 
n 
(m/f) 
Age 
Range or 
x (sd) 
Primary Method Sample Instruments Diagnoses and 
Prevalence 
Adapted? Insulin 
Omission 
Measured? 
Insulin 
Omission (n) 
Colton et al 2015 
(Canada) 
95f 27.1 (9.1) Retrospective 
Chart Review 
Attendees of Day 
Hospital  
EDE BN 47.4%   
AN 14.7%   
EDOS37.9%  
Yes Yes 78.80% 
Dickens et al 2015 
(US) 
29f 25.55 
(9.03) 
Retrospective 
Chart Review 
Inpatient EDI  BN 79.3%   
AN 10.3%  
EDNOS 10.3%  
No No n/a 
Merwin et al 2015 
(US) 
73/ 10 18 – 68 Momentary Patient registries, 
online 
advertisements, 
and flyers placed 
in nearby clinics  
DEPS-R, EDE n/a No No n/a 
Custal et al 2014 
(Spain) 
20f 25.3 (8.0) Treatment 
Outcome  
Outpatients/ Day 
patients 
Semi Structured 
Interview, EDI  
An & subAN 10.0%   
BN & subBN 25.0%  
BED10%  
EDNOS 55% 
No Yes 90% 
Powers et al 2013 
(US) 
47/ 1 26.2 
(10.3) 
Scale Comparison Initial Screening  EDE-Q, EDI n/r No No n/a 
Powers et al 2012 
(US) 
47/ 1 26.2 
(10.3) 
Exploratory 
retrospective case 
– control  
Inpatient, 
partial, or 
outpatient 
EDE-Q, EDI  EDNOS 58.3% BN 
37.5%  
AN 4.2%  
No Yes 47.90% 
Takii et al 2011 
(Japan)  
53f 14 – 44 Exploratory 
retrospective case 
– control 
Outpatients  ED module of the 
Structured Clinical 
Interview for DSM 
1V 
BN 96.2%  
AN 3.8%  
Yes N/r  n/r 
Takii et al 2008 
(Japan) 
109f 22.9 (5.2) Exploratory 
retrospective case 
– control 
Outpatients  ED module of the 
Structured Clinical 
Interview for DSM 
1V 
BN 64.2%  
BED 25.7%   
AN 6.4%  
EDNOS 3.7%  
Yes Yes 67.90% 
Takii et al 2003 
(Japan) 
19f 23.8(5) Follow up  Inpatient  Clinical Interview BN 100%  No Yes 77.80% 
EDI 
Takii et al 2002 
(Japan) 
53f 14 -36 Cross Sectional Outpatients  Clinical Interview BN 100%  Yes Yes 83% 
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Author/ Year/ 
Country of Origin 
n 
(m/f) 
Age 
Range or 
x (sd) 
Primary Method Sample Instruments Diagnoses and 
Prevalence 
Adapted? Insulin 
Omission 
Measured? 
Insulin 
Omission (n) 
EDI 
n/r = not reported, n/a = not applicable, sub = subthreshold AN = Anorexia Nervosa, BN = Bulimia Nervosa, EDNOS = Eating Disorder Not Otherwise Specified DEPS-
R = Diabetes Eating Problem Revised, YEDEQ/ EDEQ = The Eating Disorders Examination and Youth Eating Disorders Examination Questionnaire, EDI = The Eating 
Disorder Inventory, EDE/ ChEDE = Eating Disorder Examination/ The Child Eating Disorder Examination 
 
Table 2.7: How was Insulin Omission Measured in Papers where Rates are Reported? 
Author/ Year How was insulin measured?  Clinical ED/ DEB Insulin Omission 
Altinok et al 2017 Questions on the DEPS-R > DEPS-R cut-off 29. 1%f, 
17.8%m  
22%f, 25%m 
Bachle et al 2016 In this study, all patients answered questions on the frequency of IR and the 
number of carbohydrate exchange units consumed without insulin coverage 
during the previous week. Frequent IR defined as IR occurring more than five 
times a week was used as proxy for regular, and thus likely intentional, IR. 
>SCOFF cut-off 30.9%f, 
1.1% m   
6.9%f, 7.2%m more than 
5 times per week 
Colton et al 2015  DEB was defined as reporting any of the following during the 28 days before 
the EDE interview: dieting; objective binge-eating episodes; self-induced 
vomiting; abuse of laxatives, diuretics, or diet pills; insulin omission or 
underdosing for weight control... 
AN 2.8%   26.80% f 
BN 1.4% 
EDNOS 28.2% 
subED  
DEB  59%  (all f) 
Baechle et al 2014 we assessed insulin restriction in Diabetes patients by the additional question 
“How often did you inject too little or no insulin after carbohydrate intake 
during the last week?” with the response categories “never,” “once or twice a 
week,” “3 to 5 times a week,” “(almost) every day,” or “more than once a 
day.” 
> SCOFF cut-off 31.2%f, 
11.7%m  
18.5%m, 20.5%f more 
than 3 times per week 
Wilson et al 2014 Not stated  clinical ED 0% 0%* 
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Author/ Year How was insulin measured?  Clinical ED/ DEB Insulin Omission 
Phillipi et al 2013  The patients also answered socio-demographic questions and questions 
related to T1D, such as time elapsed since their Diabetes diagnosis, whether 
they use fastacting or long-acting insulin, whether they use the carbohydrate 
counting method, and whether they restrict or omit insulin in order to lose 
weight. 
cut-off 45% EAT, 40% 
BITE, 16% BES, 
Cumulative 58.7%* 
14.8%f/ 0%m  
D'Emden et al 2013 For this study, the Youth EDE-Q and EDI-3 RC were adapted for Diabetes 
with additional questions pertaining to insulin misuse, which were endorsed 
by the authors of each tool. These included questions similar to Meltzer ‘I 
take less insulin than I should to influence my shape or weight’; ‘I skip 
insulin shots to influence my shape or weight’, with an additional question 
about intention to manipulate insulin: ‘I have thought about taking less 
insulin to modify my shape or weight.’ The Insulin questions  were analysed 
separately.  
(YEDEQ) Disturbed Eating 
Behaviour 32.3%f, 25.9%m, 
7.6%f/ 3.4%m 
Bernstien et al 2013 Participants were also screened for intentional insulin omission or dose 
reduction with the question, “Do you take less insulin than you should?” 
(EDS) Disordered Eating 
20.7% * 
13%* 
Wisting et al 2013 a/b  we operationally defined insulin restriction and insulin omission according to 
the following two DEPS-R items: “When I overeat, I do not take enough 
insulin to cover the food” and “After I overeat, I skip my next insulin dose.” 
> DEPS-R cut-off 27.8% f,  
8.6%m 
36.8%f,  9.4% m 
Markowitz et al 2013  Based on the researcher assumption that the question 'When I overeat, I don't 
take enough insulin to cover the food' measures insulin omission  
n/r 14% 
d'Emden et al 2012 (YEDEQ) specific questions are also asked about the presence and frequency 
of disturbed eating behaviours, such as restraint, binge eating, self-induced 
vomiting, use of diuretics or laxatives and driven exercise for the purpose of 
weight control. Questions regarding insulin misuse for weight control were 
added by us with permission from the authors and rated similarly as a 
disturbed eating behaviour, but the original scoring of the tools remained 
intact. (EDI - 3RC) The EDI-3RC takes 5 min to complete. Questions 
regarding insulin misuse were added, with permission from the author; 
however, the integrity of the original scoring was maintained. 
n/r 3.4%m / 7.6% f 
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Author/ Year How was insulin measured?  Clinical ED/ DEB Insulin Omission 
Goebel - Fabbri et al 2011 We used responses to the screening statement, “I take less insulin than I 
should,” to determine insulin restriction status in this cohort. Responses were 
on a 6-point Likert scale ranging from “never,” “rarely,” “sometimes,” 
“often,” “usually,” to “always.” We decided on the following definition of 
insulin restriction, because we believed that social desirability pressures 
could influence women to underreport insulin restriction as a symptom, 
particularly as part of research being done in a specialty Diabetes center... We 
used their responses at baseline to categorize women as insulin restrictors if 
they reported any form of restriction from, “rarely” to “always.” They were 
categorized as appropriate insulin users if they endorsed “never.” 
n/r 36% 
Markowitz et al 2010  To rate adherence to insulin therapy, clinicians indicated whether or not they 
thought the patient was “skipping shots, misusing insulin, or ‘forgetting’ to 
bolus on the pump.” Such patients are categorized as those missing or 
restricting insulin. This rating of insulin restriction was based on clinician 
assessment and lab results, but did not specify that insulin restriction was for 
purposes of weight management.  
n/r 24%m, 29%f 
Goebel- Fabbri et al 2008  The screening item “I take less insulin than I should” in a self-administered 
survey developed for the original study was used to determine insulin 
restriction status in this patient cohort. Based on their responses at baseline, 
women were categorized as insulin restrictors if they reported restriction at 
any level of frequency from “rarely” to “always” in response to this 
statement. They were categorized as appropriate insulin users if they 
endorsed “never” on this same item. 
n/r 30%f 
Ackard et al (2008) Two additional 'extreme’ weight control behaviors were included in the 
AHEAD survey only and were included as 'extreme’weight control 
behaviors: skipped insulin dose(s) and took less insulin than prescribed. 
Any unhealthy weight 
control behaviour 4.3% m/ 
20.7f,  
2.8%m 17.7%f 
Less extreme unhealthy 
weight control 3.7%m/ 
16.1%f  
Extreme unhealthy weight 
control 2.3%m/ 5.1% f 
Olmsted et al 2008, 
Baseline 
The cEDE consists of 38 items including questions that were added regarding 
the use of insulin dosage manipulation or omission as a weight control 
strategy 
(ChEDE) 15% DEB (all f) 2.40% 
87 
 
Author/ Year How was insulin measured?  Clinical ED/ DEB Insulin Omission 
Battaglia et al 2006 Two additional questions (“I skip insulin shots to lose weight” and “I take 
less insulin than I am supposed to, to lose weight”) were included to address 
insulin omission (Meltzer et al., 2001). 
n/r 15% 
Pinar et al 2005 The questions in the second part were for diabetic patients and were related to 
Diabetes and adherence to Diabetes regimen. These questions were on 
duration of Diabetes, level of HbA1c, adherence to recommended diet, strict 
diet restriction, and intentional insulin misuse to lose weight. 
>EAT cut-off 68.9%* 40% 
Pollock - BarZiv et al 
2005  
Subjects with Eating Disorder: symptoms included those in whom one or 
more of the following behaviors occurred at least twice a month during the 
preceding 3 months: binge eating, insulin omission or manipulation of an 
insulin dose to promote weight loss, self-induced vomiting, and laxative use. 
(EDE - Q, DSMED) 
Combined  > cut-off 27% 
(all f) 
27.5%f 
Peveler et al 2005  Not stated  Clinical ED, 14.9% 35.60% 
Subclinical ED, 11.1% (all f) 
Colton et al 2004  Insulin dosage omission or reduction was diagnosed only if it was primarily a 
purging strategy to promote weight loss and not if it was occurring for other 
reasons 
EDNOS % 2,  2% 
SubED % 6 (all f) 
Maharaj et al 2003  Highly eating disturbed included… engagement in one or more disordered 
eating and/or weight loss behaviours, including binge eating, self-induced 
vomiting, laxative/diuretic use, insulin omission to promote weight loss, or 
complete food avoidance, at a frequency of at least 2–3r/month to >1r/day, 
over the preceding 3 months. Mildly eating disturbed included girls who 
reported one or both of the following: (1) engagement in one or more of the 
above disordered eating and/or weight loss behaviours at a frequency of 
1r/month or less, over the preceding 3 months 
Combined Highly Eating 
Disturbed = 20.5%  
17% 
Mildly Eating Disturbed = 
34% 
Non-Eating Disturbed = 
45.5% 
Sevenson et al 2003  The patients also answered anonymously a few questions concerning their 
Diabetes treatment and whether they had ever taken less insulin than they 
should in order to lose weight. 
DFT (EDI) 1.4%  (all m) 2.1%m 
Neumark – Sztainer et al 
2002 
Items assessing weight perceptions and weight control behaviors were drawn 
from the Project EAT (Eating Among Teens) Survey (24). The Diabetes 
Eating Problems Survey (DEPS) (2) was used to further assess disordered 
eating attitudes and behaviors and manipulation of insulin  or weight control 
purposes among the respondents. 
No weight control = 46.4% 
m / 7.6% f 
1.4%m/ 10%f 
Healthy weight control =  
37.7% m/ 54.5% f 
Unhealthy weight control = 
13% m / 18.2% f 
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Author/ Year How was insulin measured?  Clinical ED/ DEB Insulin Omission 
Very Unhealthy weight 
control = 2.9% m /19.7% f 
n/r = not reported, n/a = not applicable,  
DEPS-R = Diabetes Eating Problem Revised, SCOFF =  Sick, Control, One, Fat,  Food. YEDEQ/ EDEQ = The Eating Disorders Examination and Youth Eating Disorders 
Examination Questionnaire, EAT = Eating Attitudes Test, EDI = The Eating Disorder Inventory, EDS = The Eating Disturbance Scale, BITE = Bulimia Inventory Test 
Edinburgh, BES = The Binge Eating Scale, TFEQ = The Three Factor Eating Questionnaire, NEQ = The Night Eating Questionnaire,  AHEAD = Assessing Health and 
Eating among Adolescents with Diabetes, QWEPR = Questionnaire of Weight and Eating Patterns, DSMED = The Diagnostic Survey for Eating Disorders, PFS = Power 
of Food Scale 
sub = subthreshold AN = Anorexia Nervosa, BN = Bulimia Nervosa, EDNOS = Eating Disorder Not Otherwise Specified, DEB = Disordered Eating Behaviour 
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2.5 Discussion 
2.5.1 Summary  
This is the largest systematic review to date investigating how EDs are measured in the T1 
population. This review shows that there are many inconsistencies between research papers 
in a number of important aspects and that there are serious methodological issues in the 
canon. The majority of research used a cross-sectional approach and came from the US 
followed by Canada. The UK seems to be somewhat behind with very few articles. Sample 
size and recruitment methodology were often flawed with most of the research utilising too 
small a sample from a small geographical area to adequately make population assumptions. 
There does appear to be a general consensus that females are more susceptible to T1EDs but 
the review also found a worrying trend with more males displaying higher levels of ED 
symptomology and insulin omission in more recent years. This is especially concerning as 
only one paper focussed exclusively on males.  Researchers seemed to be predominantly 
interested in young adults and adolescents which is interesting as it is understood that EDs 
appear later in the Diabetic population or at least have a higher age threshold when looking 
at risk (Goebel-Fabbri et al., 2011). When looking at research with patients who have been 
diagnosed with EDs this trend appears with most of the papers focussing on adults. Among 
this group BN and EDNOS were the most frequent diagnoses and although it has been argued 
that AN is less frequently seen several papers reported diagnoses. 
In self-report based research it was less likely that clinical diagnoses would be offered, rather 
a plethora of risk categories were reported such as ‘probable ED’ (Powers et al., 2016), 
‘Elevated Eating Disorder Behaviour’ (Johnson et al., 2014), ‘Very Unhealthy Weight 
Control’ (Schwartz et al., 2002) and ‘Mildly Eating Disturbed’ (Maharaj et al., 2003). A large 
variety of instruments used to make these assumptions with the EDEQ, DEPS-R and the EDI 
being the most popular. In interview-based research the EDE or the chEDE were used nearly 
exclusively. While most researchers reported adapting their instruments to account for the 
effects of Diabetes there were still a substantial number who did not, furthermore while 
insulin omission was measured by the majority of researchers it was not necessarily reported.  
Rates of insulin omission varied widely but generally samples including adults reported 
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higher levels than those based on adolescents and children. In those utilising a clinical 
sample, much higher levels of insulin omission were seen with rates reported to be as high 
as 90% suggesting that for those diagnosed with an Eating Disorder, this is a key tenet of the 
illness. 
2.5.2 Interview Research 
Although clinical interview is thought of as the gold standard when diagnosing EDs there are 
sizable issues utilising this methodology in T1ED. The most probable issue of using clinical 
interviews with the T1D population is awareness of insulin omission as a weight loss tool. 
Even then, someone who is omitting for weight loss may not screen as being clinically 
concerning, indeed they may not score high enough on any of the EDE subscales because 
they are omitting insulin. In T1ED the food may be less fear inducing than administering 
insulin, or it may be the combination of food and insulin that elicits psychopathology (Goebel 
– Fabbri, 2017). The most recent version of the EDE (ver 17) does not mention insulin 
omission directly. Similarly, to its adult counterpart the chEDE interviewer would need an 
operational knowledge of how Eating Disorders present in those with T1D in order to make 
an accurate assessment. Regardless of this several researchers do not mention adapting the 
interview to account for insulin omission (Grylli et al., 2010; Grylli et al., 2005), which may 
account for a number of ‘no ED diagnosis’ cases. Other researchers do adapt the interviews 
but amalgamate insulin omission into ‘Disordered Eating Behaviour’ without reporting 
individual levels (Wisting et al., 2015; Colton et al., 2013).  It is important to note that using 
interviews may lead to a lower reporting of insulin omission than self-report, and this may 
be more pronounced in males. It should also be considered that this demographic are 
acclimatised to talking to HCPs about their health and potentially hiding aspects that they do 
not want to discuss (Svenson et al., 2003; d’Emden et al., 2012). For clinical purposes this 
may suggest that a self-report measure administered prior to an invitation to interview may 
be more appropriate for use as a tool, once insulin omission has been confirmed by 
questionnaire it can be discussed. It may be suggested that an entirely new diagnostic 
interview specific to T1ED should be developed that can separate the nuances of T1D from 
what is true Eating Disorder pathology and insulin omission for weight loss. 
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2.5.3 Regimen Effects 
This is not however to say that self-reporting was free from issues. One of the main problems 
is that the questionnaires that are not Diabetes specific do not take into account how Diabetes 
regimen may bias responses. For example, a study undertaken using those with T1ED and 
those with ED suggested that around 50% of the questions in the EDEQ could be influenced 
by T1D (Powers et al., 2013). There are ambiguous items in the scale whereby ‘abnormal’ 
eating behaviour may be due to T1D and rather than an ED (Items 7,9 13, 14) which would 
inflate estimates of prevalence. However, one of the potential benefits of using the EDEQ 
lies in the wording. The specifier ‘because of weight and shape’ eradicates any potential for 
regimen related effects to be scored as Eating Disorder symptomology. For example, ‘Have 
you tried to exclude from your diet any foods that you like’ may elicit a false positive among 
those with T1D who use a low carbohydrate diet to control blood glucose. Similar issues 
arise when using the EDI. The most common composite used was EDI-3RC (Drive for 
Thinness, Bulimia Scale, and Body Dissatisfaction Scale). The use of composites rather than 
the full scale allows for a shorter questionnaire which may be advantageous especially in 
large scale studies using multiple instruments. In this composite however, there are items that 
may relate to Diabetes regimen (Items 1, 5 and 7 Drive for thinness). This having been said 
a study undertaken comparing those with T1ED and those with ED suggested that only 
around 7% of the questions in the EDI3 could be influenced by T1D (Powers et al., 2013). 
Issues are also apparent in the SCOFF questionnaire which only utilises five questions, one 
of which (question 2) may be sensitive to T1D regime effects. Regardless some authors have 
used this to measure with little mention of potential problems (Bachle et al., 2015). The EAT 
suffers from similar issues. A T1D may avoid eating when hungry depending on their BG 
reading, similarly they are advised by specialists to be aware of the nutritional content of 
their food and many follow a low carbohydrate diet which may include consuming ‘diet 
foods’ avoiding high carbohydrate/ sugar items. This is an issue when using any of the 
subscales, particularly dietary restraint (Battaglia et al., 2006). Research that does employ 
this instrument has found startlingly increased ED symptomology in T1EDs compared to 
those without T1, some suggesting that EDs may be four times as common (Pinar et al., 
2005). Hunger may also be dysregulated in T1D, episodes of hypo and hyper glycemia 
markedly affect appetite, increasing it drastically, so asking questions regarding ‘being out 
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of control’ or ‘eating lots of food at once’ needs to take that into account which this scale, 
the BITE and the EDI do not. Even questions such as ‘can you leave food’ are inappropriate 
as that may be determined by what point the participant takes insulin; the carbohydrate 
counting approach to T1D management advises patients to inject for the amount they are 
going to consume at the start at the meal.  
Given that all of the scales used are fundamental flawed it could be argued that none are 
appropriate, they pathologise behaviour that is normal in a T1D context while missing aspects 
(and often the most dangerous behaviour, insulin omission) specific to that demographic. 
Furthermore, prevalence estimates cannot be trusted using these instruments for the same 
reason.    
2.5.4 Psychological Effects 
Regimen effects are not the only T1 related issues when utilising standard questionnaires. 
Type 1 Diabetes carries a heavy psychologically burden often in relation to issues addressed 
in these scales such as feelings and thoughts around food. T1Ds often proclaim that food is 
a domineering influence in their lives, that they are preoccupied with it and give too much 
thought to it, while also displaying self-control in order to manage BGs. There is guilt around 
breaking a strict diet that may be for BG control rather than weight loss. Many consultants 
encourage their patients to keep food diaries with nutritional information. This may influence 
responses to questions on all of the scales. For example, the PFS asks the participants to rate 
the question ‘It's scary to think of the power that food has over me’ (de Cássia, Sparapani, 
Jacob & Nascimento, 2015; Rohan et al., 2013; Rossi et al., 2013; Goebel-Fabbri, 2017)   
Furthermore, T1EDs which are defined behaviourally by insulin omission may circumvent 
the intentions of this screening instrument. Battaglia et al., (2006) for example removed the 
question “I eat sweets and carbohydrates without feeling nervous” from the EDI when it 
could be argued that those who are insulin restrictors happily consume carbohydrates and 
sweets, that is the exact mechanism via which they increase their blood glucose and thus lose 
weight. If they had added ‘and then take insulin’ or some variant thereof they may have a 
better understanding of how T1EDs operate. These issues further highlight the need to 
eradicate the use of non T1D specific instruments from research in this population.  
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2.5.5 Modifications & Questions on Insulin Omission.  
Several researchers offered specific modifications for the scales that would make them less 
biased to Diabetes specific regimen and psychological effects, for example a modified 
SCOFF (MSCOFF) was proposed whereby the last question was removed and replaced by a 
question addressing insulin ‘Do you ever take less insulin than you should?’ (Zuijdwijk et 
al., 2014) or ‘How often did you inject too little or no insulin after carbohydrate intake during 
the last week?’ with the response categories ‘never,’ ‘once or twice a week’, ‘3 to 5 times a 
week’, ‘(almost) every day’, or ‘more than once a day’ (Baechle et al., 2014) however it may 
still generate a false positive by failing to inquire whether insulin omission is due to weight 
and shape concerns or other issues rather than other issues such as fear of hypoglycaemia (In 
this particular piece of research patients with a known ED history were excluded from the 
analysis which removed a potential reference category).  Research using this questionnaire 
has claimed that disturbed eating behaviour is not more common in youth with T1D (Baechle 
et al., 2014).  
As the EDE and the YEDE has a subscale relating to disturbed eating behaviours it may be 
ideally placed to add in questions surrounding insulin omission as a DEB. Indeed, researchers 
have done this and kept the original scoring intact, concluding that insulin omission for 
weight and shape concerns may be over reported due to the omission of this specifier 
(d’Emen et al., 2012).  Goebel-Fabbri et al (2008) asked participants to rate the statement ‘I 
take less insulin than I should’ with a Likert response that ranged from ‘never’ to ‘always’ in 
a longitudinal study which aimed to ascertain the associated complications and mortality rate 
of insulin restriction. They demonstrate that those who have higher levels of insulin 
restriction also score higher on a number of ED measures but also on psychological issues 
regarding T1D that are not necessarily related to ED for example ‘fear of hypoglycaemia’. 
Snyder (2016) surveyed adolescents with T1D in order to find out how many young people 
were misusing insulin and found that out of 11 participants who admitted to intentionally 
under or over dosing on insulin only 2 did so out of a desire for weight control. However 
Goebel-Fabbri (2011) justifies the use of such questioning by pointing out that directly asking 
whether insulin omission is due to weight and shape concerns may elicit a false answer from 
participants who feel pressure to be compliant and it should be added that Snyder asked his 
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questions to adolescents with their parents in a room next door which may have biased 
results.  
When questions on insulin omission are added they may be so as an addendum and not part 
of any particular subscale or overall eating pathology (Battaglia et al., 2006). Some 
researchers have attempted to circumvent these issues by creating their own questionnaires 
with questions such as ‘I am afraid that getting my blood sugars in good control will cause 
me to gain weight’ and ‘Taking insulin makes me gain weight’ (Goebel – Fabbri 2011). 
However, there is not enough consensus on how and when modifications should be made nor 
is there enough research to contrast unmodified and modified versions of instruments to 
recommend which scales or specific questions are suitable to be used. As a result, it maybe 
concluded that indeed none are suitable and a T1D specific instrument is the only acceptable 
option or alternatively, something new must be conceived.   
2.5.6 Diabetes Specific Instruments  
There appears to be more consensus on levels of disturbed eating behaviour when using T1D 
specific instruments. The DEPS-R in female population consistently reports symptomology 
of around 30 % although rates in males are less consistent. However, the DEPS-R does not 
provide diagnoses estimates and instead opts for a cut-off point for clinical concern.. The 
studies using the AHEAD protocol found much lower rates of Eating Problems but that may 
be due to the researcher recruiting much younger participants. It could be argued then that 
currently the DESPR produces the most consistent results and thus should be recommended 
for use (please see chapter 9 for a larger discussion on the use of the DEPS-R).   
2.5.7 Diagnoses 
Perhaps due to changing attitudes regarding insulin omission, Eating Disorders in T1D are 
described differently. Several authors use the moniker Disordered Eating Behaviour (DEB) 
and a scale of severity to describe unhealthy weight control practices in this group. Olmsted 
et al define DEB as ‘dieting for weight control binge eating, self -induced vomiting, or the 
use of diuretics, laxatives, insulin omission, or intense exercise for weight control’ (2008, p. 
1978).  Nomenclature tends to depend on the instrument used however. Many researchers 
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are quick to highlight that insulin misuse is the differential factor for Eating Disorder between 
those who do and do not have T1D. What is potentially worrying is that even when insulin 
omission is present and is the primary symptom, diagnoses vary. Thus, two patients 
displaying exactly the same pathology and behaviour may vary on diagnosis by one factor 
such as BMI (Custal et al., 2014).  BMI is particularly problematic for use in this population 
as T1 carries a weight penalty of around 15% (DCCT, 1995).   
A longitudinal study by Olmsted et al found that Disordered Eating Behaviour may predict 
later insulin omission (2008). They highlight this while stating that despite nearly half of 
their study participants developing DEB none of them met the criteria for a clinical diagnosis.  
Similarly, a large prevalence of DEB in T1Ds may be found and yet no increase in prevalence 
of EDs reported (Iafusco et al., 2004). 
The use of the diagnostic label Eating Disorder Not Otherwise Specified is often used for 
T1s who ‘only’ omit insulin but do not display any other Eating Disorder symptoms (Colton 
et al., 2013). This is problematic as research has shown that T1EDs who engage in 
‘Diabulimia’ do not see themselves as having EDNOS (Allan, 2014), furthermore there are 
treatment implications for this diagnosis. It is often seen as a less serious variant of Eating 
Disorders or not a ‘full’ Eating Disorder (Colton et al., 2004) and while this may hold true 
for the general population, given the dangers associated with insulin omission it may be 
inappropriate and potentially hazardous for this demographic. Similarly diagnoses of 
‘subclinical Eating Disorders’ are also common (Grylli et al., 2010; Colton et al., 2013; 
Colton et al., 2015) and perhaps more problematic. Given that insulin omission events are 
often equated to excessive exercise or purging and are thus rated on frequency it could be 
argued that a subclinical diagnosis is inappropriate. DKA is frequently fatal, one episode of 
omission could lead this biological state, so even if this occurs only once a month (extremely 
low frequency) the risk is much higher and therefore must be dealt with as a matter of 
urgency, something that may not occur with the nomenclature ‘subclinical’. This can also be 
seen in questionnaires that ask about frequency of insulin omission without explaining how 
boundaries have been met or if this has been done with any clinical consideration or just 
completely arbitrarily, for example severe omission is seen by Takii et al., (2002, 2003) as 
omission of at least 25% of the total dose of insulin prescribed while others set other limits 
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(Baechle et al., 2014; Pollock-BarZiv & Davis, 2005). It may be that this attempt to 
amalgamate insulin omission into wider Eating Disorder pathology is in order to demonstrate 
that other than this behaviour, EDs appear in this population as it does in the general 
population, however when looking at patient attributions of what contributed to the 
development of their Eating Disorders (see chapter 7) Diabetes specific aspects feature 
heavily. That they do shows that by nature EDs in this population are different. In research 
focussing on patients with confirmed ED it is consistently reported that T1Ds have much 
worse outcomes and higher dropout rates than their non T1D counterparts (Colton et al., 
2015a; Colton et al.,2015b). This may suggest that the treatment is not working because 
regardless of the diagnoses, in T1D EDs are fundamentally different. It could therefore be 
argued that what is required in order to treat these patients is an approach separate from that 
taken in standard ED. In T1EDs who omit insulin food is a mechanism by which to lose 
weight, the more one eats the quicker blood glucose rises and the more weight can be lost. 
For these patients, food may not be, as assumed in standard models of EDs, ‘the enemy’. It 
is in fact the insulin and taking the correct dosage that is the source of pathology.   
It should be noted that in some of the surveys non-responders were more likely to have higher 
HbA1c levels (Svenson et al., 2003; Neumark – Sztaine et al., 2002; d’Emden et al., 2014), 
in some cases this is taken to suggest higher levels of ED symptomology but again there is 
an issue with boundaries between high and normal HbA1c. For example, one study may use 
above the recommended NICE guideline and another may select one somewhat arbitrarily 
stating that these are ‘generally accepted’ (Bernstien et al., 2013, p. 11) but not by whom. It 
must also be considered that not all raised HbA1c are due to EDs, there are many factors that 
may affect that BG, periods of stress, periods of growth, bereavement to name but a few.  
The above may explain why diagnoses vacillate widely. As such it could be argued that 
diagnostic categories are currently of little use in this population. They do not describe the 
main feature of insulin omission appropriately, they do not weight it in any considered 
manner and there is not any consensus on what constitutes severity either.  
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2.5.8 Strengths  
The purpose of the current review was to provide the broadest overview possible of how EDs 
in the T1D population have been measured since Nielson’s 2002 article. In doing so this is 
the largest systematic review to date in this area and it las looked at every aspect possible. 
Unlike other studies it has not focussed on controlled research, clinical samples or interview 
research only and as such can make broader assumptions.    
2.5.9 Limitations 
The purpose of this review was to be as broad as possible but in doing so there may have 
been some finer details that have been omitted. It was deemed inappropriate to only review 
controlled studies as there is a strong argument that for this group, there is no appropriate or 
equivalent control in the general population. Further research may wish to focus on the 
differences between those with T1D who do and do not have EDs, rather than on a control 
group of non T1Ds.  
As the aim of the current study was to be as broad as possible, quality was not considered as 
a prerequisite for inclusion. On reviewing the literature, it became apparent that the majority 
of assumptions made regarding T1ED were based on fundamentally flawed instruments. 
Therefore, even studies with excellent methodology are essentially problematic. It is for this 
reason that alpha levels reported in the studies were considered irrelevant (this is further 
expanded in the proceeding chapter).     
2.6 Conclusion  
The canon of research investigating Eating Disorders in Type 1 Diabetes is, for lack of a 
better term, messy. There is little consensus as to which instrument to use, if or how it should 
be modified, what diagnoses should correspond to insulin omission and sample sizes tend to 
be problematically low and from small geographical regions. Prevalence rates of both clinical 
diagnoses and insulin omission vary wildly and conclusions regarding this group as a whole 
are difficult to make.    
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The vast majority of research investigating treatment programmes for these patients have 
concluded that standard models don’t work and that relapse and dropout rates are higher 
(Colton et al., 2015a; Colton et al., 2015b). That would seem a relatively obvious outcome if 
we accept that the reason for this failure is an error in what actually needs to be treated. This 
would also concur with evidence that shows that patients themselves differentiate between 
diagnoses, they see ‘Diabulimic’ as behavioural (insulin restriction or omission), just as they 
appear to differentiate as bulimic when they binge and purge (Allan, 2014). There is not a 
scale for these participants. Even Diabetes specific questionnaires have issues. It may be that 
a serious effort to explore these patients qualitatively would bear more accurate instruments 
to describe the psychopathology of this group. For example, Peveler et al state  
It is clear that insulin misuse for the purpose of weight control is not confined 
to subjects with a clinical Eating Disorder. (Peveler et al., 2005, p. 87) 
And herein may lie the fundamental problem. For this group Eating Disorders and 
maladaptive weight and shape control are fundamentally different from the general 
population because of insulin omission and other T1D specific factors; their ‘clinical’ is not 
something that is adequately described by looking to standardised models. Validation studies 
stress the importance of assessing the ‘full spectrum of Eating Disorder pathology’ (d’Emden 
et al., 2012, p 997) but it appears that for those with T1ED we do not understand that full 
spectrum yet.  
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3 Scale Comparison 
3.1 Introduction 
The systematic review undertaken in the previous chapter demonstrates that from the 60 
papers reporting ED symptomology more than 21 different measurement instruments were 
used. Among these articles though, few investigate the potential problems of utilising the 
scales in a population who by nature have what may be viewed as abnormal eating patterns, 
in a systematic or meaningful way despite acknowledgement that these are genuine issues. 
As previously discussed people with T1D for example may utilise more restrictive diets, 
avoid certain food groups, feel like their eating is out of control or experience negative 
emotions around food that are due to the pressures of the Diabetes regimen rather than as a 
result of an ED. Furthermore, insulin omission for weight loss is a behaviour uniquely 
available to this population and as such is not covered by standardised Eating Disorder 
questionnaires with researchers often adding items regarding this action as an adjunct. 
Powers et al. (2012, 2013) sought to ascertain the effect that T1D would have on two common 
self-report scales; the Eating Disorders Examination Questionnaire (EDEQ) and the Eating 
Disorder Inventory (EDI). They did this by first comparing screening scores between those 
with T1ED who had been treated at an Eating Disorder clinic and those with ED but no T1 
(2012) and then by investigating the effects T1D may have on individual items by way of an 
expert panel (2013). The 2012 study using 2:1 matched controls found that those with T1D 
actually fared better on EDEQ and EDI scores and were less ‘psychologically compromised’ 
(Powers et al., 2012, p. 252) particularly on the questions relating to food restriction and 
control. The authors conclude that this may be due to a healthier approach to meal planning 
and health monitoring that accompanies T1D, however as nearly half of their participants 
were insulin omitters an alternative explanation would be that they do not need to exercise 
restraint as they can control their weight easily via insulin manipulation.  The authors claim 
that they managed to control for participants who utilised insulin omission as their sole ED 
behaviour by using participants without T1D who had ‘diverse compensatory behaviours’ 
(Powers et al., 2012, p. 253) but there is an argument that insulin omission is a unique feature 
of T1ED that has specific biological and psychological mechanisms that cannot be controlled 
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for and thus these results may not be ecologically valid. The study only investigated the 
difference between responses on these questionnaires and did not emphasise the difference 
between clinical diagnoses which might have usefully highlighted the different behaviours 
within the diagnostic categories. 
The 2013 paper by the same team utilised an expert panel who assessed the questions on the 
EDEQ and the EDI and rated whether they thought T1D would influence the answers. They 
suggested that half of the items in the EDEQ could be heavily influenced by T1D. The EDI 
fared better with only around 7% of the questions deemed potentially influenced by T1D.  
Another ED questionnaire that is used routinely is the Eating Attitudes Test (Garner, 
Olmsted, Bohr & Garfinkel, 1982; Garner & Garfinkel, 1979). Steel et al (1989) were among 
the first to highlight that T1D could potentially bias answers to an ED measurement 
instrument. They also used an expert panel to complete the EAT 40 as if they were ‘sensible 
young Diabetics without an Eating Disorder’ (Steel et al., 1989, p. 515) and concluded that 
6 of the questions were potentially sensitive to T1D. They found in a cross-sectional, 
controlled sample that the unadjusted EAT-40 classified more T1Ds as clinically concerning 
in comparison to controls, than the modified version. In women there was still a significantly 
higher proportion scoring as concerning compared to controls but for men the difference 
became insignificant. A reduced item version of EAT has been more commonly used in 
recent years. The EAT-26 (Garner et al., 1982; Garner & Garfinkel, 1979) is widely reported 
as one of the most commonly used Eating Disorder screening measures. It consists of 26 
items that form 3 subscales, Dieting, Bulimia and Food Preoccupation and Oral Control 
scored on a 6 point Likert scale with answers ranging from ‘Always’ to ‘Never’. Items 
include Am terrified about being overweight, Find myself preoccupied with food and Avoid 
eating when I am hungry. A cut-off point of 20 is recommended for further clinical 
investigation (Patton, Johnson-Sabine, Wood, Mann, & Wakeling, 1990; Dotti & Lazzari, 
1998) unlike the EDI and the EDEQ no one has seriously considered the effect of T1D in this 
questionnaire. There have been various attempts but no general consensus as to which 
questions should be added regarding insulin omission or subtracted regarding the effects of 
Type 1 Diabetes (Jones et al., 2000).  
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A perhaps obvious solution to the issue of screening and detecting T1ED is to make sure that 
any instrument used takes regimen effects into consideration. Such an instrument would also 
need to be cognisant of the availability of insulin omission to this demographic. Such a scale 
was proposed by Antisdel et al. in 2001 and revised by Markowitz et al. in 2010. The Diabetes 
Eating Problem Survey Revised is one of the most commonly used instruments in the T1ED 
population. The DEPS-R is a unidirectional scale that is designed to give a global score of 
ED symptomology. In this sense it treats Diabetes related Eating Disorders as a homogenous 
syndrome. However, researchers have pointed out that sections of the DEPS-R deal 
exclusively with Eating Disorder symptomology attributed to insulin administration. Merwin 
(2014) states that the five items on the DEPS-R relating to insulin omission are I try to keep 
my blood sugar high so that I will lose weight,  I try to eat to the point of spilling ketones in 
my urine,  I feel fat when I take all of my insulin,  After I overeat, I don’t take enough insulin 
to cover the food and After I overeat, I skip my next insulin dose.. Wisting et al. (2013) 
describe a large-scale registry study whereby they utilise a sample of T1D adolescents to 
explore the structure of the DEPS-R suggesting a 3-factor solution broadly relating to eating 
habits, drive for thinness and insulin omission. Similarly, Altinok et al. (2017) state that they 
performed a confirmatory factor analysis on the DEPS-R using a Turkish sample of a similar 
age, but they do not state the factor structure found.  
3.2 The Current Study  
The purpose of the current study was to examine the properties of the EAT 26 and the DEPS-
R using a large cross-sectional sample of adults with T1D.  
The EAT 26 was first used to investigate how many participants screened above the cut-off 
point for clinical concern compared to the DEPS-R. Then questions that could be considered 
biased by T1D by decision of an expert panel were removed from the EAT-26 and the 
analysis repeated to explore whether this reduced the number of participants scoring above 
the cut-off point. Gender differences were also explored. It was hypothesised that initially 
the EAT-26 should identify more participants above the cut-off point than the DEPS-R but 
by removing items potentially biased by T1D should reduce that proportion. 
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The factor structure of the DEPS-R was then investigated using exploratory factor analysis 
with methodology replicated from Wisting et al. (2013) in order to ascertain whether the 
DEPS-R performed similarly in an adult sample (as compared to the adolescent samples used 
by Wisting et al. (2013) and Altinok et al. (2017) and to explore whether subscales relating 
to different behaviours may be viable. The response patterns to the questions suggested by 
Merwin et al. (2014) that relate directly to relating to insulin omission were then described 
in terms of whether the behaviour is ever present and the potential of using them as a subscale 
was tested. It was hypothesised that the questions in the DEPS-R would be related to 
underlying factors that potentially describe different types of ED behaviour and that the 
questions suggested by Merwin (2014) would form a subscale relating directly to insulin 
omission.  
3.3 Methodology 
3.3.1 Design 
For the first section comparing global EAT-26 score to global DEPS-R score, as the variables 
were categorical and within subjects, McNemar’s test was used to investigate the difference 
in proportions of those scoring above the cut-off point for clinical concern. Following this a 
modified version of the EAT 26 was analysed to determine if this lowered the proportion 
scoring above the modified cut-off point. Then in line with Wisting et al. (2013) a Principal 
axis factoring with oblimin rotation was performed on the DEPS-R data to ascertain any 
underlying latent structure. Next as the DEPS-R utilises a Likert scale with the response 
options ‘never’, ‘rarely’, ‘sometimes’, ‘often’, ‘usually’, and ‘always’, the data relating to 
the five items on the relating to insulin omission as defined by Merwin et al (2014) were 
transformed so that any presence of the behaviour was coded as yes response and no presence 
as defined by a ‘never response’ was coded as a no response.  
3.3.2 Ethical Approval, Setting, Procedure, Survey Participants  
Please note that the data collected for the current study was part of a larger data collection 
that informs chapters 4 – 7.  
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3.3.3 Ethical Approval  
Ethics approval for this study was granted by the Birkbeck departmental ethics committee on 
the 27th January 2014, approval number 131462 
3.3.4 Setting  
Recruitment took place over the period of 04/05/2015 – 01/10/2015. An advert was posted 
on the social media pages of the registered charities: Diabetes UK, the Juvenile Diabetes 
Research Foundation, Diabetics with Eating Disorders. The same advert was also posted on 
every Facebook page offering support and information to those with Type 1 Diabetes and the 
biggest online support forums for Type 1 Diabetes: Diabetes.co.uk, TuDiabetes and 
Diabetessupport.co.uk. A shorter version was also put on Twitter using the popular Diabetes 
hashtags #T1D, #DOC and #GBDOC. Participants were invited to share the advert on their 
social media pages and notify their Type1 friends/colleagues/health care professionals. 
(please see appendix H).   
3.3.5 Procedure 
If participants decided to take part they were taken to the website 
www.typeoneandpsychology.org where specially designed ‘questioner’ software was hosted. 
The website was built using Wordpress and the software was built in the python 
programming language. The resultant database utilised MySQL and was held on a private 
secure virtual server owned by the researcher. The landing page gave information about the 
study and asked for consent, on completing the ethics questions, the participants were taken 
through to the Questioner programme (please see appendix I). The Questioner programme 
was designed so that after the demographics questions were answered, if they chose, 
participants could create a user account that allowed them to sign in and out of the programme 
at their convenience as the study was long. A number of scales were presented for completion  
(that inform other sections of this research) including those used in the present chapter and 
then the participants were debriefed (please see appendix J). 
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3.3.6 Participants 
Eligibility criteria for the participants were being over the age of 16, having been diagnosed 
by a medical professional as having Type 1 Diabetes and having a good grasp of English. As 
the study was conducted online internet access was also essential. This may have been via a 
computer/ table/ laptop/ smartphone. All of the participants fulfilled this criteria none were 
excluded from the final analysis. 
3.3.7 Expert Panel  
An expert panel including 2 Diabetes consultants, a Diabetes dietician, a diabetic specialist 
nurse, 2 Diabetes consultant psychiatrists, a psychiatrist with experience of Diabetes and the 
researcher, 2 of whom also have T1D rated each of the items on the EAT 26 as potentially 
biased by Diabetes via email communication with the researcher.    
3.3.8 Materials   
The Diabetes Eating Problem Survey Revised (see section 2.4.8.1) and the Eating Attitudes 
test 26 Item was used (see section 2.4.7.3).   
3.3.9 Software  
IBM statistics SPSS ver 23 (IBM Corp. 2016) was used to perform the analyses 
3.4 Results  
Please note that the demographic information for this study is also noted in section 6.2 
3.4.1 Sample Characteristics 
3.4.1.1 Initial Numbers 
687 participants started the questionnaire having being recruited mostly by social media (610/ 
88.8%). All participants completed the gender question. 92 (13.4%) were male, 592 (86.2%) 
were female, 2 were transgendered (0.3%) and 1 selected prefer not to say (0.15%). 686 
participants gave their age. They had mean age of 33.73 (12.01) years (range:16 – 69). Many 
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nationalities were reported but most were UK/ Eire and US nationals living in those countries 
all participants answered these questions and the ethnicity question, the majority (599/ 
87.2%) were white and a large minority selected prefer not to say (81/ 11.8%) (for the full 
characteristics of the participants please see appendix K).  
3.4.1.2 Medical Status 
686 participants reported a mean age at diagnosis of 15.48 (11.58)8 years (range: 0 – 61) and 
a mean duration T1D of 18.25 (11.98) years (range: 0 – 59). 659 participants reported a mean 
HbA1c% of 8 (2.24, range: 4 – 29%). 530 participants reported their methods of blood sugar 
management. 319 (60.2%) utilised a pump, 200 (37.7%) were on multiple daily injections, 4 
(0.75%) used a mixtard9, 6 (1.13%) used syringes and vials and 1 (0.19%) used inhaled 
insulin. 222 (41.89%) of these patients also utilised a continuous glucose measurement 
device. 684 participants reported a mean of 0.67 (1.12) Diabetes related complications.  The 
most commonly reported were Retinopathy and other eye issues (Macular Oedema, Cataracts 
and Glaucoma) (162/ 23.7%), Neuropathy (101/ 14.7%), Gastroparesis (47/ 6.9%) and 
Nephropathy (36/ 5.3%). The 684 participants were taking an average of 0.23 (0.84) 
medications to manage these conditions. Of the 687 asked, 325 (47.3%) participants reported 
having more than Diabetes as a medical diagnosis. Of these the most common conditions 
experienced were Hypothyroidism (95/ 13.8%), Asthma (56/ 8.15%) and Coeliac Disease 
(23/ 3.3%) (for full participant medical status please see appendix K). 
3.4.1.3 Participants Mental Health Information 
439 participants answered the question ‘have you ever had a mental health diagnosis (except 
an Eating Disorder diagnosis)’ 193 (44%) answered yes so participants had a mean of 0.678 
                                                 
 
8 Please note that this statistics in this thesis follows the following convention when reporting means. 
MEAN (STANDARD DEVIATION)  
9 A mixtard is an injectable form of insulin that contains both long acting and short acting insulin. 
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(.913). Of those who did report other diagnoses the most common were depression (155/ 
35.3%), anxiety (79/ 18%) borderline personality disorder (14/ 3.2%), bipolar disorder (10/ 
2.3%), and post-traumatic stress disorder (10/ 2.3%) for full participant mental health 
characteristics please see table 1.6.  Participants who had reported having another mental 
health diagnosis had a mean of 1.52 (0.78 min 1 – max 5) conditions. 435 participants 
answered the question ‘to the best of your knowledge does anyone in your family have a 
mental health diagnosis?’. Of them 217 (49.9%) answered yes, 173 (39.7%) answered no and 
45 (10.3%) stated that they weren’t sure. 435 participants answered the question ‘to your 
knowledge has anyone in your family ever had an Eating Disorder?’ of these 60 (13.8%) 
answered yes, 354 (81.4%) answered no and 21 (4.8%) stated that they weren’t sure.  439 
participants answered the question ‘have you ever been diagnosed with or thought that you 
had an Eating Disorder’ of these 130 (29.9%) answered yes (for full participant mental health 
status please see appendix K). 
3.4.2 Modified EAT 26  
An item was deemed potentially sensitive to T1D if it was selected by 5 out of the 8 expert 
panel. The panel concluded that 50% of the items as detailed in the table below were 
potentially biased  
Table 3.1: EAT-26 and Potentially Biased Items.  
Question Subscale Remove 
1) Am terrified about being overweight. Dieting 
 
2)      Avoid eating when I am hungry. Oral Control  x 
3)      Find myself preoccupied with food. Bulimia and Food 
Preoccupation 
x 
4)      Have gone on eating binges where I feel 
that I may not be able to stop. 
Bulimia and Food 
Preoccupation 
x 
5)      Cut my food into small pieces. Oral Control  
 
6)      Aware of the calorie content of foods 
that I eat. 
Dieting x 
7)      Particularly avoid food with a high 
carbohydrate content (i.e. bread, rice, 
potatoes, etc.) 
Dieting x 
8)      Feel that others would prefer if I ate 
more. 
Oral Control  
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Question Subscale Remove 
9)      Vomit after I have eaten. Bulimia and Food 
Preoccupation 
 
10)   Feel extremely guilty after eating. Dieting x 
11)   Am preoccupied with a desire to be 
thinner. 
Dieting 
 
12)   Think about burning up calories when I 
exercise. 
Dieting 
 
13)   Other people think that I am too thin. Oral Control  
 
14)   Am preoccupied with the thought of 
having fat on my body. 
Dieting 
 
15)   Take longer than others to eat my meals. Oral Control  
 
16)   Avoid foods with sugar in them. Dieting x 
17)   Eat diet foods. Dieting x 
18)   Feel that food controls my life. Bulimia and Food 
Preoccupation 
x 
19)   Display self-control around food. Oral Control  x 
20)   Feel that others pressure me to eat. Oral Control  
 
21)   Give too much time and thought to food. Bulimia and Food 
Preoccupation 
x 
22)   Feel uncomfortable after eating sweets. Dieting x 
23)   Engage in dieting behaviour. Dieting x 
24)   Like my stomach to be empty. Dieting 
 
25)   Have the impulse to vomit after meals. Bulimia and Food 
Preoccupation 
 
26)   Enjoy trying new rich foods. Dieting 
 
  
3.4.3 Completion  
516 participants completed the Eating Attitudes Test 26 in its entirety. 491 participants 
completed the Diabetes Eating Problem Survey Revised in its entirety. Only whole responses 
were analysed, data was missing completely at random (Littles test Chi-Square = 2901.456, 
df = 3356 p =1) 
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3.4.4 EAT 26 vs DEPS-R  
3.4.4.1 Reliability  
In this sample the total EAT 26 scale showed good internal reliability (Cronbach’s alpha = 
.908). The dieting subscale also demonstrated good validity (Cronbach’s alpha = .877) as did 
the Bulimia and food preoccupation subscale (Cronbach’s alpha = .813) but was reduced for 
oral control (Cronbach’s alpha = .718). The modified EAT containing the 13 questions which 
were assumed to be unbiased also had good validity (Cronbach’s =.833), the dieting subscale 
had good validity (Cronbach’s = .817), as did the oral control subscale (Cronbach’s alpha = 
.719) and the bulimia and food preoccupation subscale (Cronbach’s alpha = .816) 
The DEPS-R demonstrated very good validity (Cronbach’s alpha =.936) 
3.4.4.2 Cut-Off Points  
As the EAT-26 has a cut-off point of 20 and 50% of the items were deemed to be potentially 
biased the cut-off point for the modified EAT 26 was 10.  
Table 3.2 Means and Frequencies of those Scoring above the Cut-Off Point  
 
Mean (sd) Above cut-
off  
% 
(valid) 
Missing % (total) 
Total Sample           
DEPS R  23.19 (17.24) 217 44.2 196 28.5 
EAT-26  38.55 (16.1) 443 85.9 171 24.9 
Modified EAT 28.32 (8.48) 475 92.1 171 24.9 
Males            
DEPS-R  15.89 (14.48) 13 20.6 29 31.5 
EAT-26 47.55 (20.73) 62 93.9 26 28.3 
Modified EAT 27.15 (10.96) 63 95.5 26 28.3 
Females            
DEPS-R  24.33 (17.39) 204 47.9 166 28.0 
EAT-26 37.16 (14.84) 378 84.6 145 24.5 
Modified EAT 22.7 (7.9) 409 91.5 145 24.5 
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3.4.5 McNemar Chi Square  
A McNemar Chi square showed that there was a significant difference between those scoring 
yes and no for further investigation with participants scoring yes significantly more often 
using the EAT-26 than the DEPS-R. (n = 459, chi square = 109.829, p <0.001) when looking 
at the population as a whole. This assumption held when looking individually at male 
participants (n = 56, chi square = 36.54, p <0.001) and female participants (n = 401, chi 
square = 75.52, p <0.001). 
A McNemar Chi square also showed that there was a significant difference between those 
scoring yes and no for further investigation with participants scoring yes significantly more 
often using the modified EAT than the DEPS-R (n = 459, chi square = 158.305, p<0.001) 
when looking at the population as a whole. This assumption held when looking individually 
at male participants (n = 56, chi square = 35.021, p <0.001) and female participants (n = 401, 
chi square = 120.831, p<0.001). 
As expected the unmodified EAT 26 identified more participants as clinically concerning 
than the DEPS-R but unexpectedly, using a modified version of the EAT actually increased 
the rates of those scoring as clinically concerning. More males were also identified as 
concerning than females.  
3.4.6 Factor Structure of the DEPS-R  
3.4.6.1 Data Screening  
Item correlations between all of the items were checked to ensure that they had values above 
r = .3 indicating that they had sufficient relationships. No variables were removed from the 
analysis (please see appendix L for the full correlation matrix). 
3.4.6.2 Sampling Adequacy   
The Kaiser-Meyer-Olkin measure of sampling adequacy was over the recommended value 
of .5  (KMO = .945) indicating that there is a sufficient proportion of variance in the sample 
which may be attributable to underlying factors. Bartlett’s test of sphericity was significant 
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Chi Square = 5449.596 df = 120 p < 0.001 suggesting that there are related variables and 
therefore a factor analysis is a suitable procedure.  
3.4.6.3 Extraction and Rotation  
In replication of Wisting et al (2013) a Principal axis factoring with oblimin rotation was 
performed. Using the Kaiser – Gutman Criteria of retaining factors with an Eigen value over 
1 a 2 factor solution was suggested, factor 1 explained 53.1% of the variance and factor 2 
8.6% with a cumulative explanatory power of 61.7%.  
Figure 3.1 Scree Plot of Suggested Factors  
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3.4.6.4 Factor Loadings  
Table 3.3: Factor Structure 
 
Factor 
1 2 
DEPS-R1 Losing weight is an important goal to me 
 
0.717 
DEPS-R2 I skip meals and/or snacks 
  
DEPS-R3 Other people have told me that my eating is out of control 0.448 
 
DEPS-R4 When I overeat, I don’t take enough insulin to cover the 
food 
0.671 
 
DEPS-R5 I eat more when I am alone than when I am with others 
 
0.530 
DEPS-R6 I feel that it’s difficult to lose weight and control my 
Diabetes at the same time 
 
0.728 
DEPS-R7 I avoid checking my blood sugar when I feel like it is out 
of range 
0.605 
 
DEPS-R8 I make myself vomit 0.471 
 
DEPS-R9 I try to keep my blood sugar high 0.995 
 
DEPS-R10 I try to eat to the point of spilling ketones in my urine 0.950 
 
DEPS-R11 I feel fat when I take all of my insulin 0.569 
 
DEPS-R12 Other people tell me to take better care of my Diabetes 0.613 
 
DEPS-R13 After I overeat, I skip my next insulin dose 1.021 
 
DEPS-R14 I feel that my eating is out of control 
 
0.516 
DEPS-R15 I alternate between eating very little and eating huge 
amounts 
 
0.468 
DEPS-R16 I would rather be thin than to have good control of my 
Diabetes 
0.676 
 
 
3.4.6.5 Reliability  
The first factor which could be conceptualised as the more severe behaviours such as insulin 
omission, vomiting and neglecting Diabetes self-care behaviour had high reliability 
(Cronbach’s alpha = .923). The second factor which could be conceptualised as the less 
severe behaviours surrounding ED like cognitions and actions around food demonstrated 
good validity (Cronbach’s alpha = .857). 
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3.4.6.6 Insulin Subscale  
3.4.6.6.1 Insulin Subscale Reliability  
The five items as a scale showed good validity (Cronbach’s alpha = .905) which would have 
been improved with the removal of DESPR11 I feel fat when I take all of my insulin 
(Cronbach’s alpha = .91). 
3.4.6.6.2 Insulin Subscale Cut-Off 
 As the cut-off point for clinical concern in the DEPS-R was 20 the cut-off point for the 
insulin subscale equalled 6.25, which was rounded down to 6 as the responses were only 
possible in whole numbers, to ascertain how many participants were identified by the 
subscale as clinically concerning.  
Table 3.4 Mean Scores and Cut- off Points by Total Sample and Gender  
 
Mean (sd) Above cut-
off  
% (valid) Missing % (total) 
Total Sample           
Insulin Subscale 4.34 (6.02) 116 16.9 185 26.9 
Males       
Insulin Subscale 2.8 (4.91) 8 12.5 28 30.4 
Females       
Insulin Subscale 4.54 (6.08) 107 24.6 157 26.5 
 
Females scored higher on the insulin subscale with nearly a quarter scoring above the cut-off 
point than men with around an eighth. This is similar to rates of insulin omission seen in the 
systematic review (please see previous chapter). It should be noted however that the original 
responses on the DEPS-R are in Likert formula. In order to investigate whether the 
behaviours/ thoughts described by the subscale were ever present in the sample the items 
were transposed into binary format.  
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Table 3.5: Response Patterns to the Insulin Subscale  
  Total Sample Males Females 
 
yes % yes % yes % 
When I overeat, I don’t take enough insulin to 
cover the food  
345 67.9 45 69.2 299 68 
I try to keep my blood sugar high so that I will 
lose weight 
123 24.2 7 10.8 115 26.1 
I try to eat to the point of spilling ketones in my 
urine 
79 15.6 8 12.5 70 15.9 
I feel fat when I take all of my insulin 212 41.7 11 16.9 200 45.4 
After I overeat, I skip my next insulin dose  117 22.9 6 9.2 110 24.9 
 
There were inconsistent responses to the insulin omission behaviour subscale and males 
scored higher than females on the first item which is inconsistent with previous research 
suggesting that maladaptive insulin behaviour is more common in females (please see 
previous chapter). A significant majority of participants stated that they don’t take enough 
insulin to cover overeating but far less participants stated that they deliberately overeaten in 
order to spill ketones. This suggests that a further investigation of the questions is warranted 
in order to ascertain what they are actually measuring and how closely that matches ED.    
3.4.7 Figure 3.2: Percentage of Participants Scoring above the Cut-off Point for 
Clinical Concern 
 
ss = subscale, m = modified  
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3.5 Discussion  
This study hypothesised that the EAT-26 would screen more participants as clinically 
concerning than the DEPS-R and this was the case. This held for both men and women, but 
a larger proportion of men screened positive on the EAT-26 which is a reversal of what would 
normally be expected. When using the DEPS-R a higher proportion of Females screened as 
clinically concerning which is concordant with previous research (See previous chapter). It 
was then hypothesised that removing items on the EAT-26 which were deemed to be 
potentially influenced by T1D that the amount of those screening clinically concerning would 
be reduced but the opposite was seen, and the modified version screened nearly the whole 
sample as clinically concerning.  
The factor structure of the DEPR was then investigated and a 2-factor solution suggested. 
This is different from previous research using a child and adolescent sample. It appears that 
the first and largest factor relates to behaviours which are situated at the more severe end of 
the ED spectrum such as omitting insulin, vomiting and deliberately inducing ketones 
whereas the second and smaller factor is more related to feelings and behaviours around food 
which are less severe behaviourally, also it is notable that this factor contained no items 
relating to insulin behaviour.   
The insulin items suggested by Merwin (2014) formed a reliable scale. Less participants 
scored above the cut-off point than for the full DEPS-R indicating that the items were 
potentially are measuring a different behaviour. Females also scored higher than males which 
is consistent with other research measuring insulin omission (please see previous chapters).  
It was also interesting that the only question which would have improved reliability via 
removal related to feelings rather than action I feel fat when I take all of my insulin. It could 
possibly be argued that the other four questions are specifically measuring the performative 
aspects of ‘Diabulimia’. 
When investigating binary response patterns to the 5 questions that relate directly to insulin 
an interesting pattern was found, there were much lower levels of participants saying that 
they tried to keep their blood sugar high, tried to attain ketones or skip their insulin dose after 
over eating than not covering their overeating with appropriate insulin. Also, more males said 
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that they under dosed following overeating than women. however nearly half of the female 
sample stated that they felt fat when taking their insulin which was much higher than males.  
The high levels of clinically concerning behaviour using the EAT-26 in this sample is not 
seen in previous research using this scale. This having been said a study utilising the EAT-
40 in an adolescent sample found that around 70% of participants screened above the cut-off 
point (Pinar et al., 2005) while Phillipi et al (2013) found rates of around 45% in adults, 
neither of these studies modified the scale in any way. It should be noted that these studies 
also recruited from Diabetes clinics whereas this study utilised an anonymous cross-sectional 
internet sample. As such the results may be interpreted in one of 2 ways, the first, as this is 
an internet sample and completely anonymous participants felt more able to be truthful about 
their thoughts and behaviours, the second, this sample is qualitatively different than previous 
research.  
It could be that the nature of T1D simply makes one vulnerable to displaying ED behaviour 
and having ED like cognitions as measured by the EAT and thus the cut-off point represents 
too low a threshold. It should be noted that the cut-off is supposed to be diagnostically 
relevant and aid in the recognition of clinically significant behaviour and perhaps T1D results 
in thoughts and actions that in other populations are seen as pathological. Parents of Type 1 
children report more meal time related behavioural problems than parents of children without 
T1D and children with other clinical feeding problems, including intense disruptive 
behaviour (Patton, Dolan & Powers, 2006). It may be that some sort of behavioural pattern, 
set early on following the onset of T1D is influencing the patterns seen using this instrument. 
This having been said not all T1Ds are diagnosed in childhood or even adolescence.  
Based on the findings of this study it may be justifiable to recommend against the use of any 
version of the EAT in those with T1D. It is relatively inconceivable that all those with T1D 
have an ED.  
The DEPS-R provided a more conservative prevalence estimate and the insulin subscale 
lower still. However, in this sample there are inconsistencies when looking at statements 
pertaining to the manipulation and omission of insulin. It maybe that these inconsistencies 
are due to the wording of the questions, participants are asked whether they try to keep their 
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blood sugar high or spill ketones into their urine and this implies intent. Also missing an 
entire dose may be argued to be on the more severe end of ED behaviour which is why a 
lower level of participants answer in the affirmative. Furthermore, it could be argued that 
T1Ds are more aware of when they overeat as if their blood sugar after a meal is higher than 
expected that would indicate that they have underestimated the amount they consumed. Also, 
as insulin is normally administered before eating it may follow that participants are cognisant 
that they have under dosed which may affect answers to that question. This having been said 
the rates of those screening as clinically concerning is higher but not overly dissimilar to that 
reported by other studies (please see previous chapter)   
What does seem to be apparent is that a large proportion of participants display at least some 
level of insulin manipulation and that this is in direct relation to at least the perception of 
over eating. Given that only around 40% of participants screened as being concerning using 
the DEPR this is significant. It could be that this demographic by nature are more 
pathological and that unlike the general population those with T1D have a way to negate the 
effects of overeating. Alternatively, it maybe that the Likert scale format needs to be 
revaluated as ‘rarely’ performing an action that is as physically damaging as insulin omission 
is not weighted appropriately.  That nearly half of the female participants in this sample stated 
that taking their insulin correctly made them feel fat is also noteworthy and potentially 
justifies some kind of behavioural intervention where insulin can be seen in a more positive 
manner or disassociated from negative weight perceptions.    
3.5.1 Strengths 
The sample size of the current study is a significant strength as stated in the previous chapter 
very little large scale research into this population has been carried out, it also utilised a 
global sample which is significantly different from other research which tends to focus on 
clinical participants from defined geographical areas. This is the first study which has utilised 
an expert panel of T1ED specialists to assess the suitability of the EAT-26 for use in this 
demographic. Also, little deconstruction has been done of the DEPS-R and the current study 
represents a significant progression in further enquiring on the nature of this instrument.   
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3.5.2 Limitations  
There is no gold standard by which comparisons can be made, although that is not an issue 
unique to this study but rather to all research utilising those with T1D. As stated in the 
previous chapter, investigating EDs in this population is complicated and fraught with 
methodological issues.  
Part of this study aimed to investigate gender differences in Eating Disorder symptomology 
as measured by the EAT-26 and DEPS-R but there was a relatively small sample size for 
males so any conclusions regarding gender specific ED behaviour should be interpreted with 
caution. This may have been influenced by the recruitment process which advertised the 
study as measuring psychological variables. It maybe that the males responding to the 
advertisement represent a biased sample for which the participants are not representative of 
the male gender but rather those who are willing to confront psychological issues or have 
some sort of insight in to their own psychological profile. It has been well reported that males 
are less likely to report psychological difficulties. Also, this sample was recruited mostly via 
the internet and the Diabetes Online Community (DOC). Membership of the DOC may have 
exposed participants to subjects relating to psychological aspects of Type 1 Diabetes and 
therefore the whole sample may be generally representative of those members who are 
comfortable discussing these issues or who have joined the DOC because of experience in 
these matters.  
The limitations observed in this study could be overcome by a few modifications, for example 
a clinical sample using patients from nationwide Diabetes clinics may be able to produce a 
larger more gender equal representation of those with T1D. Carefully worded clinical 
interviews may also be able to untangle a more accurate picture of what is happening with 
these patients. It maybe that neither of the EAT-26 or any kind of modified version is suitable 
for use in this population or alternatively that what we are actually perceiving as ED 
symptomology is some other type of behavioural and cognitive phenomena unique to T1D. 
Qualitative researchers may want to take note of these findings and explore the structure of 
ED scale item responses in a more focussed manner.  
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Although the DEPS-R in this sample seemed to be more reliable there are still issues with its 
use that should be further investigated (please see chapter 9 for a larger discussion on the use 
of the DEPS-R) 
3.6 Conclusion 
Measuring Eating Disorders in Type 1 Diabetes is a complicated process that appears to be 
heavily affected by the nature of the illness. The EAT-26 may be unsuitable for use in this 
population given that even when it is modified to allow for potential T1D regimen effects it 
identifies almost all participants as high in ED symptomology. The DEPS-R while 
identifying a much lower range of participants as below the cut-off point, still has issues and 
those who demonstrate lower levels of ED symptomology that still have significant negative 
clinical implications may screen out. This having been said, the DEPS-R is arguably the most 
suitable instrument for use in this population currently.  It could be suggested, given the 
severity of the consequences observed in those with T1ED, that a dual measure is warranted, 
one which can highlight problematic cognitions and behaviours and one which can highlight 
clinical risk such as the HbA1c. These two measures combined would give a clearer indicator 
of what kind of intervention the patient needs.    
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4 Chapter 4: Risk Factors and Co-morbidities  
4.1 Introduction  
As stated in previous chapters the literature on Eating Disorder in Type 1 Diabetes is 
complicated but there appears to be a general consensus that Eating Disorders and Disordered 
Eating Behaviour are more common in this population.  This suggests that Diabetes specific 
aetiology and risk factors are important. Given that the pilot study10 reported a complicated 
psychological profile consisting of co/multimorbid mental health issues and several Diabetes 
specific latent variables as attributional to ED development, the following section reviews 
these issues in more detail and then explores a structural model based on these factors that 
predicts HbA1c and DEPS-R scores.  
4.2 Demographic Risk Factors  
4.2.1 Age 
Age specific factors may act as protective or risky. In children and young people there is 
research that suggests that pre pubertal T1D diagnosis is predictive of worse glycaemic 
control and earlier onset of retinopathy (Kordonouri, Danne, Enders & Weber, 1998). There 
is also evidence that in those diagnosed in infancy <6 years T1D contributes to cognitive 
impairments (Gaudieri, Chen, Greer & Holmes, 2008). Puberty comes with many 
physiological challenges for those with T1D, it has been shown that it is often delayed which 
may have psychosocial implications, dawn phenomenon, whereby the liver secretes glucose 
in the early morning (Chowdhury, 2015) and insulin resistance is at its most pronounced 
during this time making insulin requirement estimations difficult and variable (Amiel, 
Sherwin & Simonson, 1986). For females particularly, the onset of menarche can prove 
particularly challenging as rapid weight gain and fluctuating hormones adds to changing 
insulin requirements. T1D onset in adulthood is not problem-free, however, and research 
                                                 
 
10 please see appendices E & F 
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suggests that Diabetes control gets worse the longer the duration of the illness (Kovacs, 
Goldston, Obrosky & Iyengar, 1992).  These pubertal difficulties for those with T1D also 
coincide with what is deemed to be a risky time for the development of EDs in the general 
population. Eating Disorders have been somewhat popularised in the media to affect young 
teenage girls, and there is evidence suggesting that this may be the case. Early attempts by 
researchers to ascertain the age of onset in AN hypothesised that there may be a bimodal 
distribution whereby risk is highest at the age of 14 and then 18 for females (Halmi, Casper, 
Eckert, Goldberg, & Davis, 1979). A recent large-scale review of Primary Care registers in 
the UK found that for females the peak incidence of diagnoses was between the ages of 15 – 
19 for girls but was much lower for boys at 10 – 14 (Micali, Hagberg, Petersen & Treasure, 
2013).  
However, age of onset for T1EDs may be higher than that for EDs in the general population. 
One study assessing inpatients found that the average age of assessment for those with T1D 
was 26.2 (Powers et al., 2012), which coincides with the considerable evidence that in the 
majority of cases T1D diagnoses preceded that of an ED (Powers et al., 2012). Furthermore 
Goebel-Fabbri., (2011) found that in a longitudinal study of the onset and remission of insulin 
restriction, new restriction occurred in a significant number of older T1D females at follow-
up (average age of the sample was 44). ED behaviour in the T1 population also appears to 
increase with age post puberty. Longitudinal studies show that while levels remain relatively 
low in childhood and early adolescence they rise exponentially until in females, by the age 
of 25, one particular group of researchers found a 60 % chance that a clinically significant 
Eating Disorder will have occurred (Wisting et al., 2013, Colton et al., 2015, Olmsted et al., 
2008). It should be noted that females are hugely overrepresented in this research and as such, 
the evidence should only be extrapolated to the female population of T1Ds. As such it is 
unclear whether age will be a predictive variable in the structural model.   
4.2.2 Gender  
Several studies have suggested that certain psychological issues which are commonly 
comorbid are more prevalent in T1 women than in T1 men. These include studies on 
depression (Anderson et al., 2001; Trief et al., 2014) and anxiety (Grigsby et al., 2002; 
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Rechenberg, Whittemore, & Grey, 2017). Adult T1D females are also more likely to seek 
medical help for mental/ emotional problems and drugs or alcohol problems (Shin, 
Poltavskiy, Kim, Hasan, & Bang, 2017) although this potentially means that they are more 
likely to seek help, not necessarily that they are more likely to develop those issues. In line 
with research in the general population, T1D adult males are significantly more likely to 
commit suicide than T1D adult females (Wang, An, Shi & Zhang, 2017).  
Eating Disorders were historically seen as illnesses that affected nearly exclusively females. 
(Bruch, 1978). As such much of the early research focusses on this demographic only. In 
more recent years however the incidence of EDs in males has seen a substantial rise. In the 
UK the increase in males was around 27% between 2000 and 2009 in the General Practice 
Research Database (Micali et al., 2013). There is still a huge gender divide in prevalence 
however, in the aforementioned study ED diagnosis reached a peak of 63.8 diagnoses per 
100,000 female patients in 2008 compared to the peak diagnosis of 7.1 per 100, 000 males 
in 2009.  It may be that there are gender based behavioural differences for those with EDs 
also. Twin studies have shown that females twins are more likely to report classical 
symptoms such as dieting or purging food and report higher levels of weight dissatisfaction 
than their male brothers (Anderson & Bulik, 2004). This is similar to research in the T1D 
population which also suggests differences in the type of Disordered Eating Behaviour 
reported (please see section 2.4.3) 
As can also be seen in chapter 2 there appears to be a higher proportion of males with 
Disordered Eating Behaviour in T1D than in the general population and the gap between the 
percentage of female and male sufferers is lower. Insulin omission has been reported by 
males in increasing numbers). In a recent Australian survey nearly a fifth of males were above 
the cut-off point for the DEPS-R, a level, which has also been found in similar studies and 
over half of male respondents reported binge eating in the previous week. Furthermore, while 
in this study over three quarters of the male participants reported being dissatisfied with their 
body shape nearly a third expressed a desire to be bigger. This may represent an important 
differential factor that is currently poorly understood (please see section 2.4.3; Doyle et 
al.,2017; Araia et al., 2017). It may be then, that in those with T1D gender is not such a strong 
predictor of Eating Disorder behaviour than in the general population.   
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4.3 Psychosocial Risk Factors  
4.3.1 Depression 
Depression is one of the most commonly diagnosed mental illnesses in the general population 
with around 3.3% screening as positive (Moran, Rooney, Tyrer & Coid, 2014). Adults with 
T1D are at a significantly higher risk of depression than the general population (Gendelman 
et al., 2009). Depression predicts decreased self-care and blood sugar control (Anderson, 
Freedland, Clouse, & Lustman, 2001; Barnard, Skinner & Peveler, 2006; Maia et al., 2014) 
and has been significantly associated with Diabetes related complications such as 
neuropathy, (Bai et al., 2017). Depression also affects children and adolescents with T1D 
where prevalence may be double than in the general population, a recent meta-analysis found 
depressive symptomology in around a third of patients. Furthermore, the presence of 
symptomology negatively affects self-care and is predictive of worse glycaemic control 
(Hood et al., 2006; Whittemore et al., 2002; Adal et al., 2015; Buchberger et al., 2016; 
Bernstein, Stockwell, Gallagher, Rosenthal & Soren, 2013). Studies have also found that the 
presence of depression in young people with T1D can negatively affect other aspects of 
development related to illness perceptions, illness functioning, and self-esteem (Oris et al., 
2016). Some researchers have pointed out, however, that depression may be confused with 
Diabetes specific distress and that overdiagnosis is a significant problem (please see section 
4.4 below). They have also suggested that levels of depression are much lower than reported 
in the research literature (Fisher et al., 2016). There is also conflicting evidence that higher 
depression levels do not predict poorer T1D management (Strandberg, Graue, Wentzel-
Larsen, Peyrot & Rokne, 2014).   
Depression is a common comorbidity in EDs in the non diabetic population also. (Braun, 
Sunday & Halmi, 1994; Lewinsohn, Striegel-Moore & Seeley 2000) in one study 
investigating the characteristics of female inpatients depression was found in nearly all of the 
patients (Blinder, Cumella & Sanathara, 2006). It is not entirely clear how depression affects 
Eating Disorder symptomology in those without T1D; some researchers have argued that it 
mediates the relationship between ED behaviours and body dissatisfaction (Brechan & 
Kvalem, 2015) while others have stated that the cultural overvaluation of thinness promotes 
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depression especially in young women, which then leaves them vulnerable to EDs 
(McCarthy, 1990). Depression has also been shown to directly predict binge and emotional 
eating (Brechan & Kvalem, 2015; Goossens, Braet, Van Vlierberghe & Mels, 2009). In 
adolescents with T1ED, less positive attitudes towards life, lower joy in life and higher 
depressive mood is found than in those without ED (Grylli et al., 2005).  Longitudinal 
research has suggested that while ED and depression may co occur in younger individuals 
with T1, such symptoms are ‘commonly but not universally associated’ therefore this might 
be indicative of an underlying vulnerability (Colton et al., 2013, p. 375). Other research has 
found a link between depression and Eating Disorder onset in T1D (Olmsted et al., 2008). It 
should be noted that depression levels considered average or only slightly elevated, may be 
predictive, particularly in adolescent females of later eating issues (Olmsted et al., 2008). 
When investigating relationships between depression and T1ED it has been argued that while 
depression scores and ED symptomology are significantly positively related, for women at 
least this does not translate to a worsening of HbA1c (Bächle et al., 2015; Colton et al., 2013). 
Furthermore, there is some evidence that those without T1D related Eating Disorders may 
display higher levels of depression compared to those with T1ED (Powers, 2012) but this 
should be interpreted with caution due to sample size.  In the pilot study (appendix E & F) 
depression was found in nearly half of the participants so it is assumed that depression will 
be a predictive factor in the structural model.  
4.3.2 Anxiety 
Anxiety encompasses a number of syndromes. In the DSM V these include phobias, social 
anxiety disorder, panic disorder, agoraphobia and generalised anxiety disorder. It should be 
noted that in DSM IV, Obsessive Compulsive Disorder (OCD) was also included under the 
anxiety label (APA, 2013) and the pilot study in which this model is based treated it as such. 
In the DSM V there is also an option for Unspecified Anxiety Disorder and research often 
looks at subsyndromal or subclinical representation (APA, 2013).  
Research has shown that both clinical and subclinical presentations of anxiety disorders are 
significantly more present in adults with T1D than in the general population with Generalised 
Anxiety Disorder being the most frequently diagnosed (Grigsby, Anderson, Freedland 
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Clouse & Lustman, 2002). The presence of anxiety is related with decreased Diabetes control 
and elevated HbA1c (Friedman, Vila, Timsit, Boitard, & Mouren-Simeoni, 1998; Maia et al., 
2014). Similar results have been found in adolescents (Herzer & Hood, 2009; Adal et al., 
2015; Bernstein et al., 2013). A 2017 systematic review found similar results but added 
poorer self-care behaviours including BG testing, elevated depressive symptoms and fear of 
hypoglycaemia. The authors also found that state anxiety and trait anxiety affected Diabetes 
care differentially. Family conflict and suboptimal monitoring was better predicted by state 
anxiety and fear of negative Diabetes outcomes by trait anxiety (Rechenberg, Whittemore & 
Grey, 2017). In children and adolescents with T1D a similar pattern is found, a recent 
systematic review estimated that around a third of patients showed anxiety symptoms and 
that this was a risk factor for poor BG control (Buchberger et al., 2016). There is conflicting 
evidence, however, that suggests higher anxiety levels do not predict poorer T1D 
management (Strandberg et al., 2014)  
Anxiety disorders are also highly comorbid with Eating Disorders in the Non T1D population 
(Braun et al., 1994). A 2004 study found elevated symptoms in both AN and BN and that 
anxiety disorders appear before the development of ED suggesting that such a diagnosis 
maybe a sign of vulnerability and that ‘childhood anxiety represents one important 
genetically mediated pathway’ to AN particularly (Kaye et al., 2004, p. 2215). In one study 
evaluating female ED inpatients anxiety was found in over half of the sample (Blinder et al., 
2004).  Several relationships between anxiety symptomology and EDs have been proposed 
in BN, binging and purging may be anxiolytic and body dissatisfaction may lead to 
significant social anxiety. In AN anxiety is apparent particularly around food and any 
perceived weight gain. (Bulik, 2002). There is a paucity of research relating to the 
relationship between T1ED and anxiety, but generally higher levels are seen (Takii et al., 
2011). There is some evidence that drive for thinness and bulimic symptomology predict 
anxiety (Helgeson et al., 2007) and further evidence that shows that anxiety is predictive of 
weight preoccupation in subjects with T1ED (Pollock-BarZiv, & Davis, 2005). A study 
investigating momentary predictors of insulin omission also found that anxiety and 
nervousness before eating predicted insulin omission at the proceeding meal (Merwin et al., 
2015). Although there is little research focusing on the relationship between anxiety and ED 
in T1Ds it has been suggested that treatment for T1ED lowers anxiety scores suggesting that 
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there may be a comorbid relationship (Gagnon, Aimé, Bélanger & Markowitz, 2012). In the 
pilot study anxiety had been diagnosed in just under 30% of patients which is much higher 
than in the general population (Moran, Rooney, Tyrer & Coid, 2014). It is thus hypothesised 
that anxiety will be predictive of HbA1c and DEPS-R scores.  
4.3.3 Borderline Personality Disorder  
Borderline Personality Disorder (BPD) is a cluster B personality diagnosis in the DSM. There 
has been considerable debate about the validity of the diagnosis in recent years, but it 
survived the cull observed in the DSM 1VR personality disorders and is currently 
diagnosable under the DSM V. A BPD diagnosis is hallmarked by extreme emotional 
instability, an intense feeling of abandonment, suicide ideation and or self-harm and it may 
or may not be accompanied by dissociative episodes (APA, 2013). In the last adult 
psychiatric morbidity survey, 2.4% of 16 – 64 year olds screened positive for Borderline 
Personality Disorder (Moran et al., 2014).  There is a notable lack of published research on 
BPD in relation to T1D but what there is suggests that it hinders T1D management 
substantially. In a 2005 review Leichter & Dreelin discuss the substantive issues of treating 
these co morbid T1D and BPD patients.  
When seen in the health care setting, patients with BPD are often a challenge to 
provider organizations. They arouse intense emotional reactions from medical 
staff and others. They can pit care providers against each other. They often 
occupy substantial amounts of time and resources in frequently futile attempts 
to help them solve either their medical conditions or their recurrent 
dissatisfactions with the care process. And usually, but not always, they end 
their stormy course with a health care organization with a negative termination 
of the therapeutic relationship, complete with a vigorous litany of the many 
failings of the health care group. They are more apt to litigate against health 
care providers than are other patients. (Leichter & Dreelin, 2008, p. 101) 
Although there is a scarcity of literature exploring the relationship between T1D and BPD, 
there is some evidence that cluster B personality disorders in general predict worse glycaemic 
control (Orlandini et al., 1997). There is more evidence linking BPD particularly to EDs in 
the general population and rates are reported at around 30%, (Herzog, Keller, Lavori, Kenny 
& Sacks, 1992; Sansone, Levitt & Sansone, 2004). In T1ED perhaps somewhat 
unsurprisingly there is also a lack of research into the relationship with BPD but in a rare 
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study Pollock-BarZiv & Davis (2005) found that borderline traits significantly predicted 
whether or not patients would engage in ED behaviours such as binge eating and insulin 
omission. They also highlight that given that self-harm is a symptom of BPD, in patients with 
both BPD and T1D overdose by insulin may be reported, and there may also be crossover 
between what is deemed to be ED behaviour and what is being driven by BPD (Pollock-
BarZiv & Davis, 2005). In the pilot study, personality disorders were reported by around a 
fifth of participants of which the most common was borderline. The relationship between 
BPD and T1ED is unclear but should be considered in modelling ED behaviour given the 
high comorbidity. 
4.3.4 Self-Esteem 
Self-esteem broadly relates to how much value and worth one finds in oneself (Hewitt, 2009). 
There appears to be conflicting evidence regarding self-esteem among those with T1D. Some 
researchers have found lower levels of Self-esteem in T1D females compared to their non-D 
peers and a converse or no relationship with males, suggesting that male gender may be 
protective for these issues in T1D (Rassart, Luyckx, Moons & Weets, 2014; Kaminsky & 
Dewey, 2014). There is alternative evidence that there is no difference in self-esteem levels 
between those with and without T1 in both adults and children/ adolescents (Powers et al., 
2013; Vlachioti et al., 2010).  
This having been said longitudinal studies have provided some support for the idea that 
higher levels of self-esteem are predictive of better HbA1c levels and cross sectional research 
has produced similar findings (Luyckx & Seiffge-Krenke 2009; Zoffmann, Vistisen & Due-
Christensen, 2014). In females particularly, it also seems that higher BMI is associated with 
lower levels of self-esteem in T1D (Kaminsky & Dewey, 2014). Self-esteem may also act as 
a mediating factor for treatment outcomes in this demographic (Jaser et al., 2013). Other 
authors have argued that there are aspects of self-esteem that are explicitly related to T1D 
and that T1D specific aspects of self-esteem predict BG control (Schneider et al., 2008). In 
those with T1ED Low self-esteem is especially related to weight and shape; this may be 
predictive of ED onset in T1D and should be seen as a clinical red flag (Olmsted et al., 2008; 
Racicka & Bryńska, 2015). In adolescents who have been diagnosed with ED and T1 lower 
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rates of self-esteem and social withdrawal are more commonly found than in those who do 
not have ED (Grylli et al., 2005). Similar results have been found in T1ED adolescents in 
relation to body image concerns with those with ED showing lower levels (Pinar et al., 2005), 
and this was particularly pronounced in female T1Ds. These issues are similarly found in the 
general ED population where socially, people with EDs appear to have higher sensitivity 
toward social stimuli compared to their non-ED counterparts. The authors suggest that they 
are more vulnerable to negative social comparison, which may have a significant relationship 
with self-esteem (Cardi, Di Matteo, Gilbert & Treasure, 2014). Lower self-esteem has been 
found to predict lower levels of recovery in those undergoing CBT treatment (La Mela, 
Maglietta, Lucarelli, Mori & Sassaroli, 2013). 
 Low self-esteem has been positively related to T1ED symptomology in adolescent samples 
(Colton, Olmsted, Daneman, Rydall & Rodin, 2007; Maharaj et al., 2003) and models of 
T1ED include low levels of self-esteem as a preceding factor (Treasure et al., 2015). It should 
be noted that even levels considered average or only slightly elevated of low self-esteem and 
weight and shape concern may be predictive, particularly in adolescent females of later eating 
issues (Olmsted et al., 2008). Lower levels of self-esteem were found to be important in the 
development of Eating Disorders in those participating in the pilot study and thus are 
included in the structural model.   
4.3.5 Perfectionism  
Hollender (1965) defined perfectionism as ‘demanding of oneself or others a higher quality 
of performance than is required by the situation’ (Hollender 1965, p.384). While there is not 
an extensive literature on perfectionism in T1D, Diabetes support group facilitators have 
reported that part of their job is to disseminate that ‘perfectionism as neither possible nor 
desirable in self-management’ (Costello, 2013, p. 178). Similarly, parents of T1D females 
state that combatting perfectionism in relation to disease management is a major challenge 
of dealing with their children (Mellin, Neumark-Sztainer & Patterson, 2004). Other measures 
of psychological functioning in T1Ds such as Diabetes specific distress (DSD) (please see 
section 4.4) are related to perfectionism with higher levels of distress coinciding with higher 
levels of perfectionism (Powers, Richter, Ackard & Craft, 2017). It is worth noting however 
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that there is conflicting evidence that perfectionism is not elevated in adolescents with T1D 
compared to their non-T1D peers (Sivertsen et al 2014).  
For some authors, perfectionism is seen as preceding risk factor in T1ED (Treasure et al., 
2015) and this is also seen in those with ED but no T1D, since early researchers such as 
Bruch, claimed that such patients are chasing ‘super perfection’ (Bruch, 1979, p. 56). 
Interventions for T1EDs have partly focussed on reducing perfectionism arguing that it is 
important for the maintenance of ED behaviour (Wilksch, Starkey, Gannoni, Kelly & Wade, 
2013) and it has been shown that it is positively associated to attitudinal factors of Eating 
Disorder such as preoccupation with weight (Pollock-BarZiv & Davis, 2005). This is also 
seen in the general population (Stice, 2002). When looking at differences between patients 
who do and do not use inappropriate compensatory behaviours (ICB) such as insulin 
omission it has been found that perfectionism is higher among those who do not use ICB 
suggesting that perfectionists may be more concerned with blood sugar control (Takii et al., 
2002). However, it may be the pressure of this perfectionistic attitude and the near impossible 
task of managing BG that pushes patients into T1ED. In her recent book Goebel-Fabbri 
interviewed 25 T1ED women who had experienced Diabulimia and states:  
Many (participants) described internalizing unrealistic, perfectionistic ideas 
about Diabetes management and giving up when they proved to be unattainable. 
They were self – critical and felt like they were failing at their health. (Goebel-
Fabrri, 2017, p. 21)  
Perfectionism was highlighted as important across several dimensions when asking 
participants what they considered relevant to the development of their EDs and thus may 
predict ED symptomology if modelled. 
4.3.6 Family Functioning  
A diagnosis of T1D can be a major familial event. There are major challenges to rearing a 
child with T1D and similar to other milestones, a developmental pathway for increasing 
autonomy has been suggested (please see table 1.1).  Age appropriate parental support 
promotes good Diabetes management, as does parental warmth. parental ability to adopt the 
child’s perspective and higher levels of family cohesiveness (Helgeson et al., 2007; Davis et 
al., 2001; Mackey et al., 2011; Blicke et al., 2015). Conversely, conflict, restrictiveness and 
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premature passing of responsibility to the child is correlated with decreased self-efficacy, 
treatment adherence and worsened BG control (Anderson, 2012; Davis et al., 2001). This is 
the case regardless of developmental stage but problems may arise particularly around the 
time of puberty as insulin needs increase and BG is more difficult to control due to rising 
levels of hormones. A recent analysis of over 7000, 13–19 year-olds with T1D demonstrated 
that only around a fifth attained HbA1c level of < 7.5% (T1D Exchange Clinic Network, 
2013) and conflict during adolescence has been shown to predict BG control longitudinally, 
demonstrating that family level effects are important across the life span (Hilliard et al., 
2011). This is especially unfortunate as good BG control throughout adolescence is predictive 
of lesser levels of microvascular complications later in life, even if post adolescence this 
control is not maintained (Cleary, Dahms, Goldstein, Malone, & Tamborlane, 2001).  
Conflict specifically around dietary regimen may lead to food related issues that would have 
been avoided without a T1 diagnosis. Furthermore, adolescents with T1D may avoid self-
care behaviours, such as checking blood sugar, in order to limit such conflict (Hilliard et al., 
2011). The family food environment also seems to be important for the development of 
T1ED. It may be understandable that parents would restrict certain foods in the house for 
their diabetic children, but the presence of such items predicts higher Eating Disorder 
symptomology as do low priority of family meals and less parental modelling of healthy 
eating (Alice Hsu, Chen, Huang, Lin & Lin, 2009; Caccavale et al., 2015). For those without 
T1D research has suggested that ED patients report on the existence of dysfunction more 
often than controls (Holtom-Viesel & Allan, 2014). Large scale registry studies have also 
shown that there is a higher risk for ED development in children (particularly daughters) of 
mothers who have experienced an ED themselves, potentially suggesting either a genetic 
effect or a replication of familial environment (Bould et al., 2015). Similarly disturbed 
parental eating attitudes and disturbed attachment profiles are associated longitudinally with 
disturbed eating behaviour while higher cohesion is protective in T1ED (Colton et al., 2007; 
Neumark-Sztainer et al., 2002). Maternal concern with weight and shape and dysfunctional 
mother daughter relationships are also predictive of higher Eating Disorder symptomology 
in adolescent T1D females. The authors suggest that as T1D carries a weight penalty these 
girls are even more vulnerable in an environment that espouses the thin ideal (Maharaj et al., 
2003). Weaker attachments are also associated with the development of T1ED (Olmsted et 
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al., 2008). In the pilot study a latent variable constructed of items associated to family 
functioning was found to be important to the attributions participants made to ED 
development and as such it may be related to other variables in a model.  
4.3.7 Summary  
There are several psychosocial factors that are associated with both suboptimal blood sugar 
management and Eating Disorders in Type 1 Diabetes. These aspects were also reported in 
the pilot study preceding the current project (please see appendix E & F). It is also notable 
that these particular psychosocial variables are also associated with EDs in the general 
population. It is conceivable then that these variables may be representative of an underlying 
psychological vulnerability that can be modelled as a latent variable to predict both blood 
glucose levels and Eating Disorder symptomology.      
4.4 Diabetes Specific Psychological Factors  
 
Figure 4.1 Cartoon Reproduced with Permission of the Artist Haidee Merrit (2012) 
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The above cartoon has become a popular meme in the Diabetes Online Community as it is 
representative of the multitude of complex and varied cognitions that may accompany a 
diagnosis of T1D. As such some researchers have proposed that there are Diabetes specific 
psychological factors that affect those with T1D.  For example, Dr William Polonsky of the 
Behavioural Diabetes institute discusses Diabetes Burnout:   
…what happens when you feel over-whelmed by Diabetes and by the frustrating 
burden of Diabetes self care. People who have burned out realise that good 
Diabetes care is important for their health, but they just don’t have the motivation 
to do it. At a fundamental level, they are at war with their Diabetes – and they 
are losing (Polonsky, 1999, p. 9) 
Polonsky, on the proposition of Diabetes specific psychological burden proposed the 
Diabetes Distress Scale (DDS) This scale is divided into 4 aspects of Diabetes related life,  
Emotional Burden, Interpersonal Burden, Regimen Burden and Physician related Burden 
(Polonsky et al., 2005). These subscales reference Diabetes specific distress (DSD) 
High levels of DDS are related to suboptimal control, particularly the regimen related distress 
that relates to the day-to-day mechanics of managing T1 (Strandberg et al., 2014; Strandberg 
et al., 2015). Importantly in several studies DDS operated as an independent predictor of 
HbA1c, regardless of other variables such as anxiety or depression (Strandberg et al., 2014). 
This suggests that DSD is a specific aspect of life unique to this population which is 
incomparable to controls. Any model attempting to explore relationships between 
psychological aspects of T1D should take in unique aspects of this population’s experience 
and several DDS related items were highlighted in the pilot study as attributional (please see 
appendices E & F). 
4.4.1 Regimen Related Distress 
It is notable that dieting behaviour is a major risk factor for the development of EDs in the 
general population. Arguably a diagnosis of T1D requires a regimen that to the wider world 
may be considered dieting behaviour. Comparisons have been made between the prescribed 
advice given to those with T1D and their carers and the tell-tale signs of ED development. 
Rigidity, food group restriction, limiting common ‘treats’, timed meal and counting 
nutritional values share commonality with good Diabetes care (B-eat, 2018). Carbohydrate 
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counting whereby a patient matches their insulin intake to the amount of carbohydrate they 
are consuming is the most recent advice for dietary T1D management, but a recent Brazilian 
study found that for some patients this practice led to obsessive behaviour and anxiety around 
issues such as portion sizes. The same study also found high levels of ED behaviour in those 
not utilising carbohydrate counting suggesting that this was due to the extended flexibility of 
the approach (Philippi et al., 2013). It appears then that dietary management in T1D 
regardless of the approach can lead to maladaptive behaviours and cognitions.  
Other regimen issues can affect blood sugar control and ED behaviours. Unsurprisingly 
blood, needle or injury phobias have a significant impact on adherence to T1D regimen with 
those expressing injection anxiety citing this as a reason for insulin avoidance (Zambanini, 
Newson, Maisey & Feher, 1999). Patients are also much less likely to check their blood sugar 
as it involves pricking the fingertips with a small needle (Berlin et al., 1997; Babler & 
Strickland, 2015).  
4.4.2  Emotional Burden of Diabetes  
There are several aspects of T1D that contribute to emotional burden. A qualitative study by 
Browne and colleagues in 2014 demonstrated that those with T1D feel that they are 
stigmatised, the results of this study showed that association with T2 was the largest source 
of stigmatisation with patients going as far as advocating for a change of nomenclature. They 
state:  
Reasons for this included wanting to distance themselves from those with 
T2DM so as to avoid the negative judgements and stereotypes (e.g. ‘fat’, ‘lazy’, 
‘eat too much’), wanting people to understand the seriousness of T1DM as a 
health condition (Browne et al., 2014, p. 3). 
Other themes included blame, negative social judgements, stereotyping, exclusion, rejection 
and discrimination.  Notably, the sources of stigmatisation were far reaching as participants 
reported the media, family and friends, HCPs and teachers (Browne, Ventura, Mosely, & 
Speight, 2014). In Australia the Juvenile Diabetes Research Foundation (JDRF) released a 
2014 report stating that 46% of participants they surveyed had experienced bullying or 
perceived social exclusion as a result of their condition, mostly due to misconceptions around 
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Type 1 Diabetes; namely that it is caused by overeating sugar, being fed too much sugar as a 
child or as a result of an unhealthy lifestyle (JDRF, 2014), which corresponds to the same 
misconceptions mentioned above.   
This may partly account for findings that children with T1D may have issues with social 
confidence compared to healthy peers (Helgeson et al., 2007). It has also been found that 
adolescents with T1D may be vulnerable to peer pressure when adherence to T1D conflicts 
with perceived social acceptance (Thomas, Petterson & Goldstien, 1997). 
4.4.3 Physician Related Distress  
It is of note that those with T1D like those with other chronic conditions spend more time in 
hospital than the general population. T1Ds are supposed to have access to a multidisciplinary 
team of nurses, dietitians and consultants to help manage their condition and the quality and 
quantity of these relationships can be predictive of both successful and problematic Diabetes 
management (Findley, Cha, Wong & Faulkner, 2015; Care Quality Commission, 2014).  
4.4.3.1 Paediatrics 
If a patient is diagnosed in childhood then they should attend a paediatric clinic with T1D 
specialists. This generally includes a consultant, specialist nurse, dietician and also 
potentially a psychologist (Findley et al., 2015). The UK has one of the worse paediatric 
HbA1c outcomes in Europe and the 2017 paediatric Diabetes audit found that the average 
HbA1c of those under 18 was 8.4% (RCPCH, 2017), higher than the NICE recommended 
maximum of 6.5% (NICE, 2014). One potential explanation for this is the clinic environment. 
Patients have reported feeling ‘judged’, ignored in favour of their parents, and fearful of 
potential conflict when attending clinic (Findley et al., 2015). Communication skills are 
perceived as lacking and consultants are particularly viewed as not being patient-centred and 
ignorant of the day-to-day stresses of living with and parenting for T1D. In general clinicians 
are seen as unable to offer the sort of emotional support needed (Lowes et al., 2015). The 
procedures in clinic may also within themselves be problematic, a 2011 analysis suggested 
that girls found the physical examinations such as weighing to be intrusive. The authors also 
highlight other issues: 
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The discussion groups with teenage and young girls voiced feelings of being a 
‘disappointment’ to parents and healthcare professionals, particularly when 
blood glucose results were high or they had put on weight  … Being measured 
(height and weight) in relatively public areas was particularly unpopular with 
teenage girls. (Hawthorne et al., 2011, p. 1104, 1106) 
4.4.3.2 Transition 
Adolescence and emerging adulthood can be a turbulent time. Hormonal changes, weight 
changes and psychosocial factors can all adversely affect individuals. This is also well known 
as a risk period for adopting unsafe behaviours in areas such as sex, drugs and alcohol 
(Strang, Chein & Steinberg, 2013). Adolescents and Emerging Adults with T1D are not 
immune to these challenges and all of the above aspects also affect the ability to successfully 
manage the condition. Health care professional involvement at this time is extremely 
important but often fraught with issues as the needs of the patient change.  
Transition describes a period where a patient is moving from pediatric services, which are 
often more intensive, into adult services. Some areas of the UK employ a specific clinic 
whereby young adults progress gently from one service into another, for other areas the 
change is abrupt and dictated by a cut-off age, it is broadly agreed that transition should occur 
at some point between the ages of 14 – 25 (Findley et al., 2015). A 2014 report by the Care 
Quality Commission found services for young adults in this stage of their illness to be 
woefully lacking. 
This report describes a health and social care system that is not working, that is 
letting down many desperately ill youngsters at a critical time in their lives. We 
have put the interests of a system that is no longer fit for purpose above the 
interests of the people it is supposed to serve. (Care Quality Commission, 2014 
p. 1)  
In T1D this lack of support can be devastating to long term outcomes.  A recent systematic 
review reported that many patients transitioning between paediatric and adolescent settings 
found the change distressing and the clinic environment cold. They also reported a lack of 
resources compared with the paediatric clinic, shorter appointment times and inattentive 
specialists. Moreover, those who chose as a result to receive community treatment by a GP 
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had even worse HbA1c levels (Findley et al., 2015). Support during the transition phase is 
shown to help adolescents ‘normalise’ their experience of their Diabetes (Babler & 
Strickland, 2015).    
4.4.3.3 Adults 
If transition is not handled appropriately there is a risk that younger adults will disengage 
with services altogether (White, O'Connell & Cameron, 2017). This group of people have 
been dubbed ‘the lost tribe’ by The Association of British Clinical Diabetologists (ABCD) 
They state:  
(there were) concerns that people with Type1 Diabetes had inadvertently been 
let down by wholesale system change, discharging people from secondary care 
clinics without providing robust support to primary care colleagues to manage 
this condition (ABCD, 2016, p. 1). 
This lack of care means that there may be a sizable minority of those with T1D who are not 
seeing appropriate services and therefore may have no idea what their physical status is. A 
dedicated T1D consultant will monitor the risk of ongoing complications such as neuropathy, 
retinopathy and nephropathy, whereas ABCD warn that other health care professionals may 
not (ABCD, 2016). 
4.4.4 Interpersonal Distress 
As explained above there are several family level factors that affect Type1 Diabetes and 
Eating Disorders in Type1 Diabetes. Several other interpersonal relationships are potentially 
significantly affected by T1D, however. Peer relationships are understood to be important to 
development and a recent meta-analysis investigating such relationships in adolescents with 
T1D found that there are links between peers and self-care. The results of the analysis suggest 
that although the relationship is not clear there appears to be more support for peer conflict 
being harmful than peers support assisting with management (Palladino & Helgeson, 2012). 
This is potentially worrisome as although adolescent T1Ds report less peer support than 
controls they report similar levels of peer conflict. Furthermore, female T1Ds report less 
romantic support than controls although there appears to be no difference for males, higher 
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levels of romantic conflict are also associated with higher Eating Disorder behaviours in 
T1Ds. (Helgeson et al., 2014 a/b). It should be noted that there is conflicting research, which 
suggests that peer relationships have little effect of T1D related outcomes (Helgeson et al., 
2013)  
4.4.5 Consideration of Future Consequences  
During a blog analysis co-authored by the researcher (please see appendix D) it was noted 
that when Diabulimia was mentioned in the press it was often accompanied by statements 
suggesting that sufferers had little concern regarding the future outcomes of their Eating 
Disorders. For example, an interviewee in a women’s health magazine stated  
I didn’t consider that the consequences could be deadly (Macellari, 2018, para. 
10) 
And in a metro interview, the bereaved family of a young T1ED stated 
She always thought it would never happen to her. She just didn’t want to accept 
what she had – she was willing to take the risk… She thought she was 
invincible – she lived life her way. (Harley – Parkinson, 2018, para. 22) 
This poses questions around whether or not there is a personality trait that is associated with 
T1ED in relation to whether sufferers acknowledge that the damage their ED is inflicting on 
their bodies will have proceeding ramifications.  Consideration of future consequences (CFC) 
was proposed as a concept by Strathman, Gleicher, Boniger & Edwards in 1994 as ‘a stable 
individual difference in the extent to which people consider distant versus immediate 
consequences of potential behaviors’ (Strthman et al., 1994, p. 742) The authors argue that 
this trait can be measured on a continuum and that those who exhibit low levels are more 
concerned with immediate gratification than long term outcomes. Conversely those with 
higher levels are said to be willing to tolerate short term discomfort in pursuit of long term 
benefit. Given the significant long term consequences of T1D management which are 
highlighted often by HCPs this variable is a perhaps a novel predictor of HbA1c. If it also 
predicts DEPS-R scores then there are possible implications for the clinical treatment of 
T1ED. 
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4.4.6 Summary  
The sub components that comprise Diabetes distress as measured by the Diabetes Distress 
Scale (Polonsky et al., 2005) are related to a number of poor outcomes for those with Type 1 
Diabetes including those that are associated with Eating Disorders. Consideration of future 
consequences has also been suggested as a potential factor in those who engage in T1ED. 
Aspects relating to Diabetes specific distress were also suggested as attributional to the 
development of T1ED in the pilot study (please see appendix E & F). Diabetes specific 
distress should therefore predict both HbA1c as a measure of Diabetes control and Eating 
Disorder symptomology. Furthermore, the relationship between these two variables and 
consideration of future consequences should be investigated as this is something which has 
not been explored in other research.     
4.5 The Current Study  
Several variables were identified by the pilot study as associated with Eating Disorders in 
Type 1 Diabetes and the preceding literature review suggests further evidence that these 
issues are related. These variables could broadly be defined under the umbrella terms 
demographic, psychosocial and Diabetes specific distress.  The current study therefore aims 
to model these variables as they are predictive of T1ED.  In order to do this, it is first 
investigated whether the psychosocial aspects measured individually (depression, anxiety, 
borderline personality disorder, self-esteem, perfectionism & family functioning) relate to an 
underlying latent factor which could be described as general psychological functioning. Then 
the Diabetes Distress Scale is also factor analysed in order to show that the individual 
subscales related to an underlying factor.  These latent factors are then treated as predictors 
of Eating Disorders and are hypothesised to predict both BG control and DEPS-R scores. 
Relationships with demographic factors such as gender are also explored in an alternative 
modeling fashion. As the role of the family is also seen to be important the relationship 
between family functioning and the latent variables are explored. The novel variable 
consideration of future consequences is also explored as a potential predictor of DEPS-R 
scores and HbA1c.   
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As discussed in chapters 2 and 3 measuring Eating Disorders in Type 1 Diabetes is 
complicated and there is no gold standard. The DEPS-R does appear to offer the most 
Diabetes specific symptomology and as such it has been chosen for the current study. There 
is also a lack of general agreement as to what level of insulin manipulation is clinically 
concerning as related to EDs and as such the current study accepts HbA1c as a variable 
related to insulin omission. Given how little is known about the nature of T1EDs the purpose 
of the current study is to provide an exploration of how these variables are related, whether 
they have any predictive value and if certain variables may act as mediatory.  
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5 Latent Variable Modelling  
5.1 Methodology: Latent Variable Modelling  
Given that Latent variable modelling has a number of conflicting recommendations and the 
proceeding chapters use the methodology, a brief review of the literature is given below.  
5.2 Nomenclature and Graphic Representation  
There is slightly different nomenclature used when generating latent and structural models 
than in other statistical methods. One key feature of the analysis is that relationships are often 
denoted by graphical representations whereby different classes of variables are presented 
using different standard forms. 
Table 5.1: Nomenclature and Graphic Representation used in Latent Variable Modelling.  
Unit Description Graphic 
Latent Variables, Latent Factors, f Latent variables and other non-
observed variables (i.e. error) are 
indicated by an ellipsis in the path 
diagram 
 
Errors, Residuals Error/ Residuals are often denoted 
in brackets 
() 
Observed Variables, Indicators, y Variables measured directly in the 
analysis and that are indicators of 
latent factors are in a rectangular 
box 
 
Uni Directional Arrows Denotes a causal relationship in 
the form of a regression between 
one variable (or error) and 
another. It is important to note that 
in Factor Analysis variations in 
the latent trait predicts the 
relationship. The indicators 
themselves are not predictive. 
 
Double Headed Arrows Indicates a relationship (i.e. 
correlation/ covariance) between 
variables. 
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Unit Description Graphic 
Independent Variable, Regressor, 
Predictor, Exogenous 
A variable that emits an arrow.   
 
 
Dependent Variable, Predicted A variable that receives an arrow, 
i.e. is regressed on. 
 
 
Endogenous Variable A variable that is regressed on but 
can be dependent and independent 
depending on model type 
 
 
5.3 Exploratory Factor Analysis (EFA) 
There have been methodological arguments over the appropriateness of using exploratory 
factor analysis (EFA) to model data, with researchers highlighting that only in rare cases is 
there little knowledge of potential underlying structures. In the current data set however there 
are no a priori assumptions. The suggestions made as to why EDs may be more prevalent in 
the T1D population are speculative. Although there have been arguments made regarding the 
use of EFA there is also a general consensus that when the underlying pattern is poorly 
understood an exploratory procedure is valid (Gerbin & Hamilton, 1996, Byrne, 2012). 
Furthermore, EFA is often cited as the most common form of latent variable analysis in 
psychological research and is particularly useful for Likert data (Pohlmann, 2004).  
5.3.1 Sample size  
Sample size has been one of the most contentious issues in the Factor Analysis literature with 
most of the arguments focusing on ‘rule of thumb’ sample sizes (N) and item to N ratio.  A 
Sample size of 100 is recommended by Gorsuch. (1982) and echoed by Kline. (1979), 
however other researchers have suggested a minimum sample of 200 (Guilford, 1954) or 250 
(Cattell, 1978) while such a size is deemed simply ‘fair’, 300 ‘good’, 500 ‘very good’ and 
1000 or more ‘excellent’ according to Comrey and Lee. (1992). In terms of ratios Everitt. 
(1975) argued that the item to N should be at least 10:1. Gorsuch. (1983) halved that 
recommendation to 5:1 and Cattel. (1978) reduces this recommendation to at least 3:1. In 
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their review paper on sample size in factor analysis however MacCallum, Widaman, Zhang 
and Hong. (1999) state ‘A fundamental misconception about this issue is that the minimum 
sample size, or the minimum ratio of sample size to the number of variables, is invariant 
across studies’ (MacCallum et al., 1999, p.84). Accordingly most current conclusions on 
sample size appropriateness are made by assessing how strong the data is. Costello & 
Osborne. (2005) state that this can be measured by ‘uniformly high communalities without 
cross loadings, plus several variables loading strongly on each factor’ (Costello & Osborne, 
2005 p. 4) and this sentiment is echoed by MacCallum et al. (1999) in their review. Strong 
data with those properties are widely understood to be able to withstand EFA regardless of 
sample size, N between 100 – 200 is adequate under the conditions above and some studies 
have found that this is the case even with samples under N = 50 (MacCalum et al., 1999; 
Jung, 2013). Furthermore, even under ideal conditions using a ratio of 20:1 EFA can produce 
high error rates (Costello & Osborne, 2005). Rather than using rules of thumb to determine 
whether of not sample size is sufficient there are two tests available in SPSS which asses the 
suitability of the data for factor analytic procedure. The Kaiser-Meyer-Olkin test measures 
how much variance in each variable maybe common and as such the lower the portion of 
common variance the more suitable the data. The test produces a statistic between 0 and 1 
and Kaiser denoted the values as ‘0.00 to 0.49 unacceptable. 0.50 to 0.59 miserable. 0.60 to 
0.69 mediocre. 0.70 to 0.79 middling. 0.80 to 0.89 meritorious. 0.90 to 1.00 marvellous’. 
(Kaiser 1974; Cerny & Kaiser 1977). Bartlett’s test of sphericity tests the correlation matrix 
against the null hypothesis that no factors could explain the relationships, therefore a 
significant test p<0.05 suggests that there is an underlying factor structure and the data is 
suitable for analysis (Cramer & Howitt, 2004).   
5.3.2 Rotation  
Rotation of factors in EFA are generally divided into orthogonal and oblique solutions. 
Orthogonal rotation such as the most common method, the Varimax solution (Kaiser, 1958) 
assumes no correlation between factors. In oblique rotation, some level of correlation 
between items is expected and thus unique variance is separated from common variance. 
While historically orthogonal rotation has been used, as this solution offers the most easily 
interpretable output, more recently researchers have argued that as little in psychological 
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sciences is unrelated oblique rotation is more theoretically sound (Browne, 2001; Costello & 
Osborne, 2005).   
5.3.3 Extraction  
Much debate has also surrounded the method of factor extraction. The most common 
methods in psychological research are Principle Components Analysis (PCA), Principle Axis 
Factoring (PAF) and Maximum Likelihood (ML). It should be noted that PCA is theoretically 
distinct from the other methods. PCA only seeks to explore the current sample data by 
reducing items into smaller components, thus summarising the data without taking 
measurement error into consideration and assessing the total variance in the sample. Factor 
analytic methods such as PAF and ML primarily utilise the communalities between items, 
assuming that variation in individual items scores are driven by an underlying variable not 
directly measurable and as such analyses the common variance within the sample (Haig, 
2005; Matsunaga, 2010; McNiesh, 2015). Although PCA is the most common method 
reported (possibly because it is the default in SPSS and SAS) (Pohlmann, 2004) and some 
researchers argue that there is little difference between methods (Gerbin & Hamilton, 1996; 
Zhang & Preacher, 2015), factor analytic (FA) methods are widely believed to be more 
theoretically sound (Costello & Osborne, 2005). There are various methods of extraction 
under the FA umbrella of which the most common are Maximum Likelihood and Principle 
Factor Methods also called Principle Axis Factoring (PAF).  
5.3.4 Factor Construction 
Whether an item is retained as a component of a factor is determined by various properties 
namely, correlations with other items, communalities, factor loading and cross loading.  
Velicer and Fava, (1998) recommend that high communalities (the extent to which a variable 
is related to the other variables entered into the model) are those of 0.8 or greater but as 
Costello & Osborne, (2005) highlight this level of communality is rare and in social sciences 
communalities more often lie between 0.4 -0.7 with those that are 0.4 or below being 
considered low. MacCallum et al, (1999) suggest that with sample sizes between 100 – 200 
a solid factor solution can be recovered as long as communalities are above 0.5 but 
recommend that the mean level of communality should be 0.7. In a later paper they also state 
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that high communalities can also help overcome sampling error that may be present in the 
data (MacCallum, Widman, Preaher & Hong, 2001). Factor loading can broadly be described 
as the strength of the relationship between the latent factor and the item. It follows from this 
that items that are strongly related with a factor are desirable and that others that are not may 
be screened out. An issue arises again as there is no general consensus as to what boundary 
levels should be used to define appropriate loading. Tabachnick and Fidell, (2001) propose 
.32 as a minimum loading. In a recent review the author states that a cut, off of 0.4 is liberal 
while 0.6 – 0.7 is conservative while concluding that ‘there is a certain degree of judgement 
– call involved in this procedure’ (Matsunaga, 2010, p. 101). Cross loading is another issue 
in item retention and it occurs when an item loads on more than one factor. Tabachnick and 
Fidell, (2001) consider an item to be cross loading if it has correlations on more than two or 
more factors but they also state that this is a ‘rule of thumb’.  A cross loading factor may be 
a good candidate for exclusion if there are higher loading items constituting the factor 
(Costello & Osborne, 2005). Alternatively, an approach that involves a first and second 
loading cut-off may be utilised, for example an item may be retained if it has a loading of 0.6 
on it’s primary factor and a loading of .4 or any other factor (Matsunaga, 2010) this may 
solve any potential issues with cross loading. 
Again there is conflicting advice as to the exact number of items to retain in a factor. Byrne 
(2013) using the principle of overidentification suggests that a 3 item factor is under- 
identified a 4 item factor is just identified and a 5 item factor is the minimum required for an 
overidentified factor which is the ideal situation. Costello and Osborne, (2005) quantify this 
further by recommending that these 5 items should have a minimum factor loading of equal 
to or more than 0.5. 
5.3.5 Dimensionality 
There are various recommendations regarding how many factors should be retained post 
extraction and rotation. The most common are the Kaiser – Gutman rule which advocates 
keeping factors that have an eigen value over 1, however it has been argued that this over 
identifies factors (Matsunaga, 2010) and the scree test (Cattell, 1958, 1966) which involves 
looking for an inflection point whereby after there is an insignificant cluster of results. Those 
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above the inflection point are retained as factors. Regarding the Kaiser – Gutman rule 
Costello & Osborne, (2005), in their review of best practice in EFA, state that this method is 
seriously problematic claiming ‘there is broad consensus in the literature that this is among 
the least accurate methods’ (Costello & Osborne, 2005, p.2), although they then go on to 
recommend the scree test followed by multiple FAs using the suggested number of points 
above inflection and using the ‘cleanest solution’. They then state is a factor solution ‘with 
item loadings above 0.3, no or few cross loadings (and) no factors with fewer than three 
items’ (Costello & Osborne, 2005, p.3).  A newer more validated approach to factor retention 
uses Parallel analysis (Horn, 1965; Turner, 1998). Computer programmes run a monte carlo 
simulation with a predefined number of randomised data sets with similar parameters to the 
expected solution and show the eigen values expected when there is no latent structure 
assumed.  Research suggests that this is the most accurate method (Henson & Roberts, 2006). 
5.4 Confirmatory Factor Analysis (CFA) 
Confirmatory factor analysis (CFA) is mainly used to confirm an a prioi hypothesised factor 
structure, often suggested by an EFA. Due to the nature of CFA a model is deemed 
appropriate if the predicted parameters fulfil a number of ‘goodness of fit’ criteria. Similar 
to EFA when the researcher judges which extraction and rotation methods are most 
appropriate for the sample, CFA also uses different techniques of parameter estimates that 
are data led.  
5.4.1 Parameters of the measurement model  
In confirmatory factor analysis MPLUS (Muthén & Muthén, 1998-2016) fits the data to a 
number of specified parameters in order to asses fit. These parameters are factor loadings 
(slope), for observed variables, intercepts of the observed variables, error variance of the 
observed variables and error covariance (Geiser, 2013). 
5.4.2 Estimation 
Maximum Likelihood (ML) is the most common estimation method in CFA especially for 
continuous data, it’s also the default for most programmes such as Mplus (Muthén & Muthén 
2010). However, there are assumptions that should be met such as normal distribution,   
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although it has been argued that even under non-ideal circumstances ML may be appropriate, 
there are also corrections that can be utilised in order to overcome non normality. In MPlus 
Satorra-Bentler corrections can be utilised using the MLM estimator however this procedure 
requires complete data. In the case of missing data however, Huber/Pseudo ML/sandwich 
corrections can be employed using the MLR estimator. MLR is recognised as the most robust 
method of parameter estimation when there are missing data which is either Missing at 
Random (MAR) or Missing Completely at Random (MCAR) and for this reason it is 
recommended when also dealing with non-normally distributed data (Rosseel, 2010; Byrne, 
2012; Geiser, 2013; Muthén & Muthén, 1998-2016). 
5.4.3 Goodness of Fit Statistics.  
In CFA, unlike other statistical procedures the null hypothesis is desired as it predicts that 
the model fitted holds in the population to which the sample belongs. Thus, conversely to 
standard tests, insignificance is sought (p>0.05). Chi-square is one of the most common fit 
measurements used to test the null hypothesis and it is standard in most SEM programmes. 
MPlus (Muthén & Muthén, 1998-2016) provides a ‘baseline model’ whereby there is zero 
covariation between items, called the independence or null model and also provides a chi-
square goodness of fit for that model. In essence, if the proposed model has a lower chi square 
than the baseline model then that represents a better fit. As chi-square is sensitive to sample 
size and non-normality some researchers have advocated for the use of the normed chi-square 
which is the chi-square value divided by the degrees of freedom. There are debates over 
which cut-off point to use for significance, Ullman (2001) proposes less than 2 as appropriate 
while Schumacker & Lomax. (2004) suggest under 5. However, as Byrne. (2012) highlights, 
particularly in relation to CFA and SEM, null hypothesis significance testing is particularly 
problematic, especially with non-normally distributed data and therefore further measures of 
fit are required. 
There are two main types of fit indices outside the use of chi square, incremental, whereby 
fit is measured in comparison to a generated more restricted model, and absolute, where fit 
is measured by the specified model parameters being able to reproduce the sample data 
(Byrne 2012).  
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The Bentler Comparative Fit Index (CFI) is the most commonly used incremental fit statistic 
followed closely by the Tucker and Lewis Fit Index (TLI), these tests are similar in 
computation and interpretation with values closer to 1 being indicative of best fit (Byrne, 
2012; Geiser 2010). As with other fit test there has been considerable debate as to an 
appropriate cut-off point, early research suggesting that values of over 0.9 should be 
considered good fit (Bentler, 1990) with this later being revised to 0.95 (Hu & Bentler 1995; 
Kline 1999).  
Root Mean Square Error of Approximation (RMSEA) represents the most common absolute 
fit index. This test seeks to explain the difference between the proposed model and a model 
that perfectly fits the population data RMSEA = 0. Various boundaries have been suggested 
for good fit cut-off. Stieger (1990) argues that ideally RSMEA < 0.05. Absolute fit indices 
have been argued to over reject good models when the sample size used is small according 
to Hu and Bentler (1999) and as such they argue a less conservative value of 0.6 with some 
researchers stating that values of up to 0.8 (Browne and Cudek, 1993) may be acceptable or 
at least the upper confidence interval should not exceed that boundary (Hu & Bentler, 1995). 
Mplus (Muthén & Muthén, 1998-2016) also provides a significance test of the RMSEA 
whereby insignificance demonstrates that RMSEA is <0.05 in the population, this is termed 
‘closeness of fit’ (Geiser, 2013). The Standardised Root Mean Square Error of 
Approximation (SRMSEA)  is often used in conjunction with the RMSEA, it standardises 
the differences between the observed and predicted variances. Hu and Bentler. (1999) advise 
an upper boundary of 0.8 as indicative of good fit. 
5.5 Structural Equation Modelling (SEM) 
The confirmatory or exploratory factor models, called the measurement model in SEM 
represent the development and construction of latent factors. The structural model represents 
the relationship between, and potential predictive properties of, latent variables. The 
relationships in the model can be noted as paths, hence the use of ‘path models’. Paths 
typically annotate directional regressions or covariances between variables (please see table 
5.1). The SEM approach allows for further modelling by (among other things) allowing these 
latent factors to regress on to each other and also to act as predictors for other variables 
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(observed and latent). Theoretically SEMs maybe used in a strictly confirmatory fashion, 
whereby the research is only fitting the model to data in an a priori fashion, Alternative 
modelling, where several theoretically guided assumptions are tested are used far more 
commonly in a model Generating way which attempts to find the model best fitted to the data 
(Joreskog, 1993).  
5.5.1 Assumptions  
As with any statistical testing procedure SEM also is optimal under a number of assumptions, 
namely that the data is normally distributed, mostly complete and independent. However 
even in datasets where assumptions are violated programmes such as MPLUS provide 
options to counteract non-normality such as MLR estimation (Muthén & Muthén, 1998-
2016). 
5.5.2 Model Identification 
As with factor analysis the goal of a SEM is to describe an over identified model which is a 
model whereby there are more data points than there are parameters to be estimated thus 
leaving degrees of freedom that can be used to assess model fit statistically (Byrne, 2012). In 
SEM models the parameters estimated, excluding those for the measurement model, are 
variance for exogenous factors, factor means of exogenous (independent) factors, covariance 
in exogenous factors, latent path coefficients where the latent variable is also predictor, latent 
intercepts for endogenous factors, residual variances on latent endogenous factors, residual 
covariances for endogenous latent factors (Geiser 2013).  
5.5.3 Sample Size  
In general SEM is advised only for use in larger sample sizes. Kline (2005) argues that this 
is influences by contextual factors, i.e. complexity of the model and estimation technique but 
generally should be > 200. The original rule of thumb often followed by researchers is that 
there should be at least 10 subjects per parameter (Nunally, 1967). More recent arguments 
state that ratios should be applied to the number of free parameters in the model i.e. 5:1 
(Bentler, 1989). Modern interpretations state that rules of thumb are not appropriate as 
sample size cannot be calculated via a linear function (Westland, 2010).  
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5.5.4 Latent Variable Scaling 
Parameters for latent variables are typically specified using one of two methods. A reference 
item from each latent variable construction may have their loading (typically) constrained to 
1 in order to translate that scale to the latent variable. Alternatively, the fixed factor approach 
may be utilised where by the variances of latent variables are constrained to 1 leaving all 
other parameters to be estimated freely (Byrne, 2012). Little et al. (2006) argue that latent 
variable scaling need not be arbitrary and provide a calculation to ensure this, but it can only 
be used where the indicator variables utilise the same response scale. 
5.5.5 Goodness of Fit Statistics  
The Fit statistics for SEM are the same as for CFA. 
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6 Methodology, Results & Discussion: Structural Equation Model 
6.1 Methodology 
6.1.1 Ethical Approval  
Ethics approval for this study was granted by the Birkbeck departmental ethics committee on 
the 27th January 2014, approval number 131462. 
6.1.2 Setting  
Recruitment took place over the period of 04/05/2015 – 01/10/2015. An advert was posted 
on the social media pages of the registered charities: Diabetes UK, the Juvenile Diabetes 
Research Foundation, Diabetics with Eating Disorders (please see appendix H). The same 
advert was also posted on every Facebook page offering support and information to those 
with Type 1 Diabetes and the biggest online support forums for Type 1 Diabetes: 
Diabetes.co.uk, TuDiabetes and Diabetessupport.co.uk. A shorter version was also put on 
Twitter using the popular Diabetes hashtags #T1D, #DOC and #GBDOC. Participants were 
invited to share the advert on their social media pages and notify their Type1 
friends/colleagues/health care professionals.  
6.1.3 Procedure 
If participants decided to take part they were taken to the website 
www.typeoneandpsychology.org where specially designed ‘questioner’ software was hosted. 
The website was built using Wordpress and the software was built in the python 
programming language. The resultant database utilised MySQL and was held on a private 
secure virtual server owned by the researcher. The landing page gave information about the 
study and asked for consent (please see appendix I) on selecting OK the participants were 
taken through to the Questioner programme. The Questioner programme was designed so 
that after the demographics questions were answered, if they chose, participants could create 
a user account that allowed them to sign in and out of the programme at their convenience as 
the study was long. The order in which each scale was presented was also randomised in 
order to counteract order effects. Following completion of the scales a second questionnaire 
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appeared asking about the mental health history of the participant in relation to formal 
diagnoses made by a HCP, this was asked at the end in order to avoid biasing answers to the 
scales. They were then asked if they had ever felt that they had an Eating Disorder. If they 
selected yes they were taken to the next stage of the study (Chapter 7) and if they said no 
they were directed to the debrief screen (please see appendix J). 
6.1.4 Participants 
Eligibility criteria for the participants were being over the age of 16, having been diagnosed 
by a medical professional as having Type 1 Diabetes and having a good grasp of English. As 
the study was conducted online internet access was also essential this may have been via a 
computer/ table/ laptop/ smartphone. All of the participants fulfilled this criteria none were 
excluded from the final analysis. 
6.1.5 Variables 
6.1.5.1 Demographic information 
Age, gender, recruitment method, nationality, current country of residence and ethnicity was 
recorded.  
6.1.5.2 Medical Information  
Age at diagnosis, duration of diagnosis, HbA1c, method of insulin administration, 
Contiguous Glucose Monitoring usage, T1D related complications, medications, other health 
conditions, mental health diagnoses, familial mental health and Eating Disorder status were 
recorded.    
6.1.5.3 Psychometric Variables 
Depression: The Center of Epidemiological Studies Depression 10 Items was used 
(Andersen, Malmgren, Carter, & Patrick, 1994). This scale has shown good internal 
consistency (Cronbach’s alpha = 0.86) and has been used in T1ED samples in other research 
(Powers et al., 2017).  Responses are given on a 4-point Likert scale from 0=rarely or none 
of the time, to 3=all of the time, with a minimum score of 0 and a maximum score of 30 
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indicating higher levels of depression. Items include ‘I was bothered by things that usually 
don't bother me.’ 
Anxiety: the Generalised Anxiety Disorder 7 Item scale was used (Spitzer, Kroenke, 
Williams & Löwe, 2006). This scale demonstrates good internal validity (Cronbach’s alpha 
= 0.92) and has been utilised in other studies researching T1D (Löwe, Decker, Müller, 
Brähler, Schellberg, Herzog, & Herzberg, 2008). Responses are given on a 4-point Likert 
scale from 0=not at all to 3=nearly every day. This renders a minimum score of 0 and a 
maximum score of 21. Higher scores indicate higher levels of anxiety. Items include ‘Being 
so restless that it is hard to sit still’. 
Borderline Personality traits: The Mclean Screening Instrument for Borderline Personality 
Disorder (MSI-BPD) was used (Zanarini et al., 2003). This scale demonstrates good internal 
validity (Cronbach’s alpha = 0.74) and has been used for screening (Chanen et al., 2008). 
The scale consists of 10 yes/no questions with a minimum score of 0 and a maximum of 10, 
higher scores indicate more borderline personality traits. Items include ‘Have you 
deliberately hurt yourself physically (e.g., punched yourself, cut yourself, burned yourself)? 
How about made a suicide attempt?’   
In order to assess perfectionism, the Almost Perfect Scale Revised was used (Slaney, Rice, 
Mobley, Trippi & Ashby 2001). This scale consists of 3 subscales which have all shown good 
internal validity: Order (Cronbach’s alpha= 0.86); Standards (Cronbach’s alpha = 0.85); and 
Discrepancy (Cronbach’s alpha = 0.92). It has been used in Eating Disorder samples (Paulson 
& Rutledge, 2014). The discrepancy scale consists of 12 questions, order 4 and standards 7. 
All of these utilise a 7-point Likert scale ranging from 1=strongly disagree to 7=strongly 
agree. The minimum score for the scale is 23 and the maximum is 161 with higher scores 
being indicative of higher levels of perfectionism. Items include ‘I often worry about not 
measuring up to my own expectations.’, ‘If you don’t expect much out of yourself, you will 
never succeed.’ and ‘I like to always be organized and disciplined.’ 
In order to measure Diabetes related distress, the Diabetes Distress Scale (DDS) was used 
(Polonsky, et al., 2005). This questionnaire consists of 4 subscales: Emotional Burden (5 
questions); Physician Related Distress (4 questions); Regimen Related Distress (5 questions) 
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and Interpersonal distress (3 questions). The scale shows good internal validity (Cronbach’s 
alpha = 0.87). The 17 questions that constitute the scale are measured on a 6-point Likert 
scale ranging from 1= not a problem to 6= A very serious problem. The minimum score for 
this questionnaire is 17 and the maximum is 102.   Higher scores indicate higher levels of 
Diabetes related distress. Items include ‘Feeling that I will end up with serious long-term 
complications, no matter what I do.’, ‘Feeling that I don't have a doctor who I can see 
regularly enough about my Diabetes.’, ‘Not feeling motivated to keep up my Diabetes self-
management.’ and ‘Feeling that friends or family don't give me the emotional support that I 
would like.’ 
Consideration of Future Consequences (CFC): In order to measure how concerned 
participants were regarding their disease outcomes the Consideration of Future 
Consequences questionnaire was used (Strathman, Gleicher, Boninger  & Edwards, 1994). 
This scale has shown good internal validity (Cronbach’s alpha = 0.8) and has been used in 
studies investigating health related outcomes (Von Wagner, Good, Whitaker, & Wardle, 
2011). This scale constitutes 12 questions with a minimum score of 12 and a maximum of 
60, rated on a 5-point Likert scale, with 1=extremely uncharacteristic to 5=extremely 
characteristic. Some of the items were reverse scored.  Higher scores indicate higher levels 
of consideration of future consequences. Items include ‘I think it is more important to 
perform a behaviour with important distant consequences than a behaviour with less-
important immediate consequences.’  
Family Functioning: The Family Adaptability, Cohesion Evaluation Scale (FACES) 3 
(family version) was used; this measures 2 subscales (Olson, 1985). Adaptability 
(Cronbach’s alpha = 0.62) and Cohesion (Cronbach’s alpha = 0.77) and has been utilised in 
a number of studies in health psychology (Kouneski, 2000).  Each of these subscales contain 
10 items and utilise a 5-point Likert scale going from 1=almost never to 6=almost always. 
The minimum score is 10 and the maximum is 50. Higher scores represent higher family 
functioning. Items include ‘Children have a say in their discipline’ and ‘Family members like 
to spend free time with each other’.  
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Self-esteem: the Rosenberg self-esteem scale (RES) was used (Rosenberg, 1965). This has 
shown good internal reliability (Cronbach’s alpha = 0.88) and has been used in a number of 
similar studies (Baumeister, Campbell, Krueger & Vohs, 2003). The scale is measured over 
10 questions on a 4-point Likert scale from 0=strongly disagree to 3=strongly agree. Some 
of the items are reverse scored and participants can receive a minimum of 0 and a maximum 
of 30.  Higher scores indicate higher levels of self-esteem. Items include ‘I feel that I'm a 
person of worth, at least on an equal plane with others.’ 
In order to assess Eating Disorder symptomology the Diabetes Eating Problem Scale Revised 
was used (Antisdel, Laffel & Anderson 2001).  This scale has demonstrated high internal 
reliability (Cronbach’s alpha 0.86) and has been validated in other related studies (Wisting 
et al 2013 a/b). 16 questions constitute the scale and they are scored on a 6-point Likert scale 
from 0=never to 5=always. The minimum score is 0 and the maximum is 80 with scores over 
21 deemed clinically concerning. Items include ‘I feel that it’s difficult to lose weight and 
control my Diabetes at the same time’. 
In order to compare Diabetes related Eating Disorder symptoms to those found in the general 
population the Eating Attitudes Test 26 was used (please see chapter 3). 
6.1.5.4 Variables for Analysis 
The main outcome variables of interests were HbA1c as self-reported by the participants 
from their last medical appointment and DEPS-R scores as a measure of Eating Disorder 
symptomology, with all other variables being examined as possible predictors/ mediators. 
6.2 Results  
6.2.1 Overview of Analysis 
Firstly, the sample characteristics were described in terms of demographics, medical details 
and mental health information.  Following this the descriptive data, distribution, proportion 
of missing data and scale alphas of the potential variables for structural modelling as 
identified by the pilot study and the literature review were reported. Relationships between 
the variables for structural modelling and the main outcome variables DEPS-R scores and 
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HBA1C levels were then explored via Pearson’s correlation coefficients and significant 
associations selected. 
The hypothesised variables relating to psychological functioning and Diabetes specific 
distress were then factor analysed to ascertain whether there were underlying latent variables 
to account for variations in scale responses.  Latent factors were identified; ‘Psychological 
functioning’ comprising of anxiety, depression, borderline traits, maladaptive perfectionism 
and self esteem scores and ‘Diabetes specific distress’ comprising of Emotional Burden, 
Physician Related Distress and Interpersonal Distress. These latent variables were then 
explored in SEM by using them as predictors of HbA1c and DEPS-R scores. As suggested 
by the literature gender was also entered into the model. Following this the relationship with 
family functioning and the latent variables was explored via regression and mediation 
analysis. An alternative model was considered in order to ascertain if the novel variable 
‘Consideration of Future Consequences’ predicted HbA1c and DEPRS scores. A further 
alternative model was then considered by regressing ‘Age’ onto the outcome variables also. 
6.2.2 Software   
All data was processed and analysed using IBM SPSS version 23 (IBM Corp. 2016) and 
Mplus version 8 (Muthén & Muthén 1998-2016).  
6.2.3 Sample Characteristics 
6.2.3.1 Initial Numbers 
687 participants started the questionnaire having being recruited mostly by social media (610/ 
88.8%). All participants completed the gender question. 92 (13.4%) were male, 592 (86.2%) 
were female, 2 were transgendered (0.3%) and 1 selected prefer not to say (0.15%). 686 
participants gave their age. They had mean age of 33.73 (12.01) years (range:16 – 69). Many 
nationalities were reported but most were UK/ Eire and US nationals living in those countries 
all participants answered these questions and the ethnicity question, the majority (599/ 
87.2%) were white and a large minority selected prefer not to say (81/ 11.8%) (for the full 
characteristics of the participants please see appendix K). 
155 
 
6.2.3.2 Medical Status 
686 participants reported a mean age at diagnosis of 15.48 (11.58) years (range: 0 – 61) and 
a mean T1D duration of 18.25 (11.98) years (range: 0 – 59). 659 participants reported a mean 
HbA1c% of 8 (2.24, range: 4 – 29%). 530 participants reported their methods of blood sugar 
management. 319 (60.2%) utilised a pump, 200 (37.7%) were on multiple daily injections, 4 
(0.75%) used a mixtard11, 6 (1.13%) used syringes and vials and 1 (0.19%) used inhaled 
insulin. 222 (41.89%) of these patients also utilised a continuous glucose measurement 
device. 684 participants reported a mean of 0.67 (1.12) Diabetes related complications.  The 
most commonly reported were Retinopathy and other eye issues (Macular Oedema, Cataracts 
and Glaucoma) (162/ 23.7%), Neuropathy (101/ 14.7%), Gastroparesis (47/ 6.9%) and 
Nephropathy (36/ 5.3%). The 684 participants were taking an average of 0.23 (0.84) 
medications to manage these conditions. Of the 687 asked, 325 (47.3%) participants reported 
having more than Diabetes as a medical diagnosis. Of these the most common conditions 
experienced were Hypothyroidism (95/ 13.8%), Asthma (56/ 8.15%) and Coeliac Disease 
(23/ 3.3%) (for full participant medical status please see appendix K). 
6.2.3.3 Participants Mental Health Information 
439 participants answered the question ‘have you ever had a mental health diagnosis (except 
an Eating Disorder diagnosis)’ 193 (44%) answered yes so participants had a mean of 0.678 
(.913). Of those who did report other diagnoses the most common were depression (155/ 
35.3%), anxiety (79/ 18%) borderline personality disorder (14/ 3.2%), bipolar disorder (10/ 
2.3%), and post-traumatic stress disorder (10/ 2.3%) (for full participant mental health 
characteristics please see appendix K).  Participants who had reported having another mental 
health diagnosis had a mean of 1.52 (0.78 min 1 – max 5) conditions. 435 participants 
answered the question ‘to the best of your knowledge does anyone in your family have a 
mental health diagnosis?’. Of them 217 (49.9%) answered yes, 173 (39.7%) answered no and 
                                                 
 
11 A mixtard is an injectable form of insulin that contains both long acting and short acting insulin. 
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45 (10.3%) stated that they weren’t sure. 435 participants answered the question ‘to your 
knowledge has anyone in your family ever had an Eating Disorder?’ of these 60 (13.8%) 
answered yes, 354 (81.4%) answered no and 21 (4.8%) stated that they weren’t sure.  439 
participants answered the question ‘have you ever been diagnosed with or thought that you 
had an Eating Disorder’ of these 130 (29.9%) answered yes. However, of the 491 participants 
who completed the DEPS-R questionnaire 217 (44.2%) screened positive (a score of 20 or 
above) for further clinical investigation. 
6.2.4 Main Outcome Variables and Potential Predictors/ Mediators for Structural 
Modelling  
6.2.4.1 Missing Data  
The data was missing completely at random (MCAR) Littles test Chi-Square = 2901.456, df 
= 3356 p =1) as such pairwise deletion was used for the correlation analysis, confirmatory 
factor analysis and structural equation model. Please see table 6.1 below for the distribution 
of missing data. 
6.2.4.2 Distribution  
The Distribution of some variables showed non normality, particularly HbA1c which had a 
kurtosis of 22.03, however this is to be expected given that the normal range for blood sugar 
is between 4 – 8 mmols. Furthermore, MPLUS provides an MLR estimation that is robust to 
non normality (Muthén & Muthén, 1998-2016). Please see table 6.1 below for distribution 
statistics 
6.2.4.3 Descriptive Statistics, Distribution Statistics, Missing Data and Scale Alphas for 
Variables of Interest in the Sample 
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Table 6.1: Descriptive Statistics, Distribution Statistics, Missing Data and Scale Alphas for Variables of Interest in the Sample 
 
n Mean Std. 
Deviation 
Skew SE Kurtosis SE Missing 
Count 
Missing 
Percent 
Scale 
Alpha 
Outcome Variables                     
HbA1c 659 8 2.24 3.427 0.095 22.03 0.19 28 4.1 
 
DEPS-R Scores 491 23.19 17.25 1.227 0.11 0.976 0.22 196 28.5 0.936 
Psychosocial Variables                      
Depression 505 11.78 7.06 0.5 0.109 -0.424 0.217 182 26.5 0.866 
Borderline Traits 468 4.36 3.21 0.486 0.113 0.026 0.225 219 31.9 0.831 
Generalised Anxiety 512 8.74 6.03 0.425 0.108 -0.88 0.215 175 25.5 0.929 
Perfectionism (Standards) 497 40.64 7.15 -1.532 0.11 3.321 0.219 190 27.7 0.872 
Perfectionism (Order) 501 20.59 5.21 -0.705 0.109 0.014 0.218 186 27.1 0.862 
Maladaptive Perfectionism 496 54.22 18.37 -0.248 0.11 -0.944 0.219 191 27.8 0.96 
Self Esteem 488 17.39 7.3 -0.202 0.111 -0.673 0.221 199 29 0.938 
Consideration of Future 
Consequences 
480 40.94 8.81 -0.409 0.111 -0.195 0.222 207 30.1 0.869 
Family Cohesion 471 35.48 8.51 -0.661 0.113 -0.092 0.225 216 31.4 0.897 
Family Adaptability  411 23.88 6.3 0.254 0.12 0.491 0.24 276 40.2 0.777 
Diabetes Specific Distress                     
Diabetes Emotional Burden 504 18.47 7.35 -0.049 0.109 -1.17 0.217 183 26.6 0.92 
Diabetes Physician Related 
Distress 
498 8.91 5.41 1.059 0.109 0.13 0.218 189 27.5 0.87 
Diabetes Regimen Related 
Distress 
504 14.94 7.38 0.525 0.109 -0.879 0.217 183 26.6 0.89 
Diabetes Interpersonal 
Burden 
503 9.26 4.51 0.396 0.109 -0.963 0.217 184 26.8 0.855 
Demographic Variables                      
Age 686 33.73 12.01 0.818 0.093 -0.025 0.186 1 0.1 
 
Diagnosis Age 686 15.48 11.58 1.412 0.093 2.05 0.186 1 0.1 
 
Diabetes Duration 686 18.25 11.98 0.734 0.093 0.097 0.186 1 0.1 
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6.2.5 Relationships between Psychosocial, Diabetes Specific and Demographic 
variables and HbA1c and DEPS-R scores  
Pearson’s bivariate correlation tests were run on all of the relevant variables (please see 
appendix M for the full correlation matrix). Those who were younger, had been diagnosed at 
an earlier age and had a lesser duration of Diabetes had higher DEPS-R scores.  Higher levels 
of anxiety, Diabetes specific distress (all subscales), maladaptive perfectionism, borderline 
personality traits, depression and lower levels of consideration of future consequences and 
self-esteem were all correlated with higher Eating problem symptomology. Perfectionism 
(standards and order) were not significantly related.  Higher levels of family cohesion were 
related with lower DEPS-R scores but family adaptability was not significantly correlated.  
Those who were younger and had a shorter duration of Diabetes had higher HbA1c levels 
but there was no significant correlation with age at diagnosis. Higher levels of anxiety, 
Diabetes specific distress (all subscales), maladaptive perfectionism, borderline personality 
traits, depression and lower levels of consideration of future consequences and self-esteem 
were all correlated with higher HbA1c levels. Higher standards (perfectionism) was related 
with lower levels but order (perfectionism) was not. Family variables were not significantly 
related to HbA1c levels.  
The two dependent variables DEPS-R scores and HbA1c levels were significantly correlated 
Table 6.2: Correlations between Outcome Variables and Potential Predictors/ Mediators 
 
HbA1c DEPS-R  Scores 
 
n r p n r p 
Outcome Variables              
Eating Problem Symptomology (DEPS-R Scores) 476 .54** <0.01   
 
  
HbA1c   
 
  476 .54** 0 
Psychosocial Variables              
Self Esteem Scores 469 -.35** <0.01 437 -.60** <0.01 
Generalised Anxiety Scores 495 .32** <0.01 461 .49** <0.01 
Depression Scores 487 .33** <0.01 460 .51** <0.01 
Perfectionism Discrepancy Scores 478 .26** <0.01 450 .51** <0.01 
Perfectionism (standards) Scores 479 -.11* 0.02 452 -0.03 0.52 
Perfectionism (order) Scores 483 -0.02 0.69 452 -0.06 0.24 
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HbA1c DEPS-R  Scores 
Consideration of Future Consequences Scores 464 -.29** <0.01 435 -.45** <0.01 
Borderline Personality Scores 452 .35** <0.01 421 .56** <0.01 
Family Cohesion Scores 455 0.08 -0.08 425 -.21** <0.01 
Family Adaptability Scores  399 0.07 0.18 371 -0.06 0.26 
Diabetes Specific Distress             
Emotional Burden of Diabetes Scores 484 .37** <0.01 460 .56** <0.01 
Physician Related Burden Scores 479 .21** <0.01 453 .29** <0.01 
Diabetes Regimen Burden Scores 485 .49** <0.01 459 .74** <0.01 
Interpersonal Distress due to Diabetes Scores 483 .26** <0.01 459 .42** <0.01 
Demographic Variables    
 
    
 
  
Age 658 -.18** <0.01 490 -.32** <0.01 
Age at Diagnosis 658 -0.06 0.14 490 -.16** <0.01 
Diabetes Duration (years) 658 -.13** <0.01 490 -.17** <0.01 
*Significant <0.05, **Significant <0.01 
6.3 Structural Equation Model  
6.3.1 Factor Analysis  
As proposed the psychological variables (anxiety, depression, borderline traits, maladaptive 
perfectionism and self-esteem) were added to the model and regressed on the latent trait  
‘Psychological Functioning’. The variables all had factor loadings > 0.7 (please see table 
6.3). The 3 scales of the Diabetes Distress Scale ‘Emotional Burden’, ‘Physician Related 
Distress’ and ‘Interpersonal Distress’ were then regressed onto the latent trait ‘Diabetes 
specific distress’ and all variables had loadings > .5. As there was a .74 correlation between 
DEPS-R scores and Regimen Related Distress this variable was not entered into the model 
due to potential issues with collinearity (please see discussion).  This revealed a relatively 
well-fitting model: 𝑥2 (19) =82.203, p< 0.000, RMSEA = 0.074, CFI = 0.962, TLI = 0.945. 
In order to assess whether a better fit was possible, modification indices were consulted, 
which suggested allowing self-esteem to correlate with both maladaptive perfectionism and 
general anxiety scores. This yielded a better fitting model: 𝑥2  (17) =29.770, p< 0.0281, 
RMSEA = 0.035, CFI = 0.992, TLI = 0.987. 
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Table 6.3:  Latent Factor Construction (standardised) 
 
Estimate S.E. P-Value 95% CI 
Lower 2.5% 
95% Upper 
2.5% 
R square 
Psychological 
Functioning  
      
Anxiety 0.823 0.022 <0.001 0.779 0.867 0.678 
Self Esteem -0.844 0.02 <0.001 -0.884 -0.804 0.712 
Maladaptive 
Perfectionism 
0.712 0.026 <0.001 0.661 0.764 0.507 
Borderline 
Traits 
0.741 0.029 <0.001 0.684 0.799 0.55 
Depression 0.871 0.014 <0.001 0.844 0.897 0.758 
Diabetes  
Distress 
      
Emotional  
Burden 
0.876 0.021 <0.001 0.835 0.918 0.768 
Physician  
Burden  
0.526 0.04 <0.001 0.447 0.604 0.276 
Interpersonal  
Distress 
0.703 0.03 <0.001 0.644 0.763 0.495 
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Figure 6.1: Construction of Latent Factors ‘Psychological Functioning’ and ‘Diabetes 
Specific Distress’ (standardised) 
 
6.3.2 Structural Model One  
In order to predict the role of psychological functioning (PF) and Diabetes specific distress 
(DSD) on BG control and Eating Disorder symptomology a full structural model was 
specified. PF and DDS were regressed on HbA1c and DEPS-R while controlling for gender 
as the literature suggests that women are at higher risk for both EDs and poor control and a 
well-fitting model was revealed (𝑥2 (37) =90.873, p< 0.000, RMSEA = 0.046, CFI = 0.975, 
TLI = 0.963).  
The results suggest that psychological functioning predicted HBA1C  (β=0.193 SE=0.030, 
95% CI = 0.030, 0.357) and DESPR (β=0.431 SE=0.082, 95% CI = 0.271, 0.590). As 
suggested by the literature higher levels of impaired psychological functioning predicted 
higher HBA1C levels and DESPR scores. Similarly, higher levels of diabetic specific distress 
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predicted increased levels of HBA1C (β=0.245 SE=0.091, 95% CI = 0.066, 0.424) and 
DESPR (β=0.261 SE=0.081, 95% CI = 0.106, 0.424).  Gender predicted DESPR (β=0.220 
SE=0.094, 95% CI = 0.035, 0.406), but did not predict HBA1C. This suggest that women are 
.20 of a standard deviation more likely than men to experience Eating Disorder 
symptomatology, but that diabetic specific distress was not associated with gender. Overall 
the model explained 17.4% of variance in HBA1C and 44.6% of variance in DESPR.   
Table 6.4:  SEM Model 1 Construction (standardised) 
 
Estimate S.E.  E P-Value 95% CI Lower 2.5% 95%  CI Upper 
2.5% 
Psychological 
Functioning  
     
Anxiety 0.815 0.022 <0.001 0.771 0.859 
Self Esteem -0.854 0.02 <0.001 -0.893 -0.814 
Maladaptive 
Perfectionism 
0.717 0.027 <0.001 0.665 0.769 
Borderline 
Traits 
0.749 0.029 <0.001 0.692 0.806 
Depression 0.861 0.014 <0.001 0.834 0.888 
Diabetes  
Distress 
     
Emotional  
Burden 
0.882 0.021 <0.001 0.841 0.923 
Physician  
Burden  
0.517 0.04 <0.001 0.438 0.595 
Interpersonal  
Distress 
0.697 0.031 <0.001 0.637 0.756 
HBA1C   
     
Psychological 
functioning 
0.193 0.083 0.02 0.03 0.357 
Diabetes Specific 
Distress 
0.245 0.091 0.007 0.066 0.424 
DEPS-R   
     
Psychological 
functioning 
0.431 0.082 <0.001 0.271 0.59 
Diabetes Specific 
Distress 
0.265 0.081 0.001 0.106 0.424 
HBA1C    
     
Gender 0.017 0.091 0.852 -0.161 0.195 
DEPS-R   
     
Gender 0.22 0.094 0.02 0.035 0.406 
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Figure 6.2: Structural Model 1 (standardised)  
 
6.3.3 Structural Model 2: The Role of Family Functioning  
Family functioning is related to psychological functioning and potentially then it may also 
be to HBA1C and DEPS-R. The next step tested the role of family functioning on HbA1c 
and DEPS-R. While there was no significant relationship between Diabetes specific distress 
and Family cohesion (estimate = -0.099 SE = 0.056 p = 0.080) there was for Psychological 
Functioning. As such the model was prespecified to only consider family functioning in 
relation to general psychological functioning.  
Following this indirect effects were tested to ascertain whether psychological functioning 
mediate the effects of family cohesion on HBA1C and DESPR levels. A relatively well-
fitting model was found (𝑥2 (46) =118.198, p< 0.000, RMSEA = 0.058, CFI = 0.963, TLI = 
0.948). 
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The results suggest that family cohesion acted as a protective factor, predicting reduction in 
problematic psychological functioning (β= -0.235 SE=0.039, 95% CI = -0.312, -0.158).  
What is more, indirect effects were found, suggesting that psychological functioning 
mediated the effects of family cohesion on HBA1C levels (β=-0.045 SE=0.023, 95% CI = -
0.090, 0.000), and DEPS-R levels (β=-0.115 SE=0.029, 95% CI = -0.171, -0.058). The 
effects were just significant in the case of HBA1C, but significant at the p< .05 in the case of 
DEPS-R, this suggests that higher levels of cohesion in the family predicts less psychological 
problems, which in turn predict reduced levels of HBA1C and DEPS-R.  
6.5: Structural Model 2, Family Cohesion (standardised) 
 
Estimate S.E. P-Value 95% CI Lower 2.5% 95%  CI Upper 2.5% 
Psychological  
Functioning 
     
Anxiety 0.809 0.024 <0.001 0.762 0.855 
Self Esteem -0.843 0.022 <0.001 -0.886 -0.801 
Maladaptive 
Perfectionism 
0.701 0.029 <0.001 0.644 0.758 
Borderline 
Traits 
0.744 0.031 <0.001 0.684 0.804 
Depression 0.864 0.014 <0.001 0.836 0.892 
Diabetes  
Distress 
     
Emotional  
Burden 
0.904 0.023 <0.001 0.858 0.949 
Physician  
Burden  
0.487 0.045 <0.001 0.399 0.574 
Interpersonal  
Distress 
0.666 0.035 <0.001 0.598 0.734 
Psychological 
Functioning 
     
Family 
Cohesion 
-0.235 0.039 <0.001 -0.037 -0.019 
HBA1C    
     
Psychological 
Functioning 
0.19 0.088 0.03 0.019 0.362 
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Estimate S.E. P-Value 95% CI Lower 2.5% 95%  CI Upper 2.5% 
Diabetes 
Distress 
0.259 0.091 0.004 0.081 0.437 
DEPS-R 
     
Psychological 
Functioning 
0.488 0.08 <0.001 0.33 0.645 
Diabetes 
Distress 
0.211 0.08 0.008 0.055 0.367 
DEPS-R     
     
Gender 0.231 0.036 0.04 0.011 0.45 
Indirect Effects      
HbA1c      
Psychological 
Functioning 
     
Family 
Cohesion 
-0.045 0.023 0.05 -0.09 0 
DEPS-R      
Psychological 
Functioning 
     
Family 
Cohesion 
-0.115 0.029 <0.001 -0.171 -0.058 
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Figure 6.3: Structural Model 2, Family Cohesion (standardised) 
 
6.3.4 Structural Model 3: Consideration of Future Consequences  
As stated in the literature review the relationship with consideration of future consequences 
is not well defined in the academic literature regarding T1ED but rather suggested by media 
source. As such in an alternative model CFC was added as an independent predictor of 
HBA1C and DEPS-R. A moderately well fitting model was found  (𝑥2 (46) = 144.833, p< 
0.000, RMSEA = 0.067, CFI = 0.953, TLI = 0.933). Higher levels of consideration of future 
consequences predicted both lower HbA1c (β=-0.237 SE=0.046, 95% CI = -0.328, -0.146) 
and DEPS-R scores latter (β=-0.307 SE=0.043, 95% CI = -0.391, -0.223) suggesting that this 
maybe a protective factor. Also, on inclusion of consideration of future consequences to the 
model, psychological functioning no longer significantly predicted HbA1c. 
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Table 6.6: Structural Model 3, Consideration of Future Consequences (standardised)  
 
Estimate S.E. P-Value 95% CI Lower 2.5% 95%  CI Upper 2.5% 
Psychological  
Functioning 
     
Anxiety 0.818 0.023 <0.001 0.771 0.858 
Self Esteem -0.845 0.022 <0.001 -0.893 -0.814 
Maladaptive 
Perfectionism 
0.718 0.028 <0.001 0.665 0.769 
Borderline 
Traits 
0.768 0.027 <0.001 0.692 0.806 
Depression 0.865 0.014 <0.001 0.834 0.888 
Diabetes  
Distress 
     
Emotional  
Burden 
0.879 0.023 <0.001 0.84 0.923 
Physician  
Burden  
0.510 0.044 <0.001 0.438 0.595 
Interpersonal  
Distress 
0.679 0.034 <0.001 0.637 0.757 
HBA1C    
     
Psychological  
Functioning 
0.096 0.093 0.308 0.034 0.36 
Diabetes 
Distress 
0.242 0.091 <0.001 0.062 0.421 
DEPS-R    
     
Psychological  
Functioning 
0.324 0.086 <0.001 0.275 0.594 
Diabetes 
Distress 
0.310 0.080 <0.001 0.101 0.42 
HBA1C    
     
Consideration of 
Future 
Consequences 
 
-0.237 0.046 <0.001 -0.328 -0.146 
DEPS-R      
Consideration of 
Future 
Consequences 
 
-0.307 0.043 <0.001 -0.391 -0.223 
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Figure 6.4: Structural Model 3 (standardised): Consideration of Future Consequences 
 
6.3.5 Relationship with age  
In order to ascertain the relationship between HbA1c and DEPS-R and Age, Age was 
regressed onto those variables. The inclusion of age however significantly reduced the fit of 
the model: 𝑥2 (58) =423.009, p< 0.000, RMSEA = 0.116, CFI = 0.822, TLI = 0.763 and thus 
it was not a predictor. 
6.4 Discussion 
As hypothesised, there were significant relationships between the variables highlighted in the 
literature review and the pilot study and both blood sugar management and Eating Disorder 
symptomology. These two variables were chosen as while there is no gold standard of 
defining EDs in T1D, the DEPS-R appears to be the measure that produces the most 
consistent results and HbA1c is higher in those who have Type 1 related Eating Disorders, 
this is consistent with the current study which shows a significant relationship between the 
two outcome variables. Also, as predicted individual scale scores formed two reliable latent 
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variables ‘Psychological Functioning’ and ‘Diabetes Distress’. Psychological functioning 
predicted both HbA1c and DEPS-R scores the latter stronger than the former as did Diabetes 
distress in the initial structural model. The two latent variables were also strongly related. 
Gender predicted higher ED scores (only by .2 of a standard deviation which is lesser than 
would be suggested by the literature) but not worse blood sugar control.  Family cohesion 
was related to psychological functioning but not Diabetes distress. A mediation analysis also 
suggested that higher levels of cohesion in the family predicted less psychological problems, 
which in turn predicted reduced levels of HBA1C and DEPS-R. Consideration of future 
consequences which was suggested as important by media reports was revealed to be related 
as higher levels predicted both lower blood sugar levels and Eating Disorder symptomology 
but inclusion of the variable into the model altered the predictive value of psychological 
functioning to HbA1c as no longer significant. Age however, when added to the model 
decreased model fit substantially and therefore could not be considered as a predictor in the 
current sample.  
The latent variable ‘Psychological functioning’ was comprised of higher levels of anxiety, 
depression, borderline traits and maladaptive perfectionism and lower levels of self-esteem 
which was all suggested by the pilot study and the literature review. All of these variables 
were strongly related to the latent factor suggesting that in these patients there may be an 
underlying vulnerability which makes them less psychologically stable or more prone to the 
symptoms of mental illness.  Given that all of these patients share a diagnosis of T1D it could 
therefore be argued that T1D is potentially causal to that vulnerability. Furthermore, these 
variables are also highlighted as risk factors/ comorbidities for those without T1D and ED. 
This may go some way to explain the higher prevalence of EDs in T1, the patients are already 
at a higher level of risk as they display higher levels of these traits, which have more far 
reaching consequences, particularly in relation to blood sugar control and Eating Disorder 
onset. In all of the models the two latent variables were also closely related so it may be that 
it is the combination of psychological dysfunction and Diabetes specific distress that is 
important for the development of EDs.   
Psychological functioning predicted both Eating Disorder symptomology and blood sugar 
control and while it could be argued that a number of factors are associated with blood sugar 
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management, that a latent factor can predict both has substantial clinical value. While we do 
not have a gold standard for defining T1EDs we know that the DESPR is measuring 
behaviour related to EDs and that blood sugar management is significantly disrupted by the 
presence of these behaviours.     
The latent variable ‘Diabetes Distress’ was comprised of the DDS subscales except regimen 
related distress (please see below) and significantly predicted both HbA1c and DEPS-R 
scores. Interestingly the modification indices did not suggest covariance between any of the 
psychometric variables and that of the emotional burden, physician related and interpersonal 
subscales.. This further points to Diabetes specific distress as an independent entity that is 
not beholden to other psychological vulnerability. Researchers have postulated several 
reasons as to why this demographic are more vulnerable to EDs and it may be that DSD is 
an explanation for that. This may also help explain why insulin omission can appear 
(particularly in women) significantly at much older ages (Goebel-Fabbri et al., 2015) than 
seen for standard ED behaviour in the general population. Diabetes specific distress adds an 
extra temporal dimension, and DSD can presumably be affected by life events for example 
the death of a family member or some other loss. In this case the stressor that is DSD is a 
lifelong vulnerability, which is unique to this population. Furthermore, in Diabetes burnout 
whereby you do not have the energy to look after blood glucose properly there may be a side 
effect, weight loss. Burnout leads to lower concern over managing blood sugars and if that 
translates into general higher glycaemia then it may be that this weight loss is seen as a 
positive change and this facilitates further ED behaviour. In this sense the patient may feel 
rewarded for not looking after their Diabetes with weight loss. That combined with 
maladaptive perfectionism, which is hard to imagine would be easy to deal with in the face 
of burning out or failing at T1D, and lower levels of self-esteem and other psychological 
variables may create the perfect storm for ED development. 
That the two latent variables were strongly related is also of significance. There is evidence 
to suggest that while psychological conditions or Diabetes distress alone do not predict blood 
sugar control, when you combine them self-care is decreased, despite access to specialist 
services aimed at doing so (Sturt et al., 2015). 
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Being female was a risk factor for higher scores on the DESPR but not for higher HbA1c. It 
is of note that the increase in risk was not as high as would have been suggested in the 
literature at only .2 of a standard deviation. This may be consistent with research that suggests 
that EDs are more common in T1D males than in their non diabetic peers, and that the 
proportion of difference between male and female sufferers is lessened. If we accept HbA1c 
as a measure of insulin omission then the model would suggest that as there is no predictive 
value of gender then males and females are omitting insulin at the same rate which is in 
opposition to previous literature. However, this may also be due to specific limitations of the 
current study (please see below)                                                                      
As it was suggested in the literature that family functioning was important to several Diabetes 
related aspects of life, family cohesion and adaptability was measured. Adaptability did not 
significantly relate to the variables of interest, but cohesion was found to have predictive 
power in relation to ‘Psychological functioning’. Furthermore, cohesion was protective with 
increased levels mediating HbA1c and DEPS-R scores. Clinically this is important as 
interventions that target improving cohesion could feasibly improve both outcome variables. 
It was somewhat unexpected that family cohesion did not predict Diabetes distress scores 
however.        
That consideration of future consequence is relevant in the model poses some difficult 
questions. Firstly, this is a novel variable that has not been measured in relation to T1D 
before.  It has been seen in qualitative research that those with Diabulimia report feeling 
‘doomed’ by their diagnosis or that no matter what they do they are going to be afflicted by 
Diabetes related complications such as retinopathy or neuropathy and this suggests that 
perhaps these aspects should not be overstated in clinic visits. The current model however 
would suggest that consideration of these aspects is an important protective factor in the 
development of T1ED. As two recent participants stated: 
I could already foresee the future. I was like “I’m going to be 32 one day, and 35 
one day, and I’ll want to have kids”, but I’m not going to be able to have kids, 
I’m not going to have legs, I’ll be blind because of what I’m doing right now 
(Goebel-Fabbri, 2017, p. 11) 
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While I was in the hospital... one of the women that was instructing me about 
everything… gave me all this literature, and it was like, “On average, if you have 
Diabetes, 15 years is going to be cut off your life”. I remember staying up in bed 
in the middle of the night the time I was diagnosed, reading all this stuff that was 
all the horror stories of Diabetes that you hear about. Why would you give this 
literature to a 15-year-old girl to have her read in her hospital bed? And I think 
that really stuck with me (Goebel-Fabbri, 2017, p. 22-23)  
It is hard to imagine that these participants and others like them are not considering the future 
consequences of their actions and this may highlight the difference between awareness and 
action. One can be highly aware of future consequences without being able to do anything 
about them. In fact, it could be argued that this is an important part of what makes T1ED a 
mental illness  
The inclusion of the CFC also reduced the predictive value of psychological functioning to 
insignificant in the case of HbA1c but not DEPS-R scores, perhaps further highlighting the 
previous point. This raises further questions also about the appropriateness of the DEPS-R 
as a screening tool also (for a further discussion of this please see chapter 9), One can feel, 
for example, fat when using the appropriate dose of insulin without resorting to insulin 
omission to rectify it. This having been said the relationship between T1ED and CFC is not 
clear, as this is the first study to explore this variable in relation to the T1D demographic.  
Regimen related distress was not added as a predictor as it was highly related to DEPS-R 
scores and could have therefore skewed the model. Theoretically it could be argued that the 
same items that measure regimen related distress such as ‘Feeling that I am not testing my 
blood sugars frequently enough’ or ‘Feeling that I am not sticking closely enough to a good 
meal plan’ also measure T1EDs, particularly Diabulimia. It is akin in this sense to asking 
those with AN how they feel about the regimen of eating. Age could also not be predictably 
used in the model either but that coincides with evidence that insulin omission for weight 
loss can appear (particularly in women) significantly at much older ages than in the general 
population (Goebel-Fabbri et al., 2015).  
6.4.1 Strengths 
There are implications for the uncovering of these latent variables including potentially being 
able to indirectly measure T1ED. Given that researchers have suggested most people 
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‘discover’ Diabulimia through indirect sources (Balfe et al 2013; Goebel Fabrri, 2017), it is 
not out with the realms of possibility that the DEPS-R could function as one of these indirect 
sources. Being able to measure psychological variables around T1ED may be a safer way of 
gauging risk in the T1D population. Also this is the first model to identify that Diabetes 
specific distress is predictive of Eating Disorders as well as BG control highlighting that this 
population has unique risk factors that are not currently addressed in routine ED treatment.  
6.4.2 Limitations  
There are several limitations of the current study. As with any theoretical model it may be 
that there are further variables that remained unidentified by the pilot study which on 
inclusion would have provided a different solution. A perhaps significant exclusion is weight. 
BMI has been found to predict Eating Disorders in a number of studies, higher weight has 
been shown to predict low self-esteem and body image in the general population and this is 
also seen in those with T1D (Tse et al., 2012, Powers et al., 2012). Those T1D’s who report 
being overweight also report higher levels of ED behaviour (Markowitz et al., 2009) and 
being overweight may predict the onset of ED in T1D (Olmsted et al., 2008). However 
patients have stated how distressing being weighed is and as presumably a sizeable minority 
of this sample were assumed to be struggling with or recovering from EDs it was omitted 
from the current study.  
A further potential limitation is that while around 30% of the sample stated that they had 
current or previous experience of an ED, nearly 45% scored above the DEPS-R cut-off point, 
suggesting either that they are partaking in behaviour they may not be aware is related to 
EDS or that there are issues with the DEPS-R as a measure potentially related to the 
difference between feeling and actions alluded to above.  
There are several key differences in the reported sample than in other research into T1EDs. 
Firstly this research utilised a global sample rather than a localised one, this may mean that 
further research may want to specify regional variations.  The sample was also collected via 
the internet particularly through social media and as such it may be that this model is more 
representative of the Diabetes online community. The sample is also self-selecting and given 
that the recruitment advert was forthcoming regarding the psychological nature of the study 
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it may also be the case that the current sample is more representative of those who are more 
comfortable disclosing these sorts of issues. The internet also made it possible to collect a 
much larger sample of those with T1D, nearly 700 participants responded to the study which 
is considerably higher than the vast majority of studies into T1ED (please see section 2.4.2). 
Regardless of this however there was still an over-representation of females, had there been 
a more equal gender split then two models investigating each gender may have been 
warranted, this lack of male representation is an issue that is prevalent in other research in 
this area and future researchers should make a concerted effort to address this. Perhaps 
however, the main difference between this sample and others is the proportion of participants 
who utilise Diabetes technology. Given that rates of pump usage are reported at around 15% 
by NHS England, the rates seen in this sample at 38% may represent a significant bias. 
Although data on continuous glucose monitors is scarce the insulin pump awareness group  
(IPAG) reports that for the year 2018/19 there are only 153 individually funded in Scotland, 
a significantly lower proportion that the 42% of this study utilising the technology. There are 
implications for this in terms of both HbA1c and DEPS-R. NHS Digital reports that those 
using Diabetes technology are more much more likely to achieve recommended blood sugar 
levels and there is further evidence that pump usage reduces T1ED symptomology (NHS 
Digital 2018; IPAG Scotland 2018; Markowitz et al., 2013). This would suggest that the 
assumptions made in this study are conservative.   
As stated elsewhere there is no gold standard for measuring or defining T1EDs and while it 
may be customary to suggest that future studies may wish to involve clinical interviews, it 
has been shown that participants are more likely to under report Diabetes specific Eating 
Disorder behaviours such as insulin omission under these conditions and currently there is 
no Diabetes specific ED interview (please see chapter 2).  It may also be argued that there 
are further issues in that there is no non-diabetic control group to compare with some sort of 
similar ED measure, but those without T1D do not have outcomes such as HbA1c and DDS 
to consider, so a lack of control group may be justified.  
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6.5 Conclusion 
This model tested factors around T1ED, measured by the DEPS-R and HbA1c and found that 
‘Psychological functioning’ and ‘Diabetes distress’ predicted both, that family cohesion was 
protective for psychological function, and that higher levels of consideration of future 
consequences was protective in terms of DEPS-R and HbA1c. This is important particularly 
for clinicians who are seeking to treat this population given that the majority of the evidence 
suggests that standard treatment rarely works. It may be that given the unique experience of 
T1D and its relation to weight control behaviour that EDs in T1D are just too different to be 
even considered alongside EDs in the general population.  
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7 Patient Attributions as to what Caused their Eating Disorder 
7.1 Introduction 
As research into Eating Disorders in Type 1 Diabetes has predominantly focussed on 
prevalence rates and academic debate has neglected much that falls outside clinical 
diagnoses, little is known about the profile of those suffering. There are important questions 
that remain chronically under-investigated such as whether or not they have reached out for 
help, who they have reached out to and whether or not they have other issues that may relate 
to treatment outcomes such as psychological comorbidity. There is also a lack of research 
investigating how these patients self identify their EDs and what diagnoses are attributed to 
them in the face of the non clinical term that references insulin omission for weight loss 
‘Diabulimia’, nomenclature that is widely accepted in Diabetes community if not in the 
Doctors office (BBC, 2017).   
It is also important to understand what these patients attribute to the development of their 
T1ED. Presently, although NICE has recognised the need for consistent practice, the 
guidelines are not obligatory and there is no other national policy on how to deal with T1EDs. 
Furthermore HCPs have reported that they feel significantly out of their depth dealing with 
this population (Allan, 201712; Tierney et al., 2009). Understanding attribution may inform 
future guidance which may lessen the impact of such factors or provide a framework for early 
intervention. Causal attributions can affect a number of health related behaviours and 
outcomes. For example, at 8 year follow up for patients who had suffered a heart attack, it 
was shown that those who attributed the event to stress or other people were more likely to 
have another attack and die than those who saw the initiating event as an indication to make 
behavioural changes (Affleck, Tennen, Croog & Levine, 1987). In mental health, attributions 
as to what is causal to the illness has also been shown to affect treatment seeking behaviour 
(Narikiyo & Kameoka, 1992). In T1D research attributional inquiry is extremely limited. In 
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one study though it was shown that negative attributions to perceptions of friend reactions to 
regimen adherence predicts poorer glycaemic control, demonstrating that attributions may be 
important to health behaviours (Hains, Berlin, Davies, Parton & Alemzadeh, 2006; Hains et 
al., 2006). Causal attributions have not been explored in T1EDs. In order to address this gap 
in the literature a pilot study was undertaken by the researcher in 201313 using participants 
who had at least 2 years recovery from T1ED. A questionnaire was constructed that reflected 
suggestions made in the research literature as to why EDs are more common in T1D and this 
was then subjected to an exploratory factor analysis. Other aspects were also investigated 
such as psychiatric comorbidity, ED diagnoses and insulin omission. Please note it is not the 
purpose of this study to assess the validity of the attributions that researchers suggest as 
aetiological in the development of T1ED, rather it is to describe them, ask the participants 
how much they agree with them and ascertain whether they form any useful pattern.  
7.2 Item Generation  
A review of the literature until 2013 was undertaken in order to ascertain what researchers 
suggested as aetiological to the development of T1EDs. The attributions took the format of 
6 broad categories: Diabetes specific factors, Weight and Body Image issues, Dietary aspects 
of T1D, Iatrogenic factors, Family problems affected by T1D and more Classic Risk factors 
that can be also seen in Eating Disorders in the general population.    
7.2.1 Diabetes Specific Factors  
In searching for potential reasons as to why EDs may develop in those with T1ED many 
researchers point out that insulin omission as a successful weight loss tool is a unique to this 
demographic and this uniqueness and/ or the realisation alone of how much weight can be 
lost my omitting is enough to encourage this behaviour (Goebel-Fabbri et al., 2008; Ackard 
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et al 2008; Markowitz et al 2009; Nash & Skinner 2005; Daneman et al., 2002; Jones et al., 
2000; Colton, Rodin, Bergenstal & Parkin, 2009; Ishmail & Treasure, 2010) 
Several Diabetes specific psychological factors were suggested in the literature to be 
important to the development of EDs in those with T1D including general Diabetes stress, 
fear of hypoglycaemia, fear or embarrassment of injecting or testing, denial and/ or 
resentment of the diagnosis and burnout (Nielsen, Børner & Kabel, 1987; Steel et al., 1989;  
Goebel- Fabrri et al.,  2008; Colton et al., 2009; Ishmail & Treasure, 2010). 
Other personality aspects such as perfectionism have been suggested to be detrimental to 
adherence, trying to attain perfection in relation to blood sugars with an illness as 
unpredictable as Diabetes has been related to ED development (Nielsen et al., 1987; Peveler 
& Fairburn, 1989; Steel et al., 1989; Pollock Barziv & Davis 2005; Young-Hyman  & Davis, 
2010). 
7.2.2 Weight/ Body Image Related Factors  
Pre-diagnosis many T1Ds will lose a substantial amount of weight and as such several 
researchers have suggested that this is a triggering factor for the development of EDs (Pinar 
et al., 2005; Markowitz et al., 2009; Jones et al., 2000; Ishmail & Treasure 2010). This initial 
weight loss is also typically reversed on commencement of insulin therapy which can act as 
a second or compounding trigger (Peveler & Fairburn, 1989; Steel et al., 1989; Crow, Keel, 
& Kendall, 1998; Nielsen & Mølbak, 1998;  Pinar et al., 2005; Grylli et al., 2005; Battaglia 
et al., 2006; Jones et al.,  2000; Young-Hyman  & Davis, 2010; Ishmail & Treasure, 2010).  
It has also been argued that this initial loss then gain can promote a fear of increased weight 
which then promotes Eating Disordered behaviour (Goebel- Fabrri et al., 2008; Olmsted et 
al., 2008).   This is particularly problematic as T1D carries around a 15% weight penalty 
meaning that regardless of T1D concern over higher a higher BMI can promote ED 
behaviours (DCCT, 1995; Alice Hsu et al., 2008; Markowitz et al., 2009; Tse et al 2012; 
Schwartz et al., 2002; Nash & Skinner, 2005; Daneman et al., 2002; Meltzer et al., 2001; 
Colton et al., 2009). Several researchers recognise that T1D may promote body image 
disturbances either due to the weight penalty or as T1D may increase body awareness, which 
may encourage ED behaviour (Steel et al., 1989; Striegel-Moore et al., 1992; Pinar et al., 
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2005; Alice Hsu et al., 2008; Schwartz et al., 2002; Daneman et al., 2002; Meltzer et al., 
2001; Young-Hyman  & Davis, 2010). As weight is a salient aspect of T1D management, 
researchers have suggested that compared with healthy peers a sense of achievement at losing 
weight is potentially heightened which also contributes to ED development (Peveler & 
Fairburn, 1989; Smith et al., 2008; Daneman et al., 2002).   
7.2.3 Dietary Factors  
Unsurprisingly the dietary aspects of T1D were suggested by many researchers as 
aetiological to T1ED, particularly dietary restriction (Powers, Malone, Coovert, & Schulman, 
1990; Striegel-Moore et al., 1992; Crow et al., 1998; Pinar et al., 2005; Goebel-Fabbri et al., 
2008; Nash & Skinner, 2005; Daneman et al., 2002; Jones et al., 2000), having to correct for 
hypoglycaemia which may lead to overeating/ bingeing and subsequent weight gain 
(Battaglia et al., 2005; Goebel-Fabbri et al 2008; Daneman et al., 2002; Young-Hyman  & 
Davis, 2010; Criego et al., 2009). The excessive focus on food which often included 
adherence to strictly timed meals was also suggested by several researchers to promote a 
disturbed attitude which was related to ED onset (Ackard et al., 2008; Olmsted et al., 2008; 
Alice Hsu et al, 2008; Markowitz et al., 2009; Powers et al., 2012; Quick et al 2012; Tse et 
al., 2012; Schwartz et al., 2002; Colton et al., 2009). 
7.2.4 Iatrogenic Factors 
As stated in chapter 4, those with T1D have increased interactions with HCPs compared with 
the general population and it has been suggested that certain negative feelings regarding these 
interactions may be iatrogenic in the development of T1ED, particularly attention on weight, 
pressure to be a ‘good’ diabetic and an over – emphasis on future complications which can 
lead a patient to feel hopeless.  (Szmukler, 1984; Steel et al., 1989; Smith et al., 2008; Quick 
et al., 2012; Nash & Skinner ,2005; Daneman et al., 2002; Crow et al., 1998; Colton et al, 
2009).  
7.2.5 Family Factors  
Family factors have been discussed as important to the development and maintenance of 
T1EDs (please see chapter 4). Family profiles that are high in general dysfunction and rigidity 
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have been suggested to encouraged ED development (Malone & Armstrong, 1985; Peveler 
& Fairburn, 1989; Colton et al., 2007; Daneman et al., 2002). Of particular interest is the 
conflict that can arise from developing a chronic illness which requires intense management 
at the time, developmentally, when healthy adolescents would be striving for growing 
autonomy and individualism. Several researchers have suggested that this conflict and 
disagreement over Diabetes management between parents and their T1 children is important 
to the development of T1ED (Malone & Armstrong, 1985; Nielsen et al., 1987;  Striegel -
Moore et al., 1992; Grylli et al., 2005; Grylli et al., 2010; Schwartz et al 2002; Daneman et 
al., 2002; Young-Hyman  & Davis, 2010; Szmukler, 1984).  
Examples of disturbed eating in the family is also suggested as related to T1ED (Colton et 
al., 2007; Daneman et al., 2002) The mother daughter relationship appears to be particularly 
important attributionally, especially maternal concerns with weight and shape (Quick et al., 
2012; Colton et al 2007; Daneman et al., 2002).  
7.2.6 Classical Eating Disorder Attributions  
Need for control is a common attribute of EDs in the non T1D population. It is perhaps 
expected then, that in an illness which is as difficult to manage as T1D, that need for control 
would feature heavily in suggestions as to why EDs are more common (Nielsen et al., 1987; 
Grylli et al., 2010; Schwartz et al 2002; Nash & Skinner 2005; Young-Hyman & Davis, 
2010).   
There is some evidence that those who have T1D have disrupted onset of menses which is a 
known risk for EDs in the non T1D population, several researchers argue that in those with 
T1D this period of time is even more risky as pubertal hormones can substantially increase 
insulin requirements leading to weight gain (Smith et al., 2008; Alice Hsu et al., 2008; Grylli 
et al., 2010; Schwartz et al., 2002; Meltzer et al., 2001).   
Some researchers have argued that while ED families may be high in disfunction that does 
not negate them from expecting high achievements, and this is no different in families 
experiencing T1ED ,with academic pressure posing a suggested risk (Neilsen et al., 1987; 
Daneman et al., 2002). Those with T1D are not immune to the societal pressure to conform 
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to a thin ideal either and as such several researchers suggested that cultural issues surrounding 
body composition were important for ED development, (Nielsen & Mølbak, 1998; Pinar et 
al., 2005: Quick et al 2012; Meltzer et al., 2001; Colton et al., 2009) neither are they immune 
the negative consequences of conflict in peer relationships with some researchers arguing 
that peer issues contribute to ED development (Szmukler, 1984; Peveler & Fairburn, 1989). 
Several authors have linked comorbid mental health problems to the development of EDs in 
both the T1 and non T1 population as discussed in chapter 4. As the focus of the current study 
was to measure attributions rather than clinical diagnoses for the purposes of the 
questionnaire, participants were asked if they felt that mental illness had contributed to the 
development of their ED rather than for the individual diagnoses. A question regarding self-
esteem was also asked in the same manner given numerous suggestions in the literature that 
is important (see chapter 4). A pre T1 diagnosis of an Eating Disorder has also been suggested 
as a risk factor by early researchers (Roland & Bhanji, 1982; Nielsen et al., 1987) and was 
thus also included.  
7.3 The Current Study  
There were considerable limitations in the pilot study that the current study seeks to address. 
As the original research only took those in recovery into consideration the attributions were 
retrospective. The study was also hampered by not having a follow up confirmation of the 
factor structure. The purpose of this study is to replicate the pilot study but with a larger 
sample size, including those who are currently suffering with T1ED, in order to get a better 
understanding of the profile of these patients and potentially confirm an underlying structure 
to what they attribute to the development of their ED.   It is hypothesised that there will be 
an underlying structure which can be confirmed and shows a meaningful pattern of latent 
factors. 
7.4 Study Methodology 
Data was collected at 2 time points in order to achieve a large enough sample for both an 
exploratory and a confirmatory factor analysis. At time 1 this was as part of a larger study 
(please see section 6.1 for ethical approval, setting, procedure and participants). On 
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completion of the questionnaire section of that study participants were asked if they had ever 
suffered with an Eating Disorder, if they answered yes to this question they were taken to the 
‘Factors in Eating Disorders questionnaire’ where they answered demographic and other 
profile questions (please see appendix N) Some of the questions in the scale were worded so 
that the patient had to think carefully about their answer in order to avoid response bias.   
For the confirmatory sample collected between May and June 2018, everything was 
replicated except the advert was tailored to appeal to those who had experience of an Eating 
Disorder (please see appendix O) as this was the only population of interest and as such only 
the Demographics & Factors in Eating Disorders Questionnaire was administered.  
7.5 Results 
7.5.1 Overview of Analysis 
Firstly, the demographic details of the participants are described at time 1 (exploratory) and 
time 2 (confirmatory). Following this, the exploratory and confirmatory factor analyses are 
described and the underlying latent variables constructed. In order to further investigate 
specific aspects of this population the samples are then combined for descriptive purposes.     
7.5.2 Software   
IBM SPSS vs 23 was used for the Exploratory Factor Analysis.  FACTOR was used for the 
parallel analysis (Lorenzo-Seva & Ferrando 2006), Mplus version 8 was used for the 
Confirmatory Factory Analysis (Muthén & Muthén, 1998-2016). 
7.5.3  Participants  
132 participants elected that they had current or previous experience of T1ED and were 
presented with the Factors in Eating Disorder Questionnaire at time 1. 127 participants 
provided complete answers. 189 participants originally answered the questionnaire at time 2 
but respondents who stated that they had completed the questionnaire before had their 
answers were removed. This left 161 participants providing responses. There were no 
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significant demographic differences between the samples using independent T- Tests (please 
tables 7.1 & 7.2).   
Table 7.1: Sample Characteristics and Means Difference Tests 
Exploratory Sample     Confirmatory Sample      t df p 
Age (n = 130) 32.62 
(11.52) 
Age (n = 161) 31.89 
(8.96) 
0.612* 289 0.541 
Age at Diagnosis (n = 
130) 
14.49 
(10.05) 
Age at Diagnosis (n = 
161) 
13.34 
(8.52) 
1.058 289 0.291 
Time from T1D to ED in 
years (n= 122) 
4.88 
(5.12) 
Time from T1D to ED in 
years (n = 160) 
5.97 
(5.67) 
-1.621 280 0.103 
HbA1c (n = 124) 8.93 
(3.29) 
HbA1c (m = 160) 9.24 
(2.73) 
-0.864 282 0.388 
 
Table 7.2: Sample Gender, Nationality and Ethnicity  
  n Valid 
Percent 
Gender     
Male 12 4.15 
Female 277 95.85 
Nationality     
British 131 45.0 
American 105 36.1 
Australian 11 3.8 
Canadian 10 3.4 
Irish 9 3.1 
New Zealander 4 1.4 
South African 4 1.4 
Danish 3 1.0 
Euro/US 2 0.7 
German 2 0.7 
Barbadian 1 0.3 
Norwegian 1 0.3 
Swedish 1 0.3 
Polish 1 0.3 
Bulgarian 1 0.3 
Greek 1 0.3 
Israeli 1 0.3 
French 1 0.3 
Egyptian 1 0.3 
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  n Valid 
Percent 
Finnish 1 0.3 
Ethnicity      
White/Caucasian 253 92.3 
Mixed Race 9 3.3 
Hispanic 4 1.5 
Black 3 1.1 
Jewish 3 1.1 
Asian 1 .4 
Native American 1 .4 
 
7.5.4 Medical profile and Health Seeking Behaviour 
291 participants provided at least partial answers to questions regarding their medical status 
and health seeking behaviour. For missing data patterns please see below  
Table 7.3 Missing Data  
 
n missing % 
Eating Disorder Diagnosis  281 10 3.4 
Perceived Eating Disorders 283 8 2.7 
Insulin Omission 286 5 1.7 
Mental Health Comorbidities  285 6 2.1 
Bullying T1D 272 19 6.5 
Bullying Weight 271 20 6.9 
 
7.5.4.1 Eating Disorder Diagnoses & Perceived Eating Disorders 
The participants who self-identified as having experience of an ED (n = 281) had been 
formally diagnosed with a variety of ED diagnoses. The most common diagnosis was 
EDNOS and co and multi morbidity was frequent although more than 40% had received no 
diagnoses at all.  When asked what ED they thought they have the majority of participants 
responded with Diabulimia but again they often perceived themselves to have co morbid 
conditions. A sizable majority of the participants also reported insulin omission (please see 
figures 7.3, 7.4 & 7.5). The majority of participants did approach a HCP for help regarding 
their ED. Of the UK based participants, the general practitioner was the most commonly 
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approached but it was also common for patients to seek out private treatment (please see 
figures 7.6 & 7.7). 
 Figure 7.1 Eating Disorder Diagnoses 
 
AN = Anorexia Nervosa, BN = Bulimia Nervosa, EDNOS = Eating Disorder Not Otherwise Specified, BED = 
Binge Eating Disorder, RMN = Rumination Disorder, No Dx = No Diagnoses  
 
Figure 7.2: Perceived Eating Disorder Diagnoses 
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DBN = Diabulimia, AN = Anorexia Nervosa, BN = Bulimia Nervosa, EDNOS = Eating Disorder Not Otherwise 
Specified, BED = Binge Eating Disorder, RMN = Rumination Disorder 
 
Figure 7.3: Insulin Omission for Weight Loss Purposes  
 
Figure 7.4: Did you Approach a HCP for Help?  
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Figure 7.5 Help Seeking Behaviour of UK Based Participants  
  
7.5.4.2 Mental Health Comorbidities and Bullying  
Most of the participants had experience of other mental health issues with depression also 
being diagnosed in nearly half of the participants and anxiety in over a third. The full 
spectrum of diagnoses can be seen in figure 3.7 below. More than half of respondents had 
experienced weight related bullying and 40% had experienced bullying due to T1D (figure 
3.8).  
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Figure 7.8: Mental Health Comorbidity.  
 
Borderline = Borderline Personality Disorder, PTSD = Post Traumatic Stress Disorder, OCD = Obsessive 
compulsive Disorder, ADHD = Attention Deficit Hyperactive Disorder, BDD = Body Dysmorphic Disorder, 
DID = Dissociative Identity Disorder 
 
 
Figure 7.9 Bullying  
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7.5.5 Exploratory Factor Analysis  
7.5.5.1 Data Properties  
133 participants provided at least partial answers to the Factors in Eating Disorder 
Questionnaire, 127 provided complete answers. The data was found to be MCAR. Little's 
test: Chi-Square = 200.626, DF = 185, Sig. = .205. Missing data = 4.5% which is stated as 
the ideal conditions (McNiesh, 2016) as such all missing cases were treated to pairwise 
deletion.  The final ratio of participants to variables was over 4:1. 22 data points were 
missing. The Kaiser-Meyer-Olkin measure of sampling adequacy was over the recommended 
value of .5 (KMO = .838) Bartlett’s test of sphericity was significant x2 = (595) = 2611.715 
p < 0.001.  
7.5.5.2 Data Screening  
Following data screening, several items were removed from the analysis as they yielded few 
correlations > 0.3 Question 5 ‘Early Puberty contributed to the development of my Eating 
Disorder’, 17 ‘Academic Pressure did not contribute to the development of my Eating 
Disorder’, 23 ‘An over – emphasis on what would happen if I didn’t look after myself did 
not contribute to the development of my Eating Disorder’, 32 ‘An Eating Disorder prior to 
developing Type 1 Diabetes contributed to the development of my Eating Disorder’ & 37 ‘I 
had pre-existing Mental Health issues and this contributed to the development of my Eating 
Disorder’. Following the analysis items with communalities under .5 were removed which 
were ‘Weight gain after I started insulin’, ‘Perfectionist attitude towards my blood sugar’, 30 
‘A distorted body image’, 19 ‘Conflict among my peer group’ and 40 ‘A disturbed attitude 
to food’. (Please see appendix P for the correlation matrix)  
7.5.5.3 Extraction & Rotation 
Following data screening Principal Axis Factoring Analysis with Promax rotation for oblique 
factors was utilised. Using the Kaiser – Gutman Criteria of retaining factors with an Eigen 
value over 1, a 5-factor solution was initially suggested that explained cumulatively 63% of 
the variance within the sample. Looking at the scree plot however the inflection point occurs 
at the fourth factor (please see figure 3.1 below). As such a parallel analysis was run based 
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on minimum rank factor analysis (Timmerman & Lorenzo-Seva, 2011) using 500 randomly 
generated correlation matrices. The results suggested a four-factor solution and as such the 
analysis was rerun specifying this parameter.  The resulting solution is presented in the tables 
below 
Figure 7.10: Scree Plot of Factors 
 
Table 7.4: Eigenvalues and Variance Explained in 4 Factor Solution 
Factor Total Eigen Value % of Variance Cumulative % 
1 9.518 32.82 32.82 
2 3.116 10.74 43.56 
3 2.467 8.51 52.1 
4 1.954 6.72 58.81 
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Table 7.5: Pattern Matrix 
 
Factor 
1 2 3 4 
34) I felt I couldn’t talk to my parents 0.826 
   
35) Family dysfunction 0.817 
   
36) Feeling that I was not an individual within my family 0.803 
   
11) Conflict at home within my family 0.714 
   
39) My family was very rigid 0.682 
   
29) Maternal concern with weight and shape 0.557 
   
33) Disagreement with the way my parents dealt with my Diabetes 0.537 
   
26) Examples of disturbed eating in my family 0.473 
   
38 I didn’t like the way my body looked 
 
0.943 
  
18) A sense of achievement at losing weight 
 
0.873 
  
25) Societal pressure to be thinner 
 
0.823 
  
6) Low self-esteem 
 
0.701 
  
9) Regardless of my Diabetes I was unhappy I was gaining weight 
 
0.628 
  
1) needed to feel in control 
 
0.548 
  
12) realisation I could lose weight quickly 
 
0.524 
 
0.400 
14) Fear of weight gain 
 
0.457 
  
7) Too much focus on my diet 
  
0.786 
 
28) Pressure from my health care professionals 
  
0.705 
 
3) restrained diet 
  
0.656 
 
27) Overeating/ binging, following episodes of hypoglycaemia 
  
0.596 
 
8) Attention to my weight from Medical Staff 
  
0.553 
 
10) Adherence to timed meals 
  
0.526 
 
22) Diabetes Burn Out 
  
0.507 
 
13) General Diabetes stress 
  
0.457 0.405 
16) Denial that I had Diabetes 
   
0.766 
21) Embarrassment at injecting or testing 
   
0.664 
24) Fear of injecting and or self-testing 
   
0.636 
31) Resentment of having Diabetes 
   
0.547 
20) Fear of hypoglycaemia 
   
0.522 
 
The items that were cross loading in this solution were analysed in the factor in which they 
had the highest loading and then factor scores and scale reliability were computed 
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Table 7.6: Scale Mean Scores and Reliability 
 
N Mean SD Cronbach’s alpha  
Factor 1 132 2.82 1.13 0.899 
Factor 2 132 3.89 0.99 0.877 
Factor 3 132 3.21 0.99 0.865 
Factor 4 132 2.78 1.04 0.817 
 
As predicted the factors were related.  
Table 7.7: Factor Correlations (Pearson’s r) 
Factor 1 2 3 4 
1 1.000 0.325 0.417 0.355 
2 0.325 1.000 0.458 0.370 
3 0.417 0.458 1.000 0.473 
4 0.355 0.370 0.473 1.000 
 
7.5.6 Confirmatory Factor Analysis Results 
7.5.6.1 Data Properties & Initial Analysis 
161 participants completed the Factors in Eating Disorders Questionnaire at time 2. The final 
ratio of participants to items was 1:5.5. The data was missing completely at random. Little's 
MCAR test: Chi-Square = 451.527, DF = 447, Sig. = .431. The items and factor composition 
suggested by the EFA were entered into MPUS using the MLR estimator to account for 
missing data.  
The initial analysis yielded a poorly fitted model: Chi square = (371) 640.457, p <0.001, 
normed chi square = 1.73, RMSEA = 0.067 (90% CI 0.058 - 0.076), Probability RMSEA <= 
.05 = 0.001. SRMR =  0.086. CFI = 0.744, TLI = 0.720,  
7.5.6.2 Data Screening  
On further investigation it was apparent that several items did not meet the criteria of loading 
>0.05 and thus the following items were removed: from factor 1; 36) Feeling that I was not 
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an individual within my family, 29) Maternal concern with weight and shape and 26) 
Examples of disturbed eating in my family. From factor 2; 6) Low self-esteem, 9) Regardless 
of my Diabetes I was unhappy I was gaining weight and 14) Fear of weight gain. From factor 
3; 3) Restrained diet, 22) Diabetes Burn Out and 13) General Diabetes stress and from factor 
4; 31) Resentment of having Diabetes and 20) Fear of hypoglycaemia. This produced a better 
but not ideal fit Chi-Square Test of Model Fit: Chi Square (113) = 205.929, p <0.001, normed 
chi square = 1.82. RMSEA = 0.071 (90% CI = 0.056 - 0.087). SDMD = 0.068. Probability 
RMSEA <= .05 = 0.014. CFI = 0.864, TLI = 0.836. 
7.5.6.3 Final Model 
The modification indices produced by Mplus also suggested allowing items within the same 
factor to correlate so this was also entered into the analysis. This produced a much better fit  
(please see figure 7.2).   
7.5.6.4 Goodness of Fit Statistics 
7.5.6.4.1 Chi Square 
The chi square value for the proposed model = (108)123.409, p = 0.1475, (Scaling correction 
factor for  MLR = 0.9953) The chi square value for the independence model = (136) 819.678,  
p >  0.001 indicating that the proposed model represents a better fit of the data. The normed 
chi square value = 1.14 indicating a well-fitting model. 
7.5.6.4.2 Incremental Fit Indices 
CFI = 0.977 indicating a well-fitting model,  TLI =  0.972 indicating a well-fitting model.          
7.5.6.4.3 Absolute Fit Indices 
RMSEA = 0.03 (90% CI 0 - 0.052), Probability RMSEA < .05 = 0.930 indicating a close fit. 
SMRSEA = 0.059 also indicating good fit.  
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7.5.6.4.4 Factor Composition 
Table 7.8: Standardised Loadings, Standard Error, Estimated Standard Error and P – 
Values  
 Loading SE Est/SE P- Value 
Factor 1     
34) I felt I couldn’t talk to my parents 0.746 0.047 15.892 <0.001 
35) Family dysfunction 0.733 0.050 14.547 <0.001 
11) Conflict at home within my family 0.641 0.062 10.306 <0.001 
39) My family was very rigid 0.754 0.059 12.569 <0.001 
33) Disagreement with the way my parents dealt with my Diabetes 0.786 0.040 19.598 <0.001 
Factor 2     
38) I didn’t like the way my body looked 0.487 0.139 3.517 <0.001 
18) A sense of achievement at losing weight 0.724 0.090 3.517 <0.001 
25) Societal pressure to be thinner 0.582 0.099 5.883 <0.001 
12) Realisation I could lose weight quickly 0.599 0.098 6.093 <0.001 
Factor 3      
7) Too much focus on my diet 0.641 0.077 8.303 <0.001 
3) Restrained diet 0.613 0.089 6.868 <0.001 
28) Pressure from my health care professionals 0.435 0.091 4.787 <0.001 
8) Attention to my weight from Medical Staff 0.531 0.106 5.024 <0.001 
10) Adherence to timed meals 0.697 0.072 9.669 <0.001 
Factor 4     
16) Denial that I had Diabetes 0.598 0.091 6.547 <0.001 
21) Embarrassment at injecting or testing 0.625 0.099 6.340 <0.001 
24) Fear of injecting and or self-testing 0.587 0.088 6.703 <0.001 
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Table 7.9: Scale Scores and Reliability Analyses 
Factor  Mean Score Standard Deviation Cronbach’s Alpha 
1 3.04 1.12 0.86 
2 4.33 .73 0.69 
3 3.5 .9 0.73 
4 2.57 1.04 0.61 
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Figure 7.11: Confirmatory Factor Model, Standardised Results – Graphic Representation
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7.6 Discussion 
As hypothesised there was an underlying structure to the attributions that participants gave 
for ED development and this was suggested by an exploratory factor analysis and then a 
confirmatory factor analysis. Initially a 5-factor structure was suggested but a monte carlo 
analysis suggested that the structure should be reduced to 4. The 4 confirmed factors related 
to issues surrounding 1) the family, 2) weight and body image, 3) Diabetes diet and HCP 
interactions and 4) Diabetes specific psychological issues. These factors had reliability values 
ranging from acceptable to excellent.  
The first confirmed factor demonstrated how important the family environment is to ED 
development. The items included were 34) I felt I couldn’t talk to my parents, 35) Family 
dysfunction, 11) Conflict at home within my family, 39) My family was very rigid and 33) 
Disagreement with the way my parents dealt with my Diabetes. This factor highlights how 
important family intervention may be for these patients. It should be noted that family factors 
are implicated in a number of T1D outcomes (please see chapter 4) further suggesting that 
this type of intervention is warranted. The second confirmed factor and the factor on which 
participants scored the highest was related to weight and body image issues and was 
composed of the items 38) I didn’t like the way my body looked, 18) A sense of achievement 
at losing weight, 25) Societal pressure to be thinner and 12) Realisation I could lose weight 
quickly. It could be argued that these relate to classical risk factors with the added ability that 
those with T1D have in order to lose weight quickly. While it is understandable that 
approaching weight loss via insulin omission is sensitive it may be that more work needs to 
be undertaken around how to address this issue. The third confirmed factor Diabetes Diet and 
HCP Interactions contained the items 7) Too much focus on my diet, 3) Restrained diet, 28) 
Pressure from my health care professionals, 8) Attention to my weight from Medical Staff 
and 10) Adherence to timed meals. This factor suggests some kind of interaction between 
perceived dietary rigidity necessary for T1D and a negative clinical environment that 
combines to form a risk factor for T1ED development. A negative clinical experience has 
been shown to affect a number of adverse T1D related outcomes. (Please see chapter 4) The 
final confirmed factor Diabetes Specific Psychological issues contained the items 16) Denial 
that I had Diabetes, 21) Embarrassment at injecting or testing and 24) Fear of injecting and 
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or self-testing. This factor highlights that there are very specific psychological aspects to both 
being diagnosed with and dealing with the daily regimen of T1D that preclude the 
development of T1ED.  
Despite do not attends being more prevalent in this demographic as reported in chapter 4,  a 
significant majority had approached HCPs for help which is opposite to the attitudes of HCPs 
who often assume that these patients are not willing to discuss issues with them (Teirney et 
al., 2009).  Respondents had also approached a number of health care professionals to report 
their difficulties, in the UK the most approached was the GP which is also concerning as, of 
the multidisciplinary team, it is feasible that the GP is the least specialised member and no 
research has been undertaking researching on how T1ED presents in primary care. 
Participants, similarly to the pilot study also reported high levels of psychological 
comorbidity with only just over 20% having no other diagnoses. This is concordant that levels 
of mental illness are higher in those with T1D anyway (please see chapter 4). That morbidity 
is so high and also so varied, may go some way to explain why treatment is so difficult for 
this demographic. (please see chapter 8) Also bullying due to weight was reported by over 
half the participants while bullying because of T1D was present in 40% suggesting that 
school based interventions may also be justified.  
7.6.1 Nomenclature and Diagnoses: The Importance of the term ‘Diabulimia’ 
Worryingly over 40% of participants who perceived themselves to have an ED had not been 
formally diagnosed and of those who had EDNOS was the most common singular diagnoses, 
this is even more alarming given that nearly all of the participants had reached out for help. 
Of those who had been diagnosed, comorbidity was common, in some cases patients reported 
4 concurrent ED diagnoses. This provides further evidence for the idea that T1ED is not 
homogenous, rather multiple clinical behaviours may be seen. When asked what the 
participants perceived their diagnoses to be, the majority stated Diabulimia or a comorbidity 
with Diabulimia and over 80% of the respondents had deliberately reduced or omitted their 
insulin in order to lose weight. This is not reflected in the diagnostic categories attributed to 
them and represents a substantial disconnect between what they feel they are suffering with 
and what they are diagnosed with. The term has gained recent notoriety due to media events 
199 
 
such as the release of the BBC documentary Diabulimia: The World’s most Dangerous 
Eating Disorder (BBC, 2017) but before this, was used most frequently in the T1D 
community. The lack of a recognised clinical diagnosis appears to be massively problematic 
for those who consider themselves Diabulimic and even for those who don’t but recognise 
that the regimen demands of T1D contradict with standard ED treatment and feel that AN, 
BN and EDNOS are not appropriate descriptors for their experience. 
Recently the British Psychological Society’s division of Clinical Psychology released a 
position statement regarding the usefulness of organising around diagnostic labels 
The DCP is of the view that it is timely and appropriately to affirm publicly that 
the current classification system as outlined in the DSM and the ICD, in respect 
of the functional psychiatric diagnoses, has significant conceptual and empirical 
limitations. Consequently, there is a need for a paradigm shift in relation to the 
experiences that these diagnoses refer to, towards a conceptual system which is 
no longer based on a ‘disease’ model. (BPS, 2013, p. 1) 
They go on to claim that the disease model promotes a number of negative outcomes for 
patients including stigmatisation surrounding a clinical diagnosis which can negatively affect 
self-esteem, disempowerment over disagreements with diagnoses, marginalisation of the 
patients own experience and how diagnoses affect the decision-making processes of Health 
Care Professionals (BPS, 2013). It maybe that a paradigm shift would be useful, but it is 
important to recognise that not having a recognised clinical diagnosis with clinical 
symptomology can be equally as problematic. In a recent paper Hastings et al. found that 
those with Diabulimia see themselves as having a ‘unique illness identity’ of which ‘insulin 
omission as a defining feature of their illness identity that distinguished them from other 
eating disorder groups’ (Hasting et al., 2016, p. 2). Furthermore, participants also described 
a similar pattern when comparing themselves to those with T1 who were not concurrently 
suffering with an ED. These patients perceive their identity as isolating, a barrier to 
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appropriate support and not helpful to recovery in the context of the current healthcare system 
(Hasting et al., 201614)  
At a group level, identification as ‘Diabulimic’ may promote several positive strategies for 
recovery.  Cruwys et al. (2014) found that ED group identification could be the basis for 
‘normative change’. Using a group intervention protocol, they suggested that the shift from 
ED identification to recovery identification reduced thin – ideal internalisation, body 
dissatisfaction and dieting intentions via the norms of the group becoming more recovery 
focussed during the course of the intervention. Further positive effects of a ‘recovery identity’ 
whereby an ED sufferer shifts their perspective of themselves from someone as actively ill 
to someone working on recovery, have been found in lower levels of relapse and higher levels 
of engagement in treatment (Buckingham, Frings & Albery, 2013; Beckwith, Best, Dingle, 
Perryman & Lubman, 2015). 
In Diabulimia, benefits of group identity also seem apparent. Members of a T1ED support 
group reported that the online group provided protection from the isolation of their conditions 
by providing an alternative, supportive and understanding community of in which there was 
a strong shared identity. The authors state:  
The support offered by those who share a sense of identity was perceived as 
qualitatively different from outside the group… Specifically participants felt 
that they could share experiences without being judged and that they could 
receive the emotional support and encouragement from group members that 
was absent from their other support networks (however well -intentioned the 
support offered may be) (Hastings et al., 2016, p. 5)  
The group also validated the feelings of members, allowing them to identify as having this 
new and different condition. They also used the group as the primary source of illness related 
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information both related to regimen issues such as useful medications and the potential 
consequences of not recovering:  
Participant: It’s like the start point do I look it up on google or go to the GP, no 
I ask the group if that makes sense, it’s like the first thing I do    
Interviewer: That’s great, and why is it the first place you go to over other 
places? Participant: Because no one knows more about Diabulimia than 
Diabulimics (Hasting et al 2016, p.5) 
 
Other qualitative research has reported similar themes. A recent blog analysis has shown that 
healthy, understanding networks are vital for successful recovery and for Diabulimia that 
incudes peer support. Furthermore, these networks may encourage identity change from a 
‘sufferer’ to a ‘supporter’ as one participant stated:  
They are women who, not only help encourage me to live my best life in 
harmony with my diabetes, but also provide me with valuable wisdom, 
guidance, and most importantly, a supportive shoulder to lean on when needed 
(Staite et al., 2018 please see appendix, p. 39) 
Given then, that the use of the term ‘Diabulimia’ is validatory and provides access to 
inavaluable social resources for patients, it would seem sensible that legitimising it with a 
clinical diagnosis or something more formal would help sufferers further particularly as the 
usage of a non-medical term when engaging with medical professionals provokes a range of 
reactions, some patients even reporting that HCPs have claimed ‘that’s made up on the 
internet’ (Allan, 2015, p. 10015). Furthermore, given that T1EDs represent a rarity, finding 
HCPs who specialise or have expertise in this area is difficult. This is felt acutely by 
participants in qualitative research on this subject who describe feeling ostracised by HCPs, 
that the treatment they receive is not suitable for their comorbidity and that clinicians are 
unwilling to accept that their ED is symptomatically distinct. As one participant stated 
I’ve tried counselling and therapy but none of them had a clue what Diabulimia 
was so they weren’t much help whatsoever. Everyone I tried to explain to 
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they’d just ignore me and talk about other eating disorders that I may have 
(Hastings et al 2016, p. 4) 
Other qualitative research has found similar attitudes. McDonald et al. 201716 please see 
appendix for full article) reported that most of their participants experienced more negative 
than positive interactions with HCPs and that not only were these interactions unhelpful, in 
some instances they were potentially negligent. As one participant stated:  
Then there were the incidents with things like them forgetting to give me my 
insulin, forgetting to do blood tests… I was in there to be treated for my eating 
disorder and part of that is struggling with taking it so for me to remind them 
that I needed to do it or that they needed to test my blood, was just ridiculous  
(McDonald et al., 2017, p. 226) 
With this kind of treatment experience, it is perhaps understandable that in this demographic 
there is a level of mistrust towards medical professionals. Participants went on to state that 
there were issues with HCPs understanding the uniqueness of the situation they were in as 
T1ED and that they expected HCPs to just ‘not get it’. They also complained that there was 
a lack of collaboration between teams which led to misunderstandings and inappropriate 
treatment. It would appear apparent then that HCPs are unfamiliar with the workings of T1ED 
and insulin omission. A distinct diagnosis would promote futher understanding, after all how 
do you train HCPs for something that does not officially exist.  
These sentiments were inadvertently validated by HCPs (ED specialist) who in one incidence 
essentially stated that T1D was simply another comorbidity that should be dealt with in the 
same way one would deal with a condition such as depression. This demonstrates a clear 
conflict between what the patients and those treating them recognise as appropriate attitudes 
to the comorbidity (MacDonald et al., 2017). Perhaps worse still Tierney et al. reported that 
HCPs may be openly hostile to patients with T1ED. One of her HCP participants reported  
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You can tell that some people won’t give them the time of day and you have to 
be careful yourself not to think, oh no, he’s in again (Tierney et al., 2009, p. 
338)  
Having a recognised clinical description would surely lessen some of this anxiety. Other 
healthcare professionals in this and other samples appear to recognise that there were 
potential skills and training gaps and there was a need for specialists in each discipline 
(Eating Disorders and Diabetes) to have at least a rudimentary understanding of the other. 
There was also a recognition in some of the HCPs that T1ED was challenging and this was 
compounded by limitations and constraints placed on their positions in the overarching NHS 
structure, the authors state: 
By far, the greatest challenge was working with problematic thoughts and 
behaviours; i.e. insulin omission, difficulties in engaging, high anxiety, 
unrealistic recovery goals, diagnostic ambiguities, transient nature of barriers 
put up and threats of self harm and suicide. Other concerns included 
responsibility of clinical risk and the anxiety inducing effects on their own team 
members. (MacDonald et al., 2017, p. 227) 
The HCP participants recognise that part of the solution to these challenges is close 
multidisciplinary working which helps overcome treatment barriers but simultaneously they 
also reported that challenges in treating T1EDs extended to issues caused within the team  
due to patient centric effects. This included the process of ‘splitting’ whereby a patient will 
play one health care professional off against another often using nefarious means such as 
lying in order to achieve a desired outcome. As one Diabetes specialist HCP noted:  
Because often the patients know a lot about diabetes, so they can blind the 
psychiatrist or eating disorders person with the diabetes… They will cheat the 
nurse (MacDonald et al., 2017, p. 228) 
Other qualitative research in HCP subjects has shown similar frustrations. Teirney et al 
(2009) highlighted that within a sample of Diabetes Specialists, patients with T1ED were 
anxiety inducing and identified 4 main themes; classification, detection, treatment and lack 
of training. It would make sense however that much of this is due to a lack of any concrete 
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diagnosis of insulin omission as a weight loss behaviour, Splitting is much easier when there 
is confusion.  
An interesting finding of this research is that many of the Diabetes specialists separated 
‘classic’ eating disorder behaviour such as bingeing and purging or severe food restriction to 
those more generally seen in those with T1, this potentially shows a significant difference 
between the attitudes of those working in Diabetes and those working in ED who may simply 
view diabetes as a mostly irrelevant side note. It also coincides with patient attitudes towards 
diagnosis. The Diabetes specialists in the Teirney et al. sample appeared to have a good 
working knowledge of the potential psychological mechanisms behind T1ED cases, citing 
focus on nutrition, obsessive diets for glycaemic control, resentment of T1D, weight gain 
associated with good control and were reflective about how their own practice may have been 
iatrogenic. This having been said they were acutely aware that they were not trained in this 
area, had a serious lack of expertise and were often afraid to bring up insulin omission in 
appointments in case they broke established rapport, this was reported in other samples also 
((MacDonald et al., 2017; Balfe et al 2013). This may represent a missed opportunity as 
research has suggested that it is just this rapport that makes it more likely for sufferers to 
‘open up’ to HCPs (Balfe et al 2013). Perhaps due to the relationships fostered, HCPs in this 
sample reported trying to contain milder T1ED problems within the diabetes clinic. The 
authors highlight that 
‘psychologists and other experts in eating disorders did not always have a good 
understanding of these problems within the context of diabetes’ (Teirney et al., 
2009)  
This may be indicative of the core issue, despite recognising that they are ill equipped to 
either recognise or treat these issues, Diabetes specialists are reluctant to bring in outside 
help. When that help is brought in it is also seen to be ill equipped. A diagnostic term unique 
to this condition would surely assist in these aspects.  
As such it would seem of prime importance that the we acknowledge ‘Diabulimia’ as a term. 
Regardless of how academics, clinicians or researchers may feel about the term, it has 
obviously been adopted by those who omit insulin for weight loss and given that it describes 
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a specific and unique illness, with distinct behavioural features it would appear that it does 
have utility.  
7.6.2 Strengths 
This is the first piece of research to examine patient attributions as to what caused their ED 
to develop. It used a large cross sectional, global sample which provides a wider 
comprehension of issues facing this demographic. It has hopefully gone some way to address 
a significant gap in the literature. Furthermore this research should help our understanding 
of where these patients appear in service and the issues they are likely to be facing when they 
do reach out for help.  
7.6.3 Limitations 
The pilot project on which the current study is based utilised was conducted in 2013 as part 
of a bachelors degree and as such it maybe that newer suggestions in the literature as to why 
EDs develop in T1D would have been suggested and thus a different factor structure 
concluded. Also, this was an international sample and as such the results should not be 
generalised to a specific geographical region. It should also be noted that the sample used 
was recruited via the internet whereby issues around T1ED are discussed openly and this 
may have biased results. Similarly, there were not enough male participants in this study to 
generalise the results to males. Although it could be argued that there is not enough literature 
on the male experience of T1ED to currently generalise any conclusions.  
A substantial limitation of the current study is that although these suggestions are in the 
literature they are not necessarily coming from patients, these attributions are suggested by 
researchers. A meta-synthesis of qualitative data may have provided different and perhaps 
more valid attributions. 
7.6.4 Future Directions 
It appears obvious that the terminology that HCPs use in relation to these patients should be 
addressed and the taxonomy of EDs in T1D should be the subject of considerable future study 
given that unique Diabetes specific factors feature so prominently in patients’ attributions as 
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to what caused development. It may be useful to redefine what EDs in T1D are separately 
from EDs in the general population given the substantial differences in both aetiology, 
physical processes and outcomes. Furthermore, as these patients are accessing a wide variety 
of services in order to ask for help it would be prudent to consider some kind of training 
programme for not only health care professionals but also those in related positions such as 
social services and education.  
7.7 Conclusion 
The most important finding of the current study is that while there are latent factors that those 
with or recovering from T1ED attribute to their ED, T1D is inextricable from most of these 
factors. The implications of this are that one cannot address factors in T1ED without the T1D 
which may go some way to explain why treatment for this group so often fails. Furthermore, 
it is obvious that the diagnoses that are being attributed to this group are missing the main 
diagnosis that they feel they have which is Diabulimia. While on the surface this may seem 
like an issue of nomenclature it is beyond that. Diabulimia is a descriptor of a unique 
behaviour that only effects T1D and given that these patients are also highly comorbid for 
other mental illnesses one can only hypothesise on how having an undiagnosable illness 
influences these patients.  They are presumably approaching their multitude of HCPs with 
this terminology. The next stage of research effort in this area should seek to develop a new 
taxonomy that takes into account the unique aspects of ED development and behaviour of 
those with T1D.    
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8 Treating Eating Disorders in Type 1 Diabetes  
8.1 Introduction  
There have been repeated calls for both psychological support and Diabetes education 
programmes from patients, caregivers and clinicians dealing with Type 1 Diabetes. Standard 
models of T1D care often leave the entirety of management down to what the patient and 
those close to them can ascertain for themselves with sporadic input from specialists. 
Furthermore, accessing high quality mental health support is increasingly difficult. That these 
resources are lacking for treatment as usual is obvious but the near complete absence of 
resources for the combined diagnosis of T1ED is alarming, especially as the accompanying 
consequences are devastating. There are various structural explanations as to why there 
appear to be no defined programmes or treatment pathways for T1ED in the UK; lack of 
resources, little professional training, issues surrounding diagnosis, changing guidelines, 
clinical responsibility, funding, lack of specialist knowledge, insulin omission as a clinical 
feature and overall recognition of the problems to name but a few (BBC, 2017; NICE, 
2017a/b; Diabetes UK, 2017; Tierney et al., 2009; MacDonald et al., 2017; Goebel- Fabbri, 
2017). Patient centric issues must also be taken into consideration, T1EDs are less likely to 
show up in clinic, have a poorer opinion of the clinical environment, are less trusting of 
HCPs, often have comorbid diagnoses such as anxiety and may have significant physical 
complications making travel to appointments difficult (Allan, 2015; NICE, 2017b; Tierney 
et al., 2009; MacDonald et al., 2017; Goebel-Fabbri, 2017). 
8.1.1 Treatment Recommendations 
Certain influential figures in the domain of T1EDs have made recommendations though, 
perhaps most notably the clinical academic Anne Goebel-Fabbri who treated numerous 
T1ED patients during her tenure at the Joslin Diabetes Centre, Harvard. She was primary 
investigator on 3 papers outlining how to treat these patients. In the first published in 2002 
she states that a large multidisciplinary team of specialists from both T1D and ED must be 
involved and they must communicate fluently and regularly. She also argues for the 
hospitalisation of patients until they are stable enough to benefit from psychological input. 
Treatment itself she argues should be based around incremental goal setting regarding insulin 
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dosing (she warns that intensive insulin titration is not suitable at this stage), DKA avoidance, 
increasing and regulating food intake and increasing BG monitoring.  She also highlights the 
importance of discussing T1D specific aspects of ED recovery such as the initial weight gain 
which may come from water retention, and the temptation to over treat hypoglycaemic 
episodes (Goebel-Fabbri et al., 2002).  In 2009, the paper Goebel – Fabbri et al. published 
was specifically focussed on the outpatient treatment of T1ED. The sentiments of the earlier 
paper are echoed but the importance of rapport with the patient who is often afraid of 
judgement was emphasised as was the concurrent abuse of other medications. This paper also 
produces a table of guidelines where food restriction and insulin restriction are differentiated 
in term of treatment recommendations. In a 2009 paper solely authored by Goebel-Fabbri, 
she argues that clinicians should be aware of further Diabetes specific stressors such as fear 
of hypoglycaemia, perfectionist attitudes towards BG control and the relationship between 
hyperglycaemia and depression (Goebel-Fabbri et al., 2009). Although Goebel-Fabbri 
appears to have concentrated her efforts around outpatient treatment, recommendations have 
been made regarding inpatient protocols. Bermudez et al. (2009) highlight that those with 
T1ED will present differently for IP treatment where aspects such as hyperglycaemia, DKA 
and severe dehydration should be expected and further T1D issues for management include 
T1D related complications. They also state that insulin omission is incredibly important to 
watch out for and recommend that patients do not be admitted to facilities that are not 
equipped to cope with the unique needs of T1ED. In relation to ward treatment, the authors 
are eager to point out what differentiates these patients, namely that initially, insulin dosing 
should be the responsibility of staff and BG control should be attained incrementally, pumps 
should be replaced with MDI and that weight restoration is not a necessary goal. They also 
provide a fairly comprehensive table of recommendations regarding Diabetes specific aspects 
of IP treatment. Interestingly these authors do not refer to patients by a standard ED diagnosis 
(AN, BN..etc) but rather by the moniker ED-DMT1 which stands for Eating Disorders in 
Diabetes Mellitus Type 1. This indicates that perhaps to this research team at least the 
commonality comes from Type 1 Diabetes, diagnosis type, to a large extent is irrelevant.  
Much of the aforementioned recommendations were reflected in an update to the NICE 
guidelines for Eating Disorders published in 2017. These guidelines represented a leap 
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forward in the treatment of T1ED although there were still limitations (please see appendix 
A for a further discussion of this topic).  
8.2 The Current Review  
Any researcher who is involved in this discipline could not fail to notice that nearly every 
paper regarding T1ED highlights how difficult this demographic is to treat. The purpose of 
the current review was to provide a 20 year overview (1998 – 2018) of reported treatment 
programmes for those suffering with Type 1 Diabetes and an Eating Disorder in order to 
ascertain what types of interventions have been suggested, whether they have been modified 
for Type 1 Diabetes, whether HbA1c was measured or insulin omission considered, what 
measurement instruments have been used and what  the length of treatment was. The 
discussion then uses the findings of this review and that from elsewhere in this thesis to 
suggest whether or not the perceived wisdom that this group are harder to treat is valid.     
8.3 Methodology   
8.3.1 Search Terms and Databases 
A comprehensive search was run using the MEDLINE & PubMed Databases using the 
following terms. (Diabetes Mellitus, type 1* [MeSH Terms]) AND (Feeding and Eating 
Disorders* [MeSH Terms]), Diabetes mellitus, type 1/ psychology [MeSH Terms], Diabetes 
mellitus, type 1/ psychology [MeSH Terms] AND “Eating Disorder*” [All Fields] and 
Feeding and Eating Disorders* [MeSH Terms] AND “Type 1 Diabetes” [All Fields]. A 
search was similarly run on PSYCH INFO using the terms ‘Eating Disorders’, ‘Type 1 
Diabetes’, ‘Type 1 Diabetes Mellitus’   
Following this a hand search of the references section of relevant papers was used to identify 
any other papers which may have been unidentified by the original search.   
8.3.2 Inclusion/ Exclusion Criteria  
Inclusion Criteria  
1) English Language  
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2) Discusses a Treatment Protocol for Eating Disorders in which there are Type 1 
patients. 
Exclusion Criteria  
1) Review Articles (although used in identifying references) 
2) Individual Case Studies. 
3) Does not Discuss a Treatment Protocol for Eating Disorders in which there are Type 
1 patients. 
4)  Prevention Programmes  
5) Studies with Diabetes Type not differentiated  
6) Studies not in English Language 
293 papers were suggested by the literature search for review. Of these 49 duplicates were 
removed. 2 papers were added via hand search and 2 papers utilising the same treatment 
protocol and sample were combined (please see figure 8.1) 
8.3.3 Data Extraction  
The follow data was extracted from the literature: Author/ year/ country of origin, number of 
participants, gender, age range or mean age, diagnoses, type of treatment, whether the 
programme was designed or modified for T1D, whether HbA1c or insulin omission was 
measured, what ED measurements were used, whether the programme improved outcomes, 
if there was a control group, the length of treatment and whether there was any post treatment 
follow up.   
Studies between 2001 – 2016 were read by 2 postgraduate research assistants who wanted to 
gain experience in the methodology of systematic reviewing and reviewed again by the 
researcher to ascertain suitability for inclusion in the review. Studies between 1998 – 2001 
and 2016 - 2017 were reviewed by a PhD student who wanted to gain experience in the 
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methodology of systematic reviewing and reviewed again by the researcher to ascertain 
suitability for inclusion in the review. 
Figure 8.1: Flowchart  
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8.4  Results 
Table 8.1: Features of the Papers Reviewed  
Author/ Year/ Country 
of Origin 
n 
(m/f) 
Age Range 
or x 
Diagnoses Protocol HbA1c 
or IO 
Measured 
Eating Disorder 
Measures 
Control Group Treatment 
Length 
Post 
Treatment 
Follow Up 
Colton et al 2015 
(Canada) 
32f* x=25.6 BN/AN/ 
EDNOS  
Day patient CBT Yes  EDE 801 no T1D  6 – 8 weeks 
EDNOS, 10 – 
14 weeks AN 
No 
Dickens et al 2015 
(US) 
29f x= 25.55 BN/ AN/ 
EDNOS 
Inpatient  Yes EDI No n/s No 
Custal et al 2014 
(Spain) 
20f x=25.3 AN/ BN/ 
BED/ 
EDNOS 
Day patient CBT or 
Inpatient treatment  
Yes EDI & Semi 
Structured 
Interview 
20 non T1d 16 sessions 
outpatient CBT 
or 3-month day 
patient  
Mo 
Takii et al 2002; 2003 
(Japan) 
28f  IP x= 23.8 BN/ BED Outpatient 
Counselling or 
Integrated Inpatient 
Therapy 
Yes Clinical 
Interview & 
EDI 
No n/s 6mo, 
24mo, 
36mo 
Olmsted et al 2002 
(Canada) 
50f 12 - 20 >cut- off Psychoeducation Yes EDI, EDE & 
DSED 
35 T1D 6 sessions 4wks, 6mo 
Alloway et al 2001 
(Canada) 
8f 32.5 subED Psychoeducation Yes EDI, EAT 
modified for 
T1D 
6 T1D 6 sessions 1 mo 
N=5, 6 mo 
IO = insulin omission, n/s = not stated, IP = Inpatient, EDE = The Eating Disorders Examination, EDI = The Eating Disorder Inventory, DSED = The Diagnostic Survey 
for Eating Disorders, EAT = Eating Attitudes Test, sub= subthreshold, mo = months 
*this is the number of people who attended the programme > 4wks,
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Table 8.2: Content and Success of Programmes Reported  
Paper  Designed 
for T1D 
Modified 
for T1D 
Improvements  Modification 
Dickens et al 
(2015) 
Yes Yes Yes in both ED 
symptomology 
and HbA1c 
In line with current treatment recommendations (Goebel-Fabbri, 2009), clinical staff at the multi-
disciplinary residential treatment center included licensed psychotherapists and their supervisees, 
registered dieticians, psychiatrists, physicians (including an endocrinologist), registered nurses, and 
mental health technicians. Therapeutic approaches included cognitive behavioral, person-centered, 
family, and feminist approaches. The primary goal of treatment was to teach patients cognitive and 
emotional skills to manage eating disorder thoughts and urges that interrupted diabetes management. 
Patients received medical monitoring of blood sugar levels several times daily by nursing staff. 
(Dickens et al., 2015, p 3) 
 
Diabetic patients were taught to practice intuitive eating by administering insulin dose for half of their 
portion prior to eating, and then administering the remainder of the dose following the meal according 
to the amount they consumed while attending to internal hunger and satiety cues. Meals were eaten 
under supervision of trained staff. (Dickens et al., 2015, p 4) 
Colton et al 
(2015) 
No Yes 6 = Good 
outcome 
14 = 
Intermediate 
outcome  
12 = Poor 
Outcome 
Day hospital treatment protocol was the same for those with and without diabetes, with the following 
modifications for those with type 1 diabetes: endocrinology consultation and follow-up throughout; 
expectation of full adherence with blood-glucose monitoring and insulin administration; and further 
diabetes education is provided as needed. (Colton et al., 2015, p313) 
Custal et al 
(2014) 
n/s n/s 50% Partial or 
Full Remission 
No modifications stated.  
Takii et al 
(2002;2003) 
Yes Yes  While treating those with T1D and BED, which was diagnosed in the absence of ICBs Takii et al., 
(2002) utilised a counselling session at the time of screening which was focused on T1D.  They state 
that this protocol is as follows  
 
‘1. Bring out patient feeling about diabetes by listening for a sufficient amount of time that the patient 
gets a feeling of ‘‘ventilation’’. 
2. Help the patient recover from the injured self-esteem. 
3. Contradict too pessimistic an image of diabetes and present a hopeful and acceptable image of it. 
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Paper  Designed 
for T1D 
Modified 
for T1D 
Improvements  Modification 
4. Teach the patient the importance of finding the easiest and most suitable form of diabetes self-care. 
5. Encourage recovery/improvement of communication between the patient and family members, 
especially the mother’ (Takii et al, 2002., p 293.) 
 
It should be noted that in the event that 1st episode counselling did not produce the desired outcome of 
a 1% drop in HbA1c in 6 – 12 months the patients were referred to an Integrated Inpatient Programme 
which focused on limiting control over injecting insulin until better eating behaviour was established. 
The authors give an outline:  
 
‘The basic elements of integrated inpatient therapy 
I. Recovery period for the mind and body 
a. Recovery from mental and physical fatigue and depression 
b. Normalization of biorhythms 
II. Modification of behaviors and cognition 
a. Improvement of eating behavior 
(Therapist control stage) 
Decision, by the patient, of the initial calorie intake and insulin dose 
Completely and regularly eating meals 
Not eating snacks or confectioneries 
Incremental increases in the volume of the meal (200 kcal at a time) 
(Patient control stage) 
Free ingestion training 
Snack training 
Eating out training 
Staying at home training 
b. Promoting glycemic control competence 
Self-measurement of blood glucose 
Self-injection of insulin 
Practical coaching and training in adjustment of the insulin dose 
c. Modification of cognitive aspects 
Individual counseling 
Group therapy for eating disorders 
III. Restoration of family relationships 
a. Spontaneous restoration process 
b. Family counseling 
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Paper  Designed 
for T1D 
Modified 
for T1D 
Improvements  Modification 
c. Coaching family members: especially in how to understand and cope with the patient (Takii et al., 
2003, p 351)’ 
Olmsted et al 
2002 
No Yes Yes in both ED 
symptomology 
and HbA1c 
The relationship between disordered eating and diabetes, body image concerns relating to diabetes , 
how eating attitudes and behaviour affect diabetes control, the dangers of insulin omission and family 
communication strategies. Strategies for change and a nondeprivaional , nondieting approach to normal 
eating were emphasised. (Olmsted et al., 2002, p.234) 
 
Alloway et al 
2001 
No Yes Not as an effect 
of the 
intervention 
They state that ‘slight modifications’ were made but do not explain exactly what these modifications 
were and state that the programme had sessions on  
…eating disorders, "normal" eating, healthy body weights, assertiveness training, stress management, 
improving self- esteem, perfectionism, media and societal expectations of thinness, and enhancing 
body image. (Alloway et al., 2001. p2) 
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8.4.1 Country of Origin  
There were very few geographical regions represented in this study. 3 papers came from 
Canada, 1 from the US, 1 from Spain and 2 from Japan.  
8.4.2 Sample Size  
As is the case with most research in to T1ED there was a serious issue with sample sizing in 
most of these research articles. For example, Alloway et al. (2001) only used a sample size 
of 8, Takii et al. (2002) did extended their study with a sample size of 28 but this was divided 
into 10 BED and 18 BN patients, of which only 9 would accept inpatient treatment to be 
described in their later paper (Takii et al., 2003). Similarly, Custal et al. (2014) divide their 
20 participants between diagnoses. Colton et al (2015) describe a sample of 32 who 
completed adequate treatment but it should be noted that the data from these participants 
were collected retrospectively over a 22 year period. Olmsted et al. (2002) reported the 
highest participant numbers at n= 50.  
8.4.3 Gender  
All treatment programmes exclusively treated females. Some researchers deliberately 
excluded males (Custal et al., 2014) although it should be noted that authors claim to do so 
due to such a limited sample. Colton et al. (2015) do state that 2 T1D men did come to their 
clinic within a 22 year period but they were deemed to not have an ED and so were excluded 
from research.  
8.4.4 Age Range  
Consistent with research that shows that in T1D Eating Disorders tend to manifest at older 
ages most of the research undertaken was with adults. Olmsted et al. (2002) used a younger 
cohort aged 12 -20, arguably there is a significant difference between the needs of a 12 and 
a 20 year old which may explain why the protocol was relatively unsuccessful.  
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8.4.5 Diagnoses  
A variety of diagnoses were represented in the intervention literature. Alloway et al. (2010) 
utilised a sample of subED patients excluding anyone who qualified as having full clinical 
EDs. Takii et al. (2002) separated patients into either BN or BED depending on whether they 
utilised ICBs including insulin omission. Other researchers did not use diagnosed ED patients 
at all, preferring instead to rely on information gleaned from clinical interviews or cut-off 
points from ED screening interviews (Olmsted et al., 2002). Similarly to other research in 
this demographic however, even when diagnoses reported run the spectrum of ED disorder 
possibilities, insulin omission still appears to be the main feature of the illness. (Takii et al. 
2002/2003; Custal et al., 2014; Dickens et al; 2015; Colton et al. 2015).  
8.4.6 Type of Protocol  
8.4.6.1 Outpatient: Counselling & Cognitive Behavioural Therapy  
Takii et al. (2002;2003) describe a treatment protocol whereby they separated patients who 
have BED to receive 1 session of counselling that is related to Diabetes. For BED they claim 
this intervention has significant effects on both behavioural and biological measures at 3 year 
follow up (please see below). Custal et al. (2014) describe providing their T1ED patients 
(who don’t have AN diagnosis) 16 sessions of Cognitive Behavioural Therapy but they don’t 
explain any further than that.  
8.4.6.2 Outpatient: Psychoeducation  
Olmsted at al. (2002) describe psychoeducation as ‘the provision of information about an 
illness or problem and strategies for changing or coping with it’ (Olmsted at al., 2002, p.231). 
The format of their programme was a 6, 90-minute, weekly sessions whereby mothers and 
their T1D daughters were given information delivered by an ED specialist and a T1D 
specialist (subjects and their mothers in separate rooms) alongside a treatment manual 
adapted from a standard ED programme. They emphasise that the main approach used was 
‘nondeprivational’ which encourages patients away from dieting behaviour. They found that 
following this intervention patients’ attitudes towards food and body image improved but 
HbA1c and rates of insulin omission did not. Alloway et al. (2001) found that a 
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psychoeducation group was no more effective at reducing psychological distress or HbA1c 
than a waiting list. 
8.4.6.3 Outpatient: Day Hospitalisation 
Day hospitalisation represents a middle ground between outpatient and inpatient treatment. 
Patients attend intensive treatment during the day but are allowed home in the evening. 
Colton et al. (2015) provide a retrospective chart review of T1D patients who attended this 
programme, based on CBT principles and delivered via group therapy with a 
multidisciplinary team over a 22 year period. It should be noted however than less than half 
of patients offered this treatment accepted it.  Custal et al. (2014) found similar results. In a 
retrospective chart review they compared outcomes between those with T1D and those 
without who had attended treatment at a single ED unit in Spain. They subjected their AN 
patients’ to day hospitalisation but do not extrapolate any further on that.  
8.4.6.4 Inpatient Treatment 
Takii et al. (2002; 2003) published two studies regarding the treatment of BED and BN in 
T1D. For those with BN they describe an ‘integrated inpatient’ programme. This programme 
consisted of many T1D specific elements such as deciding insulin dose administration and 
close supervision at meals regarding insulin. The authors argue that this inpatient protocol 
significantly improved HBA1c and ED behaviours including insulin omission to the extent 
that at 3 year follow up 78% of patients did not meet criteria for either full or subthreshold 
EDs.  
Dickens et al. (2015) describe both significant ED and HbA1c improvements in a sample of 
T1EDs who went through a residential treatment programme at a clinic in the US. The 
authors report that the programme used a large multidisciplinary team which included an 
endocrinologist. Patients were closely medically monitored daily in relation to blood sugar. 
The programme involved multiple weekly individual therapy sessions, bi monthly or monthly 
family sessions, weekly nutritionist and psychiatrist appointments, multiple daily group 
therapy sessions and weekly MDT meetings to review progress. They authors do highlight 
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that the use of such an integrated approach makes it difficult to suggest which elements of 
treatments are the most successful.       
8.4.7 Eating Disorder Measures 
Alloway et al. (2001) used the EDI and the EAT to screen patients into their group 
psychoeducation programme for subclinical EDs and also added 2 questions regarding 
insulin omission. They found no significant differences between control and treatment 
conditions on these measures. Takii et al. (2002; 2003) also used the EDI but also a clinical 
interview based on the DSMIV which included questions on insulin. They found significant 
differences in ED behaviours using these instruments as a result of treatment. Olmsted et al. 
(2002) used a mix of ED measurements which they stated were modified for use in the T1D 
population, the EDI, the EDE and the DSED and they found a significant reduction in ED 
attitudes as a result of treatment. Custal et al. (2014) used the EDI and a semi structured 
interview. There were also questions asked about insulin omission. Dickens et al. (2014) also 
used the EDI and found improvements as a result of treatment. Colton et al. (2015) describe 
using the EDE initially to screen participants but they specify more behavioural measures in 
terms of outcomes. They measured both weight restoration and frequency of bingeing and 
purging to ascertain whether outcomes were good, intermediate or poor.  
8.4.8 HbA1c & Insulin Omission 
Alloway. (2001) excluded anyone who had ICBs as a indication of bulimia. They do not 
mention if that includes those who omitted insulin but they did record HbA1c at baseline. 
They found that following a psychoeducation program both the treatment and control had 
improved HbA1c as an effect of time concluding that there was no difference between 
groups. Olmsted et al. (2002) measured both HbA1c and frequency of insulin omission and 
they found no significant effect of treatment for either at 6 month follow up. Takii et al. 
(2002;2003) found that there were significant longitudinal effects of treatment whereby those 
with BN who did not enter IP treatment did not improve their HBA1c or insulin omission 
frequency while those in the treatment group recovered significantly and stayed as such 
through follow up.  For BED however one counselling session was enough to improve 
HbA1c at follow up. Custal et al. (2014) reported HbA1c levels and self-reported insulin 
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omission at baseline but did not provide any follow up data. Colton et al. (2015) reported on 
outcomes based on behaviours such as binging and purging but did not explain what ratio of 
those behaviours included insulin omission and despite measuring HbA1c at baseline they 
do not report it post treatment.   
8.4.9 Control Group  
Several researchers used a T1D control group but in some cases,  this was very small, 
Alloway et al. (2001) for example used a control group of 6. Olmsted et al. (2002) used a 
TAU group of N = 35 T1Ds. As seen in other research some authors utilise a non T1D control 
group stating that the only statistical difference is insulin omission. It should be noted that 
the authors claim that they have provided appropriate control they also state that nearly all 
(90%) of their Diabetic sample manipulated insulin for weight control (Custal et al., 2014). 
Colton et al. (2015) used a comparison group of 801 non Diabetics. Other researchers use no 
control group at all (Dickens et al., 2014). Of specific interest is Takii et al’.s assertion (2003) 
that ‘leaving motivated patients untreated would be unethical’ (p.354). 
8.4.10 Treatment Length  
Takii et al. (2002) describe the shortest intervention which was one session of counselling at 
the time of assessment, perhaps somewhat surprisingly the authors state that for with T1Ds 
and BED this is effective at long term follow up. Other researches attribute failure to shorter 
interventions, particularly those of a psychoeducational nature, both of those reported here 
were only 6 sessions long. (Alloway et al., 2001; Olmsted et al., 2002). Longer programmes 
extended to 3 months and that is certainly in line with standard CBT where programmes 
typically last no more than 3 months at 1 session per week (Custal et al., 2014). Even inpatient 
treatment may only last between 4 – 12 weeks (Custal et al., 2014; Dickens et al., 2016). 
Longer treatment length was associated with better outcomes according to Dickens et al. 
(2015) but no mention of actual length was given.  
8.4.11 Post Treatment Follow Up  
Follow up varied widely, Alloway et al. for example only utilised a 1month follow up with 
most of their participants and 6 month follow up with others, there was no significant 
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differences. Olmsted et al. also used a 6 month follow up time (2002). Takii et al. (2002;2003) 
followed up with their patient at 6, 12, 24 ad 36 months representing perhaps the most 
thorough post treatment assessments. Other researchers provide no follow up data (Custal et 
al., 2014; Colton et al., 2015; Dickens et al., 2015) 
8.5 Discussion  
8.5.1 Summary  
There are very obvious problems with the canon of literature relating to treating Eating 
Disorders in Type 1 Diabetes. No publications in the last 20 years have come from the UK, 
this is significant and somewhat disappointing given that the most recent set of 
recommendations come from here (NICE, 2017). It would also be unwise to extrapolate any 
generalisations from any of this research given that taken as a whole it represents the 
treatment of only 167 patients. It is of real concern that none of these patients were males 
given the soaring rates of insulin omission in this demographic over recent years (please see 
chapter 2), and this may signal a looming crisis. Of the 7 papers reviewed, all focussed on 
adults apart from 1 (Olmsted et al., 2002) and while this is consistent with research that T1ED 
appears in adulthood there is research suggesting that insulin omission for weight loss is often 
present in both male and female adolescents. Diagnoses were varied but in line with other 
research reported in chapter 2, insulin omission was seen as the most prescient symptom.  
Treatment modalities were also varied; there were 3 inpatient programmes, 2 day patient 
programmes and 2 psychoeducation programmes, a course of CBT and an at assessment 
counselling session reported. The inpatient protocols were the most successful and the 
psychoeducation programmes appear to be the least effective. Inpatient protocols explicitly 
based on Diabetes specific aspects of ED improved HbA1c and incidences of insulin 
omission but no other treatment was successful in improving these variables where they were 
reported. Of note is that one of the successful programmes stated that outcomes improved 
further with longer treatment. Treatment length, where reported, seemed to be relatively short 
with no interventions stretching longer than a period of 3 months. In terms of measurement 
instruments the EDI was the most common and although most authors highlight that they 
used either modified versions of instruments or added questions regarding insulin behaviours, 
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no papers utilised a Diabetes specific scale such as the DEPS-R to monitor outcomes. T1D 
control groups were utilised in some research but not in others and in some cases the control 
groups consisted of non Diabetics (please see chapter 2 for a larger discussion around the 
problems with these issues). Various follow up times were also utilised and while some 
researchers preferred to use a simple pre and post treatment paradigm others utilised slightly 
longer times. 1 paper reported an extensive follow up for a period of 36 months This is of 
interest as HbA1c generally is measured at 3 month increments and behavioural change can 
take time, particularly in this demographic.  
8.5.2 Treatment Features 
It is of extreme importance that three of these programmes reported success and they were 
primarily based on aspects of T1 that relate to EDs (please see table 8.1). While it may be 
unsurprising that inpatient treatment demonstrated the most efficacy as it is widely regarded 
as the most intensive of the treatment modalities, the nature of the programme should not be 
discounted, particularly as in the Takii et al. (2002;2003) research recovery was maintained 
at 36 month follow up. Dicken’s et al. specifically referenced Goebel-Fabbri’s 
recommendations in relation to their programme and Takii et al. (2002;2003) reference the 
American Diabetes Association showing that these programmes put Diabetes at the forefront. 
Perhaps one of the main reasons that they showed improvements is that as suggested by 
Goebel Fabbri et al. (2002; 2008; 2009) and Bermudez et al. (2009) initial responsibility for 
insulin dosing is abdicated to the ward staff or at least medically supervised until the patient 
is in a reasonable psychological state. Unfortunately details about the content of therapy 
sessions were not forthcoming in the articles published but in suggesting reasons for long 
term success Takii et al. (2003) suggest: 
the following elements of this inpatient therapy seem to be important in 
maintaining a good course after discharge: (1) calming the patient’s mind and 
modifying behavior by controlling stimuli that lead to eating problems such as 
binge eating, (2) allowing incremental psychological/ behavioral conflicts by 
lifting the controls little by little, and (3) allowing the patient to experience 
recovery from the conflicts with careful coaching by the therapist. (Takii et al., 
2003, p. 355)  
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It is of also of particular note that this research team describe that one treatment session of 
counselling for individuals with comorbid T1D and BED was successful at long term follow 
up (please see table 8.1 for details). This may provide further support for the idea that a new 
taxonomy for T1ED should be developed which considers severity levels and behavioural 
profiles. More research is certainly warranted.     
In the psychoeducation treatments described the authors explain that the interventions may 
have been too short (Olmsted et al., 2002) or that this particular sub group require a much 
more targeted and intensive approach involving much one to one clinical time in order to 
improve (Alloway et al., 2001). However Takii et al. (2002) were successful in treating BED 
in just on session. It is of not that both psychoeducation interventions based on others which 
are designed for EDs in the general population. It appears that Alloway et al. (2010) may 
have fallen foul of only focussing on classic symptoms of Eating Disorders rather than those 
that are unique to T1ED (please see chapters 4 & 7). Similar issues may have affected 
Olmsted et al’s. (2002) study where they also adapted a programme originally designed for 
use in the general population but claim to have modified for Diabetes. There is nothing in the 
article to suggest that they are actually doing anything to assist patients who are actively 
Eating Disordered though, rather this intervention appears like discussions around the topic 
rather than directly addressing behaviours (please see table 8.2). 
Colton et al. (2015) describe the patients that they have treated over a 22 year period using a 
day patient protocol which they state they do not significantly change for their Type 1 
patients. They state that those with T1 do significantly worse than their non Diabetic peers 
and that this could be due to ‘low readiness to change’ (p. 316). This seems more than a little 
presumptuous given that the programme was not tailored at all to the needs of these of 
patients. The authors do give further suggestions for treatment resistance however 
hypothesising that: 
Individuals with Type 1 diabetes may feel poorly understood by other group 
members or staff who do not have diabetes themselves, and who may have 
limited knowledge of the broad ways in which diabetes can influence daily life, 
long-term health and self concept. This may make it more difficult for those 
with type 1 diabetes to make full use of group therapy sessions or to form an 
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effective alliance with the team and their peers in treatment.  (Colton et al., 
2015, p.316) 
This is a more likely explanation and congruent with qualitative research (please see 
appendices B, C & D). Furthermore, their programme demands absolute insulin adherence 
which is not only contrary to all published recommendations but also unrealistic, given that 
these patients only attended the treatment during the day, leaving them with complete control 
over night.      
In programmes which do not describe content the authors nonetheless suggest why those with 
T1D are more resistant. For example, Custal et al. (2014) postulate that those with type 1ED 
do not benefit from therapeutic treatment in the way that non T1EDs do due to temperamental 
attributes such as low perseverance, instability and low frustration tolerance. However an 
alternative explanation is that these patients demonstrate these attributes in the face of 
treatment which they know is not going to be suitable for the nature of their ED or tailored 
to take into account the unique aspects of T1E. The authors state that there is no clinical 
difference in ED symptomology between those with T1ED and ED other than insulin 
omission but this thesis provides significant evidence to the contrary and thus assumptions 
should not be made. Also, this research does not appear to have taken notice of any 
recommendations made when dealing with this population.     
8.5.3 Strengths  
The purpose of the current review was to provide a broad overview of treatment programmes 
reported over the last 2 decades (1998 – 2018). In doing so this is the one of the largest 
systematic reviews to date in this area. Unlike other reviews this review has not focussed on 
controlled treatments only and as such can make broader assumptions. Also given the nature 
of the other sections of this thesis the current review maybe better placed to make suggestions 
as to why perceived wisdom may be incorrect.     
8.5.4 Limitations 
There were a number of case reports detailing treatment of individual T1EDs that were 
screened out of the review. Given the small sample sizes reported in the articles included it 
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could be that this was overly conservative and these case reports actually warranted inclusion. 
Also, as the details of the treatment programmes in terms of actual content was extremely 
limited it may be that the assertions made in this review are overly speculative, to a certain 
extent though, given the lack of information this was unavoidable. Quality was not 
considered as a prerequisite for inclusion, this was due to other assertions made in this thesis 
that there is no gold standard, and often the underlying principles of dealing with T1ED are 
misguided and therefore, even studies which would otherwise be deemed to have excellent 
methodology are essentially problematic. There may also be an argument that only 
randomised controlled trials should be included in any treatment review but as stated 
elsewhere there is no consensus on what an acceptable control group for this demographic 
is.   
8.6 Conclusion 
This review concludes that authors should hesitate to claim that those with Eating Disorder 
and Type 1 Diabetes are hard to treat when basing that claim on the treatment literature. Such 
a statement is based on a sample size of less than 200 patients, who for the most part have 
not participated in suitable treatments. A more accurate statement would be that those with 
Type 1 Diabetes and an Eating Disorder do not recover in treatment programmes that are 
designed for those with an Eating Disorder but not Type 1 Diabetes. It is significant that 
when these patients participate in interventions which are designed specifically for them and 
not based on preconceptions from traditional treatment, that not only do they get better, they 
can also stay better.   
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9 Final Discussion and Conclusion 
9.1 Discussion  
9.1.1 Measuring Eating Disorders in Type 1 Diabetes  
9.1.1.1 Chapter 2: Eating Disorders and Insulin Omission for Weight Loss in those with 
Type 1 Diabetes: A Systematic Review 
The main aim of chapter 2 was to provide a very broad overview (in the form of a systematic 
review of all papers published in this area since 2002), of how Eating Disorders have been 
measured in Type 1 Diabetes and whether previous assumptions made about this population 
are valid by considering sample size, age of participants, primary methodology, sample 
recruitment, measurement instrument used, whether that measurement has been modified for 
T1D regimen, prevalence of diagnoses or number of those scoring above designated cut-off 
points reported if any, whether and how insulin omission was measured and what the 
prevalence of insulin omission was.  The review showed research in this area was inconsistent 
and seriously methodologically flawed. There were particular issues with sample size and 
lack of male participants. Measurement instruments were often used ‘as is’ with no 
modifications for T1D and where modifications had been used there was little consensus as 
to how this should be done. When a Diabetes specific scale was used it was the DEPS-R in 
the majority of cases (please see below for a larger discussion on this). 
BN and EDNOS were the most common diagnoses although there were varying methods 
used to ascertain diagnosis, the status of insulin omission was unclear in many papers, 
completely ignored in others and not given the appropriate weighting considering the 
consequences. Where diagnoses were not made a various risk categories were reported 
instead such as ‘probable ED’ (Powers et al., 2016), ‘Elevated Eating Disorder Behaviour’ 
(Johnson et al., 2014), ‘Very Unhealthy Weight Control’ (Schwartz et al., 2002) and ‘Mildly 
Eating Disturbed’ (Maharaj et al., 2003). These terms were concluded to be relatively 
ineffectual. Where insulin omission was measured the prevalence rates reported varied 
widely but in general this behaviour was more common in adult females than any other 
227 
 
demographic. In research utilising clinical samples IO was reported in as many of 90% of 
participants demonstrating that this is a key tenet of the illness.  
9.1.1.2 Chapter 3: Scale Comparison  
The aim of chapter 3 was to compare rates of T1Ds scoring above the cut-off point for clinical 
concern using both the EAT-26 and the DEPS-R and then to modify the EAT-26 by removing 
items deemed to be influenced by T1D regimen by an expert panel. It was hypothesised that 
the EAT-26 would identify more participants as being of clinical concern than the DEPS-R 
but that modification should reduce the ratio of those scoring above the cut off point. The 
DEPS-R was then subjected to a factor analysis to ascertain if there was underlying structure 
that differentiated Eating Behaviours in the T1D population and the insulin behaviour 
subscale identified by Merwin et al (2014) was investigated further.  As expected the EAT-
26 did screen more patients as clinically concerning than the DEPS-R but unexpectedly 
modifications actually increased that ratio, almost screening the entire sample as probably 
having an Eating Disorder suggesting that the EAT-26 is inappropriate for use in the T1D 
population. 
A 2 factor solution was found when factor analysing the DEPS-R. These subscales related to 
more severe and less severe ED behaviours and cognitions. The insulin items suggested by 
Merwin (2014) also formed a reliable scale and less participants scored above the cut-off 
point than for the full DEPS-R indicating that the items were potentially are measuring a 
different behaviour closer related to the concept of ‘Diabulimia’.  This having been said there 
are still issues with the use of the DEPS-R (please see below). 
9.1.2 Understanding Eating Disorders in Type 1 Diabetes 
9.1.2.1 Chapter 4-6: Risk Factors and Co-morbidities 
The aim of the study reported in these chapters was to ascertain if variables identified in a 
pilot study and subsequent literature review could be modelled to predict Eating Disordered 
behaviour as suggested by elevated HbA1c and DEPS-R Scores. Latent variable modelling 
demonstrated psychosocial aspects (depression, anxiety, borderline personality disorder, 
self-esteem, perfectionism, consideration of future consequences & family functioning), 
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Diabetes specific distress (measured by certain subscales of the Diabetes distress scale) and 
demographic variables (gender) could be modelled in a meaningful way to predict Eating 
Disorder indicators. The individual scale scores formed two reliable latent variables 
‘Psychological functioning’ and ‘Diabetes specific distress’. Psychological functioning 
predicted both HbA1c and DEPS-R as did Diabetes distress in the structural model. Female 
gender also predicted higher DEPS-R scores but only slightly and higher levels of family 
cohesiveness predicted less psychological problems, which in turn predicted reduced levels 
of HbA1c and DEPS-R. The novel variable ‘consideration of future consequences’ also 
predicted the outcome variables with those who were more considerate of the future scoring 
lower on the DEPS-R and having better BG control.  
9.1.2.2 Chapter7: Patient Attributions as to what Caused their Eating Disorder 
The main aim of chapter 7 was to replicate a study previously undertaken by the researcher 
in which suggestions as to why EDs in T1D are more common were transformed into a Likert 
scale and presented to those who had recovered from T1ED. The study reported used a larger 
and more representative sample in order to confirm that there was an underlying factor 
structure to this questionnaire which broadly relates to attributions patients make to what 
caused their ED. As hypothesised, there was an underlying structure. The 4 confirmed factors 
were 1) the family, 2) weight and body image, 3) Diabetes diet and HCP interactions and 4) 
Diabetes specific psychological issues.  
9.1.3 Treating Eating Disorders in Type 1 Diabetes 
9.1.3.1 Chapter 8: Treating Eating Disorders in Type 1 Diabetes.  
The purpose of chapter 8 was to ascertain if the assertion that those with T1 are more difficult 
treat for EDs than those without was valid. A review of treatment protocols employed in this 
population over the last 20 years found that, when programmes are built explicitly with T1D 
in mind then this assertion if false, rather the main issue appears to be that those with T1ED 
are either subjected to programmes which are not initially built for them or shoehorned into 
standard ED treatment. A significant finding of this review is that the literature covers the 
treatment of less than 200 patients and therefore no generalisations should be made.  
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9.2 Recommendations  
9.2.1 The Need for more Research around Co-Morbidities  
It should be noted that many of the same risk factors/ comorbidities for Eating Disorders in 
the General Population also apply to those with T1D. The main difference might be that these 
traits are also generally higher in T1D which may help explain why ED prevalence is 
increased. More research needs to be focussed on the co-morbidity of mental health 
diagnoses in T1ED also particularly on disorders such as borderline personality which seems 
to be increased both in the general T1D population and in those with T1ED. As BPD is an 
illness marked by significant self-harm episodes this is even more important given that T1Ds 
are prescribed insulin, a medication that could be used dangerously for that purpose, yet only 
3 articles have been written on the subject. Even where research has looked at co-morbidity 
there is little more than speculation as to the link between T1ED and the features of co morbid 
mental-health conditions.   
9.2.2 Changes to Current Protocols  
In order to avoid EDs everything in the T1D environment should be examined; it could be 
that understanding the impacts of T1D on mental health and the important relationship with 
Diabetes specific distress could significantly reduce the risk of developing EDs. At diagnosis 
this is not something that T1Ds or their families are informed about. Instructions on how to 
inject, how to carbohydrate count and even structured education programmes such as 
DAFNE(dose adjustment for normal eating) are useful for the practical aspects of living with 
T1D but this study shows that in reality how one functions is as much a product of 
psychological aspects if not more. All the knowledge available on T1D does little to address 
the daily grind of living with such a relentless illness and patients are not warned about this. 
Although psychologists are more frequently in the employ of Diabetes services this is still 
relatively rare. If psychological input was integrated from the moment of diagnosis and 
utilised as part of regular appointments it may be that these issues could be identified and 
thus acted upon earlier improving the prognosis for these patients. It would also be useful to 
explore the relationships between general psychological distress and Diabetes specific 
distress in the clinic which would be an ideal place to carry out research. Also, it is of note 
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that despite HCPs stating that they feel Diabulimics do not reach out for help this was not the 
case in the reported study with nearly all of the participants approaching HCPs for help, more 
psychological input would mean that these cries for help would be recognised.  
The addition of a psychological input would also be beneficial for the other HCPs who so 
often report feeling out of their depth dealing with this population. Iatrogenic factors seem to 
occur due to fundamental misunderstandings around the difficult of dealing with T1ED, 
insensitivities around weight and complications or unrealistic expectations. We need to ‘go 
back to the drawing board’ with clinics and restructure services with these vulnerabilities in 
mind. It does seem that the NHS are moving in that direction, having just produced a position 
statement on language and Diabetes where they introduce the document by stating:  
People with Diabetes internalise messages from the media, and from those 
around them, but most of all from their healthcare providers. When these 
messages are perceived negatively, whether it is intended or not, this can lead to 
feelings of shame, guilt and resentment. People who are ashamed of a condition 
will find it much harder to engage and manage that condition proactively (NHS 
England, 2018, p.1) 
The recommendations made in this document however are just that and more needs to be 
done at a level where implementation can be recorded and outcomes measured. Although 
there would no doubt be a financial argument against the inclusion of more paid staff this is 
a moot point when looking at the catastrophic costs of not dealing with these issues in a 
timely manner. For example, nephropathy is one of the most common complications of 
Diabulimia; the cost of dialysis for 1 patient for 1 year is an average of around £35.000 and 
kidney services utilise around 3% of the annual NHS budget (Baboolal et al., 2018; National 
Kidney Federation, 2018).  Put simply this is too costly not to deal with and proactive 
solutions will save money and heartbreak down the line.  
9.2.3 The Need for a New Taxonomy  
The current argument would be that insulin omission is a feature or AN or BN or (even less 
defined) EDNOS, but there is no evidence for that. Rather T1ED patients describe a pattern 
of Diabetes specific attributional factors and unique to Diabetes psychological disturbances 
that affect not only the aetiology of their disorder but also barriers to recovery. In fact, it 
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could be argued that insulin omission for weight control is the only behaviour in this 
population that we know as a singular T1ED symptom. From purging after a hypoglycaemic 
related binge to starving due to fear of that same hypoglycaemia all other ED symptoms 
appear entrenched in factors relating directly to Diabetes regimen. This also renders current 
ED diagnostic criteria for T1D essentially useless and non T1D control groups irrelevant. 
There are also factors which are just not applicable to the general population like the use of 
an insulin pump or Diabetic Ketoacidosis 
Due to this significant effort should to put into defining a taxonomy for T1ED, the current 
trend of assigning arbitrary categorisations such as ‘Extremely Unhealthy Weight Loss 
Behaviour’ or ‘Disturbed Eating Behaviour’ is doing nothing in terms of helping design 
treatment programmes or estimating true prevalence rates, some kind of consistency is 
needed. Similarly that 5 people with exactly the same pathology and behaviour can be defined 
as AN, BN or EDNOS, subthreshold ED or DEB depending on instrument used is alarming. 
It is time that we define EDs in this population in relation to Diabetes specific aetiological 
factors and biological outcomes so we can work on treatment programmes that will actually 
be effectual. Furthermore, nomenclature should be prioritised considering that most T1EDs 
describe their ED as ‘Diabulimia’ which is not a clinical term.  
It should also be noted that in all probability EDs in T1D are not homogenous, they are 
marked by significantly different behaviours, for example not all T1EDs will utilise insulin 
omission. A new taxonomy should be entirely separate from standard Eating Disorders and 
rather describe behaviours for weight control in relation to Type 1 Diabetes.  
9.2.4 The Need for New Measurement Instruments 
The key issue when attempting to measure EDs in T1D is that in reality we do not know what 
we are measuring. There is not anywhere near enough scrutiny on the suitability of any of 
the current scales used and how they may be affected by the presence of T1D. Even when 
instruments are modified, such as the EAT-26, unexpected results can occur. It may be that 
simply by nature of the illness, T1Ds appear more Eating Disordered. Furthermore, many of 
instruments miss the key tenet of the illness; insulin omission. In any other circumstance this 
232 
 
would seem absurd; like measuring Anorexia without considering calorie restriction or 
Bulimia without compensatory behaviours. 
The 2002 Meta- analysis by Nielsen found that 40% of T1Ds females (and increasing 
numbers of males) who screened as ED were misusing insulin for weight loss purposes and 
levels of insulin omission were also higher than rates of ED diagnoses in the studies 
described. This means that current instruments are missing inulin omission. It may be that 
these patients who are obviously engaging in extremely high-risk weight control behaviour 
represent a distinct psychological profile that is not represented at all by any of these 
instruments. 
It seems apparent that everything involved in measuring Eating Disorders in Type 1 Diabetes 
needs to be reconsidered. The instruments included in the review were fundamentally flawed 
for 2 reasons. Firstly, because unfortunately sometimes appropriate treatment for T1D looks 
like an ED and secondly, because the most common (and the most harmful) behaviour for 
weight control is unique to this population and poorly understood by those outside the T1 
community. As T1D is relatively rare it is somewhat understandable that researchers and 
clinicians in the ED field would not have considered it when developing ED measurements. 
Now we do know however it is absolutely essential that we develop T1D specific instruments 
(please see chapter 9 for a discussion on the DEPS-R) that have clinical utility.  
New, T1D specific instruments must be proposed. It would be a good idea to do more 
qualitative research in this area in order to finetune what items are should be included. Future 
research may also wish to make use of the model reported in this thesis by identifying what 
items of the individual scales correspond most closely to the latent variables of ‘Diabetes 
distress’ and ‘Psychological functioning’ in order to build a short form risk questionnaire.  
9.2.4.1 Use of the DEPS-R 
Researchers have tried to address issues with measuring T1EDs by proposing Diabetes 
specific instruments such as the DEPS-R but as demonstrated in this thesis, there are still 
problems. A worrying aspect of using a measurement such as the DEPS-R particularly in 
youth samples comes from a potential iatrogenic effect. Participants in qualitative research 
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have reported ‘finding out’ about diabulimia through informal means (Balfe et al., 2013; 
Goebel – Fabbri, 2017).   
In the original DEPS-R validation study (Markowitz et al., 2010) use clinicians to state 
whether or not insulin omission is present in their sample but participants are less likely to 
report IO to clinicians. They also validate the DEPS-R in an adolescent sample who are more 
likely to under report due to family and clinical pressures. Furthermore, they validate the 
scale against BMI, HbA1c, Diabetes-specific family conflict, youth negative affect around 
blood glucose monitoring, parental Diabetes-specific burden. frequency of blood glucose 
monitoring and quality of life which are all youth specific, (even although we know that 
T1ED has an older age of onset and significantly affects adults) but not any clinical diagnoses 
of Eating Disorders (Markowitz et al., 2010). There has only been one study to date that 
investigates the relationship between DEPS-R scores and clinically diagnosed Eating 
Disorder patients which concluded that those with clinical ED scored higher on the DEPS-R 
scores. However this study utilised participants with both Type 1 and Type 2 Diabetes and 
thus the results can not be extrapolated to just those with T1 (Pinna et al., 2017) In other 
validations studies the DEPS-R has only been validated against scales used in the general 
population which as has been covered extensively are inappropriate.   
Perhaps for these reasons there are questions as to whether the DEPS-R is accurately 
identifying ED cases. Wisting et al. (2013) for example found a high rate of insulin omission 
in their sample but only 41% of restrictors screened above the cut-off point for concern and 
in the current study when asked have you ever been diagnosed with or thought that you had 
an Eating Disorder’ of 29.9% of participants answered yes but 44.2% screened positive for 
further clinical investigation. Some of these issues lie in the way in which questions are asked 
for example  the items regarding insulin omission ‘When I overeat, I don’t take enough 
insulin to cover the food’ and ‘After I overeat, I skip my next insulin dose’ do not directly 
assess whether this is due to weight and shape concerns, there may be many reasons outside 
EDs that a T1D may avoid injecting, fear of hypoglycaemic for example. Further issues with 
utilising the DEPS-R occur when assessing what ‘overeating’ is. In this population, who may 
have skewed attitudes toward what constitutes appropriate meal size and nutrition 
‘overeating’ may be a subjective assessment.     
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It should also be noted that there are no subscales in the DEPS-R indicating that the authors 
view EDs in T1D as homogenous, rather than having distinct behavioural patterns that 
represent more AN, BN or insulin omission symptomology (not negating the relationship 
these have to Diabetes regimen). The study reported in this thesis did find 2 latent factors in 
the DEPS-R the first of which related to what would constitute more severe ED behaviour 
and the second which pertained to more feelings based risk factors. This highlights a further 
issue with this scale (and other non-Diabetes specific instruments). Feelings do not 
necessarily equal action. Feelings may suggest a useful risk profile but, in an illness, as 
deadly as Diabulimia they should not be weighted in the same manner in instruments that 
claim to measure clinical severity. An individual who is T1D who omits insulin completely 
is in immediate danger of death. This is very different to an individual who purges or starves, 
one incident will likely not cause mortality. Also, no instrument including the DEPS-R 
measured HbA1c as the most prominent indicator of how severe T1ED is in the individual 
and an objective measure of risk. Rather they favoured BMI which while important in the 
general population is of much less concern in T1ED.  The DEPS-R has been used in the 
current study due to its utility as the only commonly used instrument for this population but 
it is not without flaw. 
9.2.5 The Need for New Treatment Programmes 
Treatment programmes that are based on published recommendations are desperately 
needed. Only 2 interventions have been published in the last 20 years which were based on 
T1D related aspects and they were both successful. There are several main areas of concern 
in the literature. Men were completely unrepresented in the literature, patient feedback or 
collaboration appeared to be entirely absent, insulin omission is not understood properly and 
those with T1D are often treated alongside those without. In order to build successful 
treatment programmes in the future, those involved should disregard anything that comes 
from standard ED literature and instead focus on T1D related aspects.  
9.2.6 The Looming Crisis of Male T1EDs 
The male experience of T1ED should be prioritised for research in all areas. It could be that 
as researchers we are doing to males what standard Eating Disorder models are doing to 
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T1EDs. From what we do know it seems apparent that EDs present differently in males and 
that is no different for T1ED. Most alarming is the rapid increase in the prevalence of over 
recent years and a total lack of reported treatment.  
9.3 Conclusion 
Concluding anything about Type 1 related Eating Disorders is difficult, other than stating 
that those who have this comorbidity suffer substantially. This suffering could be avoided if 
we accept that we have fundamentally misunderstood this group and admit that what we have 
been doing is not working. Every aspect of the perceived wisdom in T1ED is flawed. It is the 
main conclusion of this research that Type 1 related Eating Disorders must be redefined 
separately from Eating Disorders in the general population. Measurement should be different, 
treatment should be different and perhaps most importantly, it must be understood that insulin 
omission is qualitatively different from any other Eating Disorder symptom. It is unique 
psychologically, behaviourally and physically. The next stage in T1ED research should seek 
to define a new taxonomy and concurrent measurement instruments and treatment 
programmes. Males T1EDs must also be addressed. We do not know the death rates from 
insulin omission for weight loss as it does not have a clinical diagnosis. At this point it could 
be argued that nomenclature, ‘Diabulimia’ or some other term does not matter as essentially, 
undiagnosable equates to untreatable and it is the patients who pay for this, sometimes with 
their sight, sometimes with their limbs and all too often with their lives.     
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Abstract 
Aims To explore the experiential perspective of people with Type 1 diabetes mellitus and eating disorders and that of 
the healthcare professionals treating them, and to understand the experience of both sides to inform future development 
of healthcare services. 
Methods Participants were recruited from Diabetics with Eating Disorders (a national UK charity), and through 
professional networks. Nine partially/fully recovered individuals with Type 1 diabetes and eating disorders and eight 
healthcare professionals participated in semi-structured interviews carried out by medically trained researchers. Data 
were transcribed and coded using a six-stage framework of thematic analysis. 
Results Four superordinate themes and several subordinate themes emerged from the Type 1 diabetes and eating  
disorders dataset: (1) perceptions surrounding service provision; (2) reflections on the recovery process; (3) the 
experiential perspective of living with Type 1 diabetes and an eating disorder; and (4) support mechanisms. Healthcare 
professional data elicited three superordinate themes and several subordinate themes: (1) service provision; (2) personal 
insight and reflection of professional role; and (3) challenges of working with dual diagnoses. 
Conclusion People with Type 1 diabetes and eating disorders and their healthcare professionals provided insight into 
healthcare services from the patient and care delivery perspectives. There was general agreement from both groups that a 
multidisciplinary, collaborative (family inclusive), clinical approach to treatment is important, as well as adequate 
training opportunities for service providers. These findings may help to inform development strategies for 
multidisciplinary care approaches to Type 1 diabetes complicated by eating disorders. 
Diabet. Med. 35, 223–231 (2018) 
 
Introduction 
 
Risk and problems 
 
Eating problems and eating disorders are twice as common in 
people with Type 1 diabetes mellitus as in people without 
diabetes, with a prevalence ranging from 8% to 36% [1–6]. A 
specific feature of eating disorders in Type 1 diabetes is 
omission/reduction of insulin to control weight and compen- 
sate for eating [7,8]. Interestingly, girls/women are 10 times 
more likely have an eating disorder than boys/men, and the 
same applies to the Type 1 diabetes population [9]. Although 
some people with Type 1 diabetes and eating disorders fulfil 
the standard criteria for an eating disorder, not all of the 
symptoms and behaviours related to the Type 1 diabetes 
comorbidity are currently appropriately reflected in the 
Diagnostic and Statistical Manual of Mental Disorders, 5th 
edition; for example, the omission/reduction of insulin to 
control weight and compensate for eating [7,8]. Eating 
disorders in the context of Type 1 diabetes are associated with 
poorer glycaemic control and accelerated development of late 
complications of diabetes (retinopathy, neuropathy, cardio- 
and cerebrovascular events, limb amputation) and increased 
rates of acute complications (diabetic ketoacidosis and severe 
hypoglycaemia), resulting in a threefold increase 
   in mortality compared with people with Type 1 diabetes 
Correspondence to: P. Macdonald. E-mail: Pamela.Macdonald@kcl.ac.uk without eating disorders [5,7,10–13]. 
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The aim of the present study was to explore experiences of 
treatment and service provision from the perspectives of 
people  with  Type  1  diabetes  and  eating  disorders  and  of 
healthcare professionals (HCPs) in both specialist diabetes 
and eating disorder settings. 
 
 
Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Models of illness 
 
The Medical Research Council recommend that the model of 
illness framework is a good starting point for developing 
complex interventions. There are many contributory risk or 
maintaining factors [14,15], and a variety of models for Type 1 
diabetes and eating disorders have been constructed. Most 
includepooradjustmentanddifficulties incopingwithdiabetes, 
body image concerns, emotional dysregulation and social 
problems [15–18]. The treatment skills require integration of 
expertise in the management of Type 1 diabetes, including its 
technologies, and knowledge about the relative importance of 
the macronutrients, eliciting and challenging unhelpful psy- 
chological beliefs and effects as well as any underlying devel- 
opmental effects, such as insecure attachments. 
 
 
Treatment/services 
 
In general, there is considerable uncertainty about how 
treatment and services for people with Type 1 diabetes and 
an eating disorder should be provided because poor out- 
comes have been achieved with standard eating disorder 
treatments, with individuals often dropping out early [19]. 
The standard evidence-based self-management strategies for 
Type 1 diabetes are complex and require a major focus on 
food macronutrient content (carbohydrate counting) in order 
to be able to match the multiple daily insulin injections, 
eating and exercise patterns, and current blood sugar levels 
with the target of keeping blood glucose levels in near- 
normoglycaemic range to avoid late and acute complications 
[20]. By contrast, eating disorder teams encourage people to 
stop calorie counting, be flexible in eating behaviour and 
moderate their high standards and perfectionism [21,22]. It 
can therefore be difficult to build a model of care that fits 
within the remit of both groups. 
Recruitment and sample 
 
People with Type 1 diabetes with eating disorders were 
recruited from a national charity, Diabetics with Eating 
Disorders, and through professional networking. Adult 
women with Type 1 diabetes (aged ≥18 years), who had a 
current or previous diagnosis of eating disorders as defined 
by Diagnostic and Statistical Manual of Mental Disorders, 5th 
edition, and who had either fully recovered or were in a stable 
medical condition were enrolled. Participants were 
purposively selected to reflect the experiential perspective at 
different ages, duration of illness and stages of recovery. 
Ethics approval was granted by UK National Health Service 
Health Research Authority (REC ref 14/LO/0423). 
The HCPs were purposively selected from a range of 
disciplines/professions at King’s College Hospital London 
and South London and the Maudsley NHS Foundation Trusts 
and large tertiary care centres in South London. Inclusion 
criteria for the professional group required nurses, therapists 
and psychologists to have had at least 1 year’s experience of 
working with adults with Type 1 diabetes and eating 
disorders. Participants of both groups had to be fluent in 
English. 
 
Data collection 
 
Face-to-face semi-structured interviews were carried out by 
three researchers (A.L.C., G.L.B. and A.H.) over the course 
of 1 year and lasted for ~1 h. Topic guides were developed 
from clinical experience and included open-ended questions 
pertaining to the research questions (Appendix 1). Having 
gained appropriate consent, all interviews were audio- 
recorded and transcribed verbatim. 
 
 
Data analysis 
 
During transcription, the typed transcripts were anonymized 
using ID numbers for all participants. A thematic analysis 
approach was then adopted, which is a qualitative method for 
identifying, analysing and reporting patterns or themes within 
a dataset. We based our analysis on Braun and Clarke’s six-
stage framework of analysis [23]. 
Two researchers worked on the coding at each stage of the 
analysis (P.M./G.B. and P.M./A.H. on the thematic frame- 
work for the data obtained from people with Type 1 diabetes 
and eating disorders, and P.M./A.L.C. for the data from 
HCPs). The transcripts were transcribed and read several 
What’s new 
 
• People with eating disorders and diabetes mellitus 
develop debilitating complications, show higher rates of 
disengagement from treatment teams, are harder to treat 
and have a higher mortality rate. 
• Few studies have explored experiential perspectives, in 
terms of treatment provision, of both people with 
diabetes and eating disorders and healthcare profes- 
sionals. 
• The present study offers a description of the experience 
of the service user with both Type 1 diabetes and an 
eating disorder and that of their healthcare professional 
counterparts. Results show the need for multidisci- 
plinary, collaborative approaches to treatment, as well 
as regular training and guidance for service providers 
and family members. 
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Duration of 
eating disorders Duration of Perceived stage 
Participant ID Age Type of eating disorder (time of diagnosis) illness, years diabetes, years of change* 
NA, not available. 
*Acute: the eating disorder has substantial and immediate impact on a participant’s ability to live a meaningful life; Partial recovery: the eating 
disorder has some impact on a participant’s ability to live a meaningful life. Recovered: the eating disorder has limited/no impact on a 
participant’s ability to live a meaningful life. 
times (phase 1), with initial codes generated before the 
transcripts were collated into potential themes (phase 2). 
Researchers worked independently in the identification of 
themes, and several face-to-face meetings and Skype calls 
took place to discuss emerging themes, an example of  which 
included whether ‘Disagreements between profes- sionals’ 
should be merged into the sub-theme ‘Splitting’. This was 
changed, after discussion, to ‘Disagreements and splitting 
within the team’. Thus, after discussion, themes were 
reviewed and refined, sub-themes consolidated or merged 
into existing themes, and descriptive labels altered to better 
reflect the subject matter or deleted if deemed irrelevant to 
research aims (phase 3). Each finalized theme represented an 
idea acquired from the data, representing all the contained 
sub-themes pertinent to the  research  aim.  The computer 
software programme, NVIVO, was used to manage the data 
[24]. In both frameworks, it was mutually agreed between the 
researchers that data saturation  had  been achieved, i.e. that 
no new themes were emerging from the narratives. 
 
 
Results 
 
People with Type 1 diabetes with eating disorders 
 
Participants’  characteristics  are  described  in  Table 1.  The 
final codebook for thematic analysis is  shown  in  Table 3. 
 
Personal accounts of living with eating disorders and Type 1 
diabetes 
Participants offered detailed accounts of  living  with both an 
eating disorder and diabetes. There was a deep  awareness of 
both physical and psychological states that influenced 
behaviours and thoughts deemed to be prob- lematic in 
recovery, some of which included accounts  of  not injecting, 
denial, perfectionism and rigid thinking patterns. 
I can get into these vicious circles where you feel bad so 
you don’t do anything then you feel bad for not doing 
anything .. . That’s hard to get out of. 
(Participant 1) 
Perceived connections or incompatibilities between the eat- 
ing disorders and diabetes were also raised in terms of 
interactions or links between the two conditions. One 
participant, for example, said that having been always self- 
conscious and focused on weight, the diabetes had come as 
an extra burden. 
I think I would have had an eating disorder anyway but I 
don’t think the diabetes helped at all because obviously, the 
focus on food and having to be very aware of what you’re 
eating and numbers .. . 
(Participant 1) 
There were several reports of potential triggers that may have 
contributed to the development of an eating disorder or even 
exacerbated it. These ranged from being in denial of having 
diabetes, coupled with a desire to be ‘normal’, to develop- 
mental issues surrounding puberty, such as fad diets, body 
image and the consequences of restricting insulin. Links 
between having hypoglycaemic events and binge-eating were 
also reported. 
Having diabetes, one had hypos and it was actually  a hypo 
that spurred my first binge. I had this really bad  hypo and 
ate some fudge – and I ended up eating the whole lot. Then 
the binge–starve cycle started. 
(Participant 6) 
Four women spoke of the benefits of having Type 1 diabetes 
and an eating disorder, citing feelings of familiarity, focus, 
control and gaining a sense of identity as positive factors. 
There was, however, also a sense of empathy and advice to 
others still in recovery, e.g. the importance of seeking help, 
perseverance, developing confidence, examining core values 
and developing a keen sense of awareness. 
Table 1 Patient characteristics 
 
 
 
 
1 26 Anorexia nervosa 13 8 Acute 
2 21 Bulimia nervosa 2.5 10 Partially recovered 
3 31 Anorexia nervosa (initially)/Bulimia nervosa (later) 14 23 Recovered 
4 22 Anorexia nervosa (initially)/Bulimia nervosa (later) 3 11 Partial recovery 
5 18 Anorexia nervosa (initially)/Bulimia nervosa (later) 4 8 Partial recovery 
6 34 Eating disorder not specified 6 7 Partial recovery 
7 26 NA 1.5 20 Recovered 
8 27 Bulimia nervosa 7 13 Partial recovery 
9 62 Bulimia nervosa (initially)/Binge-eating disorder (later) 42 49 Recovered 
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Recognizing the signs, definitely ... Also, to help that 
person make the link. I think for a long time I was like 
‘Great, I’ve got the pressure of diabetes and now I’ve got 
an eating disorder that has come from nowhere. 
(Participant 8) 
 
Recovery coping mechanisms and strategies 
All participants spoke of behavioural techniques and coping 
strategies used during recovery. These included the acquisi- 
tion of psycho-educational materials, participation in normal 
lifestyle activities and the importance of accessing help and 
support. The triggers that led to increased motivation to adopt 
a more adaptive approach were less clear. Neverthe- less, it 
was useful to hear goal-oriented actions and talk of staged 
recovery, the achievement of which often resulted in higher 
self-esteem and confidence. 
.. . every injection you make they are all small victories 
and keeping reminding yourself that, reminding yourself of 
the good things that have happened in your recovery. 
(Participant 4) 
Similarly, reports of cognitive re-framing and changing 
perceptions suggested a growing understanding of self. One 
participant spoke about unhelpful contributory factors such 
as perfectionism and obsessive thoughts, whilst another 
spoke about the need to ‘re-programme the brain to a 
different pattern’. One woman reported a changing 
perspective after retinal screening and the realization of how 
close she had come to losing her vision. Several other 
women spoke of an acceptance and realization of the 
severity of illness that then prompted changing perceptions 
to a healthier mindset and increased self-belief. Participants, 
in general, attributed vari- ous reasons to changing healthier 
perceptions from ‘eureka moments’ to a realization of what 
they were doing to their bodies as well a growing sense of 
self compassion. 
.. . being able to be a bit kinder to myself, which I had never 
done before. Definitely when I stopped the cruci- fying, 
that’s when things started to get a little better. So, strength-
wise, I learned to be kinder to myself, and I never ever done 
that before. 
(Participant 3) 
Awareness of the benefits and desire for a healthier lifestyle 
also appeared conducive to making positive changes, such 
as the desire for a greater sense of well-being, renewed 
social life, re-engaging in normal life, as well as signs of 
‘bigger picture’ thinking in terms of career plans, health, 
marriage and children. There was a sense of regret at lost 
opportunity and several references made to the emptiness of 
living with Type 1 diabetes and an eating disorder, in 
contrast to the richness of a fuller and healthier life. The 
recovery process was not linear in nature; responses 
indicated that there were steps forwards and backwards and 
ongoing challenges to address. 
When I’m binging, that’s the problem, .. . that’s when it gets 
out of control, and my weight does start going up and up. 
And that’s when I get scared, and then I do whatever I can 
to try and stop that. 
(Participant 7) 
 
Thoughts and suggestions for appropriate medical care 
provision 
Participants provided a unique experiential insight into issues 
surrounding aspects of service provision. Although data 
reflected positive reports and experience of clinical care, there 
appeared to be greater occurrences of negative accounts. 
These mainly focused on a lack of understanding about the 
links between the two conditions. There were also several 
reflections on the potentially detrimental effects of unhelpful 
guidance, inadequate care or even neglect. 
Then there were incidents with things like them forgetting 
to give me my insulin, forgetting to do blood tests . . . I was 
in there to be treated for my eating disorder and part of that 
is struggling with taking it so for me to have to remind them 
that I needed to do it or that they needed to test my blood, 
was just ridiculous. 
(Participant 1) 
Most interviewees expressed the need for the medical 
profession to have a greater knowledge and understanding  
of the illnesses in the context of a multidisciplinary, 
collaborative approach. Responses highlighted the impor- 
tance of greater awareness and understanding, appropriate 
training and adequate knowledge of both illnesses, along 
with early recognition in terms of referrals. 
I think you really have got to have the multidisciplinary 
approach, you have to have different places on  board. You 
have to be willing to liaise with the diabetes team, and you 
really have to work together to pull all your knowledge 
together. 
(Participant 5) 
Participants offered suggestions of how future service plans 
should be developed and implemented. It was important for 
them to be regarded as a valued member, to have emotional 
support and be listened to without judgment, for there to be 
mutual trust and for professionals to recognize their unique- 
ness and individuality in terms of differing needs. It was also 
important for them to be able to trust that their care team 
possessed the appropriate education, training and under- 
standing to treat them and that their families were also given 
adequate support. 
I think it is really important to surround yourself with 
people who you can trust, and I think that particularly 
when you are diabetic and you have an eating disorder, 
you just expect that people won’t get it, so you’ve already 
got this attitude of they’re not going to understand me, so 
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when you do have the right health professionals it just 
makes everything so much easier. 
(Participant 3) 
 
Importance of and need for social support 
Support and trust from family, friends, university counsellors 
and work colleagues and mostly from parents and partners, 
was particularly valued. One woman spoke about the 
detrimental effects of problematic interactions with her mum. 
Participants also referred to the need for family education and 
interventions. In some cases, there was concern that their 
family was not equipped to address the issues in hand. 
I think advice for loved ones is crucial to that person’s 
recovery because I think loved ones panic and they feel 
anxious and they go ‘Oh my God, my darling’s starving 
themselves’ .. . and they act in a way they might think is 
supportive but it might not be, it might hinder .. . 
(Participant 8) 
Peer support was also greatly valued. The women regularly 
referred to the benefits derived from talking  to  other  
people experiencing similar problems, particularly those 
people already recovered. Online forums and both face- to-
face and online support groups were valued,  in  particular. 
I could go on there 24 hours and there would be  somebody 
else up who would also be in DKA (online forum) or 
freaking out or you know, wondering why they developed 
thrush again, or something like that. So yeah that was really, 
really massively important. 
(Participant 3) 
 
 
Healthcare professionals 
 
The characteristics of the HCPs are described in Table 2. The 
final codebook for thematic analysis is presented in Table 3. 
 
Reflections on role requirements from a professional 
perspective 
The clinicians in the study provided in-depth knowledge and 
understanding of their professional role. Responses suggested 
a strong awareness of role differentiation, as well as specialist 
knowledge in their individual fields; i.e. recognizing the need 
to refer to various specialists. HCPs also provided personal 
opinions on specific aspects of care and how these should be 
addressed. 
.. . by comparison to the rest of the eating disordered 
population, I guess it’s just like dealing with another 
comorbidity, whether we would with depression, in this 
case it is a physical comorbidity, which is diabetes. HCP 7 
(Eating disorders) 
There was considerable empathy from the HCPs. They 
recognized the difficulties and conflict between fear of 
gaining weight, necessary focus on food intake and conse- 
quent temptation to omit insulin. There was a keen sense of 
awareness and beliefs about their own role in how best to 
support this group. 
It takes a great deal of understanding. As much as they are 
experts, we do have to keep reinforcing that we can 
stabilize the diabetes with them and stabilize their eating 
pattern, their weight does not have to be erratic; it does 
not have to constantly go up, but we do have to get them 
to a relatively healthy weight range .. . HCP 5 
(Eating disorders) 
In general, HCPs showed great awareness of the interactions 
and relationships between the two conditions and knowledge 
required to provide gold standard care. 
It’d be helpful to be educated in both spheres so that the 
diabetic consultant has some idea of the impact on 
triggering eating disorder or maintaining eating disorder 
.. . and likewise, the eating disorder therapist should 
understand the clinical implications of diabetes. HCP 7 
(Eating disorders) 
 
Challenges of working with dual diagnoses 
By far, the greatest challenge was working with problematic 
thoughts and behaviours; i.e. insulin omission, difficulties in 
engaging, high anxiety, unrealistic recovery goals, diagnostic 
ambiguities, transient nature of barriers put up and threats of 
self-harm and suicide. Other concerns included responsibility 
of clinical risk and the anxiety inducing effects on their own 
team members. 
Prepare yourself for the challenge because it’s not easy! 
Because your patient is resistant to both: resistant to having 
diabetes and resistant to having an eating disorder 
.. . so it’s a double whammy. HCP 7 
 
(Eating disorders) 
Limitations and constraints were also a concern. For some 
HCPs, there was concern about proximity to adequate 
service provision for their clients, whilst others spoke about 
the difficulties time constraints imposed with regard to 
juggling different aspects of the job. One HCP referred to the 
bureaucracy involved in working within the National Health 
Service (NHS) framework. There were also confidence issues 
arising from perceived gaps in training and knowledge. 
I definitely need some assistance most of the time. If I feel 
like that, then I guess some novice is going to feel even 
worse. HCP 3 
(Diabetes) 
Finally, just under half of the HCPs made reference to clients 
consciously (or otherwise) causing disagreements within the 
team. Splitting occurred when clients played specialists 
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Table 2 Characteristics of healthcare professionals 
 
 
 
against each other by using lies or deceit to achieve individual 
desires and goals. This also included disagreements between 
team members and/or their approach to care. 
Because often the patients know a lot about diabetes, so 
they can blind the psychiatrist or eating disorders person 
with the diabetes .. . . They will cheat the nurse. HCP 3 
(Diabetes) 
 
I do get quite frustrated when a professional says, “from 
now on, instead of taking no insulin, you’re going to take 
20 units, three times a day”. In what world is that ever 
going to happen?! I think it’s a discussion with the  patient. 
HCP 6 
(Diabetes) 
 
Insights into current and future service provision 
All HCPs offered in-depth insight into aspects of care, both 
current and future, with suggestions for service development. 
 
Clinicians offered examples of strategies and approaches that 
worked well, including specific aids, information, education, 
behavioural and emotional strategies. Other tools included 
didactic information and encouraging bigger picture thinking, 
coaching, goal setting, use of motivational interviewing and 
written work as well as aids to help with diabetes, for example, 
glucose sensors. 
 
 
It is a bit like with anything really, in terms of therapy, 
CBT [cognitive behavioural therapy] particularly. It’s 
about getting them to work gradually towards a goal. 
Obviously, the fear is about putting on weight. .. .. It’s 
about making small steps to try and increase the level  of 
insulin rather than taking no insulin at all. HCP 4 
(Diabetes) 
All participants emphasized the importance of team collab- 
oration, support and being part of a multidisciplinary team. 
This gave them the opportunity to bridge any gaps in 
DAFNE, Dose Adjustment for Normal Eating; HCP, healthcare professional; KCL, King’s College London; NA, not available. 
Diabetes specialist Dietician, Clinical lead 
dietician 
12 years 
NA NA Consultant Clinical 
Psychologist 
(eating disorders 
outpatients) 
Dietician DAFNE patient education 
programme 
Diabetes 8 
Eating 
disorders 
7 
Registered Diabetes 6 years Transition 
Dietician DAFNE Educator and Peer reviewer 
Undertaken courses in 
motivational interviewing 
and cognitive behavioural 
therapy strategies 
NA 
Diabetes 6 
Fear of hypo/hyperglycaemia; eating disorders 
(e.g. insulin manipulation for weight loss/ 
management), adherence difficulties 
Interests: abnormal psychology, clinical 
psychology, neuropsychology. 
Specialist physical health care nurse/Charge 
nurse 
14 years Nurse (eating 
disorders 
outpatients) 
3 years Clinical psychologist 
20 years Specialist diabetes 
nurse 
Motivational interviewing 
training 
DAFNE 
Cognitive behavioural 
therapy, motivational 
interviewing, eye 
movement desensitization 
and reprocessing 
-Motivational inter- 
viewing training, - 
-DAFNE (observation) 
-Diabetes training 
-Carers skill workshops 
-Supported eating train- 
ing on unit 
Eating 
disorders 
5 
Diabetes 4 
Couple counsellor Counsellor and 
Hypnotherapist in private practice. 
Community treatments 
Eating disorders; deliberate self-harm; suicide 
prevention; personality disorders; aetiological 
factors; brief psychological treatments; new 
technologies in treatment; health services 
research. 
Type 1 diabetes focusing on pregnancy and 
hypoglycaemia. 
Diabetes 3 
20 years Psychiatrist 
consultant and 
professor in 
psychiatry 
NA Psychologist Cognitive analytical 
therapy 
Motivational interviewing 
trainer 
Eating 
disorders 
Eating 
disorders 
1 
 
2 
Length of 
experience Specialist area Occupation HCP ID    Speciality Training in other field 
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Table 3 Final codebook used for thematic analysis support . . . When I sit down with a psychiatrist, I see them 
tackling things much more head on or much more directly 
than I would, and moving patients more than I can in these 
situations. HCP 3 
(Diabetes) 
All HCPs made some reference to the influence of family and 
importance of family inclusion. The usefulness of psycho- 
educational skills programmes and the development of 
family skills interventions was frequently raised. There was 
also mention of potential complications in family involve- 
ment because of either problematic family dynamics or 
resistance of patients to having their family involved in their 
care package. 
I think that particularly within the adolescent group 
working with family is absolutely vital. Because some- 
body growing up with diabetes, there tends to be a greater 
sense of dependency on the family. That can become a kind 
of conflict as an adolescent control that can be quite 
difficult in terms of family dynamics. You can get a lot of 
family conflict arising. A young person trying to take more 
control in terms of diabetes or rebelling about the diabetes. 
Working with family so that they can support their child 
with diabetes . . .  For example, if they get a lot of cravings 
and are really struggling with binge-drinking, if there’s 
loads of chocolate and temptation in the house, that can 
potentially undermine the efforts of the young person. It is 
a family effort. HCP 4 
(Diabetes) 
Seven clinicians provided suggestions on service development 
including more training, supervision and improved team 
collaboration. There were several references to professional 
training programmes, e.g. motivational interviewing training 
for the Diabetes team was mentioned and courses run by 
Dose Adjustment for Normal Eating (DAFNE) for those 
individuals working in Eating Disorders. 
.. . DAFNE has helped us to understand as a team that, as 
much as they can evoke these feelings of real anxiety in us, 
we can quite easily contain and manage that. HCP 5 
(Eating disorders) 
Finally, six HCPs raised the need for establishing a warm, 
trusting alliance with those individuals with Type 1 diabetes 
and an eating disorder, emphasizing the importance of 
building rapport and a strong bond/relationship. 
 
 
 
 
 
knowledge. Most HCPs emphasized the fact that they could 
not provide service provision in isolation. 
I couldn’t imagine just doing it on my own. There is no 
way I’d be able to. I don’t have the skills. You need 
Discussion 
The aim of the present paper was to carry out an exploratory 
qualitative study to examine clients’ and HCPs’ viewpoints 
about treatment and service provision. The overriding theme 
was the need to adopt a model of care based on shared 
expertise across diabetes and mental health and training, 
encouraging relevant specialist teams to become involved 
 
People with Type 1 diabetes and an eating disorder 
 
Personal accounts of living with Type 1 diabetes and an 
eating disorder 
• Descriptions of the mental and physical adverse effects 
• Links and interactions between the illnesses 
• Illness development and perceived triggers 
• Advice and empathy for others 
• Perceived benefits to illnesses 
Recovery coping mechanisms and strategies 
• Improved self-efficacy and coping strategies 
• Cognitive reframing and changing perceptions 
• Benefits and desire for a healthier lifestyle 
• Ongoing challenges and awareness of relapse triggers 
Thoughts and suggestions for appropriate medical 
care provision 
• Positive experiences and reports of care from 
clinical service providers 
• Problematic clinical care including advice and guidance 
• The need for a holistic, multi-disciplinary approach 
to treatment 
• Suggestions on how services can be improved 
Importance and need for social support 
• Positive impact of social support 
• Need for family interventions 
• Peer support 
• Problematic family dynamics and interactions 
 
Healthcare  professionals 
 
Reflections on role requirements from a 
professional perspective 
• Role perception, beliefs and understanding 
• Empathy and understanding for patient perspective 
• Required knowledge for diabetes and eating disorders 
specialists 
• Interactions between the illnesses 
Challenges of working with dual diagnoses 
• Working with challenging thoughts and behaviours 
• Financial, manpower and service proximity constraints 
• Gaps in training, knowledge and support 
• Disagreements and splitting within the team 
Insights into current and future service provision 
• Effective therapeutic strategies and approaches 
• Importance of working in a multidisciplinary team 
• Family influences, education and inclusion] 
• Suggestions for service development 
• Importance of therapeutic alliance 
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early in care planning and management. There was widely 
shared agreement between the two samples of the need for a 
multidisciplinary, collaborative approach to treatment pro- 
vision that offers expertise in diabetes, eating disorders and 
other psychological problems. There were examples of poor 
practice where this failed to occur. 
In terms of the specific psychological/behavioural treat- 
ments, it is important to note that there is often other 
psychiatric comorbidity in addition to the eating disorders in 
people with Type 1 diabetes. In a study by Allan [15], over 
three-quarters of the sample (77.5%) were formally diag- 
nosed with another psychiatric condition, highlighting the 
need for professionals to develop transdiagnostic skills to 
provide adequate care for this complex group. In the present 
study, clients described cognitive re-framing, changing per- 
ceptions and bigger picture thinking, often outlined within a 
goal-oriented process, as important tools for recovery. 
Psychological therapies specifically designed for people with 
Type 1 diabetes and eating disorders are, therefore, likely to 
be beneficial [15]. 
The majority of participants valued support from family, 
friends and peers, and many HCPs commented on the 
importance of family inclusion. These findings support 
previous work [25,26]. For example, an analysis of feedback 
from the DEPICTED study suggested that, for young people, 
carers may need training in patient-centred communication 
skills and emotional needs also need to be considered [27]. 
Some services discourage family involvement following the 
transition from adolescence into adult services. Hostility, 
criticism or over-involvement (expressed emotions) are 
common and natural responses from carers, and expressed 
emotion has been found not only to be a maintaining factor 
of eating disorders [28] but also to have negative implica- 
tions for diabetes control [29,30]. Equipping carers with 
skills, such as motivational interviewing with an emphasis on 
affirmations and avoiding conflict, may be of particular value 
for people with Type 1 diabetes [31]. 
We believe that this is the first study to examine the 
experiential perspectives of both people with diabetes and 
eating disorders and HCPs on aspects of both living with and 
working with Type 1 diabetes and eating disorders. The study 
has several limitations. Firstly, most of the HCPs interviewed 
were recruited from a large research establish- ment with a 
strong emphasis on psychological support, therefore, this 
sample of HCPs may have had access to more resources, in 
terms of training and support. Secondly, most of the people 
with Type 1 diabetes and eating disorders were members of a 
national charity and may have been more vocal in expressing 
their needs. Thirdly, there were a few leading questions in the 
topic guides and, finally, no men with Type 1 diabetes and 
eating disorders, participated in the study. 
In conclusion, patients and HCPs agree on the importance 
of an integrated approach to treatment. In terms of the HCPs’ 
needs, appropriate training opportunities, supervision and 
monitoring are vital prerequisites to adequate service 
provision. Both clients and HCPs offered useful therapeutic 
strategies that could help inform future interventions. Con- 
sequently, it is essential that future research uses a model of a 
multidisciplinary, collaborative clinical approach that could 
be tested in clinical trials, providing an evidence-based 
treatment service to people with Type 1 diabetes and eating 
disorders. 
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M. 2018). ‘Diabulima’ through the lens of social media: a qualitative review and  analysis of  online 
blogs by people with Type 1 Diabetes mellitus and Eating Disorders. Diabetic Medicine. 
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'Diabulima' through the lens of social media: a qualitative 
review and analysis of online blogs by people with Type 1 
Diabetes mellitus and Eating Disorders 
E. Staite1, N. Zaremba1, P. Macdonald2, J. Allan3, J. Treasure2, K. Ismail1 and 
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differences between this version and the Version of Record. Please cite this article as doi: 
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London, 2Department of Psychological Medicine, Institute of Psychiatry, Psychology and 
Neuroscience, King’s College London, 3Birkbeck, University of London, 4Diabetes Research 
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What's new? 
 
 People with Type 1 Diabetes who also have an Eating Disorder are difficult to treat 
because the underlying factors are not well understood. 
 Multiple factors that trigger and maintain intentional insulin restriction have been 
identified in this thematic analysis. 
 Taking small steps at a time is a key recovery strategy described by people with diabulimia. 
 
 Triggers for insulin omission behaviour, as well as the recovery strategies identified 
in the present study, may contribute to the future development of a clinical 
intervention for people with Type 1 Diabetes and an Eating Disorder. 
 
 
 
Aims To perform a qualitative review of online blogs authored by people self-identifying as 
having Type 1 Diabetes and an Eating Disorder or 'diabulimia', a term used by people with 
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Type 1 Diabetes to describe an Eating Disorder that is characterized by deliberate restriction 
of insulin to control weight. 
Methods We conducted a structured qualitative review of online blogs published between 
2012 and 2017 authored by people who report having Type 1 Diabetes and an Eating Disorder 
or diabulimia. The subsequent thematic analysis followed a six-phase process and was 
conducted by two independent researchers. 
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Results From 147 000 search results, 11 blogs (304 posts) matched criteria for further analyses. 
Three key themes and 18 subthemes emerged: 1) different aspects of bloggers' relationship 
with insulin, including motives for omitting insulin, secrecy of insulin omission and perception 
of control; 2) bloggers’ experiences of Diabetes complications, and Diabetes ketoacidosis in 
particular, as well as their worries about future complications; 3) strategies for recovery and 
triggers for relapse, which involved Diabetes self-management and setting up a support system. 
 
 
 
Conclusions Qualitative analyses of blogs authored by people with Type 1 Diabetes and an 
Eating Disorder or diabulimia have identified high levels of Diabetes distress and provided 
insight into different motives for insulin omission and strategies for recovery. Considering 
the limited evidence for effective interventions, these findings may help the development of 
complex interventions to improve biomedical and psychological outcomes in this group. 
 
 
 
 
Introduction 
 
A diagnosis of Type 1 Diabetes mellitus is a life event, and living with the condition involves 
multiple significant practical challenges. Self-managing Type 1 Diabetes entails frequent 
checking of blood glucose levels, calculating the carbohydrate content of meals, considering 
the effects of exercise, and self-injecting insulin in adjusted doses. These burdens and role 
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transitions are predisposing factors for mental disorders, such as depression and Eating 
Disorders, and for Diabetes-specific distress, such as fears of insulin-related weight gain and 
fear of acute and chronic Diabetes complications [1,2]. 
Eating Disorders are amongst the most common mental comorbidities of Type 1 Diabetes. 
 
Eating Disorder prevalence is twice as high in young people with Type 1 Diabetes compared 
with the background population [3]. These include, but are not limited to, bulimia nervosa, 
binge Eating Disorder and anorexia nervosa [4]. 
310 
 
A
c
c
e
p
te
d
 A
r
ti
c
le
 'Diabulimia' is not currently a diagnosis separate from generic Eating Disorders in standard psychiatric classifications [International Classification of Diseases, tenth revision 
(ICD-10) and Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5)]. 
Diabulimia is a term often used by people with Diabetes to refer to their condition because it 
is only possible in Type 1 Diabetes. Diabulimia is characterized by the fear that insulin causes 
weight gain and by the deliberate restriction of insulin to control weight. Insulin restriction is 
associated with a threefold greater risk of mortality in people who practise this, compared with 
people with Type 1 Diabetes who do not [5]. 
Mortality is secondary to acceleration of microvascular and macrovascular complications [6,7] 
and to acute complications such as diabetic ketoacidosis (DKA) or severe hypoglycaemia 
[8,9]. There is currently no effective intervention that improves Diabetes control and mental 
health in people with Type 1 Diabetes and an Eating Disorder [10]. 
 
 
 
A greater understanding of the thoughts, beliefs and experiences associated with 
intentional insulin omission, Eating Disorder behaviour, and recovery from Eating Disorder 
in people with Type 1 Diabetes and Eating Disorder is needed to inform the development of 
effective interventions. 
 
 
 
Blogs are personal diary-type posts published online by an individual. Structured 
analyses of blogs represent a novel method of qualitative research as they give access to a 
range of ready-made narratives [11–13]. 
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 The aim of the present study was to perform a qualitative review of online blogs authored by people self-identifying as having Type 1 Diabetes and an Eating Disorder, or 
diabulimia. 
Participants and Methods 
 
Data collection 
 
We applied methods previously developed for a structured approach for qualitative reviewing 
of blogs [11–13]. Data for thematic analysis consisted of written content from personal online 
blogs, obtained through the search engine Google. Data collection began in February 2017 by 
identifying blog sites using the search terms ‘Type 1 Diabetes’ AND ‘Eating Disorder’ OR 
‘bulimia’ OR ‘anorexia’ OR ‘binge eating’ OR ‘diabulimia’ AND ‘blog’. The results were 
ranked in order from the most to least relevant, based on keyword occurrence. Each of the 
websites were independently reviewed by two researchers (E.S. and M.S.) to assess if they met 
the following inclusion criteria: content located on a publicly accessible and personal blog site 
or forum; blog published within the previous 5-year period; author self-identifying as having 
Type 1 Diabetes and an Eating Disorder (including the term diabulimia); and blog written in 
English. 
 
Blogs were excluded if the author mentioned other existing chronic conditions 
unrelated to their Diabetes or Eating Disorder (e.g. cancer, neurological disease). We excluded 
blogs authored by third parties (medical professionals, care givers, journalists) and blogs 
published on sites maintained by service providers. Links to related blogs that were found 
within blogs were also included if they met the criteria (n=2). 
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 All posts within each blog were fed into the primary analysis. Both analysts read these posts in full and identified those that were related to personal experience of either Diabetes or 
Eating Disorder or diabulimia. These were included in the next step for the coding process of 
the thematic analysis. In contrast to a semi-structured interview study or a focus group study 
with a clearly defined interview or topic guide, blogs also included posts referring to some 
everyday life topics that were not related to our research question and posts citing or linking 
to other sources (newspaper and research 
rticles) rather than personal experience. We excluded posts that were not related to the 
research topic. For each blog a maximum of 15 posts (the most recent) were included in 
the analyses. 
Informed consent was not required as this research focuses on the blog rather than the 
blogger and only public blogs were used [14,15]. All data were password protected and blog 
authors were given a non-identifiable ID. 
Data analysis 
 
A thematic analysis approach was adopted, which is a qualitative method for identifying, 
analysing and reporting patterns within a dataset. We applied Braun and Clarke’s six-phase 
framework of analysis [16]. Firstly, the study authors familiarized themselves with the data 
and read all blog posts in full (primary analysis). Blog posts related to the research topic were 
then input into Nvivo software for data management, where initial codes were created by two 
researchers independently and then jointly. Both worked on the coding at each stage of the 
analysis. The blog transcripts were read several times and initial codes were generated before 
being collated into potential themes. A blog extract could be un-coded, coded once or coded 
multiple times. Researchers worked independently in the identification of themes, and several 
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 face-to-face meetings took place to discuss emerging themes. Both analysts agreed that data saturation had been reached (i.e. no new codes could be created). 
Themes and subthemes were agreed through a collaborative process between the two authors 
(one diabetologist, one psychologist) conducting the analysis, and discussed within the larger 
multidisciplinary group of co-authors (psychiatrists, psychologists, people living with 
Diabetes). This multidisciplinary approach was taken to allow a broad approach to the 
qualitative analysis because of the different professional backgrounds and experiences. 
Themes were reviewed and refined, subthemes consolidated or merged into existing themes, 
and descriptive labels altered to best reflect the subject matter or deleted if deemed irrelevant. 
Lastly, theme names were defined, which ensured blog content was fully captured, and a 
report produced. 
Results 
 
Systematic search 
 
Figure 1 is a flowchart illustrating how the blogs were systematically reviewed. The search 
terms produced 147 000 results. The first 100 results produced 11 relevant blogs (304 posts). 
We had demographic information for seven bloggers, whose age ranged between 25 and 34 
years. All bloggers identified as female. Bloggers came from the UK (n=4), the USA (n=4), 
or did not provide information on their location (n=3). The number of posts per blog varied 
between three and 124. Of the 11 bloggers, 10 referred to their condition as 'diabulimia'. 
Bloggers also mentioned 'anorexia', 'Eating Disorder' and 'Type 1 Diabetes with an Eating 
Disorder'. One blogger talks about professionals referring to her as a 'SEED (severe and 
enduring Eating Disorder) patient'. 
314 
 
A
c
c
e
p
te
d
 A
r
ti
c
le
   
Thematic analysis 
Three main themes emerged: bloggers’ relationship with insulin; bloggers’ experience of 
Diabetes complications; and strategies for recovery and triggers for relapse. The themes 
and subthemes are presented in Fig. 2. 
 
Relationship with insulin 
 
The majority of bloggers reflected on their use (and omission) of insulin in an emotionally 
charged and multi-layered way, as if they were reflecting on a relationship that was difficult 
and complex. This theme was therefore labelled ‘relationship with insulin’. This theme was 
rich and multifaceted because there was a broad spectrum of perceptions, thinking patterns, 
emotions and behaviours related to insulin administration and insulin omission, respectively. 
For example, a wide variety of factors that trigger and maintain the deliberate manipulation 
of insulin, which is the key behaviour driving diabulimia, was described. 
Bloggers’ perceptions of the influence of insulin on body weight was a subtheme that occurred 
frequently in the blogs. They reported that giving the correct dose of insulin immediately led 
to sudden weight gain. Bloggers expressed their worry and fear of gaining weight as a 
consequence of injecting insulin. Some described that they began to associate insulin with fat. 
They also described the struggle they had when reintroducing insulin, because it was associated 
with weight gain. 
The weight gain was psychologically crippling. (ID 113) 
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 My weight ballooned and I gained about two stone - the teasing at school began and thus I began to associate insulin with fat. (ID 111) 
Experimenting with insulin was driven by a broad spectrum of triggers that ranged from fear 
of gaining weight to a perception of control and intentional manipulation. One blogger 
compared manipulating insulin with a game. Several bloggers appeared to have gone through 
a process of conscious decision-making, almost a quasi-experimental approach to their own 
body, when they first started intentionally omitting insulin. 
At sixteen years old, feeling the pressures of being around other girls in sixth form, I first made 
the conscious decision to cut out my insulin in order to lose weight. (ID 111) 
 
This was when the ‘experiment’ started. I decided to experiment with my insulin; taking less 
ad less, until I was taking none at all. (ID 113) 
Some bloggers attributed gambling features to their pattern of omitting insulin. Others 
described how features of addiction (in their own words) became associated with insulin 
omission. 
 
For years I played the game of omission, only intermittently having spurts of inspiration to 
become ‘a better diabetic’. (ID 121) 
 
[…] alike to a stupor I could only imagine would compare to what heroin addicts find so 
addictive. (ID 113) 
 
The secrecy of insulin omission for weight loss, as well as a perception of control over body 
weight by omitting insulin, were described and associated with a sense of empowerment. 
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With the secret eating and insulin omission, I began to lose weight. (ID 111) 
I felt as if it was my secret tool that nobody knew about and nobody else could do. (ID 111) 
The chronicity and cyclical nature of insulin omission behaviour was a theme that emerged 
from four blogs. The initial experimental approach gradually converted to chronic intentional 
omission or restriction behaviour, with the intention to manipulate body weight. Other 
common cognitions included the ambivalence of fearing weight gain but at the same time also 
wanting good Diabetes control. These cognitions became discordant when the blogger had a 
binge as a response to negative thoughts and feelings, but also wanted to be a 'good diabetic' 
by giving the correct amount of insulin that matched carbohydrate intake of the binge, in order 
to not worsen Diabetes control. 
 
I would omit my insulin to get the extra few pounds off and then would stop. Anybody with 
Diabetes and an Eating Disorder will know that this is never the case. Once becomes twice, 
twice becomes three times and so the cycle continues. (ID 111) 
I thought if I couldn’t stop the binging, I could at least stop the weight gain. So anytime I 
binged, I wouldn’t take insulin. (ID 119a) 
Experience of Diabetes complications 
 
Almost all blogs described the experience of acute and/or chronic Diabetes complications. The 
language used by the bloggers was full of medical terms to describe their acute complications 
leading to hospital admission, the chronic complications they experienced and how they coped 
with these in their daily lives. In spite of the medical terminology they used, this was a theme 
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 where the bloggers linked strong emotions to their experience, and described how they coped and their thoughts about their future health. 
The most described Diabetes complication in the blogs was DKA. It was common for most 
bloggers to describe hospital care for the treatment of DKA. Some blogs read like rational and 
distanced descriptions of the DKA experience. The bloggers also described the opposite 
experience of an excessive insulin dose leading to severe hypoglycaemia, which in turn 
triggered compensatory overeating behaviours. 
I was in such severe DKA that I needed to be in their ICU for the first 4 days. (ID 112a) 
I must have overshot with the insulin, sent myself crashing through the roof and the floor. (ID 
115) 
 
Although DKA and severe hypoglycaemia are medically classified as acute Diabetes 
complications, there were descriptions of frequent and repetitive episodes of acute Diabetes 
complications in the context of diabulimia, which represented a chronic illness type burden to 
the participants. Some reported how they continued their daily life whilst experiencing clinical 
symptoms of acute Diabetes complications, suggesting they had gloomily accepted DKA and 
severe hypoglycaemia as part of their life and had adjusted to it. 
[…] Was walking to and from work every day in severe ketoacidosis but I kept at it. (ID 111) 
 
Concentrating at school was extremely difficult. My eyes would blur due to the raised blood sugar 
levels, making simply reading the set work a challenge. (ID 113) 
Diabetes long-term complications impacting on the bloggers’ everyday life was a recurrent 
theme of most blogs; the reports vary depending on the complications experienced by the 
individual. For example, some bloggers described the symptoms of severe neuropathy 
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 causing pain and loss of autonomic function. The impact of Diabetes late complications on their quality of life was conveyed through more emotive comments, some of which were 
gloomy and cynical in nature. 
I have been told I need a permanent catheter […] I will have to live the rest of my life with a 
piss bag strapped to my leg. (ID 110) 
Thanks to the decade of damage I did to my body, I am now also the proud recipient of 
peripheral neuropathy, vasovagal syncope, and gastroparesis – which caused three ulcers and 
cyclical vomiting syndrome. (ID 112a) 
Fears of future Diabetes complications were drastically and explicitly described by the 
bloggers, including their own and future family’s wellbeing. They described the threat their 
condition posed to their physical integrity and their life. 
Diabetes always complicates things. It’s even possible the pregnancy could go horribly wrong. 
I could die; the baby could die; the baby could have serious developmental issues. (ID 119b) 
I know that I wanted a family one day, with my limbs, eyes, heart, kidneys, and myself intact. 
 
(ID 117a) 
Some bloggers described their fear of future complications from a personal and insightful 
perspective, acknowledging the self-harming component of insulin omission behaviour, 
ranging from not caring for one’s health to the extreme of referring to insulin restriction as 
'slow suicide'. 
I put my body in harm out of pure desperation to lose weight. I soon realized how damaging 
and harmful this was. I was doing no justice to myself. (ID 117b) 
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I know in my heart that the worst consequence from this slow suicide was the deceit. (ID 113) 
 
Strategies for recovery and triggers for relapse 
 
All blogs discussed recovery, and across all blogs this theme was characterized by a strong 
willingness to share one’s individual experience of recovery in order to help others. These 
included describing rational strategies for recovery that involved emotional and Diabetes self-
management strategies. Some blogs discussed new relationships appearing to be instrumental 
in recovery. Feelings of empowerment, optimism and hopefulness were often mentioned in 
the context of the recovery process. 
 
’m empowered that I can control this disease and not let it control me. (ID 117b) 
 
I am happy to say that over the past few years, I have taken my chance at recovery, and I have 
run with it. (ID 121) 
Many of the recovery strategies described by bloggers were focused on experimenting with 
structured dietary approaches and prioritizing healthy lifestyle over weight loss. Some tried to 
develop strategies to help manage weight and to be able to reduce insulin doses for meals. 
Others were instead focused on a relaxed attitude towards body weight and prioritizing being 
healthy over being thin. 
These carbs provide me with the nutrients that I need. They also help sustain my blood sugar 
throughout the day. (ID 117b) 
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There’s no undereating. There’s no starving myself or throwing up after a binge. This has 
nothing to do with my body image. It has to do with my health and how I feel about myself. (ID 
119c) 
Improving Diabetes management and recovering by taking small steps at a time and being patient was 
described as a key strategy. Even seemingly small changes made a difference on the route to recovery. 
I’m just concentrating on keeping my blood sugar levels stable, eating right, and staying active. 
The results will come with time. (ID 117b) 
You don’t need to make the decision to change the rest of your life right now. Recovery is all 
about micro-decisions - an infinite list of small choices you make every day. ID 112b 
Resources and triggers for recovery included new relationships and new roles in life (e.g. 
a new romantic relationship or motherhood), but also the experience of life-threatening 
complications. Surviving a severe DKA episode was described as a wake-up call for 
recovery by one blogger. 
I’d like to take a moment to thank my boyfriend. I thank you dearly, for looking after me when I 
could not look after myself [...] (ID 113) 
Becoming a mother was what helped me see my life in a different perspective. That there is a 
reson that I’m here. (ID 117a) 
 
[...]I had to share a room with 3 other women once I was released into a regular ward. They all 
died, and I realized that by some miracle I had been given a second chance. (ID 112a) 
Bloggers highlighted the importance of surrounding themselves with a support system in 
recovery, which included healthcare professionals as well as friends and family. 
 
The first and most important step is to set up a treatment team. (ID 112b) 
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A good tactic to evade this trap of secrecy is to choose at least one friend or family member 
that you trust - someone that you make a pact with - no lies. (ID 112b) 
Bloggers’ intentions to help others have been an important part of recovery. Previous peer 
support motivated some bloggers to continue helping others in order to reciprocate the help 
they received. 
 
They are women who, not only help encourage me to live my best life in harmony with my 
Diabetes, but also provide me with valuable wisdom, guidance, and most importantly, a 
supportive shoulder to lean on when needed. (ID 121) 
To help others, to educate, to inspire, to empower, and show compassion. (ID 117a) 
Triggers for relapse, such as peer pressure for thinness and stressful life events wre commonly described. 
 
Even friends who don’t mean to trigger are suddenly opting for skinny lattes. Comments 
overheard all around ‘oh I have to get back on the treadmill!’. (ID 114b) 
When I moved to a new city a year after my diagnosis, the troubling signs returned. (ID 119a) 
Discussion 
This structured qualitative review of internet blogs written by people with Type 1 Diabetes 
and an Eating Disorder, or diabulima, used thematic analysis of blog content to obtain 
insight into the experiences, thoughts and feelings of this group of people. 
Although wider search terms describing various subsets of Eating Disorders were used, 
the majority of blog authors used the term 'diabulimia' to refer to their condition, which 
confirms the term has face validity in the patient community [17]. The 11 diabulimia blogs 
were all authored by women in their 20s and 30s, which parallels the observations of female 
gender bias in Eating Disorders [18]. 
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Research suggests boys/men are less likely to come forward because they face greater stigma 
and as a result of traditional male gender roles [19]. Typically, the age of onset of an Eating 
Disorder is mid to late adolescence, either soon after the onset of Type 1 Diabetes or onset of 
puberty [5,20,21]. One could speculate that these adult bloggers are further along in their 
recovery and therefore able to talk (blog) about their strategies, resources and triggers. 
The subsequent thematic analysis identified three main themes: bloggers’ relationship 
with insulin; experience of medical complications; and strategies for recovery and triggers for 
relapse. Interestingly, the 'relationship with insulin' theme gave deep insight into a multifaceted 
problem with a wide variety of factors that triggered and maintained the deliberate 
manipulation of insulin, which is the key behaviour driving diabulimia. 
The pattern of fear of weight gain leading to insulin omission, as well as insulin 
overdose after binge-eating episodes are patterns which have been previously described [22], 
but the deeper- seated motives behind the insulin manipulation that bloggers described, such 
as the 'thrill', 'addictive', 'experimental' or 'secretive' aspects of insulin omission were novel 
observations. Preliminary evidence has found highly processed foods share pharmacokinetic 
properties with addictive drugs [23]. 
Additionally, animal models of bulimia suggest bingeing on food releases dopamine [24], 
similarly to human addiction processes. The acknowledgement of insulin omission as self-
harming behaviour expressed in the blogs highlights the inherent ambivalence of these 
behaviours. 
It is not surprising that the blogs discussed hospitalization after DKA, as insulin 
omission attributable to diabulimia increases DKA risk significantly [25]. Although DKA and 
severe hypoglycaemia are acute Diabetes complications, we observed that bloggers with 
diabulimia experienced repeated and cyclical patterns of these complications. Their description 
of how they adjusted to living with recurrent DKA and severe hypoglycaemia contradicts the 
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medical categorization of these as acute complications. In the context of Type 1 Diabetes with 
an Eating Disorder, recurrent Diabetes acute complications are being experienced as a chronic 
illness burden rather than as an acute event, which is a novel observation in this group. 
Interestingly, the language in which the bloggers reported their acute and late Diabetes 
complications was medicalized. This may be a result of living with Diabetes for a long time, 
which results in many interactions with healthcare rofessionals so that people with Diabetes 
adopt their use of language when talking about their condition [26]. 
Previous research suggests that people with Diabetes and an Eating Disorder may have 
unhelpful beliefs about insulin and lack coping strategies to manage recovery [21,27,28]. By 
contrast, we found that some of these bloggers were very insightful about the consequences 
of insulin omission and the self-harming nature of the Eating Disorder behaviour. Their 
accounts of the burden of having severe Diabetes late complications (including the fear of 
experiencing late complications in the future) indicate that most of the bloggers were fully 
aware of the consequences of their insulin restriction. 
This observation is confirmed by the self-reflection of some bloggers who, from a personal 
and insightful perspective, referred to their behaviour as self-harming or even 'slow suicide'. 
Some were even able to share their strategies, resources and triggers for recovery, which 
often included helping others. 
We found a mixture of healthy and unhealthy attitudes towards food in their approaches to 
recovery. Some bloggers recognized the need for carbohydrates, whereas others decided to use 
restrictive diets. The concept of approaching the recovery process in small steps was a common 
subtheme with various aspects of recovery, including insulin injections, accepting body shape 
and keeping blood glucose levels stable. Some blogs discussed peer pressure and social 
relationships, with new relationships appearing to be instrumental in recovery. 
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The present study has some limitations. Blogs are written for many reasons [29] and are not 
free from self-presentational bias, although there is also evidence that blogs can be considered 
to provide trustworthy [30] and rich data [13]. It is difficult to collect participant demographic 
data for blogs as they allow complete anonymity. Another limitation of blogs is that they do 
not capture the views of all individuals with Type 1 Diabetes and an Eating Disorder (i.e. the 
majority who do not blog). As with all qualitative studies, researchers have an influence on 
the interpretation of their findings [13]. We hoped to reduce this bias by taking a 
multidisciplinary approach. 
Qualitative analyses of blogs authored by people with Type 1 Diabetes and an Eating Disorder, 
or diabulimia, have identified high levels of Diabetes distress and provided insight into 
different motives for insulin omission and strategies for recovery. Considering the limited 
evidence for effective interventions, these findings may help the development of complex 
interventions to improve biomedical and psychological outcomes in this group of people. 
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FIGURE 1 Flowchart illustrating how blogs were systematically reviewed. 
 
FIGURE 2 Thematic map illustrating themes and subthemes. 
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Abstract 
Current academic research demonstrates that women suffering with Type 1 Diabetes are at twice the risk of 
developing a clinically significant Eating Disorder. Further study has also shown that up to 40% of women 
aged 15 – 30 with Type 1 Diabetes regularly omit insulin in order to induce hyperglycaemia and rapidly lose 
weight. This practice is popularly known as Diabulimia and the chronic omission of insulin for weight control 
will appear in the upcoming DSM-V. Eating Disorders with Type 1 Diabetes and Insulin Omission are 
extremely dangerous and the health implications for this demographic are much increased. Despite this, the 
majority of the literature has focused on prevalence rather than the factors influencing its development or the 
biopsychosocial aspects of the lives of those suffering. The current study aims to use an internet-based survey 
informed by an exhaustive literature review, together with demographic information and factor analysis, to 
explore which aspects the sufferers themselves feel are the most important in the development of their Eating 
Disorder and to explore their biopsychosocial environment.   
Introduction 
What is Type 1 Diabetes?  
Type 1 Diabetes occurs when the immune system mistakenly attacks the islet of Langerhans cells in the 
pancreas. These cells are endocrine, responsible for producing the hormone insulin which regulates the amount 
of glucose in the blood. Insulin processes carbohydrates and transports the resulting glycogen to where it is 
needed for energy around the body. There is no unifying theory as to why this immune response occurs but as 
Type 1 Diabetes is increasing in prevalence in the Western world (Gale2002) current popular theories include: 
overactive virus response, genetic mutation, and environmental factors (Peng & Hagopian 2006). Following 
the destruction of these cells the body is incapable of producing insulin, meaning that it must be injected 
synthetically. There is currently no cure for Type 1 Diabetes which is a lifelong chronic condition that needs 
micromanagement to ensure good health. In order to mimic the body’s natural processes there are two main 
ways of controlling Diabetes.   The first is to use long and short acting insulin. The long acting insulin is 
typically injected once a day to synthesise a natural baseline level of insulin in the blood; these insulins tend 
to have a lifespan of 18 – 24 hours. The short acting form is injected when eating, to synthesise the body’s 
natural reaction to incoming energy, and these are generally active for 3 – 5 hours. The second way of 
controlling Type 1 Diabetes is to use an insulin pump, which is a small machine attached to the body that drips 
in a constant stream of rapid acting insulin, using what is called a basal/ bolus regime. The basal units replicate 
background insulin at a rate per hour and the bolus units are used in response to food.  
In the UK it is estimated that approximately 300,000 people have Type 1 Diabetes (Diabetes UK 2012). Type 
1 Diabetes develops rapidly, normally over a period of weeks, and onset commonly occurs in adolescence 
with the peak age of diagnosis between 10 -14 (Diabetes UK 2012) It is a highly individual illness and patients 
339 
 
must ascertain how much background insulin they need each day and how much insulin they need to cover 
the carbohydrate content of their food. The actual amount is dependent on many factors such as: duration of 
Diabetes, sex, weight, glycaemic load of food, activity level, menstrual cycle and age. External factors like 
stress, temperature and season can also affect the blood sugar. It can be extremely challenging to control blood 
sugar, but it is of vital importance that it is kept between 4 – 8 millimoles (mmol/L) per litre. There are serious 
consequences of blood sugar being out of range. If an error occurs and there is too much insulin in the blood, 
then the Type 1 diabetic17 will experience an episode of hypoglycaemia, whereby the lack of energy leads to 
extreme disorientation, a burst of adrenaline, fight or flight responses, spasms, fits and, if left untreated, coma 
and death. If there is too little insulin in the blood, then blood sugar rises causing hyperglycaemia, and in the 
short term this causes extreme fatigue, thirst, breathing difficulties and glycosuria. If the hyperglycaemia is 
not treated, Diabetic Ketoacidosis (DKA) will develop. DKA is a state whereby in the absence of insulin the 
body is not getting enough energy from food and as a result resorts to burning protein for energy from fat, 
muscle and organ tissue and excreting it through the urine. This process induces massive weight loss and 
creates by-products known as Ketones. Ketones are highly acidic and extremely toxic to the body. There is no 
treatment other than insulin for DKA and if left untreated it is always fatal. Many complications develop from 
prolonged hyperglycaemia including Neuropathy (damage to the nerves particularly in the extremities, 
commonly resulting in amputations), Gastroparesis (damage to the nerves in the stomach), Retinopathy 
(damage to the eyes, with Diabetes currently being the leading cause of blindness)18 and Nephropathy (damage 
to the kidneys).  
Despite the threat of these complications, it has been shown that many Type 1 Diabetics, particularly females 
between the age of 15 – 30, regularly omit or manipulate their insulin to induce hyperglycaemia and DKA in 
order to control their weight. As mentioned, this practice is commonly known as Diabulimia. Type 1 males 
have also been shown to have a higher drive for thinness that their non- diabetic peers (Svensson, Engström 
& Aman 1992). Estimates on prevalence of insulin omission and manipulation vary widely (Rodin 1991, 2000, 
2004/ Peveler & Fairburn 1991/ Striegel-Moore 1992/ Polonsky1994) but are as high as 40% among women 
between the ages of 15 – 30. Further research has shown that having Type 1 Diabetes increases two fold the 
                                                 
 
17 There is much debate on the appropriate term to describe someone who has been diagnosed with Type 1 Diabetes.  
Charities such as JDRF and Diabetes UK advocate using the term Person with Type 1 Diabetes to avoid stigma. As the 
current study focuses on Eating Disorders within Type 1 Diabetes the charity ‘Diabetics with Eating Disorders’ was 
approached to ascertain the correct label for their members. They have stated that over 400 Members voted to call 
themselves Diabetics; as such the current study will use that convention.  
18 The Diabetes Control and Complications Trial Research Group. (1993). "The effect of intensive treatment of Diabetes 
on the development and progression of long-term complications in insulin-dependent Diabetes mellitus". N Engl J Med. 
329 (14): 977–86 
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chances of developing a clinically diagnosable Eating Disorder such as anorexia nervosa, bulimia nervosa or 
EDNOS (Eating Disorder not Otherwise Specified) (Jones, Lawson, Daneman , Olmsted & Rodin 2000)  
Type 1 Diabetes and Anorexia Nervosa 
Anorexia Nervosa is characterised by a pathological need to be excessively thin, obsessiveness around the 
consumption of calories and caloric expenditure, avoidance of certain food groups, moral judgements on food, 
fear of eating, body dysmorphia and often compulsive exercise. There are certain behaviours that are indicative 
of Anorexia such as keeping a diary of food and exercise and being extremely rigid around diet and exercise. 
As a Type 1 diabetic you are taught that all food must be monitored, all exercise must be monitored, routine 
is emphasised, many hospitals actively encourage the keeping of a food diary, and carbohydrate counting is 
routinely taught as part of treatment.  In Type 1 Diabetes then, Anorexic behaviours may be inadvertently 
encouraged (Rodin et al 2002; Meltzer, Johnson, Prine, Banks, Desrosiers & Silverstein 2001; Smith, 
Latchford, Hall, & Dickson 2008, Diabetes Australia 2008) which may account for the increased risk. There 
are Diabetes-specific aspects that may also be important. In order to avoid hypoglycaemic attacks, some Type 
1 Diabetics cut down on their food intake to avoid having to inject (Ishmail & Treasure 2010; Rodin et al 
2009; Goebel-Fabbri, Fikkan, Franko, Pearson, Anderson & Weinger 2008). Often numbers are accompanied 
with a moral judgement, i.e. good blood sugar number which can in turn lead to moral judgements on food 
which would be more indicative of an Eating Disorder (Goebel-Fabbri, Uplinger, Gerken & Mangham 2009; 
Tierney, Deaton, & Whitehead 2009, Diabetes Australia). Weight management also plays an important part 
and it is standard practice to weigh patients and discuss this in clinic. Type 1 Diabetes by its very nature, then, 
ensures that the patient is focused on weight, consumption and numbers and, as it is typically occurring in 
adolescence, from a young age. This may indeed explain the increased risk for Anorexia. 
Type 1 Diabetes and Bulimia Nervosa 
This moralising of food, creating ‘forbidden’ items and the constant need for control may also explain the 
increased incidence of bulimia among Type 1 Diabetics. Bulimia Nervosa is characterised by eating excessive 
amounts of food (bingeing) and then using inappropriate compensatory behaviours to rid the body of this 
consumption, by self-induced vomiting (purging), using laxatives and over exercising. Bulimics report a loss 
of control during a binge and a sense of release at the purge. In Type 1 Diabetes, when hypoglycaemic, the 
patient is out of control due to the lack of energy to the brain, and this lack of control combined with the bodily 
response of craving sugar to redress the balance can lead to serious binges. These binges in turn can lead to 
rocketing blood sugar which needs massive amounts of insulin to control. This can lead the patient to a vicious 
circle. Guilt at the overconsumption is also common and can foster these inappropriate compensatory 
behaviours (Criego, Crow & Goebel-Fabbri 2009; Rodin et al 2002). These are aspects that could help explain 
the increased risk for bulimia in those with Type 1 Diabetes.    
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Type 1 Diabetes and Insulin Omission  
According to the office of national statistics,  last year in England and Wales there were 8000 accident and 
emergency admissions for DKA19, and it is reasonable to assume that many of these were due to the onset of 
Type 1 Diabetes. One of the major symptoms of undiagnosed Type 1 is extreme and rapid weight loss. Thus 
at diagnosis, most Type 1 Diabetics will have experienced weight reduction. Unfortunately, this can give rise 
to praise from peers or the family and thus create a conflict within the Diabetic as they are being complimented 
for their changing shape but this is due to a life threatening health condition (Ishmail &Treasure 2010; Rodin 
et al 2002; Crow, Keel & Kendall 1998). On commencement of insulin therapy, this weight may return which 
may cause further disturbance at what is recognised to be a sensitive age, particularly for females (Rodin et al 
2002, 2009; Jack 2003). This initial weight loss means that most Type 1 Diabetics know that lack of insulin 
leads to extreme weight loss immediately from diagnosis.  
There are other aspects of Type 1 Diabetes and Diabetes care that may explain the increased risk factor for 
the development of an Eating Disorder. Denial and Resentment of Diabetes can lead to the patient not looking 
after themselves appropriately as they can fear testing and injecting. They may fall into the hyperglycaemic 
process which induces weight loss. ‘Burnout’, whereby the constant micromanagement of the condition leads 
the patient to lapse in self-care (Ishmail & Treasure 2010, Teirney et al, 2009; Rodin 2002) may also be 
contributory as this can result in the same weight loss. Although this weight reduction is at times an 
unintentional by-product and symptom of another psychological problem, it can none the less become 
problematic and an initiating factor of the onset of an Eating Disorder.  
Healthcare providers can also unwittingly encourage disturbed attitudes in regard to Diabetes. The constant 
warnings of complications such as blindness and amputation may desensitise patients to the seriousness of 
high blood sugar or they may feel that regardless of how ‘good’ they are, they are somewhat doomed to illness 
anyway (Goebel Fabbri, Teirney 2009). Also the message may be construed as something that will happen at 
some distant point in the future or to ‘someone’ else. Diabetes Clinic can be a source of frustration for many 
Type 1 Diabetics, health professionals may come across as judgemental and patronising, and this can lead to 
disengagement with them and further resentment of their condition. 
Type 1 Diabetes, Societal Pressure & Family Environment  
                                                 
 
19 National Diabetes Audit 2012  
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Type 1 Diabetes is typically diagnosed in adolescence which may cause many problems for the psychological 
development of the child. At a time where typically one is trying to become more autonomous and assert 
independence, the onset of a life-threating illness can lead to increased parental involvement and this can 
increase family conflict (Rodin 2002). The patient may disagree with parental management of the Diabetes or 
feel that just as they were gaining control over their life, this is then taken away by the illness (Rodin, Diabetes 
Australia). Adolescence is a time of increased sensitivity regarding body image and self-esteem, and the 
development of Type 1 Diabetes may make them feel different, they may be embarrassed about testing or 
injecting in front of their peers and may fear peer rejection. Recent research from the Juvenile Diabetes 
Research Foundation has shown that children with Type 1 Diabetes are more likely to be bullied than their 
non-Diabetic peers20.  It has been suggested that the readily available mechanism for weight loss is alone to 
blame for the increased risk factors as teenagers are desperate to fit in (Ishmail & Treasure 2010). 
Type 2 Diabetes has seen a massive increase in media coverage. It is typically caused by diet and lifestyle, 
with obesity and inactivity being the main risk factors, and is around 10 times more common that Type 1 
Diabetes, with 3.5 million estimated sufferers in the UK (Diabetes UK). It is typically diagnosed in adults but 
societies’ increasingly poor diet and the ‘obesity crisis’ has seen it becoming more prevalent in younger people  
(Diabetes UK). The increased media coverage and the common failure of the media to distinguish between 
the two types of Diabetes have led to increased ignorance around Type 1. Many people do not know that there 
are two Types and as such many Type 1s are misunderstood, having to field ignorant questions from people 
who believe that they ‘ate too much sugar as a child’, that they have ‘done this to themselves’ or that their 
disease is ‘the same thing that my gran died of’. This can then lead to a weight complex and the need to 
separate oneself from the stereotype of the ‘fat lazy’ Diabetic21.   
Other Eating Disorder Risk Factors: 
Outwith Type1 Diabetes and those previously noted, there are many risk factors for development of an Eating 
Disorder. Family factors seem to be important, with family dysfunction, family conflict, family rigidity, 
maternal concerns with weight and shape, maternal mental health problems, lack of autonomy within the 
family system and family history of Eating Disorders all being significant. Personality factors such as 
perfectionistic tendencies, low self-esteem and distorted body image are also important, as are external factors 
                                                 
 
20 www.jdrf.org.uk 
21 www.dwed.org.uk 
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such as academic pressure, involvement in sport, peer group conflict and being bullied (Fairburn 2001,2008; 
Schmidt 2001) 
The Current Study  
The current study aims to explore which of the preceding aspects accounts for the increased risk factor among 
those with Type 1 Diabetes for developing an Eating Disorder. While most of the literature to date has focussed 
on the prevalence of Eating Disorders or the medical implications of them, very little has been done to 
ascertain the opinions of the sufferers themselves or their environment. This study uses a questionnaire 
informed by an extensive literature review and designed to analyse which of the suggested aspects are most 
important. Current sufferers report that there are many barriers to effective treatment. Eating Disorders 
consultants tend to be woefully inadequate at dealing with Diabetes, often diagnosing anorexia in those who 
are underweight and treating them as such. There are many problems with this approach, as a Type 1 Diabetic 
food must be tightly controlled and treatment for anorexia often focusses on relaxing around food, so not only 
are patients treated for an illness that they don’t have, but treatment may be in direct contradiction to good 
Diabetes practice. There have also been cases of patients being diagnosed with bulimia as they are sick after 
eating but this vomiting is due to gastroparesis (whereby the nerves in the stomach are so damaged by high 
blood sugar that they are no longer able to push food into the intestine, resulting in food being regurgitated). 
They are therefore deemed non-compliant in Eating Disorder treatment which can in turn lead to total 
disengagement. Often treatment is focused solely on food and completely ignores any issues related to the 
psychological implications of injecting or insulin. Moreover, if these are not addressed, then treatment is likely 
to fail. Diabetes specialists often have no training in Eating Disorders and this can lead to a misunderstanding 
of the patient who is often chastised for having high blood sugar, is repeatedly weighed at appointments and 
increasingly frustrated with the lack of empathy. This in turn can lead to further disengagement. 22 The 
ignorance of health professionals can be potentially life threatening to the patient. If it transpires that ‘classic’ 
Eating Disorder factors account for the increased risk, then serious questions about the Diabetic environment 
must be asked to inform future policy. If the results of the current study show that Diabetes related factors 
account for the risk, then that also has serious implications for the treatment of those suffering with Eating 
Disorders.  Demographic information has also been collated to further understand the issues surrounding 
treatment and the biopsychosocial environment of the patient. The results of this study may then have 
important ramifications for all of those involved in treating Type 1 Diabetics who also have Eating Disorders. 
                                                 
 
22 www.dwed.org.uk/resources 
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Method  
Participants: Participants were recruited via the Registered Charity, Diabetics with Eating Disorders’, Social 
Media Pages. The Social Media Sites used were Twitter, Facebook, Tumblr, TuDiabetes, YouTube and 
Google +.  Participants were 95 females and 3 respondents who did not wish to state their gender (ages of 18 
– 65) with more than 2 years recovery as recommended by the National Eating Disorder Association (b-eat).  
23 
Procedure: Participants were asked to follow a link to the questionnaire and read and consent to the briefing. 
They were then instructed that they should have 10 – 20 minutes in a quiet environment available to 
participate.  Participation in the research involved completing an online questionnaire in two parts. Part 1 
asked questions about the participant (but not anything identifying). Part 2 asked 50 questions to be rated on 
a likert scale. They were asked to rate the importance of factors in the development of Eating Disorders in 
Type 1 Diabetics. Participants were reminded at the top of the online questionnaire that should they feel 
uncomfortable answering any of the questions they could select the ‘prefer not to say option’ or could exit the 
questionnaire completely by closing the relevant tab on their browser.  
Materials: Online questionnaire by http://www.questionpro.com/  
http://Jacqs.questionpro.com 
Questionnaire & Literature Review: The questionnaire created was informed by an extensive literature review 
collected by the researcher over 6 years using Google Scholar. The terms providing notification were [Insulin 
non compliance “Type 1 Diabetes”], [Eating Disorder intitle: “Type 1 Diabetes”] [intitle: Diabulimia] [intitle: 
ED-DMT1] [Psychological intitle “Type 1 Diabetes”].  One hundred and fifty academic papers were reviewed 
and suggested reasons for the development of Eating Disorders among Type 1 Diabetics extracted and put 
into a questionnaire. There were a total of 40 items on the questionnaire to be answered using a 5 point likert 
scale. Questions were randomised using a random number generator and, to avoid response bias, randomly 
selected questions were reverse scored i.e. 
39) My family was very rigid and this contributed to the development of my Eating Disorder 
40) A disturbed attitude to food did not contribute to the development of my Eating Disorder 
                                                 
 
23 For Advert please see Appendix 
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Design:   A Principal Component Factor Analysis was run using SPSS ver 20. 
Results  
Demographics:   
98 participants responded to the advert and completed the questionnaire.  Of these 98, 66 were from the UK, 
3 were from Australia, 13 were from the United States, 6 were from Eire, 2 were from Iceland, 4 were from 
Canada, 1 was from Italy and 1 was from Brazil.   
Of the respondents 3 did not wish to state their gender and 95 were female. Respondent age ranged from 18 – 
65 with a mean age of 28.49 (SD = 9.66). The age at which respondents were diagnosed with Type 1 Diabetes 
ranged from 0 – 45 years old with a mean age  of 11.9 (SD = 8.98), and the age at which they felt they were 
developing an Eating Disorder ranged from 7 – 45 years old with the mean age being 16.96 (SD = 7.06). The 
average time between diagnosis of Type 1 Diabetes and onset of an Eating Disorder was 4.76 years (SD = 
4.7) but ranged from 0 - 19 years. However, it may be assumed that of those people who have said 0 years 
some were already suffering from an Eating Disorder prior to the diagnosis of Type 1 Diabetes.  
Of the 98 participants 38 had another family member with Type 1 Diabetes, the most common of which was 
the brother (n = 14) followed by father (n = 13), grandparent (n= 11) cousin (n =8), sister (n = 6), aunt (n = 
4), niece (n = 3), mother (n= 2), son (n = 1). 
Ninety-four of the 98 respondents (95.9%) had omitted or manipulated insulin during their Eating Disorder. 
Four believed they had anorexia (4.1%), 27 believed they had Diabulimia (27.5%), 19 believed they had a 
combination of bulimia and Diabulimia (19.4%), 18 believed they had a combination of Anorexia and 
Diabulimia (18.4%), and 28 believed that they had a combination of all 3 conditions (28.6%). Two selected 
the prefer not to say option.  
Demographic Chart 1: Do you think you had? 
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Despite all of the respondents feeling that they did have an Eating Disorder, 38 participants had never been 
diagnosed with one (38.8%). Of those who had been diagnosed, 22 had been given a diagnosis of Bulimia 
Nervosa (22.4%), 9 had been given an diagnosis of Anorexia Nervosa (9.2%), 13 had received an Eating 
Disorder not Otherwise Specified (EDNOS) diagnosis (13.3%), 10 had been given dual Anorexia and Bulimia 
Nervosa diagnoses (10.2%), 4 had dual diagnoses of Bulimia and EDNOS (4.1%) and 2 had been given a 
triple diagnosis of Bulimia, Anorexia and EDNOS (2%) 
 
Demographic Chart 2: What were you diagnosed with? 
 
Seventy-six of the 98 respondents had approached a health professional about their Eating Disorder (77.6%), 
50 approached their GP (51%), 24 approached their Diabetic Specialist Nurse (DSN) (24.5%), 46 approached 
their Diabetic Consultant (46.9%), 29 approached a Dietician (29.6%, 13 approached an Eating Disorder 
Nurse (13.3%), 24 approached an Eating Disorder Consultant (24.5%), 29 approached a psychologist (29.6%), 
25 approached a Psychiatrist (25.5%), 17 approached a councillor (17.4%), 3 approached a social worker 
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(3.1%), 22 approached a mental health worker (22.4%), and 10 approached another health professional 
(10.2%). 
Demographic Chart 3: Whom did you approach for help? 
 
Only 22 of the 98 respondents did not have another mental health diagnosis (22.4%).  Of those who did, 27 
were diagnosed with depressions (27.5%), 2 had a Personality Disorder (2%), 2 had Bi-Polar (2%), 15 had 
depression and anxiety (15.2%), 1 had Depression and PTSD (1%), 9 had Depression and Personality disorder 
(9.3%), 2 had Depression and Addiction (2%), 7 had Obsessive compulsive disorder (7.2%), 1 had Personality 
Disorder, Depression, OCD and Bi-Polar (1%), 2 had Attention Deficit Hyperactivity Disorder (2%), 2 had 
Anxiety and Personality Disorder (2%), 3 had Depression, Anxiety and Personality Disorder (3.1%) 
Demographic Chart 4: Do you have any other Mental Illnesses? 
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44 respondents were bullied because of their weight (45.8%) and 24 were bullied because of Type 1 Diabetes 
(24.5%). 
Factor Analysis: 
Data Screening: Following data screening, several variables were removed from the analysis as they yielded 
few correlations > 0.3. (Field 2009). The following items were removed: disturbed attitude to food (item 40), 
lack of autonomy within the family unit (item 36), family dysfunction (item 35), realisation of quick weight 
loss (item 11), societal pressure (item 25), distorted body image (item 30), a sense of achievement at losing 
weight (item 18), academic pressure (item 17), conflict amongst peer group (Item 19), fear of injecting and 
testing (item 24) and adherence to timed meals (item 10). No outliers were identified and there were no missing 
cases. 
Principal Component Analysis (PCA): PCA was chosen as the method of extraction as the aim of the study 
was to provide an exploratory analysis. Although the Kaiser-Meyer-Olkin measure of sampling adequacy was 
just short of the recommended value of .5  (KMO = .451) and the diagonals of the anti-image correlation 
matrix were between .391 and .688, Bartlett’s test of sphericity was significant x2 = (378) = 1703.112 p < 
0.001 and communalities were all above .3 demonstrating common variance and justifying a Factor Analysis.   
Output: The initial analysis extracted 8 factors using Kaiser’s Criterion of Eigenvalue > 1. Using the scree 
plot it was shown that the point of inflexion occurred at the 6th component and as such a 5-factor solution was 
appropriate. 
Factor Plot 1 
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Orthogonal rotation (Varimax) was used to increase the explanatory power of the analysis. After rotation, 
Factor 1 explained the largest amount of variance (eigenvalue = 5.317, variance = 18.991) and clustered items 
relating to Diabetes specific distress. Factor 2 clustered highest on Diabetes Diet related items and explained 
11.5 % of the variance (Eigenvalue = 3.21). Factor 3 items clustered on more classic risk factors out with 
Diabetes and explained 10.95% of the variance (Eigenvalue 3.06). Factor 4 explained 10.8% of the variance 
(Eigen value 3.02) and items related to communication and self-esteem problems. Factor 5 related to issues 
with Diabetes treatment and explained 8.56% of variance (Eigen value 2.37). In total, then, the 5 Factors 
extracted explained 60.8% of the total variance in the data.  
 
 Factors      
Table 1: Rotated Component Matrix 
and Communalities 
Diabetes 
Distress 
Diabetes 
Diet 
Classic 
Risk 
Factors 
Self 
Esteem 
Diabetes 
Treatment  Communalities 
General Diabetes Stress 0.887         0.652 
Resentment of Diabetes 0.868         0.706 
Denial of Diabetes 0.734         0.643 
embarrassment of testing and or 
injecting 0.73         0.779 
Diabetes Burn out 0.676 0.463       0.438 
Fear of Hypos 0.616         0.551 
Needed to feel in control 0.58     0.437   0.537 
Over - Emphasis of complication 0.555 0.476       0.745 
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Restrained Diet   0.767       0.699 
Binging after Hypos   0.666       0.534 
Perfectionist Attitude 0.504 0.531       0.867 
Early Puberty   0.49       0.455 
ED prior to Dx     0.768     0.593 
Initial Weightloss     0.698     0.656 
Weight Gain After Dx     0.698   0.517 0.462 
Fear of weight gain     0.563     0.551 
Examples of disturbed eating in the 
family     0.532     0.719 
Pre Existing Mental Health problems     0.514     0.553 
Unhappy gaining weight regardless of 
DX       0.784   0.52 
Didn’t like the way my body looked       0.753   0.634 
Low self esteem       0.62   0.801 
Couldn't talk to parents       0.514   0.522 
Conflict at home with family       0.476   0.84 
Disagreement with parental Diabetes 
treatment   0.403   0.451   0.618 
Attention to weight from med staff         0.835 0.424 
Pressure from Health Professionals 0.427       0.759 0.491 
Maternal Concern with weight and 
shape   0.433     0.519 0.38 
Too much Dietary focus         0.405 0.652 
Extraction Method: Principal 
Component Analysis.        
 Rotation Method: Varimax with 
Kaiser Normalization.       
a. Rotation converged in 10 iterations.       
Please note loadings <0.4 excluded  
 
 
      
Discussion 
Demographic analysis implications 
Although participants were recruited from predominantly UK-based sources and as such the majority were 
UK nationals (67%), there were also a relatively large number of international respondents, demonstrating 
that this issue is one of global importance. While there is increasing awareness of this issue in the UK, a 
concentrated global effort may be required. As would possibly be expected, the vast majority of the 
participants were female, corresponding to current literature suggesting that women are more likely to develop 
Eating Disorders. (Fairburn, Treasure, Schmidt date).  There were, however, 3 respondents who selected the 
‘prefer not to say’ option which could be indicative of the stigma surrounding male Eating Disorders (Peate 
2001). Furthermore, the participants were recruited from predominantly female-occupied support groups, 
which could also explain the lack of male respondents. 
There was a wide range of ages both for onset of Type 1 Diabetes and onset of an Eating Disorder, with 
respondents showing deviation from the popular misunderstanding that Eating Disorders only affect teenagers, 
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the youngest being just 7 at the time of onset and the oldest being 45. However, the mean age of Eating 
Disorder onset was 16.96 years corresponding with research into Eating Disorders among the general 
population and demonstrating that this is a critical period of which clinicians should be aware. Noteworthy is 
that it is during this time that Diabetic teenagers under NHS care undergo ‘transition’ whereby they are 
discharged from paediatric care and assigned a new adult clinic. Given the outcome of this study, this transition 
period may be an ideal time to screen for Eating Disturbances. Professor Jane Morris from the Eden Unit in 
Aberdeen has undertaken to produce a questionnaire for Type 1 Diabetics who may be at risk of developing 
an Eating Disorder24. Previous attempts at screening have used insufficient measures, for example, the EAT-
2625 which does not measure any levels of Diabetes-related distress. The results of this study show that a 
thorough screening process at this time may be warranted.  However, the range between the time of Type 1 
diagnosis and the development of an Eating Disorder (0 – 19 years) also shows that many people may already 
be showing signs of disturbed eating at diagnosis and as such screening measures as part of the initial treatment 
and training plan are also warranted. If these high-risk patients can be identified at this time, they may be able 
to not only get support for the issues they currently have but also may avoid developing Diabulimia which is 
much more physically dangerous. The range identified, however, suggests that regular screening for an Eating 
Disorder is also warranted as it can appear long after diagnosis. This may be problematic in that it may appear 
that yet more focus is on food and weight or worse inform vulnerable patients about the hyperglycaemic 
process. However, criteria such as HbA1c level could avoid exposure to those deemed not at risk. The HbA1c 
is a measure of average blood sugar over 3 months and is the measure of how well blood sugar is controlled. 
Thus if HbA1c is within the normal range, screening at least for insulin manipulation is not necessary.  
Data were collected on whether or not the participant had relatives who also had Type 1 Diabetes. It is a 
common theory in research into Eating Disorders that disturbances may arise from modelling eating habits of 
the mother (Polivy & Herman 2002; Agras, Hammer, & McNicholas 1999). If the same were to hold for Type 
1 Diabetes, then a family-based intervention could provide a basis for treatment. However, the current results 
show that of the sizeable minority of those who have relatives with Type 1 Diabetes, the brother is the most 
likely and only 2 of the 98 respondents had mothers with the diagnosis.     
A significant finding of this study is that of the 98 respondents, all but 4 stated that they had manipulated or 
omitted insulin, the remaining 4 having selected the ‘prefer not to say’ option. Ninety-six percent of the 
                                                 
 
24 Contact:  janemorris1@nhs.net 
25Garner, D. M., & Garfinkel, P. E. (1979). The Eating Attitudes Test: An index of the symptoms of anorexia nervosa. 
Psychological medicine, 9(2), 273-279. 
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respondents, then, have had a form of what is commonly termed Diabulimia. This has massive implications 
as to how we conceive of Eating Disorders. Currently, the manipulation or omission of insulin has no 
psychiatric diagnosis attached to it and, although it will appear in the DSM V, it is to be categorised as an 
inappropriate compensatory behaviour in bulimia 26 .  The present study has shown that this is clearly 
problematic. Although 22.4% of the participants had received an official diagnosis of bulimia and this was 
most common, not one of them identified with that diagnosis. Several stated that they believed they had a 
mixture of conditions including bulimia, but none identified with that term alone. Thus to diagnose this as 
bulimia could cause confusion not only among sufferers but also professionals. The physical mechanics of 
Diabulimia alone are so different from that of bulimia that it is inevitable that for this demographic, this 
diagnosis may be detrimental. The diagnostic criteria are also inadequate; if the criteria hold from the DSM 
IV, then periods of manipulation or omission must have recurred over 3 months27. As previously discussed, 
DKA is always fatal if left untreated regardless if this is a single incident or one that has happened twice a 
week for 3 months. To expect a sufferer to wait 3 months for a diagnosis is potentially life threatening. Also, 
insulin omission need not occur after a binge or episodic loss of control, because the sufferer may eat a normal 
amount and withhold the necessary insulin. The categorisation of bulimia for this demographic, then, appears 
to be somewhat arbitrary and could promote the wrong message to those charged with diagnosing it. However, 
it may be that additional criteria for those who use this as an ‘inappropriate compensatory’ measure will be 
included; it certainly warrants further explanation than that currently given. 
Of those who reported approaching a health professional, GP’s were the most likely choice (51%). This is 
significant as in terms of specialism they are arguably the least equipped to deal with patients reporting these 
problems. As Diabulimia is not an official diagnosis, getting access to any kind of support can prove difficult. 
Diabetes Consultants were also likely to be approached (46.9%).  Again, this is problematic as the main job 
of a Diabetes consultant is to ensure that blood sugars are stable and in range; they are not trained to deal with 
psychological aspects of Type 1 Diabetes. The same applies to Diabetic Specialist Nurses who were also likely 
to be approached (24.5%). Similarly, Diabetes Dieticians (29.6% approached) are trained to provide 
information about what foods are best for blood sugar, so it may be difficult when a patient presents with an 
Eating Disorder - particularly insulin omission - and if the patient is binging, the situation is further 
                                                 
 
26 This was confirmed via email with Stephen Wonderlich, Ph.D.Chester Fritz Distinguished Professor 
Associate Chairman, Department of Clinical Neuroscience, University of North Dakota School of Medicine & Health 
Sciences who is charged with the structure of the wording for DSM V. 
27 American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). 
Washington, DC: Author. 
353 
 
complicated. Eating Disorder Specialists were also approached: 24.5 % saw an Eating Disorder Consultant 
and 14.5 % an Eating Disorder Nurse. Conversely, the problem is that Eating Disorder Specialists are not 
trained in Diabetes, with the separation of mental health nursing into its own specialism whereby trainees are 
only trained in rudimentary physical medicine, then this becomes even more apparent. Patients who have been 
in treatment have stated that they felt that most of their sessions are about educating the therapist and that this 
fosters mistrust and a lack of respect for the treatment provider.28  Out with the aforementioned specialisms 
the respondents also approached psychologists (29.6%), psychiatrists (25.5%), social workers (3.1%) mental 
health workers (22.4%) and other health professionals (10.2%). Many of the respondents approached multiple 
professionals and as such a system-wide education programme and protocol are warranted.  
It has been an important finding of the current study that of the 98 participants only 22.4% did not have co-
morbid mental health diagnoses. The most common concurrent diagnosis was depression (27.5%), but this is 
an expected finding as it has previously been shown that those with Type 1 Diabetes are twice as likely to 
suffer from the condition. Within females it is more prevalent (Anderson, Freedland, Clouse & Lustman2001), 
a further 15.9% having co-morbid anxiety and depression and many having further diagnoses such as OCD, 
ADHD and PTSD. There were also many instances of Personality Disorder. These findings have significant 
implications for the treatment of this demographic. With such a high incidence of dual, triple and sometimes 
quadruple diagnoses, it may be worth investigating if the Eating Disorder is a symptom of a broader mental 
health syndrome. At the very least, other issues should be investigated concurrently with the Eating Disorder. 
It may also be relevant that bullying was common among the respondents, with 44.9% being victimised 
because of their weight and 24.5% experiencing bullying due to Type 1 Diabetes. 
Factor analysis and implications 
The first and largest factor extracted named Diabetes Distress demonstrates how important the Diabetes 
Environment is to the development of an Eating Disorder. The items most highly correlated were: General 
Diabetes Stress, Resentment of Diabetes, Denial of Diabetes, Embarrassment of Injecting and/or testing, 
Diabetes Burn Out, Fear of Hypos, Over-Emphasis of Complications and Pressure from health care 
professionals combined with a Perfectionist Attitude and a Need to feel in control. This demonstrates why 
health care providers need to be fully aware of the vulnerabilities of their patients. The combination of Need 
for Control and a Perfectionist attitude with the Diabetes Aspects suggests that clinicians, by pushing for 
perfect control of blood sugars and trying to scare their patients with the threat of complications and 
                                                 
 
28 www.dwed.org.uk 
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hypoglycaemia, may be inadvertently pushing the patient away from optimal control and encouraging a 
stressful Diabetes environment that precipitates Eating Disorder development.  
The 2nd factor extracted represents labelled Diabetes Diet the relationship between some Diabetes diet aspects, 
Binging after Episodes of Hypoglycaemia, Diabetes Burn Out and Over Emphasis of Complications and what 
would be considered more ‘classic’ Eating Disorder predictors, Restrained Diet, Perfectionist Attitude, Early 
Puberty and to a lesser extent, family issues, disagreement with Parents on Diabetes treatment and Maternal 
Concern with Weight and Shape. This shows a complex interplay of environments but demonstrates that 
education about diet could be beneficial. Currently most clinics in the UK offer a programme called DAFNE, 
(Dose Adjustment for Normal Eating) and early screening for eating disturbances could identify patients who 
could benefit from an early intervention, if this were coupled with information for families and mothers about 
the risk factors for Eating Disorders, then perhaps development could be averted.       
Factor 3, Classic Risk was composed of items that described those already highly at risk at diagnosis and 
included already having an Eating Disorder and a Previous Mental Health Diagnosis with Initial Weight Loss, 
Weight Gain after Diagnosis, Fear of Weight Gain and Examples of Disturbed Eating in the Family.  The 
identification of this Factor justifies screening for an Eating Disorder at the time of diagnosis so that patients 
can get help before Diabulimia has a chance to develop.  
The 4th Factor, Self Esteem, identified shows the importance of Self Esteem, Body Image and Family 
Cohesion. The highest loadings were on Didn’t like the way my body looked, Unhappy with Weight and low 
self-esteem as well as lesser loadings on Couldn’t Talk to Parents, Disagreement with Family over Diabetes 
Treatment and Conflict with Family at Home. Self Esteem and Body image are as important to this 
demographic as they are to the general population, but as the results show that family communication are also 
important in concurrence; this is suggestive of a larger environmental problem. Further questions arise about 
whether body image is affected by having Type 1 Diabetes and if this is exacerbated by communication 
problems in the family.  Intervention at the family level could then provide the basis for treatment.  
Factor 5, Diabetes Treatment, had the highest loading on Attention to Weight from Medical Staff, Pressure 
from Health Professionals and Weight Gain on Diagnosis, with lower loadings on Maternal Concern with 
Weight and Shape and Too Much Dietary Focus. This may be representative of sensitivity to weight concerns 
that are then exacerbated by health care professionals. As such, training for health care professionals that 
explains potential vulnerability of those with Type 1 Diabetes could be beneficial. For example, being weighed 
is part of the quarterly checks that a Diabetic undertakes in clinic, this could be eradicated for at least those in 
transition services or within the critical age period who have no visually obvious weight issues. This could 
potentially avoid health professionals inadvertently triggering the development of Eating Disorders.       
Limitations 
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There are obvious limitations with the current study. Firstly as an undergraduate project, work with clinical 
populations is forbidden and as such the pool of participants in greatly reduced. This may partly explain the 
small sample size and where the study’s main limitations lie. A larger sample size may have produced higher 
correlations and factor loadings also more of the variables may have reached the significance criterion to be 
included.  
Conclusion   
Suggestions for Further Research 
It has been confirmed that in the upcoming DSM-V compulsive overeating will be included in the Eating 
Disorders section as Binge Eating Disorder29. A future study may take this into consideration and investigate 
whether there is also a higher incidence of BED among this population, as that would also have significant 
ramifications for the treatment of Type 1 Diabetes. Given the limited scope of the current study as work 
undertaken as part of an undergraduate degree, a larger study focussing on a global scale would certainly be 
warranted.  Thirty-three percent of the respondents were not of UK nationality and an investigation into 
differences between countries and cultures could yield interesting results and help inform a global policy on 
Eating Disorders in Type 1 Diabetes. It has also been widely reported that incidences of males developing 
Eating Disorders is rising. A future study could concentrate on aiming to recruit more male participants.  
Summary 
The current study has demonstrated that Type 1 Diabetes and Eating Disorders are extremely complicated. 
Many issues are highly inter related. The demographic information shows that those suffering with Eating 
Disorders also often have multiple other mental health diagnoses, have been bullied and will approach a 
multitude of health professionals.  The Factor Analysis has demonstrated that several aspects of the Diabetes 
environment diet, distress or treatment are incredibly important in the development of Eating Disorders but 
that individual differences may also play an important role. There are obvious problems with the status quo 
and the current study has hopefully illuminated some possible suggestions on how best to change the current 
situation. What is certain is that currently this demographic are misunderstood, under represented and under 
treated.      
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Appendix 
Appendix A: Original Advert 
Are you female and over the age of 18 with at least two years solid recovery from a 
Type 1 Diabetes related Eating Disorder? Jacqueline Allan from Birkbeck, University 
who many of you will know from the support forums is carrying out research into why 
Eating Disorders develop among women with type 1 Diabetes as compared to those 
without. If you would like to participate in this research by answering a brief 
questionnaire that will look at feelings towards the development of your illness, please 
follow the below link. Please note that no identifying information is required so answers 
are completely confidential.  
 
Appendix B: Questionnaire  
Questionnaire  
Please ensure that you have 10 - 20 free minutes to answer this questionnaire in a quiet environment with no 
distractions. This questionnaire has 2 parts. In part 1 you will be asked some basic questions about yourself, 
if at any point you do not want to give an answer please select the rather not say option.  If at any point you 
would like to withdraw from the study you can just close your browser. 
Please only proceed if you have more than two years in recovery and are over the age of 16 
Part 1:  
How old are you  
At what age were you diagnosed with Type 1 Diabetes? 
What nationality are you  
Do any other family members have type 1 Diabetes? 
What is their relationship to you? 
How long after diagnosis did you develop an Eating Disorder?  
Did you manipulate or omit insulin 
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Do you think that you had anorexia, bulimia, Diabulimia, or a combination of bulimia and Diabulimia, a 
combination of anorexia and Diabulimia, a combination of anorexia and bulimia, a combination of all 3?  
In the time that you were suffering from your Eating Disorder did you seek professional help? 
If so who did you approach, GP, DSN, Diabetic Consultant, Dietician, Eating Disorder Specialist, Other health 
professional please state…… 
Have you ever received an official Eating Disorder Diagnosis? If so what  
Have you ever received another mental health diagnosis? If so What  
Where you the victim of bullying because of weight? 
Were you the victim of bullying because of Type 1 Diabetes? 
Part 2  
Directions: The following statements concern your perception of the environment you were in at the time of 
developing an Eating Disorder. Please indicate how strongly you agree with each statement by using the below 
judgements. In the boxes after each statement, click a number from 1 to 5 from the following scale: 
1) Strongly disagree 
2) Disagree 
3) Neither disagree nor agree 
4) Agree 
5) Strongly agree 
Please note that there are no right or wrong answers. Take your time and consider each statement carefully. 
Once you have completed all questions please select submit at the bottom of the page. If at any point you do 
not wish to continue please just close your browser. 
In the second section you are asked to rate if you feel certain statements and factors contributed to the 
development of your Eating Disorder, or if they did not.  In some questions you are asked if a particular factor 
did contribute to the development of your Eating Disorder, for example:  
a) Pressure to be good at sports contributed to the development of my Eating Disorder 
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If you don’t agree with this statement then you would select 1) Strongly Disagree or 2) Disagree, if you feel 
neutral about this particular issue you would select 3) Neither Agree or Disagree, if however you felt that it 
did contribute you would select 4) Agree and if you felt that this played a significant part in the development 
you would select 5) Strongly Agree  
You will notice that some of the questions are worded differently to this, the reason they are is to avoid a 
phenomenon called response bias, which is where a participant may get into a habit of selecting responses. 
For this reason you should consider these questions carefully before responding, for example 
b) Sibling Rivalry did not contribute to the development of my Eating Disorder 
In this case you may feel that in fact sibling rivalry did play a part in the development of your Eating Disorder 
so in this case you would 2) disagree or, 1) strongly disagree. You may feel neutral about sibling rivalry so in 
that case you would select 3) Neither agree or disagree or you may feel like it did not contribute, in which 
case you would either 4) agree or 5) strongly agree with the statement 
1) Strongly Disagree 2) Disagree 3)Neither Disagree or Agree 4) Agree          5)Strongly  Agree 
1) I needed to feel in control of something and this contributed to the development of my Eating Disorder 
2) Initial weight loss at diagnosis did not contribute to the development of my Eating Disorder 
3) A restrained diet did not contribute to the development of my Eating Disorder  
4) Weight gain after I started on Insulin did not contribute to the development of my Eating Disorder 
5) Early Puberty contributed to the development of my Eating Disorder 
6) Low self-esteem contributed to the development of my Eating Disorder 
7) Too much focus on my diet contributed to the development of my Eating Disorder 
8) Attention to my weight from Medical Staff did not contribute to the development of my Eating Disorder 
9) Regardless of my Diabetes I was unhappy I was gaining weight and this contributed to the development of 
my Eating Disorder 
10) Adherence to timed meals contributed to the development of my Eating Disorder 
11) Conflict at home within my family did not contribute to the development of my Eating Disorder 
12) The realisation I could lose weight quickly contributed to the development of my Eating Disorder 
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13) General Diabetes stress contributed to the development of my Eating Disorder 
14)  Fear of weight gain did not contribute to the development of my Eating Disorder 
15) A perfectionist attitude towards my blood sugar did not contribute to the development of my Eating 
Disorder 
16) Denial that I had Diabetes did not contribute to the development of my Eating Disorder 
17)   Academic Pressure did not contribute to the development of my Eating Disorder 
18) A sense of achievement at losing weight contributed to the development of my Eating Disorder 
19) Conflict among my peer group contributed to the development of my Eating Disorder 
20) Fear of hypoglycaemia contributed to the development of my Eating Disorder 
21) Embarrassment at injecting or testing in front of anyone contributed to the development of my Eating 
Disorder 
22) Diabetes Burn Out did not contribute to the development of my Eating Disorder 
23) An over – emphasis on what would happen if I didn’t look after myself did not contribute to the 
development of my Eating Disorder 
24)  Fear of injecting and or self-testing contributed to the development of my Eating Disorder 
25) Societal pressure to be thinner contributed to the development of my Eating Disorder 
26) Examples of disturbed eating in my family contributed to the development of my Eating Disorder 
27) Overeating/ binging, following episodes of hypoglycaemia contributed to the development of my Eating 
Disorder 
28) Pressure from my health care professionals contributed to the development of my Eating Disorder 
29) Maternal concern with weight and shape did not contribute to the development of my Eating Disorder 
30) A distorted body image did not contribute to the development of my Eating Disorder 
31) Resentment of having Diabetes did not contribute to the development of my Eating Disorder 
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32) An Eating Disorder prior to developing Type 1 Diabetes contributed to the development of my Eating 
Disorder 
33) Disagreement with the way my parents dealt with my Diabetes contributed to the development of my 
Eating Disorder 
34) I felt I couldn’t talk to my parents and this contributed to the development of my Eating Disorder 
35) Family dysfunction contributed to the development of my Eating Disorder 
36) Feeling that I was not an individual within my family did not contribute to the development of my Eating 
Disorder 
37) I had pre-existing Mental Health issues and this contributed to the development of my Eating Disorder 
38) I didn’t like the way my body looked and this contributed to the development of my Eating Disorder 
39) My family was very rigid and this contributed to the development of my Eating Disorder 
40) A disturbed attitude to food did not contribute to the development of my Eating Disorder 
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Appendix H: Recruitment Advert 
 
Do you have some time to contribute to research on Type 1 Diabetes? My name is Jacqueline Allan and I am 
a Type 1 Diabetic currently undertaking a phd in research and my dissertation is on psychological aspects of 
Type 1 Diabetes and Blood Sugar Control. This questionnaire will discuss potentially sensitive subjects, such 
as relationship to food, Diabetes distress, family relations and psychological state. All you need to do is answer 
a questionnaire that you can find here. (www.typeoneandpsychology.org.uk) This is quite a long questionnaire 
and you can save your progress and complete it in your own time (it shouldn’t take any more than 45 mins) 
For the duration of the study you will receive a log in based on your email address if you wish to complete it 
in more than one session. This system is entirely computerised however so no-one including the researcher 
will know or keep your email after the study is completed. There is absolutely no identifying information 
required so your responses will remain completely anonymous. You are also free to withdraw your 
participation at any time. 
 
Appendix I: First Page of the Website & Ethics Screening  
 
The aim of the (Psychological Aspects in Type 1 Diabetes (PA1D) project is to understand how 
Type 1 Diabetes affects YOU and therefore what you and those who treat you, need to know to 
help manage your blood sugar. The hope is that this will be a large scale study with wide 
reaching implications across the healthcare system.  We have designed the study to be as easy to 
complete as possible but as it may take longer than 10 minutes you can log in and out as and 
when you see fit. Please also share this website with your Type 1 friends and colleagues so that 
we can get as many responses as possible. The bigger the response, the more we can do with the 
data. Thank you so much for getting involved in this ground breaking research. Hopefully 
together we can improve treatment and outcomes for Type 1 Diabetes everywhere.  
Kind Regards  
The (pancreatically challenged) Researcher   
Share (facebook, twitter, linkedin, tumblr)  
I would like to take part 
Click YES  
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Ethics Screen  
 
DEPARTMENT OF PSYCHOLOGICAL SCIENCES 
BIRKBECK UNIVERSITY OF LONDON 
 
Title of Study:  Psychological Factors effecting Blood Sugar Control 
Name of researcher: Jacqueline Anne Allan 
Dear Participant 
The study is being undertaken as part of a Doctoral degree in the Department of Psychological Sciences, 
Birkbeck University of London. The study has received ethical approval and the researcher has a DBS 
certificate 
This is a study of how psychosocial factors affect variations in blood sugar. If you agree to participate you 
will take part in a series of questionnaires. These questionnaires will discuss potentially sensitive subjects, 
such as relationship to food, Diabetes distress, family relations and psychological state.  
This is quite a long questionnaire and you can save your progress and complete it in your own time (it shouldn’t 
take any more than 45 mins). For the duration of the study you will receive a log in based on your email 
address if you wish to complete it in more than one session. The system for providing this is entirely 
computerised so no-one including the researcher will know or keep your email after the study is completed 
unless you request this. There is absolutely no identifying information required so your responses will remain 
completely anonymous. You are also free to withdraw your participation at any time.    There will be 
opportunity for involvement in a future project at the ned of this questionnaire for which you can leave your 
email address if you wish to participate. This information will be stored securely and separately from your 
responses to the questionnaire so there will be no way of identifying your responses to the questionnaire.  
All Data will remain totally anonymous and all information will be treated with the utmost confidentiality. A 
dedicated secure server has been purchased for this purpose. No identifying information will be recorded 
unless you wish to participate in the future research 
The results of the study will be written up in a report of the study for my Masters degree. You will not be 
identifiable in the write up or any publication which might ensue.  
If you have any questions at all regarding this study please feel free to contact the researcher 
Jacqueline Allan  
j.allan@bbk.ac.uk 
07869 116 832 
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Please confirm the below before starting the questionnaire 
I have had the details of the study explained to me and willingly consent to take part.  
 
YES/NO 
My questions have been answered to my satisfaction and I understand that I may ask further questions at any 
time.  
 
YES/NO 
I understand that I will remain anonymous and that all the information I give will be used for this study only. 
 
YES/NO 
I understand that I may withdraw my consent for the study at any time and to decline to answer any particular 
questions. 
 
YES/NO 
I confirm that I am over 16 years of age. 
 
YES/NO 
 
The study is supervised by Dr Anne Miles If you wish to contact the supervisor, contact details are: 
Dr Anne Miles 
ae.miles@bbk.ac.uk 
020 7079 0868 
 
Departmental address: Department of Psychological Sciences, Birkbeck University of London, Malet St, 
London WC1E 7HX   
 
 
If you have any questions at all you may also contact the researcher 
 
Jacqueline Allan  
j.allan@bbk.ac.uk 
07869 116 832 
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Appendix J: Debrief Screen  
 
Dear Participant 
Thank you so much for participating in this research. Your input will help develop the canon of research about 
psychosocial factors relating to blood sugar. If you would like to see the dissertation that results from this 
research, announcements will be available through the website you have answered the questionnaire on. 
There are a number of resources to help you if you feel that you have been affected by any issues raised by 
this survey. Please see the below links for further support  
 
http://www.Diabetessupport.co.uk/ 
www.dwed.org.uk  
http://www.diabulimiahelpline.org/ 
www.Diabetes.org.uk 
http://www.bpdworld.org/ 
http://www.mind.org.uk/ 
http://www.sane.org.uk/ 
http://www.rethink.org/ 
http://www.Diabetes.co.uk/forum/ 
You can also contact the researcher at any time  
Jacqueline Allan  
j.allan@bbk.ac.uk  
07869 116 832 
And don’t forget to share this study fb/tw/tb/ln/G+ 
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Appendix K: Full Sample Characteristics  
 
Nationality n 
American 278 
British  257 
Australian  31 
Canadian  30 
Irish  13 
Danish 13 
New Zealander 9 
European/ American 9 
South African 5 
Swedish 4 
Greek 3 
Prefer not to say  3 
German 2 
Barbadian 2 
Norwegian 2 
Polish 2 
Latvian 2 
Mexican/ American 2 
More than dual national 2 
Finish 1 
Dutch 1 
Jordanian 1 
Czech 1 
Indian 1 
Italian 1 
Filipino 1 
Singaporean 1 
Bulgarian 1 
Austrian 1 
Croatian 1 
Malaysian 1 
Israeli 1 
French 1 
Lithuanian 1 
Russian/ European 1 
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Country of Residence n 
America 293 
UK 274 
Canada 34 
Australia 32 
Denmark 17 
New Zeland 8 
Eire 4 
South Africa 3 
Sweden 3 
Germany 2 
Greece 2 
Latvia 2 
Jordan 1 
Czech Republic 1 
India 1 
Barbados 1 
Norway 1 
The Philippines 1 
Poland 1 
Bulgaria 1 
Austria 1 
Malaysia 1 
Israel 1 
France 1 
China 1 
 
Ethnicity n 
Caucasian 559 
Prefer not to say  81 
Mixed Race 18 
Hispanic 8 
Black 6 
Jewish 4 
Asian  4 
Chinese 2 
Arabic 2 
Native American 1 
Aborigine 1 
South East Asian 1 
 
Diabetes Related Complication n 
Retinopathy 135 
Neuropathy 101 
Gastroparesis and other stomach related issues 47 
Nephropathy 36 
High Blood Pressure 19 
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Diabetes Related Complication n 
Tendon issues 15 
Cardiovascular Disease 13 
Macular Oedema 13 
Autonomic Neuropathy 9 
High Cholesterol 8 
Dental Issues 7 
Cataracts 7 
Glaucoma 6 
 Necrobiosis Lipoidica Diabeticorum 6 
Ulcers 6 
Charcot Foot/  neuroarthropathy 5 
Erectile Dysfunction 4 
Osteoporosis/ penia 4 
Hyperlipidaemia 3 
Diabetic mastopathy 3 
Vitamin Deficiencies 2 
Amputation 2 
Liver Damage 2 
myofascial pain syndrome 1 
Papilledema 1 
Nodular perigo 1 
 
Other Diagnosed Health Condition n 
Hypothyroidism 95 
Asthma 56 
Coeliac 23 
Allergies 19 
Hypertension 16 
PCOS 12 
Arthritis 12 
IBS 9 
Vitamin Deficiencies 9 
Rheumatoid Arthritis 8 
Epilepsy 7 
Hyperthyroid 7 
Migraines 7 
Fibromyalgia 7 
Carpal Tunnel/ Raynaud’s 6 
Endometriosis 6 
Psoriasis 5 
Chronic Fatigue 5 
Hyper Mobility 4 
Eczema 4 
Gastritis 4 
Cancer 4 
Gastro -Oesophageal Reflux Disease 3 
Duputrens Contracture 3 
Ulcerative colitis 3 
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Other Diagnosed Health Condition n 
Familial Hypercholesterolemia 3 
Heart Disease 3 
Addison’s 2 
Cystic Fibrosis 2 
Vertigo 2 
Chron’s Disease  2 
Dry Eye 2 
Amenorrhea 2 
Meniere’s 2 
Incontinence 2 
Morton’s Neuroma 2 
Pancreatitis 2 
Sinus Tachycardia 2 
Psoriatic Arthritis 2 
Temporomandibular Joint Disorder 2 
Coronary Artery Disease 1 
Pernicious Anaemia 1 
Antiphospholid Syndrome 1 
Parkinson’s 1 
Polymorphic Light Eruptions 1 
Emphysema 1 
Ehlers Dan - los Syndrome 1 
Barret’s Oesophagus 1 
Sciatica 1 
Oral Lichen Planus 1 
Restless Legs Syndrome 1 
Peritonitis 1 
Congenital Scoliosis 1 
Early Menopause 1 
Faecal Incontinence 1 
Sleep Apnoea 1 
Spondyloestesis 1 
Chronic Idiopathic Cough 1 
Syndrome of Inappropriate Antidiuretic Hormone 1 
Sarcoidosis 1 
Supraventricular Tachycardia 1 
Chronic Obstructive Pulmonary Disease 1 
Gilberts Syndrome 1 
Uveitis 1 
Pituitary Adenomas 1 
Ankylosing Spondylitis 1 
Postural Tachycardia Syndrome 1 
Plantar Fasciitis 1 
Vitiligo 1 
Interstitial Cystitis 1 
Congestive Heart Failure 1 
Thalassemia 1 
Hirschsprung’s Disease 1 
Spherocytosis 1 
Sickle Cell 1 
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Other Diagnosed Health Condition n 
Lupus 1 
Sjogren’s 1 
Myasthenia Gravis 1 
Goitre 1 
Microplactinoma 1 
Glaucoma 1 
Multiple Sclerosis 1 
Primary Biliary Cirrhosis 1 
haemochromatosis 1 
 
Mental Health Diagnoses n 
Depression 155 
Anxiety 68 
Borderline 14 
Generalised Anxiety Disorder 11 
Bipolar Disorder 10 
Post-Traumatic Stress Disorder 10 
Obsessive Compulsive Disorder 7 
Attention deficit disorders 5 
Social Phobia 4 
Panic Disorder 4 
Asperger’s 3 
Specific Phobia 2 
Adjustment Disorder 1 
Agoraphobia 1 
Disassociation 1 
Seasonal Affective Disorder 1 
Avoidant Personality Disorder 1 
Dependent Personality Disorder  1 
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Appendix L: Correlation Matrix DEPS-R  
 
  
DEPS1 
Losing 
weight is 
an 
important 
goal to 
me 
DEPS2 
I skip 
meals 
and/or 
snacks 
DEPS3 
Other 
people 
have 
told me 
that my 
eating 
is out 
of 
control 
DEPS4 
When I 
overeat, 
I don’t 
take 
enough 
insulin 
to cover 
the food 
DEPS5 
I eat 
more 
when I 
am 
alone 
than 
when I 
am 
with 
others 
DEPS6 I 
feel that 
it’s 
difficult 
to lose 
weight 
and 
control 
my 
Diabetes 
at the 
same 
time 
DEPS7 I 
avoid 
checking 
my 
blood 
sugar 
when I 
feel like 
it is out 
of range 
DEPS8 
I make 
myself 
vomit 
DEPS9 
I try to 
keep 
my 
blood 
sugar 
high 
DEPS10 
I try to 
eat to 
the point 
of 
spilling 
ketones 
in my 
urine 
DEPS11 
I feel fat 
when I 
take all 
of my 
insulin 
DEPS12 
Other 
people 
tell me 
to take 
better 
care of 
my 
Diabetes 
DEPS13 
After I 
overeat, 
I skip 
my next 
insulin 
dose 
DEPS14 
I feel 
that my 
eating is 
out of 
control 
DEPS15 
I 
alternate 
between 
eating 
very 
little and 
eating 
huge 
amounts 
DEPS16 
I would 
rather be 
thin than 
to have 
good 
control 
of my 
Diabetes 
DEPS1 
Losing 
weight is 
an 
important 
goal to 
me 
Pearson 
Correlation 1 0.319 0.331 0.297 0.454 0.606 0.322 0.232 0.322 0.282 0.438 0.239 0.309 0.523 0.445 0.448 
Sig. (2-
tailed)   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N 
509 509 508 507 507 504 509 508 508 505 508 508 509 509 508 502 
DEPS2 I 
skip 
meals 
and/or 
snacks 
Pearson 
Correlation 0.319 1 0.370 0.349 0.300 0.294 0.370 0.336 0.448 0.391 0.420 0.347 0.417 0.347 0.536 0.471 
Sig. (2-
tailed) 0.000   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N 509 510 509 508 507 504 510 509 509 506 509 509 510 509 509 502 
DEPS3 
Other 
people 
have told 
me that 
my eating 
is out of 
control 
Pearson 
Correlation 0.331 0.370 1 0.443 0.432 0.340 0.436 0.404 0.492 0.449 0.486 0.515 0.489 0.603 0.507 0.527 
Sig. (2-
tailed) 0.000 0.000   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N 
508 509 509 508 507 503 509 508 508 505 508 509 509 508 509 501 
DEPS4 
When I 
overeat, I 
don’t take 
enough 
insulin to 
Pearson 
Correlation 0.297 0.349 0.443 1 0.531 0.399 0.618 0.323 0.665 0.569 0.577 0.580 0.679 0.600 0.548 0.606 
Sig. (2-
tailed) 
0.000 0.000 0.000   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N 507 508 508 508 506 502 508 507 507 504 507 508 508 507 508 501 
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cover the 
food 
DEPS5 I 
eat more 
when I 
am alone 
than 
when I 
am with 
others 
Pearson 
Correlation 0.454 0.300 0.432 0.531 1 0.483 0.454 0.301 0.473 0.369 0.495 0.400 0.464 0.627 0.593 0.511 
Sig. (2-
tailed) 0.000 0.000 0.000 0.000   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N 
507 507 507 506 507 502 507 506 506 503 506 507 507 507 507 500 
DEPS6 I 
feel that 
it’s 
difficult 
to lose 
weight 
and 
control 
my 
Diabetes 
at the 
same time 
Pearson 
Correlation 0.606 0.294 0.340 0.399 0.483 1 0.433 0.202 0.368 0.282 0.490 0.352 0.345 0.538 0.487 0.456 
Sig. (2-
tailed) 
0.000 0.000 0.000 0.000 0.000   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N 
504 504 503 502 502 504 504 503 503 500 503 503 504 504 503 498 
DEPS7 I 
avoid 
checking 
my blood 
sugar 
when I 
feel like it 
is out of 
range 
Pearson 
Correlation 0.322 0.370 0.436 0.618 0.454 0.433 1 0.361 0.605 0.529 0.520 0.562 0.651 0.570 0.591 0.582 
Sig. (2-
tailed) 0.000 0.000 0.000 0.000 0.000 0.000   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N 
509 510 509 508 507 504 510 509 509 506 509 509 510 509 509 502 
DEPS8 I 
make 
myself 
vomit 
Pearson 
Correlation 0.232 0.336 0.404 0.323 0.301 0.202 0.361 1 0.470 0.434 0.419 0.294 0.412 0.406 0.393 0.454 
Sig. (2-
tailed) 
0.000 0.000 0.000 0.000 0.000 0.000 0.000   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N 508 509 508 507 506 503 509 509 508 505 508 508 509 508 508 501 
DEPS9 I 
try to 
keep my 
blood 
sugar 
high 
Pearson 
Correlation 0.322 0.448 0.492 0.665 0.473 0.368 0.605 0.470 1 0.820 0.661 0.582 0.861 0.606 0.585 0.737 
Sig. (2-
tailed) 
0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000   0.000 0.000 0.000 0.000 0.000 0.000 0.000 
N 508 509 508 507 506 503 509 508 509 505 508 508 509 508 508 502 
DEPS10 I 
try to eat 
Pearson 
Correlation 0.282 0.391 0.449 0.569 0.369 0.282 0.529 0.434 0.820 1 0.569 0.479 0.831 0.539 0.481 0.613 
378 
 
to the 
point of 
spilling 
ketones in 
my urine 
Sig. (2-
tailed) 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000   0.000 0.000 0.000 0.000 0.000 0.000 
N 
505 506 505 504 503 500 506 505 505 506 505 505 506 505 505 498 
DEPS11 I 
feel fat 
when I 
take all of 
my 
insulin 
Pearson 
Correlation 
0.438 0.420 0.486 0.577 0.495 0.490 0.520 0.419 0.661 0.569 1 0.528 0.655 0.625 0.607 0.663 
Sig. (2-
tailed) 
0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000   0.000 0.000 0.000 0.000 0.000 
N 508 509 508 507 506 503 509 508 508 505 509 508 509 508 508 502 
DEPS12 
Other 
people 
tell me to 
take 
better 
care of 
my 
Diabetes 
Pearson 
Correlation 0.239 0.347 0.515 0.580 0.400 0.352 0.562 0.294 0.582 0.479 0.528 1 0.596 0.515 0.535 0.564 
Sig. (2-
tailed) 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000   0.000 0.000 0.000 0.000 
N 
508 509 509 508 507 503 509 508 508 505 508 509 509 508 509 501 
DEPS13 
After I 
overeat, I 
skip my 
next 
insulin 
dose 
Pearson 
Correlation 
0.309 0.417 0.489 0.679 0.464 0.345 0.651 0.412 0.861 0.831 0.655 0.596 1 0.623 0.577 0.722 
Sig. (2-
tailed) 
0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000   0.000 0.000 0.000 
N 
509 510 509 508 507 504 510 509 509 506 509 509 510 509 509 502 
DEPS14 I 
feel that 
my eating 
is out of 
control 
Pearson 
Correlation 0.523 0.347 0.603 0.600 0.627 0.538 0.570 0.406 0.606 0.539 0.625 0.515 0.623 1 0.698 0.639 
Sig. (2-
tailed) 
0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000   0.000 0.000 
N 509 509 508 507 507 504 509 508 508 505 508 508 509 509 508 502 
DEPS15 I 
alternate 
between 
eating 
very little 
and 
eating 
huge 
amounts 
Pearson 
Correlation 0.445 0.536 0.507 0.548 0.593 0.487 0.591 0.393 0.585 0.481 0.607 0.535 0.577 0.698 1 0.631 
Sig. (2-
tailed) 
0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000   0.000 
N 
508 509 509 508 507 503 509 508 508 505 508 509 509 508 509 501 
DEPS16 I 
would 
rather be 
thin than 
Pearson 
Correlation 
0.448 0.471 0.527 0.606 0.511 0.456 0.582 0.454 0.737 0.613 0.663 0.564 0.722 0.639 0.631 1 
Sig. (2-
tailed) 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000   
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to have 
good 
control of 
my 
Diabetes 
N 
502 502 501 501 500 498 502 501 502 498 502 501 502 502 501 502 
 
 
Appendix M: Full Correlation Matrix for SEM 
 
  Age 
Age 
at 
Dx 
DiabetesDu
ration 
HbA1
c% 
DEP
S-R 
GA
DT 
FAM
CH 
FAM
AT 
RE
ST 
DDSE
BT 
DDSP
RDT 
DDSR
RDT 
DDSI
DT 
DDSTO
TAL 
APSD
ISC 
CF
C 
ZP
DT 
APSS
TD 
APSO
RD 
CED
ST 
Age Pearson 
Correla
tion 
1 
0.48
5 
0.534 -0.180 
-
0.31
8 
-
0.29
0 
0.025 0.075 
0.28
6 
-0.307 -0.056 -0.347 
-
0.194 
-0.288 -0.206 
0.14
3 
-
0.31
2 
-0.003 0.105 
-
0.24
1 
Sig. (2-
tailed)   
0.00
0 
0.000 0.000 
0.00
0 
0.00
0 
0.593 0.128 
0.00
0 
0.000 0.215 0.000 0.000 0.000 0.000 
0.00
2 
0.00
0 
0.941 0.019 
0.00
0 
N 686 686 686 658 490 512 471 411 488 504 498 504 503 494 495 480 468 496 500 505 
Age at Dx Pearson 
Correla
tion 
0.48
5 
1 -0.480 -0.058 
-
0.15
8 
-
0.13
1 
0.024 0.079 
0.13
8 
-0.132 -0.038 -0.157 
-
0.083 
-0.122 -0.117 
0.05
6 
-
0.20
7 
-0.054 -0.003 
-
0.15
0 
Sig. (2-
tailed) 
0.00
0 
  0.000 0.136 
0.00
0 
0.00
3 
0.610 0.111 
0.00
2 
0.003 0.400 0.000 0.064 0.007 0.009 
0.21
9 
0.00
0 
0.227 0.949 
0.00
1 
N 686 686 686 658 490 512 471 411 488 504 498 504 503 494 495 480 468 496 500 505 
DiabetesDu
ration 
Pearson 
Correla
tion 
0.53
4 
-
0.48
0 
1 -0.125 
-
0.16
6 
-
0.16
7 
0.002 0.001 
0.15
3 
-0.181 -0.020 -0.197 
-
0.115 
-0.171 -0.092 
0.08
8 
-
0.10
9 
0.049 0.107 
-
0.09
7 
Sig. (2-
tailed) 
0.00
0 
0.00
0 
  0.001 
0.00
0 
0.00
0 
0.962 0.988 
0.00
1 
0.000 0.658 0.000 0.010 0.000 0.041 
0.05
4 
0.01
8 
0.278 0.017 
0.03
0 
N 686 686 686 658 490 512 471 411 488 504 498 504 503 494 495 480 468 496 500 505 
HbA1c% Pearson 
Correla
tion 
-
0.18
0 
-
0.05
8 
-0.125 1 
0.54
3 
0.32
2 
-
0.082 
0.067 
-
0.35
3 
0.376 0.213 0.494 0.263 0.435 0.262 
-
0.28
5 
0.35
0 
-0.106 -0.018 
0.32
7 
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Sig. (2-
tailed) 
0.00
0 
0.13
6 
0.001   
0.00
0 
0.00
0 
0.080 0.183 
0.00
0 
0.000 0.000 0.000 0.000 0.000 0.000 
0.00
0 
0.00
0 
0.020 0.690 
0.00
0 
N 658 658 658 659 476 495 455 399 469 484 479 485 483 476 478 464 452 479 483 487 
DEPS-R Pearson 
Correla
tion 
-
0.31
8 
-
0.15
8 
-0.166 0.543 1 
0.48
5 
-
0.205 
-
0.059 
-
0.60
4 
0.559 0.291 0.737 0.418 0.650 0.508 
-
0.44
5 
0.56
2 
-0.030 -0.056 
0.51
3 
Sig. (2-
tailed) 
0.00
0 
0.00
0 
0.000 0.000   
0.00
0 
0.000 0.260 
0.00
0 
0.000 0.000 0.000 0.000 0.000 0.000 
0.00
0 
0.00
0 
0.519 0.239 
0.00
0 
N 490 490 490 476 491 461 425 371 437 460 453 459 459 451 450 435 421 452 452 460 
GADT Pearson 
Correla
tion 
-
0.29
0 
-
0.13
1 
-0.167 0.322 
0.48
5 
1 
-
0.139 
0.027 
-
0.61
5 
0.617 0.390 0.527 0.456 0.630 0.587 
-
0.22
4 
0.61
8 
-0.017 -0.015 
0.71
4 
Sig. (2-
tailed) 
0.00
0 
0.00
3 
0.000 0.000 
0.00
0 
  0.004 0.609 
0.00
0 
0.000 0.000 0.000 0.000 0.000 0.000 
0.00
0 
0.00
0 
0.716 0.753 
0.00
0 
N 512 512 512 495 461 512 431 375 450 471 464 470 470 462 462 449 434 465 466 480 
FAMCH Pearson 
Correla
tion 
0.02
5 
0.02
4 
0.002 -0.082 
-
0.20
5 
-
0.13
9 
1 0.412 
0.29
1 
-0.039 -0.145 -0.137 
-
0.166 
-0.143 -0.167 
0.24
3 
-
0.25
3 
0.083 0.129 
-
0.26
0 
Sig. (2-
tailed) 
0.59
3 
0.61
0 
0.962 0.080 
0.00
0 
0.00
4 
  0.000 
0.00
0 
0.415 0.003 0.004 0.000 0.003 0.000 
0.00
0 
0.00
0 
0.087 0.007 
0.00
0 
N 471 471 471 455 425 431 471 405 422 436 431 436 435 428 430 419 406 431 434 429 
FAMAT Pearson 
Correla
tion 
0.07
5 
0.07
9 
0.001 0.067 
-
0.05
9 
0.02
7 
0.412 1 
0.05
7 
-0.043 0.079 -0.015 
-
0.070 
-0.030 -0.070 
0.13
0 
-
0.08
1 
0.034 0.006 
-
0.09
6 
Sig. (2-
tailed) 
0.12
8 
0.11
1 
0.988 0.183 
0.26
0 
0.60
9 
0.000   
0.27
4 
0.411 0.128 0.766 0.179 0.559 0.180 
0.01
3 
0.13
1 
0.517 0.906 
0.06
4 
N 411 411 411 399 371 375 405 411 365 376 373 376 375 370 372 365 352 373 375 371 
REST Pearson 
Correla
tion 
0.28
6 
0.13
8 
0.153 -0.353 
-
0.60
4 
-
0.61
5 
0.291 0.057 1 -0.584 -0.310 -0.581 
-
0.434 
-0.615 -0.729 
0.32
5 
-
0.64
4 
0.146 0.103 
-
0.75
4 
Sig. (2-
tailed) 
0.00
0 
0.00
2 
0.001 0.000 
0.00
0 
0.00
0 
0.000 0.274   0.000 0.000 0.000 0.000 0.000 0.000 
0.00
0 
0.00
0 
0.002 0.029 
0.00
0 
N 488 488 488 469 437 450 422 365 488 447 442 447 447 440 443 428 415 445 447 446 
DDSEBT Pearson 
Correla
tion 
-
0.30
7 
-
0.13
2 
-0.181 0.376 
0.55
9 
0.61
7 
-
0.039 
-
0.043 
-
0.58
4 
1 0.448 0.711 0.618 0.888 0.545 
-
0.20
1 
0.54
5 
-0.026 0.006 
0.62
9 
Sig. (2-
tailed) 
0.00
0 
0.00
3 
0.000 0.000 
0.00
0 
0.00
0 
0.415 0.411 
0.00
0 
  0.000 0.000 0.000 0.000 0.000 
0.00
0 
0.00
0 
0.573 0.899 
0.00
0 
N 504 504 504 484 460 471 436 376 447 504 496 503 503 494 460 445 433 463 465 467 
DDSPRDT Pearson 
Correla
tion 
-
0.05
6 
-
0.03
8 
-0.020 0.213 
0.29
1 
0.39
0 
-
0.145 
0.079 
-
0.31
0 
0.448 1 0.436 0.419 0.686 0.344 
-
0.09
4 
0.37
5 
0.026 0.025 
0.36
0 
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Sig. (2-
tailed) 
0.21
5 
0.40
0 
0.658 0.000 
0.00
0 
0.00
0 
0.003 0.128 
0.00
0 
0.000   0.000 0.000 0.000 0.000 
0.05
0 
0.00
0 
0.586 0.589 
0.00
0 
N 498 498 498 479 453 464 431 373 442 496 498 496 495 494 454 439 427 456 458 460 
DDSRRDT Pearson 
Correla
tion 
-
0.34
7 
-
0.15
7 
-0.197 0.494 
0.73
7 
0.52
7 
-
0.137 
-
0.015 
-
0.58
1 
0.711 0.436 1 0.524 0.862 0.510 
-
0.38
1 
0.56
9 
-0.092 -0.040 
0.52
2 
Sig. (2-
tailed) 
0.00
0 
0.00
0 
0.000 0.000 
0.00
0 
0.00
0 
0.004 0.766 
0.00
0 
0.000 0.000   0.000 0.000 0.000 
0.00
0 
0.00
0 
0.048 0.389 
0.00
0 
N 504 504 504 485 459 470 436 376 447 503 496 504 502 494 459 445 432 462 464 466 
DDSIDT Pearson 
Correla
tion 
-
0.19
4 
-
0.08
3 
-0.115 0.263 
0.41
8 
0.45
6 
-
0.166 
-
0.070 
-
0.43
4 
0.618 0.419 0.524 1 0.756 0.385 
-
0.18
9 
0.47
3 
0.017 0.017 
0.49
7 
Sig. (2-
tailed) 
0.00
0 
0.06
4 
0.010 0.000 
0.00
0 
0.00
0 
0.000 0.179 
0.00
0 
0.000 0.000 0.000   0.000 0.000 
0.00
0 
0.00
0 
0.721 0.721 
0.00
0 
N 503 503 503 483 459 470 435 375 447 503 495 502 503 494 459 444 433 462 464 466 
DDSTOTA
L 
Pearson 
Correla
tion 
-
0.28
8 
-
0.12
2 
-0.171 0.435 
0.65
0 
0.63
0 
-
0.143 
-
0.030 
-
0.61
5 
0.888 0.686 0.862 0.756 1 0.567 
-
0.29
0 
0.61
7 
-0.035 -0.001 
0.63
2 
Sig. (2-
tailed) 
0.00
0 
0.00
7 
0.000 0.000 
0.00
0 
0.00
0 
0.003 0.559 
0.00
0 
0.000 0.000 0.000 0.000   0.000 
0.00
0 
0.00
0 
0.463 0.979 
0.00
0 
N 494 494 494 476 451 462 428 370 440 494 494 494 494 494 452 438 426 454 456 458 
APSDISC Pearson 
Correla
tion 
-
0.20
6 
-
0.11
7 
-0.092 0.262 
0.50
8 
0.58
7 
-
0.167 
-
0.070 
-
0.72
9 
0.545 0.344 0.510 0.385 0.567 1 
-
0.24
7 
0.52
4 
0.130 0.077 
0.61
7 
Sig. (2-
tailed) 
0.00
0 
0.00
9 
0.041 0.000 
0.00
0 
0.00
0 
0.000 0.180 
0.00
0 
0.000 0.000 0.000 0.000 0.000   
0.00
0 
0.00
0 
0.004 0.087 
0.00
0 
N 495 495 495 478 450 462 430 372 443 460 454 459 459 452 496 438 429 491 494 465 
CFC Pearson 
Correla
tion 
0.14
3 
0.05
6 
0.088 -0.285 
-
0.44
5 
-
0.22
4 
0.243 0.130 
0.32
5 
-0.201 -0.094 -0.381 
-
0.189 
-0.290 -0.247 1 
-
0.34
6 
0.239 0.189 
-
0.25
2 
Sig. (2-
tailed) 
0.00
2 
0.21
9 
0.054 0.000 
0.00
0 
0.00
0 
0.000 0.013 
0.00
0 
0.000 0.050 0.000 0.000 0.000 0.000   
0.00
0 
0.000 0.000 
0.00
0 
N 480 480 480 464 435 449 419 365 428 445 439 445 444 438 438 480 413 440 440 448 
ZPDT Pearson 
Correla
tion 
-
0.31
2 
-
0.20
7 
-0.109 0.350 
0.56
2 
0.61
8 
-
0.253 
-
0.081 
-
0.64
4 
0.545 0.375 0.569 0.473 0.617 0.524 
-
0.34
6 
1 -0.072 -0.069 
0.62
8 
Sig. (2-
tailed) 
0.00
0 
0.00
0 
0.018 0.000 
0.00
0 
0.00
0 
0.000 0.131 
0.00
0 
0.000 0.000 0.000 0.000 0.000 0.000 
0.00
0 
  0.134 0.149 
0.00
0 
N 468 468 468 452 421 434 406 352 415 433 427 432 433 426 429 413 468 432 433 436 
APSSTD Pearson 
Correla
tion 
-
0.00
3 
-
0.05
4 
0.049 -0.106 
-
0.03
0 
-
0.01
7 
0.083 0.034 
0.14
6 
-0.026 0.026 -0.092 0.017 -0.035 0.130 
0.23
9 
-
0.07
2 
1 0.500 
-
0.07
3 
382 
 
Sig. (2-
tailed) 
0.94
1 
0.22
7 
0.278 0.020 
0.51
9 
0.71
6 
0.087 0.517 
0.00
2 
0.573 0.586 0.048 0.721 0.463 0.004 
0.00
0 
0.13
4 
  0.000 
0.11
7 
N 496 496 496 479 452 465 431 373 445 463 456 462 462 454 491 440 432 497 494 465 
APSORD Pearson 
Correla
tion 
0.10
5 
-
0.00
3 
0.107 -0.018 
-
0.05
6 
-
0.01
5 
0.129 0.006 
0.10
3 
0.006 0.025 -0.040 0.017 -0.001 0.077 
0.18
9 
-
0.06
9 
0.500 1 
-
0.10
8 
Sig. (2-
tailed) 
0.01
9 
0.94
9 
0.017 0.690 
0.23
9 
0.75
3 
0.007 0.906 
0.02
9 
0.899 0.589 0.389 0.721 0.979 0.087 
0.00
0 
0.14
9 
0.000   
0.02
0 
N 500 500 500 483 452 466 434 375 447 465 458 464 464 456 494 440 433 494 501 466 
CEDST Pearson 
Correla
tion 
-
0.24
1 
-
0.15
0 
-0.097 0.327 
0.51
3 
0.71
4 
-
0.260 
-
0.096 
-
0.75
4 
0.629 0.360 0.522 0.497 0.632 0.617 
-
0.25
2 
0.62
8 
-0.073 -0.108 1 
Sig. (2-
tailed) 
0.00
0 
0.00
1 
0.030 0.000 
0.00
0 
0.00
0 
0.000 0.064 
0.00
0 
0.000 0.000 0.000 0.000 0.000 0.000 
0.00
0 
0.00
0 
0.117 0.020   
N 505 505 505 487 460 480 429 371 446 467 460 466 466 458 465 448 436 465 466 505 
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Appendix N: The Factors in Eating Disorder Questionnaire  
Factors in Eating Disorders questionnaire  
 
This questionnaire has 2 parts. In part 1 you will be asked some basic questions about yourself, if at any point 
you do not want to give an answer please select the rather not say option.  If at any point you would like to 
withdraw from the study you can just close your browser. 
Part 1:  
How old are you? 
What is you Gender? 
What nationality are you? 
What ethnicity are you? 
What age were you when you were diagnosed with Type 1 Diabetes? 
What was your last HbA1c%? 
How long after your Type 1 Diagnosis did you develop an Eating Disorder? 
Have you ever been formally diagnosed with an Eating Disorder by a Health Care Professional? 
What Eating Disorder(s) were you diagnosed with? 
What Eating Disorder(s) do you think you had/ have? 
Have you ever omitted insulin for weight loss purposes? 
Have you sought help from an Health Care Professional regarding your Eating Disorder? 
What Health Care Professionals did you approach? 
Have you been diagnosed by a Health Care Professional with any other mental illness? 
Have you been the victim of weight related bullying? 
Have you been the victim of T1D related bullying? 
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Part 2  
Directions: The following statements concern your perception of the environment you were in at the time of 
developing an Eating Disorder. Please indicate how strongly you agree with each statement by using the below 
judgments. In the boxes after each statement, click a number from 1 to 5 from the following scale: 
1) Strongly disagree 
2) Disagree 
3) Neither disagree nor agree 
4) Agree 
5) Strongly agree 
Please note that there are no right or wrong answers. Take your time and consider each statement carefully. 
Once you have completed all questions please select submit at the bottom of the page. If at any point you do 
not wish to continue please just close your browser. 
In the second section you are asked to rate if you feel certain statements and factors contributed to the 
development of your Eating Disorder, or if they did not.  In some questions you are asked if a particular factor 
did contribute to the development of your Eating Disorder, for example:  
a) Pressure to be good at sports contributed to the development of my Eating Disorder 
If you don’t agree with this statement then you would select 1) Strongly Disagree or 2) Disagree, if you feel 
neutral about this particular issue you would select 3) Neither Agree or Disagree, if however you felt that it 
did contribute you would select 4) Agree and if you felt that this played a significant part in the development 
you would select 5) Strongly Agree  
You will notice that some of the questions are worded differently to this, the reason they are is to avoid a 
phenomenon called response bias, which is where a participant may get into a habit of selecting responses. 
For this reason you should consider these questions carefully before responding, for example 
b) Sibling Rivalry did not contribute to the development of my Eating Disorder 
In this case you may feel that in fact sibling rivalry did play a part in the development of your Eating Disorder 
so in this case you would 2) disagree or, 1) strongly disagree. You may feel neutral about sibling rivalry so in 
that case you would select 3) Neither agree or disagree or you may feel like it did not contribute, in which 
case you would either 4) agree or 5) strongly agree with the statement 
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1) Strongly Disagree 2) Disagree 3)Neither Disagree or Agree 4) Agree          5)Strongly  Agree 
1) I needed to feel in control of something and this contributed to the development of my Eating Disorder 
2) Initial weight loss at diagnosis contributed to the development of my Eating Disorder 
3) A restrained diet contributed to the development of my Eating Disorder  
4) Weight gain after I started on Insulin contributed to the development of my Eating Disorder 
5) Early Puberty contributed to the development of my Eating Disorder 
6) Low self-esteem contributed to the development of my Eating Disorder 
7) Too much focus on my diet contributed to the development of my Eating Disorder 
8) Attention to my weight from Medical Staff did not contribute to the development of my Eating Disorder 
9) Regardless of my Diabetes I was unhappy I was gaining weight and this contributed to the development of 
my Eating Disorder 
10) Adherence to timed meals contributed to the development of my Eating Disorder 
11) Conflict at home within my family contributed to the development of my Eating Disorder 
12) The realisation I could lose weight quickly contributed to the development of my Eating Disorder 
13) General Diabetes stress contributed to the development of my Eating Disorder 
14)  Fear of weight gain contribute to the development of my Eating Disorder 
15) A perfectionist attitude towards my blood sugar did not contribute to the development of my Eating 
Disorder 
16) Denial that I had Diabetes contributed to the development of my Eating Disorder 
17)   Academic Pressure did not contribute to the development of my Eating Disorder 
18) A sense of achievement at losing weight contributed to the development of my Eating Disorder 
19) Conflict among my peer group contributed to the development of my Eating Disorder 
20) Fear of hypoglycaemia contributed to the development of my Eating Disorder 
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21) Embarrassment at injecting or testing in front of anyone contributed to the development of my Eating 
Disorder 
22) Diabetes Burn Out contributed to the development of my Eating Disorder 
23) An over – emphasis on what would happen if I didn’t look after myself contributed to the development of 
my Eating Disorder 
24)  Fear of injecting and or self-testing contributed to the development of my Eating Disorder 
25) Societal pressure to be thinner contributed to the development of my Eating Disorder 
26) Examples of disturbed eating in my family contributed to the development of my Eating Disorder 
27) Overeating/ binging, following episodes of hypoglycaemia contributed to the development of my Eating 
Disorder 
28) Pressure from my health care professionals contributed to the development of my Eating Disorder 
29) Maternal concern with weight and shape did not contribute to the development of my Eating Disorder 
30) A distorted body image contributed to the development of my Eating Disorder 
31) Resentment of having Diabetes contributed to the development of my Eating Disorder 
32) An Eating Disorder prior to developing Type 1 Diabetes contributed to the development of my Eating 
Disorder 
33) Disagreement with the way my parents dealt with my Diabetes contributed to the development of my 
Eating Disorder 
34) I felt I couldn’t talk to my parents and this contributed to the development of my Eating Disorder 
35) Family dysfunction contributed to the development of my Eating Disorder 
36) Feeling that I was not an individual within my family contributed to the development of my Eating 
Disorder 
37) I had pre-existing Mental Health issues and this contributed to the development of my Eating Disorder 
38) I didn’t like the way my body looked and this contributed to the development of my Eating Disorder 
39) My family was very rigid and this contributed to the development of my Eating Disorder 
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40) A disturbed attitude to food did not contribute to the development of my Eating Disorder 
 
Appendix O: Recruitment Advert for the Confirmatory Sample  
 
Do you have Type 1 Diabetes? Have you ever experienced and Eating Disorder or Diabulimia? Do you have 
some time to contribute to research on Type 1 Diabetes? My name is Jacqueline Allan and I am a Type 1 
Diabetic currently undertaking a phd in research and my dissertation is on Eating Disorders and Diabulimia 
in Type 1 Diabetes. This questionnaire will discuss potentially sensitive subjects, such as relationship to food, 
Diabetes distress, family relations and psychological state. All you need to do is answer a questionnaire that 
you can find here. (www.typeoneandpsychology.org.uk) This system is entirely computerised however so no-
one including the researcher will know or keep your email after the study is completed. There is absolutely no 
identifying information required so your responses will remain completely anonymous. You are also free to 
withdraw your participation at any time. 
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Appendix P: Correlation Matrix – FEDS questionnaire  
 
  1 3 4 6 7 8 9 10 11 12 13 14 15 16 18 20 21 22 24 25 26 27 28 29 30 31 33 34 35 36 38 39 40 
1) needed to 
feel in control 
1.000 .172* 0.132 
.471*
* 
.310*
* 
0.072 
.305*
* 
0.127 
.321*
* 
.330*
* 
.352*
* 
.240*
* 
.243*
* 
0.157 
.538*
* 
0.124 .204* .204* 0.059 
.445*
* 
.296*
* 
.184* 
.340*
* 
.306*
* 
.271*
* 
0.087 0.151 
.369*
* 
.334*
* 
.239*
* 
.515*
* 
.219* 0.093 
3) restrained 
diet 
.172* 1.000 
-
0.049 
.301*
* 
.641*
* 
.318*
* 
.338*
* 
.532*
* 
.249*
* 
.191* 
.370*
* 
0.082 
.375*
* 
.199* .203* 
.347*
* 
.197* 
.404*
* 
.235*
* 
.294*
* 
.349*
* 
.410*
* 
.502*
* 
.297*
* 
0.032 .211* 
.343*
* 
.243*
* 
.306*
* 
.222* 
.292*
* 
.416*
* 
.271*
* 
4) Weight gain 
after I started 
on Insulin 
0.132 
-
0.049 
1.000 0.095 0.040 .222* 0.142 0.101 0.119 
.333*
* 
.333*
* 
.395*
* 
0.105 
.259*
* 
.306*
* 
0.161 0.114 0.123 0.102 
.256*
* 
0.098 
.227*
* 
0.170 0.064 
.294*
* 
.286*
* 
0.108 0.085 0.149 .176* 
.307*
* 
0.121 
.246*
* 
6) Low self-
esteem .471*
* 
.301*
* 
0.095 1.000 
.538*
* 
0.110 
.556*
* 
.214* 
.341*
* 
.352*
* 
.394*
* 
.279*
* 
.228*
* 
.290*
* 
.567*
* 
0.152 .183* 
.269*
* 
0.139 
.621*
* 
.266*
* 
.294*
* 
.372*
* 
.306*
* 
.224*
* 
0.101 0.120 
.284*
* 
.317*
* 
.293*
* 
.682*
* 
0.129 0.157 
7) Too much 
focus on my 
diet 
.310*
* 
.641*
* 
0.040 
.538*
* 
1.000 
.354*
* 
.395*
* 
.541*
* 
.261*
* 
.174* 
.531*
* 
.185* 
.359*
* 
.268*
* 
.312*
* 
.315*
* 
.199* 
.501*
* 
0.092 
.427*
* 
.393*
* 
.490*
* 
.618*
* 
.302*
* 
-
0.016 
.215* 
.296*
* 
.347*
* 
.243*
* 
.324*
* 
.470*
* 
.322*
* 
.262*
* 
8) Attention to 
my weight 
from Medical 
Staff 
0.072 
.318*
* 
.222* 0.110 
.354*
* 
1.000 .188* 
.229*
* 
.180* 0.014 
.290*
* 
.270*
* 
.322*
* 
0.130 
-
0.005 
0.100 
.241*
* 
.282*
* 
0.036 0.143 
.233*
* 
.264*
* 
.527*
* 
.198* 0.130 
.285*
* 
0.167 
.279*
* 
.211* 0.111 0.140 
.286*
* 
.373*
* 
9) Regardless 
of my 
Diabetes I was 
unhappy I was 
gaining weight 
.305*
* 
.338*
* 
0.142 
.556*
* 
.395*
* 
.188* 1.000 
.227*
* 
.245*
* 
.342*
* 
.402*
* 
.320*
* 
.209* .206* 
.537*
* 
.274*
* 
0.129 
.394*
* 
0.141 
.632*
* 
0.166 
.329*
* 
.290*
* 
0.170 0.153 .181* 0.096 0.162 .183* 0.165 
.665*
* 
.189* 0.151 
10) Adherence 
to timed meals 
0.127 
.532*
* 
0.101 .214* 
.541*
* 
.229*
* 
.227*
* 
1.000 
.338*
* 
0.069 
.383*
* 
0.063 
.401*
* 
0.158 .173* 
.324*
* 
.274*
* 
.293*
* 
.237*
* 
0.149 
.285*
* 
.338*
* 
.429*
* 
0.111 
-
0.043 
.236*
* 
.431*
* 
.270*
* 
.337*
* 
.343*
* 
.228*
* 
.375*
* 
.238*
* 
11) Conflict at 
home within 
my family 
.321*
* 
.249*
* 
0.119 
.341*
* 
.261*
* 
.180* 
.245*
* 
.338*
* 
1.000 .194* 
.284*
* 
0.078 
.252*
* 
.318*
* 
.284*
* 
.259*
* 
.335*
* 
.272*
* 
.236*
* 
.319*
* 
.493*
* 
.212* 
.369*
* 
.427*
* 
0.120 .185* 
.472*
* 
.588*
* 
.844*
* 
.577*
* 
.268*
* 
.478*
* 
0.029 
12) realisation 
I could lose 
weight quickly 
.330*
* 
.191* 
.333*
* 
.352*
* 
.174* 0.014 
.342*
* 
0.069 .194* 1.000 
.397*
* 
.211* 0.074 
.376*
* 
.570*
* 
.273*
* 
.278*
* 
.308*
* 
.224*
* 
.408*
* 
0.067 0.152 0.146 .186* 
.297*
* 
.253*
* 
.176* 0.087 
.236*
* 
0.092 
.510*
* 
0.146 
-
0.042 
13) General 
Diabetes stress .352*
* 
.370*
* 
.333*
* 
.394*
* 
.531*
* 
.290*
* 
.402*
* 
.383*
* 
.284*
* 
.397*
* 
1.000 .209* 
.320*
* 
.525*
* 
.432*
* 
.412*
* 
.361*
* 
.633*
* 
.246*
* 
.439*
* 
.287*
* 
.569*
* 
.529*
* 
.185* 0.083 
.524*
* 
.351*
* 
.184* 
.289*
* 
.204* 
.453*
* 
.304*
* 
.355*
* 
14) Fear of 
weight gain .240*
* 
0.082 
.395*
* 
.279*
* 
.185* 
.270*
* 
.320*
* 
0.063 0.078 .211* .209* 1.000 
-
0.052 
0.040 
.349*
* 
0.017 0.055 0.141 0.009 
.468*
* 
0.171 0.108 .197* .200* 
.413*
* 
.189* 0.080 0.094 0.079 0.144 
.434*
* 
0.067 
.429*
* 
15) 
perfectionist 
attitude 
towards my 
blood sugar 
.243*
* 
.375*
* 
0.105 
.228*
* 
.359*
* 
.322*
* 
.209* 
.401*
* 
.252*
* 
0.074 
.320*
* 
-
0.052 
1.000 0.150 0.113 
.268*
* 
0.134 
.281*
* 
0.089 .190* 
.326*
* 
.328*
* 
.430*
* 
.191* 
-
0.020 
0.168 .186* 
.263*
* 
.285*
* 
.182* 
.240*
* 
.330*
* 
0.130 
16) Denial that 
I had Diabetes 
0.157 .199* 
.259*
* 
.290*
* 
.268*
* 
0.130 .206* 0.158 
.318*
* 
.376*
* 
.525*
* 
0.040 0.150 1.000 
.320*
* 
.436*
* 
.559*
* 
.379*
* 
.482*
* 
.240*
* 
.192* 
.329*
* 
.208* 0.152 0.103 
.451*
* 
.311*
* 
.245*
* 
.347*
* 
.267*
* 
.265*
* 
.275*
* 
0.118 
18) A sense of 
achievement at 
losing weight 
.538*
* 
.203* 
.306*
* 
.567*
* 
.312*
* 
-
0.005 
.537*
* 
.173* 
.284*
* 
.570*
* 
.432*
* 
.349*
* 
0.113 
.320*
* 
1.000 .208* .200* 
.239*
* 
.190* 
.641*
* 
.189* .176* 
.247*
* 
.313*
* 
.341*
* 
0.101 .218* .199* 
.268*
* 
.253*
* 
.772*
* 
.179* 0.130 
20) Fear of 
hypoglycaemi
a 
0.124 
.347*
* 
0.161 0.152 
.315*
* 
0.100 
.274*
* 
.324*
* 
.259*
* 
.273*
* 
.412*
* 
0.017 
.268*
* 
.436*
* 
.208* 1.000 
.460*
* 
.353*
* 
.379*
* 
.239*
* 
.302*
* 
.468*
* 
.331*
* 
0.133 0.028 
.380*
* 
.311*
* 
.196* 
.314*
* 
.223* .212* .223* 0.123 
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21) 
Embarrassmen
t at injecting or 
testing 
.204* .197* 0.114 .183* .199* 
.241*
* 
0.129 
.274*
* 
.335*
* 
.278*
* 
.361*
* 
0.055 0.134 
.559*
* 
.200* 
.460*
* 
1.000 
.381*
* 
.576*
* 
.189* 
.237*
* 
.280*
* 
.293*
* 
.247*
* 
0.030 
.328*
* 
.336*
* 
.359*
* 
.389*
* 
.360*
* 
.173* 
.279*
* 
0.038 
22) Diabetes 
Burn Out 
.204* 
.404*
* 
0.123 
.269*
* 
.501*
* 
.282*
* 
.394*
* 
.293*
* 
.272*
* 
.308*
* 
.633*
* 
0.141 
.281*
* 
.379*
* 
.239*
* 
.353*
* 
.381*
* 
1.000 
.243*
* 
.325*
* 
.339*
* 
.516*
* 
.458*
* 
.306*
* 
-
0.063 
.524*
* 
.271*
* 
.255*
* 
.252*
* 
0.166 
.316*
* 
.316*
* 
.239*
* 
24) Fear of 
injecting and 
or self-testing 
0.059 
.235*
* 
0.102 0.139 0.092 0.036 0.141 
.237*
* 
.236*
* 
.224*
* 
.246*
* 
0.009 0.089 
.482*
* 
.190* 
.379*
* 
.576*
* 
.243*
* 
1.000 0.154 .189* 0.146 0.112 0.146 
-
0.158 
.256*
* 
.297*
* 
.182* 
.250*
* 
.194* 0.127 .176* 0.084 
25) Societal 
pressure to be 
thinner 
.445*
* 
.294*
* 
.256*
* 
.621*
* 
.427*
* 
0.143 
.632*
* 
0.149 
.319*
* 
.408*
* 
.439*
* 
.468*
* 
.190* 
.240*
* 
.641*
* 
.239*
* 
.189* 
.325*
* 
0.154 1.000 
.310*
* 
.290*
* 
.382*
* 
.392*
* 
.245*
* 
0.136 0.151 .220* 
.230*
* 
.206* 
.778*
* 
.207* 0.163 
26) Examples 
of disturbed 
eating in my 
family 
.296*
* 
.349*
* 
0.098 
.266*
* 
.393*
* 
.233*
* 
0.166 
.285*
* 
.493*
* 
0.067 
.287*
* 
0.171 
.326*
* 
.192* .189* 
.302*
* 
.237*
* 
.339*
* 
.189* 
.310*
* 
1.000 
.297*
* 
.353*
* 
.544*
* 
0.010 0.138 
.333*
* 
.368*
* 
.474*
* 
.446*
* 
.259*
* 
.487*
* 
.212* 
27) 
Overeating/ 
binging, 
following 
episodes of 
hypoglycaemi
a 
.184* 
.410*
* 
.227*
* 
.294*
* 
.490*
* 
.264*
* 
.329*
* 
.338*
* 
.212* 0.152 
.569*
* 
0.108 
.328*
* 
.329*
* 
.176* 
.468*
* 
.280*
* 
.516*
* 
0.146 
.290*
* 
.297*
* 
1.000 
.472*
* 
.193* 
-
0.088 
.416*
* 
.291*
* 
.188* .222* .220* 
.293*
* 
.236*
* 
.265*
* 
28) Pressure 
from my 
health care 
professionals 
.340*
* 
.502*
* 
0.170 
.372*
* 
.618*
* 
.527*
* 
.290*
* 
.429*
* 
.369*
* 
0.146 
.529*
* 
.197* 
.430*
* 
.208* 
.247*
* 
.331*
* 
.293*
* 
.458*
* 
0.112 
.382*
* 
.353*
* 
.472*
* 
1.000 
.287*
* 
0.081 
.305*
* 
.314*
* 
.387*
* 
.360*
* 
.305*
* 
.381*
* 
.344*
* 
.298*
* 
29) Maternal 
concern with 
weight and 
shape 
.306*
* 
.297*
* 
0.064 
.306*
* 
.302*
* 
.198* 0.170 0.111 
.427*
* 
.186* .185* .200* .191* 0.152 
.313*
* 
0.133 
.247*
* 
.306*
* 
0.146 
.392*
* 
.544*
* 
.193* 
.287*
* 
1.000 0.086 0.010 
.285*
* 
.501*
* 
.438*
* 
.452*
* 
.295*
* 
.555*
* 
0.154 
30) A distorted 
body image .271*
* 
0.032 
.294*
* 
.224*
* 
-
0.016 
0.130 0.153 
-
0.043 
0.120 
.297*
* 
0.083 
.413*
* 
-
0.020 
0.103 
.341*
* 
0.028 0.030 
-
0.063 
-
0.158 
.245*
* 
0.010 
-
0.088 
0.081 0.086 1.000 0.091 
-
0.002 
0.061 .195* 0.036 
.361*
* 
-
0.008 
.201* 
31) 
Resentment of 
having 
Diabetes 
0.087 .211* 
.286*
* 
0.101 .215* 
.285*
* 
.181* 
.236*
* 
.185* 
.253*
* 
.524*
* 
.189* 0.168 
.451*
* 
0.101 
.380*
* 
.328*
* 
.524*
* 
.256*
* 
0.136 0.138 
.416*
* 
.305*
* 
0.010 0.091 1.000 
.227*
* 
0.041 .213* 0.086 0.157 0.167 
.401*
* 
33) 
Disagreement 
with the way 
my parents 
dealt with my 
Diabetes 
0.151 
.343*
* 
0.108 0.120 
.296*
* 
0.167 0.096 
.431*
* 
.472*
* 
.176* 
.351*
* 
0.080 .186* 
.311*
* 
.218* 
.311*
* 
.336*
* 
.271*
* 
.297*
* 
0.151 
.333*
* 
.291*
* 
.314*
* 
.285*
* 
-
0.002 
.227*
* 
1.000 
.562*
* 
.546*
* 
.506*
* 
.173* 
.586*
* 
0.133 
34) I felt I 
couldn’t talk 
to my parents 
.369*
* 
.243*
* 
0.085 
.284*
* 
.347*
* 
.279*
* 
0.162 
.270*
* 
.588*
* 
0.087 .184* 0.094 
.263*
* 
.245*
* 
.199* .196* 
.359*
* 
.255*
* 
.182* .220* 
.368*
* 
.188* 
.387*
* 
.501*
* 
0.061 0.041 
.562*
* 
1.000 
.699*
* 
.693*
* 
.223* 
.586*
* 
0.094 
35) Family 
dysfunction .334*
* 
.306*
* 
0.149 
.317*
* 
.243*
* 
.211* .183* 
.337*
* 
.844*
* 
.236*
* 
.289*
* 
0.079 
.285*
* 
.347*
* 
.268*
* 
.314*
* 
.389*
* 
.252*
* 
.250*
* 
.230*
* 
.474*
* 
.222* 
.360*
* 
.438*
* 
.195* .213* 
.546*
* 
.699*
* 
1.000 
.660*
* 
.267*
* 
.552*
* 
0.102 
36) Feeling 
that I was not 
an individual 
within my 
family 
.239*
* 
.222* .176* 
.293*
* 
.324*
* 
0.111 0.165 
.343*
* 
.577*
* 
0.092 .204* 0.144 .182* 
.267*
* 
.253*
* 
.223* 
.360*
* 
0.166 .194* .206* 
.446*
* 
.220* 
.305*
* 
.452*
* 
0.036 0.086 
.506*
* 
.693*
* 
.660*
* 
1.000 .204* 
.639*
* 
0.121 
38 I didn’t like 
the way my 
body looked 
.515*
* 
.292*
* 
.307*
* 
.682*
* 
.470*
* 
0.140 
.665*
* 
.228*
* 
.268*
* 
.510*
* 
.453*
* 
.434*
* 
.240*
* 
.265*
* 
.772*
* 
.212* .173* 
.316*
* 
0.127 
.778*
* 
.259*
* 
.293*
* 
.381*
* 
.295*
* 
.361*
* 
0.157 .173* .223* 
.267*
* 
.204* 1.000 0.131 .212* 
39) My family 
was very rigid 
.219* 
.416*
* 
0.121 0.129 
.322*
* 
.286*
* 
.189* 
.375*
* 
.478*
* 
0.146 
.304*
* 
0.067 
.330*
* 
.275*
* 
.179* .223* 
.279*
* 
.316*
* 
.176* .207* 
.487*
* 
.236*
* 
.344*
* 
.555*
* 
-
0.008 
0.167 
.586*
* 
.586*
* 
.552*
* 
.639*
* 
0.131 1.000 .187* 
40) A 
disturbed 
attitude to 
food 
0.093 
.271*
* 
.246*
* 
0.157 
.262*
* 
.373*
* 
0.151 
.238*
* 
0.029 
-
0.042 
.355*
* 
.429*
* 
0.130 0.118 0.130 0.123 0.038 
.239*
* 
0.084 0.163 .212* 
.265*
* 
.298*
* 
0.154 .201* 
.401*
* 
0.133 0.094 0.102 0.121 .212* .187* 1.000 
Pearson Correlation is significant at the 0.05 level  
** Pearson Correlation is significant at the 0.01 level (2-tailed). 
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